Text

Rev 2 to PP&L SSES Odcm.
	ML17164A589
Person / Time
Site:	Susquehanna
Issue date:	01/20/1995
From:	Shank K; PENNSYLVANIA POWER & LIGHT CO.
To:	;
Shared Package
ML17164A588	List: ML17164A587; ML17164A589; ML18030A573;
References
	PROC-950120, NUDOCS 9502210309
	Download: ML17164A589 (172)
	v • d • e

PENNSYLVANIA POWER 5 LIGHT COMPANY-"=.".

SUSGUEHANNA STEAM ELECTRIC. STN'ZON...,-.."

OFFSITE DOSE CALCULATION MAtwtUAL ":::"

jl Revision 2 wA

> ~ ~

a i Prepared By Date Reviewed By Date / /

Supervisor-Environmen al Services Reviewed By S Db Nuc ear Date i i5'pproved By Date Nanager-Nuclear Technology Itmlmmlll II<SIIIIIIE 9'5022l0309 950215 PDR ADOCK 05000387 R PDR

SUNSLRY OF ODCN CHANGES Changes other than those of a minor, editorial nature are suttittarized below.

Section 10.3 (Evaluation and Honitoring Criteria for Effluent Pathways) has been expanded to show specific plant systems evaluated in the categories NOT AN EFFLUENT PATHNY (listed in new Table 8), and INSIGNIFICANT EFFLUENT PATfNAY (listed in new Table 9). References for the bases for these evaluations are included for each system in the Table. Unless otherwise listed, most of the. systems were evaluated in PPEL Calculation EC-ENVR-1008, which .was performed in response to NRC Open Item 91-10-01-07. This revision to the ODCH is submitted in response to NRC Open Item 91-10-01-0&.

2. Equations 7, 8,'7 and 18 are revised to show the Gamma Shielding Factor (S,). This factor has always been used in GASPAR calculations (NRC code referenced in the ODCM) for whole body and skin dose from noble gas effluent: the equations are revised to be consistent with the application of the GASPAR code. The Gaaea Shielding Factor ( 0.7 for the Maximally-Exposed member of the Public) is taken from Reg. Guide 1.109 Table E-15.

3. Sections 8.1 and 8.3 have been revised to reflect the current state of liquid and solid radwaste processing, respectively. Figures 1, 3 and 4 have also been updated to show changes to'iquid and solid radwaste processing systems, including vendor interfaces,'ased on information from Effluents Management.

Rev. 2

TABLE OF CONTENTS APPROVAL REVISION 85K MAIS ~EF

1.0 INTRODUCTION

........;...................,..... 10/29/93 3/11/94 2 2/5/92 2/21/92 3 11/9/93 3/11/94 4 2/5/92 2/21/92 2.1 WATERBORNE EFFLUENT MONITORS.............. 4 2/5/92 2/21/92 5 12/11/89 12/11/89 6 2/5/92 2/21/92 7 12/11/89 12/11/89 8 12/11/89 12/11/89 2.2 AIRBORNE EFFLUENT MONITORS..............-- 9 2/5/92 2/Zl/92 10 12/11/89 12/11/89 Il 12/11/89 12/11/89 12 ll/21/92 ll/25/92 3.0 WATERBORNE EFFLUENT CONCENTRATION HEASUREMENTS 13 2/5/92 2/21/92 14 2/5/92 2(21/92 4.0 AIRBORNE EFFLUENT DOSE RATES ................. 15 2/5/92 2/21/92 4.1 NOBLE GASES............................... 15 1/16/95 1/20/95 4.2 RADIONUCLIDES OTHER THAN NOBLE GASES...." 16 1/16/95 1/20/95 17 2/11/92 2/21/92 18 2/5/92 2/21/92 19 12/Il/89 12/11/89 20 12/1/92 12/4/92 5.0 INDIVIDUAL DOSE DUE TO WATERBORNE EFFLUENT.... 21 10/29/93 3/11/94 5.1 FISH PATHWAY LIQUID EFFLUENT DOSE CALCULATION HETHODOLOGY................... 22 2/18/94 3/ll/94 5.2 POTABLE WATER PATHWAY EFFLUENT DOSE CALCULATION METHODOLOGY................... 23 1 l(9/93 3/ll(94 5.3 SHORELINE EXPOSURE PATHWAY................ 24 11/9/93 3/ll/94 5.4 PROJECTED DOSE FROM LIQUID EFFLUENT....... 24 ll/9(93 3(ll/94 25 '/18/94 3/ll/94 .

26 11/9/93 3/ll(94 6.0 INDIVIDUAL DOSE DUE TO AIRBORNE EFFLUENT...... 27 10/29/93 3/ll/94 6.1 NOBLE GASES.................-....--.--.--- 27 10/29/93 3/11/94 6.2 RADIONUCLIDES OTHER THAN NOBLE GASES...... 28 10/29/93 3/11/94 29 10/29/93 3/11/94 7.0 TOTAL DOSE.......... 0 0 ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ 30 1/16/95 1/20/95 31 10/29/93 3/11/94 8.0 OPERABILITY OF WASTE TREATHENT SYSTEMS........ 32 10/29/93 3/ll/94 8.1 LIQUID WASTE TREATMENT.................... 32 1/16/95 1/20/95 33 1/16/95 1/20/95 8.2 GASEOUS WASTE TREATHENT................... 34 1/16/95 1/20/95 35 1/16/95 1/20/95 8.3 SOLID WASTE TREATMENT .................... 36 1/16/95 1/20/95 37 1/16/95 1/20/95 OAT Vev. 2

APPROVAL REVISION ZM ~~T ~OAT 9.0 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM. 42 1/16/95 ~

1/20/95 9.1 DEFIt)ITIONS................................ 42 1/16/95 1/20/95 9.2 MONITORING PROGRAM......................'.;. 42 '/16/95 1/20/95 9.3 CENSUS PROGRAM............................ 43 1/16/95 1/20/95 9.4 INTERLABORATORY COMPARISON PROGRAM........ 44 1/16/95 1/20/95 45 1/16/95 1/20/95 10.0 DOSE ASSESSMENT POLICY STATEHENTS............ 53 1/16/95 1/20/95 10.1 SELECTION OF ANALYSIS RESULTS FOR 53 1/16/95 1/20/95 DOSE CALCULATIONS 10.2 ASSIGNMENT'F RELEASES TO THE REACTOR 53 1/16/95 1/20/95 UNITS 10.3 EVALUATION AND MONITORING CRITERIA FOR 53 1/16/95 1/20/95 EFFLUENT PATHWAYS 10.4 FLOW FROM THE SGTS VENT WHEN THE SYSTEM 54 1/16/95 1(20/95 IS NOT IN USE 10.5 ODCM SETPOINTS ARE UPPER LIHIT VALUES 55 1/16/95 1/20/95 10.6 DEFINITION OF "APPROPRIATE TREATHENT" 55 1/16/95 1/20/95 FOR LIQUID WASTES 10.7 MONITOR LINE-lOSS CORRECTIONS 57 1/)6/95 1/20/95 10.8 SELECTION OF DATA FOR DETERHINATION OF 57 1/16/95 1/20/95 DOSE RATE COMPLIANCE 10.9 LOW-LEVEL RADIOACTIVITY IN THE SEWAGE 58 1/16/95 1/20/95 TREATMENT PLANT 11.0 ODCH REVIEW AND REVISION CONTROL............. 60 1(16(95 1/20/95 APPENDIX A - SAMPLE CALCULATIONS OF ODCH PARAMETERS........ A-1 2/5/92 2/21/92 I A-2 2/5/92 2/21/92 A-3 12/ll/89 12/ll/89 A-4 2/5/92 2/21/92 A-5 10/29/93 3/ll/94 A-6 10/29/93 3/ll/94 A-7 10/29/93 3/ll/94 A-8 10/29/93 3/ll/94 A-9 2/5/92 2/21/92 A-10 2/5/92 2/21/92 A-11 10/29/93 3/ll/94 A-12 10/29/93 3/11/94 A-13 10/29/93 3/il/94 APPENDIX B REPORTING REQUIREHENTS............... 8-1 12/11/89 12/)1/89 8-2 10/29/93 3/ll/94 8-3 12/11/89 12/ll/89 8-4 12/11/89 12/11/89 OAT Rev. 2 I

~YE '0E APPROVAL REVISION ELK APPENDIX C - SITE SPECIFIC INFORMATION USED BY GASPAR CODE...............:.. C-1 12/11/89 12/11/89 APPENDIX D - SITE SPECIFIC INFORMATION USED BY LADTAP CODE.................. D-1 10/10/94 10/14/94 Rev. 1

APPROVN. REVISION MSK M53.-

Radiological Effluent Objectives and Standards.. 3 11/9/93 3/11/94 2 Dose Factors for Noble Gases ............'....... 18 2/5/92 2/21/92 Sample Annual Average Relative Concentrations and Deposition Rates...:.;...................... 19 11(9/93 3(11(94'ose Factors for Inhalation, Ingestion and Ground Exposure Pathways: Radionuclides Other Than Noble Gases................................ 20 12/1/92 12/4/92 5-la Dose Factors for Fish Pathway, Haximum Hypothetical Adult (2pp).......................5-'a(1,2) 10/10/94 '0/14/94 5-lb Dose Factors for Fish Pathway, Haximum Hypothetical Teen (2pp)........................5-1b(1,2) 10/10/94 10/14/94 5-lc Dose Factors for Fish Pathway, Haximum Hypothetical Child (2pp).......................5-1c(1,2) 10/10/94 10/1 5-2a Dose Factors for Potable Water Pathway, Haximum Hypothetical Adult (2pp).......................5-2a(1,2) 10/29/93 3/ll/94.

5-2b Dose Factors for Potable Mater Pathway, Haximum Hypothetical Teen (2pp)........................5-2b(1,2) 10/29/93 3/11/94 5-2c Dose Factors for Potable Water Pathway, Haximum Hypothetical Child (2pp).......................5-2c(1,2) 10/29/93 3/ll/94 "

5-2d Dose Factors for Potable Mater Pathway, Haximum Hypothetical Infant (2pp)......................5-2d(1,2) 10/29/93 3/11/94, 5-3 Radioactive Decay Constants.....................5-3 10/29/93 3/11/94 5-4 Dilution Factors and Transit Times for SSES Effluents to Danville, PA......................5-4(1,2) 10/29/93 3/11/94 5-5 Dose Factors for Shore Exposure Pathway, All Age Groups (2pp)...................................5-5(1,2) 10/29/93 3/11/94 5-6a Composite Dose Factors: Maximum Hypothetical Adult (2pp}....................................5-6a(1,2) 10/10/94 10/14/94 5-6b Composite Dose Factors: Haximum Hypothetical '

Teen (2pp)'.....................................5-6b(1,2) 10/10/94 10/14 Rev. 1 iv OAT

APPROVAL REVISION TABL 5-6c Composite Dose Factors: Maximum Hypothetical Child (2pp)....................................5-6c(1,2) 2/18/94 3/11/94 5-6d Mater Ingestion 'Dose Factors: Maximum Hypothetical Infant (2pp).... .--...--.-........5-6d(1,2) 2/18/94 3/11/94 6 Operational Radiological'nvi ronmental Monitoring Program........... ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ 48 1/16/95 1/20/95 49 1/16/95 1/20/95 50 1/16/95 1/20/95 7 Detection Capabilities for Environmental Sample Analysis................................. 51. 1/16/95 1/20/95 52 1/16/95 1/20/95 8 Systems Classified as Not an Effluent Pathway... 61 1/16/95 1/20/95 9 Systems Classified as Insignificant Effluent Pathway......................................... 62 1/16/95 1/20/95 B-1 Radiological Environmental Monitoring Program Annual Summary.......................,.......... B-3 12/11/89 12/11/89 B-2 Reporting Levels for Nonroutine Operating R eports......................................... 'B-4 12/11/89 3/11/94 D-1 Dilution Factors and Transit Times for SSES Effluents to Danville, PA....................... D-l 11/9/93 3/ll/94

LIST OF FI6URES APPROVAL REVISION 85K MSK MHK Figure 1 Liquid Radwaste System Flow Diagram.......................... 38 '/16/95 1/20/95 Figure 2 Offgas and Recombiner System Flow Diagram..................,........ 39 1/16/95 1/20/95 Figure 3 Solid Waste Management System Flow Diagram.........................- 40 1/16/95 1/20/95 Figure 4 SSES Dry Contaminated Maste Processing............................ 41 1/16/95 1/20/95 Figure 5 Environmental Monitoring Locations Mithin One Nile of SSES............... 46 1/16/95 1/20/95 Figure 6 Environmental Monitoring Locations Greater than One Hile from SSES....... 47 1/16/95 1/20/95 DAT vi Rev. 2

The purpose of this manual is to provide the parameters and methodology to be used in calculating offsite doses and effluent monitor setpoints for the Susquehanna Steam Electric Station, Units 1 and 2. Included are methods for determining maximum individual, whole-body, and organ doses due to waterborne and airborne effluents to ensure compliance with the dose limitations in the Technical Specifications. methods are included for performing dose calculations to ensure compliance with the waterborne and airborne treatment system operability sections of the Technical Specifications. This manual includes the methods used for determining quarterly individual doses-for inclusion in Annual Effluent and Maste Disposal Reports.

The dose models consider two release modes: airborne and waterborne.

All airborne effluents are treated as ground-level releases. Dose to each of the seven organs listed in Regulatory Guide 1.109 (bone, liver, total body, thyroid, kidney, lung, and GI-LLI) are computed based on the individual nuclide composition of the effluent. The largest of the doses are compared to 10 CFR 50, Appendix I design objectives.

Liquid effluents discharged into a river undergo mixing prior to consumption as either potable water or through the fish pathway. For releases to the Susquehanna River, river model dilution factors are used-Doses to'he seven critical organs are determined from individual nuclide contributions and are compared to the 10 CFR 50 Appendix I design objectives. Compliance with the 10 CFR 20 maximum permissible concentrations is done on a batch-by-batch basis prior to discharge.

This manual discusses the methodology to be used in determining effluent monitor alarm/trip setpoints to be used, to ensure compliance with the instantaneous release rate limits in the Technical Specifications.

Hethods are described for determining the annual cumulative dose to a real individual from liquid effluents, gaseous effluents, and direct raPiation for critical organs to ensure compliance with 40 CFR 190 limits. The calculational methodology for doses are based on models and

. data that make it unlikely to substantially underestimate the actual

exPosure of an individual through any of the appropriate pathways.

The Radiological Environmental Honitoring Program is described. in Section 9.0 of the manual, which includes the annual land use census survey and interlaboratory comparison program.

It is the responsibility of the Superintendent of Plant-Susquehanna to ensure that this manual is used in performance of the surveillince .

requirements and for compliance with the limiting conditions of.

operations stated in the Technical Specifications. It is the responsibility of the Hanager-Nuclear Technology to ensure adequacy and correctness of calculational approaches.

.ABLE I RADIOLOGICAL EFFLUENT OBJEC IVES 5 STAND DS 10 CFR 50 40 CFR 190 10CFR 20 APPENDIX I STANDARDS* STANDARDS**

DESIGN OBJECTIVES (BOTH REACTOR (BOTH REACTOR (PER REACTOR UNIT) UNITS COMBINED) UNITS COMBINED)

WATERBORNE EFFLUENTS all Pathways Dose Dose to Total to Body From any Organ From all Pathways '0 mrem/year 3 mrem/year AIRBORNE NOBLE GAS EFFLUENTS Dose Rate to Total Body 500 mrem/year Dose Rate to Skin 3000 mrem/year Gamma Dose in Air 10 mrad/year Beta Dose in Air 20 mrad/year Dose to Total Body of an Individual 5 mrem/year Dose to Skin of an Individual- 15 mrem/year AIRBORNE RADIOIOOINES AND PARTICULATES Dose Rate to any Organ 1500 mrem/year Dose to any Organ From all Pathways- 15 mrem/year TOTAL'RANIUM FUEL CYCLE Dose to Mhole Body From all Fuel Cycle Operations 25 mrem/year Dose to Thyroid From all Fuel Cycle Operations 75 mrem/year Dose to any Other Organ From all Fuel Cycle Operations 25 mrem/year

As currently reflected in Technical Specification 3.11.4.

- Technical Specification limits set to ensure compliance with 10 CFR 20 limits

2.0 ~SETPO NTS 2.1 M RBORN F tj NT MONI S S CAT 0 3.3.

- THE RADIOACTIVE LIQUID EFFLUENT NNITORING INSTRUMENTATIQN SHQMN IN TABLE 3.3.7.10-1 SHALL BE OPERABLE MITH THEIR ALARM/TRIP SETPOINTS SET TO ENSURE THAT THE LIMITS OF SPECIFICATION 3.11.1.1 ARE NOT EXCEEDED-. THE ALARM/TRIP SETPOINTS OF THESE CHANNELS SHALL BE DETERMINED IN ACCORDANCE MITH THE METHODOLOGY AND PARAMETERS DESCRIBED IN THE OFFSITE DOSE CALCULATION MANUAL (ODCM).

A gross radioactivity monitor providing automatic termination of liquid effluent releases is present on the liquid radwaste effluent line. Flow rate measurement devices are also present on the liquid radwaste effluent line and the discharge line (cooling tower blowdown). Precautions, limitations, and setpoints applicable to the operation of the Susquehanna Steam Electric Station liquid effluent monitors are provided in the applicable plant procedures. Setpoint values are to be calculated to ensure that alarm and trip actions occur upon approaching the MPC limits of 10 CFR 20, Appendix 8, Table II, Column 2 at the release point to the unrestricted area. The calculated alarm and trip action setpoints for the liquid effluent monitor and each flow measurement device must satisfy the following equation:

F+ f where:

C - the liquid effluent concentration limit implementing 10 CFR 20 for unrestricted areas (uCi/ml).

c - the setpoint (uCi/ml) of the radioactive liquid effluent monitor measuring the radioactivity concentration in the effluent line prior to dilution and subsequent release.

the radwaste discharge flow.setpoint, in volume per unit time, in the same units as F.

F = the dilution (cooling tower blowdown) water flow setpoint as measured prior to injection of the radwaste, in volume per unit time Radioactive liquid effluents from the SSKS are only discharged as batch releases and are discharged through the liquid radwaste effluent line. The radioactive liquid waste stream is diluted .in the plant discharge (cooling tower blowdown) line prior to entering the Susquehanna River. The limiting batch release concentration (c}

corresponding to the liquid radwaste effluent line monitor setpoint is calculated from the above expression. The MPC value used for the liquid effluent concentra'tion limit (C} in the above expression for the liquid radwaste effluent line monitor setpoint is 1 x 1Q uCi/ml or the actual MPC for identified mixtures. Therefore, the expression for determining the setpoint on the liquid radwaste effluent line monitor becomes:

c < (1 x 10 j f (uC1/ml) (Eq. 2)

In order to prevent spurious isolations by the LRH effluent radiation monitor, the setpoint concentration, (c) can be defined as.

c X(A) where (A) is the actual tank concentration and X p l The setpoint dilution factor must then be some factor, Y (where YP X), times the minimum dilution factor.

f m MPC where j +

f f

m the minimum dilution factor.

E+< - XE f HPC where f +f f the outpoint dilution factor The requirements of Equation (2) are then met as follows:

Y(A) HPC F+

f fiI Since, by definition, Y > X and Y(A) > X(A), then:

c X(A) <HPC + f f

The setpoint concentration (c) can be converted to a setpoint count rate by use of the monitor calibration factor.

(Eq- 3)

Setpoint (cpm) + Background (cpm)

Cal. Factor (uCi/ml per cpm)

The setpoint for the dilution water flow (cooling tower blowdown) is 5000 gpm from both cooling tower basins. The setpoint for the LRM discharge flow can then be determined from:

F+ f ee

~YQ (Eq. 4) f NPC Sample calculations for determining the release concentration limits and setpoints are given in Section A.lel of Appendix A.

The Service Mater System provides screened water from the cooling tower basin for cooling plant systems and equipment. The Residual Heat Removal (RHR) Service Mater System provides water from the

~

~vrv

~ngineered Safeguard Service Mater (ESSM) spray pond to the exchangers. In post-accident conditions, RHR Service Mater can supply water for vessel and containment flooding. The Service Water and RHR Service Mater Systems are not normal pathways for liquid effluents. Radiation monitors are in place on these systems to provide indication of leaks across heat exchangers into the service water. The high radiation setpoints for these monitors axe set at 2E-5 uCi/cc cesium-137 equivalent. 'onsidering the radionuclides predominant in SSES liquid effluents, e.g., Co-58, Co-60, Fe-59, Mn-54 and Cr-51, use of a setpoint based on the Cs-137 HPC's conservative based on the following parameters:

1) photon abundance (85%)

2) magnitude of applicable HPC (2E-5 uCi/cc}-

Because Service Mater I RHR Service Mater are not normal release pathways for liquid effluents, no credit should be taken for possible dilution scenarios. All service water should be maintained below 2E-5 uCi/cc Cs-137 equivalent.

In order to minimize the chance of a change in the background of a monitor masking a significant trend in monitored activity, the alarm setpofnts for the Service Mater and RHR Service Mater monitor s are determined as follows:

a. When moni tor background>> (2E-5)/Cal. Factor:

Hl RAD Setpoint 0.5 Background + (2E-5)/Cal. Factor DOWNSCALE or LOM RAD Setpoint ~ 0.5 Background

b. Mhen monitor background>(2E-5)/Cal. Factor:

HI RAD Setpoint Background + 0.5 (2E-5)/Cal. Factor

'OOMNSCALE or LOM RAD Setpoint ~ Background - 0.5 (2E-5)/Cal. Factor Where:

Setpoint Alarm threshold value to be entered into monitor (cps for Service Water, cpm for RHR Service Mater).

Background Monitor background at most recent background determination (cps for Service Water, cpm for RHR Service Water).

(ZE-5) Cs-137 Maximum Permissible Concentration (uCi/ml).

Cal. Factor Monitor response factor per unit Cs-137 concentration determined during most recent

calibration (uCi/ml per cps for Service Water, uCi/ml per cpm for RHR Service Mater).

The ALERT RAD setpoints for the RHR Service Mater monitors are f

maintained at 80K of the applicable HI RAD setpoint (cpm).

2.2 ORNE FF U HON ORS SPECIFICATION 3.3.7.11 - THE RADIOACTIVE GASEOUS EFFLUENT HONITORING INSTRUMENTATION CHANNELS SHOWN IN TABLE 3.3.7.11-1 SHALL BE OPERABLE THEIR ALARM/TRIP SETPQINTS SET TO ENSURE THAT THE LIHITS OF 'ITH SPECIFICATION 3.11.2.1 ARE NOT EXCEEDED. THE ALARH/TRIP SETPOINTS OF THESE CHANNELS SHALL BE DETERMINED IN ACCORDANCE WITH THE METHODOLOGY AND PARAHETERS IN THE ODCH.

Noble gas activity monitors, iodine samplers and monitors, and particulate samplers and monitors are present on the reactor building ventilation system (Units 1 and 2), the turbine building ventilation system (Units 1 and 2), and the standby gas treatment system exhaust vents. Effluent system flow rate and sampler flow rate are measured on all of the systems allowing the vent monitor microprocessor to calculate release rates based on measured flow rates. Precautions, limitations, and setpoints applicable to the operation of the SSES airborne effluent monitors are provided in the applicable plant procedures. Setpoints are conservatively established for each effluent monitor so that the instantaneous dose rates corresponding to annual dose limits in 10 CFR 20.105 for unrestricted areas will not be exceeded.

The general methodology for establishing plant ventilation airborne effluent monitor setpoints is based upon vent release rates derived from site-specific meteorological dispersion conditions, vent flow

rates, and measured or expected radionuclide mixtures in the gaseous effluents. The vent release rate can then be converted to vent concentrations for input as setpoints for the'applicable detectors.

Since the vent monitors are programmed to calculate concentrations

, of iodine-131 and particulate being released based on the rate of

'ccumulation of activity on the filters, setpoints can be established for the iodine and particulate channels.

The following method fs'sed for calculating vent monftor high radiation alarm setpoints:

An isotop~c mixture is selected for the detector in question, if applicable. Noble gas and partfculate detector setpoints are based on actual isotopic mixtures obtained from vent sample analysis or h

the FSAR/FES expected release mixtures ff actual samples do not contain sufficient detectable activity to accurately estimate the mixtures. The assumed isotopic mixtures are periodically reviewed to verify that they remain representatfve of plant effluents.

2. The selected noble gas or particulate mixture is used in the GASPAR program run to calculate the associated doses. The total source term (total curfes used for the calculatfon) does not matter as long as the proper nucl f des are present f n the relative proportions indicated in sample analysis data or FSAR/FES tables.

For the iodine-131 setpoint, any release total for I-131 can be entered. The highest calculated annual average relative 10

concentrations (X/gs) at the site boundary are used

'\

for these GASpAR calculations.

3. The following ratio concept is used to calculate a release rate limit for the assumed mixture (or I-131)'.

Calculated Dose ota GASPAR Source mrem erm m Dose Rate Limit mrem/ r tsng e ease te 'r The limiting release rate of the assumed mixture (or I-131) can therefore be calculated:

Limiting Release (Ci/yr)

Total GASPAR Source Term Ci Dose Rate Limit mrem/ r a cu ate ose, mrem For the noble gas setpoint, the. calculated. whole body and skin dose rates via the plume pathway are subject to the 10 CFR 20-derived limits of 500 and 3000 mrem/yr, respectively. The whole-body dose rate limit is usually most restrictive. For particulates and for iodine-131, the maximum calculated organ dose rate via the inhalation pathway is subject to the limit of 1S00 mrem/yr.

4. The limiting release rates are converted to limiting vent concentrations using high limit vent flow rates.

Limiting Vent Concentration, uCi/cc imitino Release Rate C 6uiC (Eq. 6)

(5.26E5 min/yr) (Vent Flow Rate, cc/min)

Sample calculations of waterborne and airborne effluent monitor setpoints are presented in Section A.1.2 of Appendix A.

Vent flow rates and sample flow rates are monitored and recorded for each of the five SSES release points. The measured flow rates are used to calculate vent concentrations and release rates. Flow channel setpoints are set at approximately lOX and 90K of the calibrated sensor ranges to provide indication of possibly abnormal flow rates.

SPECIF CATION 3. 6 - THE CONCENTRATION OF HYDROGEN OR OXYGEN IN THE. HAIN CONDENSER OFFGAS TREATMENT SYSTEM SHALL BE LIMITED TO LESS THAN OR EQUAL TO 4X BY VOLUME.

Hydrogen recombiners are used at SSES to maintain the relative concentration of components of potentially explosive gas mixtures outside the explosive envelope. The main condenser offgas treatment system explosive gas monitoring system (offgas hydrogen analyzers) have setpoints to alarm at 1X and 2X hydrogen.

'SPEC FICATION 3. 7 - The radioactivity rate of the'noble gases Kr-85m, Kr-87, Kr-88, Xe-133, Xe-135 and Xe-138 measured at the motive steam jet condenser discharge shall be limited to less than or equal to 330 millicuries/second.

The main condenser offgas pre-treatment monitor provides indication of offgas activity prior to input to the holdup system. Alarm setpoints are based on the Tech. Spec. 3.11.2.7 noble gas release rate limit of 330 millicuries/second or less at the motive steam jet condenser discharge.

12

'0 W U C S C 3 - -

THE CONCENTRATION OF RADIOACTIVE MATERIAL RELEASED IN LIQUID EFFLUENTS TO UNRESTRICTED AREAS (SEE FIGURE 5-1.3-1)

SHALL BE LIMITED TO THE CONCENTRATIONS SPECIFIED IN 10 CFR PART 20, APPENDIX B, TABLE II, COLUMN 2 FOR RADIONUGLIDES OTHER THAN DISSOLVED OR ENTRAINED NOBLE GASES. FOR DISSOLVED OR ENTRAINED NOBLE GASES, THE CONCENTRATION SHALL BE LIMITED TO THE CONCENTRATIONS SPECIFIED IN TABLE 3.11.1.1-1.

Liquid batch releases are controlled individually and each batch release is authorized based upon sample analysis and the existing dilution flow in the discharge line. The methods for sampling and analysis of each batch prior to release are given in the applicable plant procedures. A release rate limit is calculated for each batch based upon analysis, dilution flow and all procedural, conditions being met before it is authorized for release.

Table 3.11.1-1 mentioned in Specification 3.11.1.1 contains the following "Maximum Permissible Concentrations of Dissolved or Entrained Noble Gases Released From the Site to Unrestricted Areas in Liquid Waste":

~Nu 1 ide PC u m Kr-85m 2E-4 Kr-85 5E-4 Kr-87 4E-5 Kr-88 9E-5 Ar-41 7E-5 Xe-131m 7E-4 Xe-133m 5E-4 Xe-133, 6E-4 Xe-135m 2E-4 Xe-135 2E-4 I

These values were computed using Equation 20 of ICRP2 (1959), adjusted for infinite cloud submersion in water, with R equal to 0.01 rem/week, ko t'V 13 C r.T=

the density of water equal to 1.0 gm/caP, and Pw/Pt equal to 1.0, where Pw/Pt is stopping power of water. relative to tissue, and R is the dose rate limit for total body exposure. The HPC value for other liquid effluents is the actual HPC for identified mixtures, or 1E-7 uGi/ml for unidentified mixtures.

The liquid radwaste effluent stream entering the discharge line is monitored and will automatically be terminated if the pre-selected monitor setpoint is exceeded as described in Section 2.1.

Additional monthly and quarterly analyses shall be performed in accordance with Table 4.11-1 of the SSES Technica1 Specifications.

A DAT 14

4.0 ORN FF U NT 50SE RA S SP FICATION 3..1. THE DOSE RATE DUE TO RADIOACTIVE HATERIALS RELEASED IN GASEOUS EFFLUENTS FROM THE SITE (SEE FIGURE 5.1.3-1) SHALL. 'E LIMITED TO THE FOLLOMING:

a. FOR NOBLE GASES: LESS THAN OR EQUAL TO 500 HREH/YR TO THE TOTAL BODY AND LESS THAN OR EQUAL TO 3000 HREH/YR "TO THE SKIN, AND

b. FOR IODINE-131, FOR TRITIUH, AND FOR ALL RADIONUCLIDES IN PARTICULATE FORH MITH HALF-LIVES GREATER THAN 8 DAYS: LESS THAN OR EQUAL TO 1500 KAREN/YR TO ANY ORGAN (INHALATION PAT%AY ONLY) ..

4.1 ~NQB AE S Noble gas activity monitor setpoints are established at release rates which permit some margin for corrective action to be taken before exceeding offsite'dose rates corresponding to the 10 CFR 20 annual dose limits as described in Section 2.2. The methods for sampling and analysis of continuous ventilation releases are given in the applicable plant procedures. The dose rate in unrestricted areas due to radioactive materials released in airborne effluents may be determined by the following equation for whole body dose:

D - Z (K (X/Q) (Q')(S ) (Eq. 7) 1 and by the following equation for skin dose:

s Z [Li + ((1 11 (Hi)(S<))] (X/Q ~ (Q (Eq. 8) 1 DAT ~

f- Rev. 2 15

where:

V Ki the whole-body dose factor due to gaaaa emissions for each idenfified noble gas radionuclide. (i) (mrem/yr per uCi/m ) from Table. 2.

v the rel ease rate of radi onucl ide ( i ) from vent (v)

(uCi/sec).

(X/g) the highest calculated annual average relative concentration for any area at or beyond the site boundary in an upestricted area from vent release point (v) (sec/m ) such as .from Table 3.

'wb the annual whole-body dose (mrem/yr).

Li the skin dose factor due to the beta emissions for each iden)ified noble gas radionuclide (i) (mrem/yr per uCi/m ) from Table 2.

the air dose factor due to gaaea emissions for each ident)fied noble gas radionuclide (i) (mrad/yr per uCi/m ) from Table 2 (conversion constant of 1.1 converts air dose-mrad to skin dose-mrem).

the annual skin dose (mrem/yr).

the gamma shielding factor (0.7 for maximally exposed individual)

Sample calculations for determining whole body and skin doses from noble gas radionuclides released from the SSES are given in Section A.2. 1 of Appendix A.

4.2 RADIONUC ID S OTH R THAN NO GA S The methods for sampling and analysis of continuous ventilation releases for radioiodines and radioactive particulates are given in the applicable plant procedures. Additional monthly and quarterly analyses shall be performed in accordance with Table 4.11.2.1.2-1 of the SSES Technical Specifications. The dose rate in unrestricted

'reas due to inhalation of radioactive materials released in 0

Rev. 2 ,16

'I airborne effluents may be determined by the following equation for any organ:

0 Z(Rj)(Wv)(qjv) (Eq. 9) where:

Ri the dose rate parameter based on inhalation pathway for radionuclides other than noble ga~es for the inhalation pathway (mrem/yr per uCi/m ) from Table 4.

the highest annual average dispersion parameter for estimating the dose to the3critical receptor; relative concentration (X/g) (sec/m ) for the inhalation pathway, such as from Table 3.

jv the rel ease rate of radionucl ide ( i ) from vent (v)

'uCi/sec).

the annual organ dose (mrem/yr).

Sample calculations for determining doses to critical organs from radionuclides other than noble gases released from the SSES are given in Section A.2.2 of Appendix A.

II 2 17

NABLE 2 bOSE FACTORS FOR NOBLE GASES' Hhole Body Gamma Air Beta A)r Dose Factor Sk1n Dose Factor Dose Factor Dose Factor K L) H N c e c C Kr-83m 7.5&E-02 1.93E+01 2.&BE+02 kr-85m 1.17E+03 1.4&E+03 1.23E+03 1.97E+03 Kr-85 1.61E+01 1.34E+03 1.72E>0) 1.95E+03 Kr-BT 5.92E+03 9.73E+D3 6.17E+03 1.03E+D4 Kr-88 1.4TE+04 2.37E+03 1.52E+D4 2.93E+03 Kr-&9 1.66E+04 .1.01B04 1.73E+04 1.06E+04 Kr-90 1.5&E+04 7.29E<03 143E+04 7.83E~03 Xe-13 1m 9.15E+01 4.7&EIOR 1.5&E+D2 1.11B03 Xe-133m 2.51E+OR 9.94E+02 3.27E+DR 1.48E+03 Xe-133 2.94E+02 3.0&BOR 3.53E+02, 1.05E<03 0 Xe-135m 3.12E+03 7.11BDR 3.36E+03 . 7.39E>02 Xe-135 1.81E+03 1.&6E+03 1.92E+03 2.46E+03 Xe-137 1.42E+03 1.22E+04 1.51E+03 1.27E+04 Xe-138 8.83E+03 4. 13B03 9.21B03 4.75E<03 Ar-41 8.84E+03 2.&9E+03 9.30E+03 3.2&E+03

'jhe listed dose factors are for radionucIides that may be detected $n airborne effluents and der)ved from Table B-1 $ n Reg. Gu)de'.109.

7.56E-O2 ~ 7.56 x 10

TABLE 3 SAMPLE ANNUAL AVERAGE RELATIVE CONCENTRATIONS AND DEPOSITION RATES I

RELATIVE RELATIVE RELATIVE SITE CONCENTRATIONS 'ONCENTRATIONS DEPOSITION DOWNWIND BOUNDARY UNDECAYED/UNDEP ETED DECAYED, DEPL ED RATES

~SECTO QQLE~S sec c ~D WE .78 4.7E-6 3.9E-6 1.4E-8 NE .61 4;9E-.6 4.5E-6 2.8E-8 ENE .53 3.3E-6 3.1E-6 2.7E-8 E .53 1.8E-6 1.4E-6 1.2E-8 ESE .51 2.1E-6 1.8E-6 1.4E-8 SE 2.8E-6 2.5E-6 2.3E-B SSE .34 5.6E-6 4.7E-6 4.0E-8 S .34 8.0E-6 6.6E-6 3.6E-8 SSW .41 1.2E-5 1.0E-5 4.1E-8 SW. .83 6.4E-6 5.7E-6 1.5E-B WSW 1.03 1.3E-5 1.1E-5 1.9E-8 W 1.02 5.7E-6 5.2E-6 1.1E-8 WNM .62 7.0E-6 6.2E-G 1.6E-B NW .65 6.6E-6 5.4E-6 1.7E-8 NlQ .59 6.1E-6 5.8E-6 1.8E-8 N .59 6.3E-6 5.7E-6 2. 1E-.8 a

From SSES 1992 Heteorological Summary, Haliburton NUS Corporation, 5/93.

Site Boundary distances are approximate, and current as of 5/93.

19

TABLE 4 DOSE FACTORS FOR INHALATION, INGESTION AND GROUND EXPOSURE PATHMAYS: RADIONUCLIDES OTHER THAN NOBLE GASES(1) (2)

(1)Reference letter R. K. Barclay to File R9-5: Technical Documentation of Lotus 1-2-3 00CMTAB and TGTHSTR files: Gaseous Dose Factor Calculation using NUREG-0133/Reg. Guide 1.109 Hethodology, PLI 69605, 11/8/91.

(2)Reference letter R. K. Barclay to file Rg-5: Technical Documentation:

ODCNTAB.MK1 Revision 1 Correction of Tritium'in Vegetation Pathway Dose Calculations Factor Algorithms, PLI 72980, I)/24/92.

20

O.D.C.M. MAXIMUM PAlHWAY 00SE FACTORS: RAOIONUCLIDES OTHER THAN NOBLE GASES*

I'OPE: H-3 k'ATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G. I. SKIN ADULT O.DOE+00 O.OOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 TEEN O.DOE+00 0.DOE+00 0.DOE+00 0.00E+QD 0.DOE+00 Q.DOE+00 0.00E+00 O.DOE+00 CHILD 0.00E+00 0.DOE+00 0.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 O.DOE+00 INFANT O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.ODE+00 0.DOE+00 O.QDE+QD GDAT ADULT . O.DOE+00 1.3&E+03 1.3&E+03 1.38E+Q3 1.3&E+03 1.38E+Q3 1.3&E+03 N/A lQLK TEEN O.OOE+00 1.&OE+03 1.&DE+03 I.SOE+03 1.80E+03 I.&DE+03 1.&DE+03 N/A CHILD O.DOE+00 2.&4E+03 2.84E+03 2.84E+03 2.84E+03 2.84E+03 2.84E+03 N/A INFANT O.DOE+00 4.31E+03 4.31E+03 4.3IE+03 4.31E+03 4.31E+03 4.31E+03 H/A COM ADULT O.OOE+00 6.77E+02 6.7?E+02 6.77E+02 6.77E+02 6.77E+02 6.7?E+02 N/A NILK TEEN O.DOE+00 &.&2E+02 &.82E+02 8.82E+02 8.82E+02 8.82E+02 8.82E+02 H/A CHILD O.DOE+00 1.39F+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03 NgA INFANT O.DOE+00 2.11E+03 2.11E+03 Z.IIE+D3 2.11E+03 2.11E+03 2.11E+03 ADULT D.OOE+QO 2.&9E+02 2.89E+02 2.89E+02 2.89E+02 2.89E+02 2.&9E+02 N/A TEEN O.DOE+00 1.72E+02 1.72E+02 1.?ZE&2 1.?2E+02 1.?2E+02 1-72E+02 N/A CHILD 0.00E+00 2.0&E+02 2.0&E+02 2.0&E+02 2.08E+02 2.08E+02 2.0&E+02 N/A INFANT 0.00E+00 0.00E+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 N/A EGTBLE ADULT 0.00E+00 1.82E+03 1.&2E+03 1.&ZE+03 I.S2E+03 1..82E+03 1.82E+03 H/A TEEN O.DOE+00 2. l&E+03 2.1&E+03 2.1&E+03 2.1&E+03 2.18E+03 2.1&E+03 N/A CHILD 0.00E+00 3.42E+D3 3.42E+03 3.42E+03 3.42E+03 3.42E+03 3.42E+03 H/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.DOE+00 O.DOE+00 O.OOE+OD O.DOE+00 H/A TOTAL ADULT 0.00E+00 4.17Et03 4.1?E+03 4.17E+03 4.1?E+03 4.17E+03 4.17E+03 N/A-INGEST. TEEN 0.00E+00 5.03E+03 5.03E+03 5.03E+Q3 5.03E+Q3 5.Q3E+03 5.03E+03 N/A CHILD 0.00E+00 7.&6E+03 7.&6E+03 7.86E+03 7.86E+03 7.86E+03 7.86E+03 N/A INFANT O.DOE+00 6.43E+03 6.43E+03 6.43E+03 6.43E+03 6.43E+03 6.43E+03 N%A 1NHAL. ADULT 0.00E+00 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 H/A TEEN 0.DOE+00 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 N/A CHILD O.DOE+00 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 N/A INFANT 0.00E+00 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.47E+02 N/A

&ON LEV R .OY UNG "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

""*MAXEMUMVALUES FOR PATHMAYS"~*

GROUND: GROUND: GOAT COM TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: INHAL.

0.00E+00 0.00E+00 4.3lf+03 2.11E+03 2.&9E+02 3.42E+03 7.&6E+03 1.2?E+03 PAGE: 4-1

O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*

I'bufOPE: C-14 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G'- I- SKIN GROUND ADULT Q.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 TEEN O.OOE+00 0.00E+00 0.00E+00 0-QOE+00 0.00E+00 0.00E+00 O.OOE+00 Q.QQF+QQ CHILD O.OOE+00 0.00E+00 O.QQE+00 Q.QOE+00 O.QOE+QO O.OOE+00 O.QOE+00 Q.QOE+QQ INFANT Q.OOE+00 O.OOE+QO Q.QOE+00 O.QOE+00 0.00E+00 Q.QOE+00 O.OOE+00. Q.QOE+00 GOAT ADULT 1.69E+0& 3.39E+07 3.39E+07 3.39E+07 3.39E+07 3.39E+07 3.39E+07 N/A HILK TEEN 3.12E+08 6.24E+07 6.24E+07 6.24E+07 6.24E+07 6.24E+07 6.24f+07 H/A CHILD 7.6&E+08 1.54E+08 1.54E+08 1.54E+08 1.54E&8 1.54E+08 1.54E+08 N/A INFANT 1.50E+09 3.21E+08 3.21f+08 3.21E+08 3.21E+08 3.21E+08 3.21E+08 H/A COW ADULT 1.35E+08 2.71E+07 2.71E+07 2.71E+07 2.71E+07 2.71E+07 2.7IE+07 N/A MILK TEEN 2.50E+08 4.99E+07 4;99E+07 4.99E+07 4.99E+07 4.99E+07 4.99E+07 . H/A CHILD 6.14E+08 1.23E+08 1.23E+08 1.23E+08 1.23E+08 1.23E+08 1.23E+08 N/A INFANT 1.20E+09 2.57E+08 2.57E+08 2.57E+08 2.57E+08 2.57E+08 2.57E+08 H/A HEAT ADULT 1.36E+08 2.72E+07 2.72E+07 2.72E+07 2.72E+07 2.72E+07 2.72E+07 N/A TEEN 1.15E+08 2.30E+07 2.30E+07 2.30E+07 2.30E+07 2.30E+07 2.30E+07 H/A CHILD 2.16E+08 4.33E+07 4.33E+07 4.33E+07 4.33E+07 4.33E+07 4.33E+07 N/A INFANT 0.00E+00 0.00E+00 0.00E+00 O.QOE+00 O.QOE+00 0.00E+00 0;OOE+00 N/A ADULT 2.06E+08 4.13E+07 4.13E+07 4.13E+07 4.13E+07 4.13E+07 4.13E+07 H/A TEEN 3.49E+08 6.98E+07 6.9&E+07 6.98E+07 6.9&E+07 6.9&E+07 6.98E+07 N/A CHILD &.53E+08 1.7IE+08 1.71E+08 1.7IE+08 l.71E+08 1.TIE+08 1.71E+08 N/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Q.QOE+00 O.OOE+00 N/A TOTAL ADULT 6.47E+08 1.29E+08 1.29E+08 1.29E+08 1.29E+08 1.29E+08 1.29E+08 N/A NGEST TEEN 1.03E+09 2.05E+08 2.05E+08 2.05E+08 2.05E+08 2.05E+08 2;05E+08 NgA CHILD 2.45E+09 4.90E+08 4.90E+08 4.90E+08 4.90E+08 4.90E+08 4.90E+08 NP, INFANT 2.71E+09 5.7&E+08 5.7&E+08 5.78E+08 5.7&E+08 5.7&E+08 5.7&E+08 H/A XNHAL. ADULT 1.82E+04 3.41E+03 3.41E+03 3.41E+03 3.4IE+03 3.4IE+03 3.41E+03 H/A TEEN 2.60E+04 4.&7E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 H/A CHILD 3.59E+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 H/A INFANT 2.65E+04 5.31E+03 5.31E+03 5.3IE+03 5.31E+03 5.31E+03 5.3IE+03 N/A BON LIV R .BODY THYROID KIDNEY LUNG G. L. SK Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

<<*MAXIMUM VALUES FOR PA HWAYS***

GROUND: GROUND: GOAT COW TOTAL T.B./ORG .. SKIN Q.OOE+00 0.00E+00 MILK: MILK: MEAT: VEGTBLE: .INGEST: IHHAL.

1.50E+09 1.20E+09 2.16E+08 8.53E+08 2.7IF+09 3.59E+04 PAGE:

O.D.C.H. HAXINUH PATHWAY DOSE FACTORS- RADIONUCLIDES OTHER THAN NOBLE GASES*

- a~JTOPE: P-32 PATHWAY AGE GROUP BONE LIVER, T.BQOY 'HYROID KIDNEY LUNG G.I. SKIN.

ADULT D.DOE+00 0;DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 Q.DOE+00 O.DOE+00 TEEN O.DOE+00 O.DOE+DO O.DOE+DO O.DOE+00 0.DOE+00 Q.OQE+QD O.DOE+00 Q.ODE+00 CHILD .O.DOE+00 Q.QQE+QQ O.QQE+Qo O.DOE+00 0.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 INFANT D.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+QO O.DOE+00 0.DOE+00 GOAT ADULT 9.28E+09 5.77E+08 3.59E+08 D.DOE+00 O.DOE+00 O.DOE+DO 1.04E+09 N/A NILK TEEN 1.7IE+10 1.06E+09 6.64E+08 O.DOE+DO O.DOE+DO O.DOE+DO 1.44E+09 N/A CHILD 4.22E+10 1.98E+09 1.63E+09 O.DOE+00 O.DOE+00,,0.DOE+00 1.17E+09 N/A INFANT 7.25E+10 5.12E+09 3.37E+09 O.DOE+00 O.DOE+00 0.DOE+00 1.18E+09 N/A COW ADULT 4.36E+09 2.71E+08 1.69E+08 0.DOE+00 O.DOE+00 O.DOE+DO 4.91E+08 N/A NLK TEEN 8.05E+09 4.99E+08 3.12E+08 O.DOE+00 D.DOE+00 D.DOE+00 6.77E+08 N/A CHILD 1.99E+10 9.29E+0& 7.65E+08 O.DOE+00 D.DOE+DO O.QQE+QQ 5.49E+08 N/A INFANT 4.09E+10 2.41E+09 1.59E+09 O.DOE+00 O.DOE+00 O.DOE+DO 5.54E+08 N/A ADULT 1.55E+09 9.63E+07 5.99E+07 O.DOE+00 0.DOE+00 O.DOE+00 1.74E+08 N/A TEEN 1.31E+09 8.11E+07 5.07E+07 O.DOE+00 0;DOE+00 O.DOE+00 1.10E+08 N/A CHILD 2.47E+09 1.15E+QB 9.51E+07 Q.DOE+00 O.DOE+00 O.DOE+00 6.82E+QT N/A INFANT O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.ODE+q0 O.DOE+00 O.DOE+00 N/A

'LE ADULT 7.09E+08 4.41E+07 2.74E+07 O.DOE+00 D.DOE+00 D.DOE+00 7.98E+07 N/A TEEN 9.5TE+08 5.93E+D7 3.71E+07 O.OOE+OD O.DOE+00 D.DOE+DO 8.05E+07 N/A CHILD 2.16E+09 1.QlE+Q& 8.34E+07 O.DOE+00 O.DOE+00 O.DOE+00 5.98E+07 N/A INFANT O.DOE+00 O.DOE+DO O.OOE+00 O.DOE+00 O.DOE+00 O.ODE+QQ O.DOE+00 N/A TOTAL ADULT 1.59E+10 9.89E+08 6.15E+08 Q.DOE+00 O.DOE+00 O.DOE+00 1.79E+09 N/A INGEST TEEN 2 74E+10 1.70E+09 1.06E+09 0.DOE+00 O.DOE+DO Q.DOE+00 2.31E+09 N/A C HILL) 6 ATE+10 3.12E+Q9 2.57E+09 0.DOE+00 Q.DOE+DO O.DOE+00 1.84E+09 N/A INFANT 1.13E+11 7.53E+09 4.96E+09 0.DOE+00 0.DOE+00 O.ODE+OQ 1.73E+09 N/A INHAL. ADULT 1.32E+06 7.71E+04 5.01E+04 O.DOE+00 O.DOE+00 O.DOE+00 8.64E+04 N/A TEEN 1.89E+06 1.10E+05 7.16E+04 O.QQE+OD O.DOE+00 O.ODE+QQ 9.28E+04 N/A CHILD 2.60E+06 1.14E+05 9.88E+04 0.00E+00 O.DOE+DO Q.OQF+QO 4.22E+04 N/A INFANT 2.03E+06 1.12E+05 7.74E+04 O.DOE+00 0.DOE+00 O.DOE+00 1.61E+O4 N/A BONE LIVER T.BODY THYROID, KIDN Y LUNG G.l. SKIN Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

" tQXINUH VALUES fOR PA WAYS~

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN HILK: HILK: HEAT: VEGTBLE: INGEST: INHAL.

O.DOE+00 Q.DOE+00 7.25E+IQ 4.09E+IO 2.47E+09 2.16E+09 1.13E+ll 2.60E+06 PAGE: 4-3 fV D.~T"

D.D.C-M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*

ISOTOPE: Cr-51 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN ADULT 4.61E+06 4.61E+06 4.61E+06 4.61E+06 4;61E+06 4.61E+06 4.61E+06 5.45E+06 TEEN 4.61E+06 4.61E+06 4.61E+06 4.6IE+06 4.61E+06 '4.61E+06 4.61E+06 5.45E+06 CHILD 4.61E+06 4.61E+06 4.61E+D6 4.61E+06 4.61E+06 4.61E+06 4.61E+06 5.45B06 INFANT 4.6IE+06 4.61E+06 4.61E+06 4..61E+06 4.6lE+06 4.61E+06 4.61E+06 5.45E+06 GOAT 'DULT O.OOE+OO O.OOE+00 1.61E+03 9.64E+02 3.55E+02 2.14E+03 4.06E+05 N/A MILK TEEN D.DOE+00 O.DOE+00 2.82E+03 1.56E+03 6.17E+02 4.02E+03 4.?3E+05 N/A CHILD O.DOE+00 0.DOE+00 5.74E+03 3;19E+03 8.71E+02 5.82E+03 3.05E+05 N/4 INFANT O.DOE+00 0.00E+OD 9.10E+03 5.94E+03 1.30E+03 1 )6E+04 2.65E+D5 N/A ADULT 0.DOE+00 O.DOE+DO 7.99E+03 4.77E+D3 1.76E+03 1.06E+04 2.01E+06 N/A TEEN O.DOE+00 0.DOE+00 1.39E+04 7.75E+03 3.06E+03 1.99E+04 2.34E+06 H/A CHILD D.DOE+00 0.DOE+00 2.84E+04 1.58E+04 4.32E+03 2.88E+04 1.51E+06 N/A INFANT O.DOE+00 O.OOE+00 4.51E+04 2.94E+04 6.43E+03 5.72E+04 1.31E+06 H/A HEAT ADULT O.OOE+OO O.OOE+OO 2.50E+O3 1.49E+O3 5.50E+02 3.31E+03 6.28E+05 H/A TEEN D.OOE+00 D.DOE+00 2.DOE+03 1.11E+03 4.38E+02 2.85E+03 3.36E+05 N/A CHILD O.DOE+00 O.DOE+00 3.11E+03 1.73E+03 4.72E+02 3.16E+03 1-65E+05 N/A INFANT O.DOE+00 0.00E+00 0.00E+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 N/A V'LE ADULT 0.DOE+00 0.00E+00 3.35E+04 2.DIE+04 7.39E+03 4.45E+04 8.44E+06 H/A TEEN 0.DOE+00 0.DOE+00 5.02E+04 2.79E+04 1.10E+04 7.17E+04 8.44E+06 N/A CHILD O.DOE+00 O.OOEt00 9.96E+04 5.53E+04 1.51E+04 1.01E+05 5.28E+06 N/A INFANT O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.OOF+00 O.DOE+00 N/A TOTAL ADULT 0.00E+00 0.00E+OQ 4.56E+04 2.?3E+04 1.DIE+04 6.06E+04 1.15E+07 N/A INGEST TEEN 0 DOE+00 0.DOE+00 6.90E+04 3.83E+04 1.51E+04 9.85E+04 1.16E+07 H/A CHILD O.DOE+00 O.OOE+00 1.3?E+05 ?.60E+04 2.08E+04 1.39E+05 7.26E+06 N/A INFANT 0.00E+00 O.DOE+00 5.42E+04 3.53E+04 7.72E+03 6.88E+04 1.58E+06 N/A

.INHAL. ADULT O.DOE+00 O.OOE+00 I.DOE+02 5.95E+01 2.28E+01 l. 44E+04 3.32E+03 H/A TEEN O.DOE+00 O.DOE+00 1.35E+02 7.50E+Dl 3.07E+Ol 2.10E+04 3.DOE+03 N/A CHILD O.OOE+OO O.OOE+OO 1.54E+O2 8.55E+Ol 2.43E+Ol 1.70E+04 1.08E+03 N/A INFANT O.DOE+00 O.DOE+00 8.95E+Ol 5.75E+01 1.32E+Dl 1.28E+04 3.57E+D2 N/A BONE LIV R ODY LUNG G. SKIN

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

<<<<HA NUN VAL S OR PA HWAYS*<<<<

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN NILK: MILK: NEAT: VEGTB LE: INGEST: INHAL.

'4.6IE+06 5.45E+06 4.73E+05 2.34E+06 6.28E+05 8.44E+06 1.16E+07 2.10E+04 PAGE:

O.D.C.M.

~ ~ ~ HAXIHUH PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*

x~uTOPE: Hn-54 PATHWAY AGE GROUP BONE LIVER ,

T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 1.37E+09 1.37E+09 1.37E+09'.37E+09 1.37E+09 1:37E+09 1.37E+09 1.61E+09 TEEH 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.61E+09 CHILD 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.61E+09 INFANT 1.37E+09 1.37F+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09.1.61E+09 GOAT ADULT O.OOE+00 6.14E+QS 1.17E+05 O.OOE+00 1.83E+05 0.00E+00 1.88E+06 H/A MILK 'EEN 0.00E+00 1.02E+06 2.03E+05 O.OOE+00 3.05E+05 O.OOE+00 2.10E+06 N/A CHILD O.OOE+00 1.53E+06 4.07E+QS O.OOE+00 4.29E+05 O.OOE+00 1.28E+06 N/A

'NFANT O.OOE+00 2.84E+06 6.45E+05 O.OOE+00 6.30E+05 0.00E+00 1.04E+06 N/A'OW ADULT O.OOE+00 3.92E+06 7.49E+05 0.00E+00 1.17E+06 O.OOE+00 1.20E+07 H/A MILK TEEN O.OOE+00 6.54E+06 1.30E+06 O.OOE+00 1.95E+06 O.OOE+00 1.34E+07 N/A CHILD 0.00E+00 9.78E+06 2.61E+06 O.OOE+00 2.74E+06 O.OOE+00 8.2IE+06 N/A INFANT 0.00E+00 1.82E+07 4.12E+06 0.00E+00 4.03E+06 0.00E+00 6.68E+06 H/A ADULT 0.00E+00 4.79E+06 9.14E+05 O.OOE+00 1.43E+06 0.00E+00 1.47E+07 N/A TEEN O.OOE+00 3.65E+06 7.25E+05 O.OOE+00 1;09E+06 O.OOE+00 7.49E+06 N/A CHILD O.OOE+00 4.18E+06 1.1IE+06 0.00E+00 1.17E+06 O.OOE+00 3.51E+06 N/A INFANT 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 N/A

~BLE ADULT O.OOE+00 2.80E+08 5.35E+07 O.OOE+00 8.34E+07 O.OOE+00 8.58E+08 N/A TEEN O.OOE+00 4.27E+08 8.46E+07 0.00E+00 1.27E+08 0.00E+00 8.75E+08 N/A CHILD O.OOE+00 6.34E+08 1.69E+08 O.OOE+00 1.78E+08 0.00E+00 5.32E+08 'H/A INFANT 0.00E+00 0;OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 H/A TOTAL ADULT O.OOE+00 2.90E+08 5.53E+07 O.OOE+00 8.62E+07 O.OOE+00 8.87E+08 N/A JSUM TEEN O.OOE+00 4.38E+08 8.69E+07 O.OOE+00 1.31E+08 0.00E+00 8.98E+08 N/A CHILD O.OOE+00 6.49E+08 1.73E+08 0.00E+00 1.82E+08 O.OOE+00 5.45E+08 N/A INFANT O.OOE+00 2.10E+07 4.77E+06 O.OOE+00 4.66E+06 O.OOE+00 7.73E+06 H/A INHAL. ADULT O.OOE+00 3.96E+04 6.3OE+03 O.OOE+00 9.84E+03 1.40E+06 7.74E+04 H/A TEEN O.OOE+00 5.11E+04 8.40E+03 0.00E+00 1.27E+04 1.98E+06 6.68E+04 H/A CHILD O.OOE+00 4.29E+04 9.51E+03 O.OOE+00 1.00E+04 l.58E+06 2.29E+04 N/A INFANT O.OOE+00 2.53E+04 4.98E+03 O.OOE+00 4.98E+03 1.00E+06 7.06E+03 N/A BONE LIVER T.BODY HYROIO K DNEY LUNG G.l. SKIN

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

<<<<<<MAXIMUM VALU S OR PATHWAYS<<**

GROUND: GROUND: GOAT COW TOTAL T.B./ORG; SKIN HILK MILK: HEAT: VEGTBLE: INGEST: INNL.

~

I.37E+09 1.61E+09 2.84E+06 1.8ZE+07 1.47E+07 8.75E+08 8.98E+08 1.98E+06 PAGE: 4-5

O.D.C.N. NXIHUN PATHWAY DOSE FACTORS: RADIONUCLIGES OTHER THAN NOBLE GASES" lvdTOPE: Fe-55 PATHMAY AGE GROUP BONE LIVER T.BODY THYROID . KIDNEY LUNG G.I. SKIN GROUND ADULT Q.DOE+00 Q.QQE+QQ Q.DOE+00 Q.DOE+00 Q.DOE+00 'O.DOE+00 Q.DOE+00 O.QOE+QO TEEN O.DOE+00 Q.DOE+00 Q.DOE+00 Q.DOE+00 Q.DOE+00 Q.DOE+00 O.DOE+00 Q.QQE+00 CHILD . Q.ooE+Qo o.oQE+Qo o.ooE+00 O.OQE+00 O.DOE+00 O.DOE+00 D.QQE+QQ Q.DOE+00 INFANT O.'OOE+QQ Q.'QQE+QO O.OOE+OO O.OOE+QO O.OOE+QO O.QOE+OO O.OOE+OO O.OOE+QO GOAT ADULT 2.06E+05 1.42E+05 3.32E+04 O.DOE+00 O.DOE+00 7.94E+04 &.16E+04 N/A HILK TEEN 3.65E+05 2.59E+05 6.Q4E+04 Q.DOE+00 Q.DOE+00 1.64E+05 1.12E+05 N/A CHILD 9.17E+QS 4.86E+05 1.51E+05 Q.OQE+OO O.DOE+00 2.75E+05 9.01E+04 H/A INFANT &.52E+07 7.16E+05 1.91E+05 Q.DOE+00 O.oof+00 3.50E+05 9.09E+04 H/A COW ADULT 1.25E+07 8.64E+06 2.01E+06 Q.DOE+00 'Q.DOE+00 4.82E+06 4.95E+06 H/A MILK TEEN 2.22E+07 1.57E+07 3.67E+06 O.DOE+00 Q.DOE+DO 9.97E+DS 6.80E+06 N/A CHILD 5.56E+02 2.95E+07 9.14E+06 D.DOE+00'Q.DOE+00 l.67E+07 5.47E+06 H/A INFANT 6.73E+07 4.34E+07 1.16E+07 D.OOE+QD O.DOE+00 2.12E+07 5.52E+06 N/A.

ADULT 1.6)E+08 1.))E+D& 2.60E+07 Q.DOE+00 Q.QOE+OD 6.22E+07 6.39E+07 N/A TEEN 1.3)E+08 9.29E+07 2.17E+07 Q.DOE+00 Q.DOE+00 5.89E+07 4.02E+07 N/A CHILD 2.5)E+08 1.33E+Q8 4.13E+07 Q.DOE+00 Q.DOE+00 7.54E+07 2.47E+07 H/A INFANT D.DOE+00 0.DOE+00 Q.DOE+00 Q.DOE+00 O.DOE+00 Q.DOE+00 O.DOE+00 H/A

,V.~" BLE ADULT ).89E+08 1.31E+08 3.05E+07 O.DOE+00 Q.DOE+DO 7.30E+07 7.50E+07 N/A TEEN 3.08E+08 2.18E+08 5.09E+07 O.DOE+00 O.DOE+00 1.3&E+08 9.44E+07 H/A CHILD 7.67E+08 4.07E+08 1.26E+08 O.DOE+00 O.DOE+00 2.30E+08 7.53E+07 N/A INFANT O.OQE+QQ O.QQE+QQ D.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 D.DOE+00 H/A TOTAL ADULT 3.63E+08 2.5)E+Q& 5.&SE+07 Q.QOE+OQ O.DOE+00 1.4QE+08 1.44E+0& H/A XNMM TEEN 4 6)E+08 3.27E+08 7.62E+07 Q.DOE+00 Q.DOE+00 2.07E+0& 1.41E+08 H/A CHILD 1.07E+09 5.70E+08 1.77E+08 Q.QOE+OQ O.QQE+00 3.22E+08 1.06E+08 N/A INFANT 1.52E+08 4.42E+07 1.18E+07 Q.QQE+QQ Q.DOE+00 2.16E+07 5.61E+06 H/A ZHHAL. ADULT 2.46E+04 1.70E+Q4 3.94E+03 Q.DOE+00 Q.DOE+00 7.21E+04 6.03E+D3 N/A TEEN 3.34E+04 2.3&E+Q4 S.S4E+03 Q.DOE+00 D.DOE+00 1.24E+05 6.39E+D3 H/A CHILD 4.74E+04 2.52E+04 7.77E+03 Q.QQE+OO Q.QQE+QQ 1.11E+05 2.87E+D3 N/A INFANT 1.97E+Q4 1.17E+04 3.33E+03 Q.DOE+00 O.DOE+00 8.69E+04 1.09E+03 N/A BONE LIVER .BODY HYRO K NEY LUNG G. S IN Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

"".<<NAXINUN VALUES OR PA A S~~

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN HILK: HI LK: HEAT: VEGTBLE: INGEST: IHHAL.

Q.QQE+OQ O.DOE+00 8.52E+07 6.73E+07 2.51E+08 7.67E+08 1.07E+09 1.24E+Q5 PAGE: 4-6

, V DAT

D.D.C.M.

~ ~ ~ MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*

ISOTOPE:~ Mn-56 PATHWAY AGE GROUP BONE LIVER . T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND . ADULT O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 .0.00E+00 TEEN 0.00E+00 0;00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.DOE+00 CHILD O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 INFANT 0.00E+00 0.0OE+OO O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 GOAT ADULT 0.00E+00 7.17E-O4 1.27E-04 O.OOE+00 9.11E-04 O.OOE+00 N/A MILK TEEN O.OOE+OO 1.27E-O3 2.26E-04 O.OOE+00 1.61E-03 O.OOE+00 8.37E-02 N/A H/A'.29E-02 CHILD 0.00E+00 2.22E-03 5.01E-04 O.OOE+00 2.6&E-03 O.OOE+00 3s21E-Ol H/A INFANT 0.00E+00 5.43E-03 9.36E-04 O.OOE+00 4.67E-03 O.OOE+00 4.93E-01 CDM ADULT 0.00E+00 1.05E-03 1.86E-04 O.OOE+00 1.33E-03'O.OOE+00 3.34E-02 H/A MILK TEEN O.OOE+00 1.85E-03 3.30E-04 O.OOE+00 2.3SE-03 O.OOE+00 1.22E-01 H/A CHILD O.OOE+00 3.23E-03 7.30E-04 O.OOE+00 3.91E-03 O.OOE+00 4.69E-01 H/A INFANT O.OOE+OO 7.92E-03 1.37E-03 0.00E+00 6.&IE-03 O.OOE+00 7.19E-01 H/A MEAT ADULT O.OOE+OO 5.00E-54 8.86E-55 O.OOE+00 6.34E-54 O.oof+00 1.59E-52 N/A TEEN O.OOE+00 4.06E-54 7.21E-55 O.OOE+00 5.14E-54 O.OOE+00 2.67E-52 H/A CHILD O.OOE+00 5.41E-54 1.22E-54 0.00E+00 6.54E-54 O.OOE+00 7.84E-52 N/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A

'LE ADULT 0.00E+OO 5.2SE+00 9.3IE-Ol O.OOE+00 6.66E+00 O.OOE+00 1.67E+02 N/A TEEN O.OOE+00 4.73E+00 8.42E-01 O.OOE+00 5.99E+00 O.OOE+00 3.11E+02 N/A CHILD 0.00E+00 6.19E+00 1.40E+00 O.OOE+00 7.49E+OO O.OOE+00 8.97E+02 N/A INFANT O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 H/A TOTAL ADULT O.OOE+00 5.25E+OO 9.31E-01 0.00E+00 6.66E+00 Q.OOE+00 1.6&E+02 H/A JMBEST. TEEN O.OOE+00 4.73E+OO &.42E-Ol O.OOE+00 5.99E+00 O.OOE+00 3.12E+02 N/A CHILD O.OOE+00 6.20E+OO 1.40E+00 0.00E+00 7.50E+00 0.00E+00 8.98E+02 N/A INFANT 0.00E+00 1.34E-02 2.30E-03 0.00E+00 1.15E-02 0.00E+00 1.21E+00 N/A INHAL. ADULT O.OOE+00 1.24E+OO 1.&3E-Ol O.OOE+00 1.30E+00 9.44E+03 2.02E+04 H/A TEEN 0.00E+00 1.70E+00 2.52E-01 O.OOE+00 1.79E+00 1.52E+04 5.74E+04 H/A CHILD O.OOE+OO 1.66E+OO 3.12E-Ol O.OOE+OO 1.67E+OO 1.31E+04 1.23E+05 N/A INFANT O.OOE+00 1.54E+00 2.21E-01 0.00E+00 1.10E+00 1.25E+04 7.17E+04 H/A BONE LIVER . BODY H ROI ONE LUNG G.

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

~*MAXIMUMVALUES FOR PA HWAYS~~*

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: INHAL.

O.OOE+00 O.OOE+00 4.93E-01 7.19E-01 7.84E-52 &.97E+02 8.9&E+02 1.23E+05 PAGE: 4-7

O.D.C.H. MAXIMUM PATHWAY DOSE FACTORS: RADIDNUCLIDES OTHER THAN NOBLE GASES*

ISOTOPE: Co-58 PATHWAY AGE GROUP BONE LIYER T.BODY THYROID KIDNEY . G.I.

GROUND ADULT 3.75E+08 3.75E+08 3.75E+08 3-75E+08 3.75E+08 3.75E+Q8 3.75E+08 4.39E+08 TEEN 3.75E+08 3.75E+08 3.75E+08 3.75E+OS 3.75E+08 3.75E+08 3.75E+08 4.39E+0&

CHILD 3.75E+08 3.75E+08 3.75E+08 .3.75E+08 3 75E+08 3.'75E+08 3.75E+08 4.39E+08 INFANT 3.75E+OS 3.75E+08 3.75E+08 3.75E+OS 3.75E+08 3.75E+08 3.75E+08 4.39E+08 GOAT ADULT 0.DOE+00 3.DOE+05 6.72E+05 O.DOE+DO O.DOE+00 O.DOE+00 6.07E+06 N/A NLK TEEN O.DOE+00 5.05E+05 1.16E+06'O.DOE+00 O.DOE+00 O.DOE+DO 6.96E+06 N/A CHILD O.DOE+00 7.71E+05 2.36E+06 O.DOE+DO O.DOE+00 O,DOE+00 4.50E+06 N/A INFANT O.DOE+00 1.54E+06 3.85E+06 O.DOE+00 O.DOE+00 Q.DOE+00 3.84E+06 N/A COW ADUI T Q.DOE+00 1.70E+06 3.81E+06 O.DDE+00 O.DOE+00 O.ODE+00 3.44E+07 N/A NILK TEEN O.DOE+00 2.86E+06 6.59E+06 D.DOE+CD O.DOE+00 O.ODE+00 3.94E+07 N/A CHILD O.DOE+00 4.37E+06 1.34E+D7 O.DOE+00 O.DOE+00 O.DOE+DO 2.55E+07 N/A INFANT Q.DOE+00 8.74E+06 2.18E+OT D.OQF+00 O.DOE+00 O.ODE+OD 2.18E+07 N/A HEAT ADULT O.QOE+00 7.7&E+06 1.74E+OT Q.QOE+QQ O.DOE+00 O.DOE+00 1.58E+08 N/A TEEN'HILD O.DOE+DO 6.0QE+06 1.3&E+QT Q.DOE+DO O.DOE+00 O.QOE+OD 8.27E+07 NfA O.DOE+00 7.DIE+06 2.14E+0? Q.DOE+00 O.DOE+00 Q.DOE+00 4.09E+07 NfA INFANT O.DOE+00 O.DOE+00 Q.DOE+00 Q.QOE+QO O.DOE+00 O.DOE+00 O.DOE+00 N/A BLE ADULT 0.DOE+00 2.61E+07 5.86E+OT O.DOE+00 O.DOE+00 O.OOE+QO 5.29E+Q& N/A TEEN O.DOE+00 3.96E+07 9.14E+07 Q.DOE+00 O.DOE+00 O.DOE+DO 5.47E+08 N/A CHILD 0.DOE+00 5.99E+07 1.83E+08 O.DOE+00 O.DOE+00 O.DOE+00 3.49E+08 N/A INFANT Q.DOE+00 O.DOE+00 O.OOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 N/A TOTAL ADULT O.DOE+00 3.59E+07 8.05E+07 Q.DOE+00 O.DOE+00 O.DOE+00 7.28E+08 N/A INGEST TEEN D.DOE+00 4.90E+07 1.13E+08 O.DOE+00 O.DOE+00 O.DOE+00 6.76E+08 N/A CHILD Q.DOE+DO 7.20E+DT 2.2DE+08 Q.DOE+DO O.DOE+DO O.DOE+DO 4.20E+08 N/A INFANT O.DOE+00, 1.03E+07 2.56E+DT D.DOE+00 O.DOE+00 O.DOE+00 2.56E+07 N/A INHAL. ADULT O.OOE+00 1.58E+03 2.DTE+03 D.ODE+OD O.DOE+00 9.28E+05 1.06E+05 N/A TEEN Q.DOE+DO 2.07E+03 2.78E+03 D.OOE+OD O.DOE+00 1.34E+06 9.52E+04 N/A CHILD Q.OOE+QD 1.77E+03 3.16E+03 Q.DOE+00 O.DOE+00 1.11E+D6 3.44E+04 N/A INFANT Q.OOE+OO 1.22E+03 1.82E+03 O.QQE+QO O.DOE+DO 7.77E+05 1.11E+04 N/A BONE LI R .BODY HYROID KIDN Y LUNG G. SK

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

<<*MAXIMUM VALUES FOR PA MAYS~~

GROUND: GROUND: GOAT COM TOTAL T.B./ORG. 'KIN MILK: H ILK: HEAT: VEGTBLE: INGEST: INHAL.

'3.75E+08 4.39E+08 6.96E+06 3.94E+OT 1.58E+08 5.47E+08 7.28E+08 1.34E+06 PAGE: 4-8 8

DAT=

O.D.C.M. HAXINUN PATHWAY 00SE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*

.~OTOPE: Fe-59 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 2.TOE+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 3.17E+08 TEEN 2.70E+08 2.70E+OS 2.70E+08 2.70E+08 2.70E+08 2.7OE+08 2.70E+08 3.17E+08 CHILD . 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 3.17E+08 INFANT 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+OS 2.TOE+08 3.17E&8 GOAT ADULT 1.92E+05 4.52E+05 1.73E+05 0.00E+00 O.OQE+00 1.26E+05 1.51E+06 N/A MILK TEEN 3.35E+05 7.83E+05 3.02E+05 O.OQE+00 O.OQE+00 2.47E+05 1.85E+06 N/A CHILD 7.78E+05 1.26E+06 6.27E+05 O.OOE+00 O.OQE+00 3.65E+05 1.31E+06 N/A, INFANT 1.12E+08 2.54E+06 9.99E+05 Q.OOE+00 O.QQE+00 7.49E+05 1.21E+06 N/A COW ADULT 9.41E+06 2.21E+Q7 8.47E+06 O.QOE+00 'O.OOE+00 6.18E+06 7.37E+07 N/A HILK TEEN 1.64E+07 3.83E+07 1.48E+Q7 O.QQE+00 O.OOE+00 1.21E+07 9.06E+07 N/A CHILD 3.81E+07 6.16E+07 3.07E+07 0.00E+00'.OQE+00 1.79E+Q7 6.41E+07 N/A INFANT 7.11E+07 1.24E+OS 4.89E+07 O.OOE+OO O.QQE+00 3.67E+07 5.93E+07 N/A ADULT 1.03E+08 2.42E+08 9.27E+07 0.00E+00 0.00E+00 6.76E+07 8.06E+08 N/A TEEN 8.23E+07 1.92E+08 7.41E+07 O.OOE+00 0;OQE+00 6.0SE+07 4-54E+08 N/A CHILD 1.4&E+08 2.36E+08 1.18E+08 O.OOE+00 O.OQE+00 6.84E+07 2.46E+08 N/A INFANT O.OQE+00 O.OOE+00 Q.OOE+00 O.OOE+00 O.QOE+00 O.OQE+00 O.OOE+00 N/A

'TBLE ADULT 1.0ZE+08 2.39E+OS 9.17E+07 O.OOE+00 O.OOE+00 6.68E+07 7.97E+08 N/A TEEN 1.58E+08 3.6SE+08 1.42E+OS O.OOE+00 0.00E+00 1.16E+08 8.71E+08 N/A CHILD 3.60E+08 5.82E+08 2.9OE+OS O.OOE+00 O.QOE+00 1.69E+08 6.06E+08 N/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 N/A TOTAL ADULT 2.14E+08 5.04E+08 1.93E+08 O.OQE+00 Q.QQE+00 1.41E+08 1.6&E+09 N/A

~

INGEST. TEEN 2 57E+08 5.99E+08 2.31E+08 O.OQE+00 O.OQE+00 1.89E+QB 1.42E+09 N/A CHILD 5.45E+08 8.81E+08 4.39E+08 O.OOE+00 0.00E+00 2.55E+08 9.18E+08 N/A INFANT 1.83E+08 1.27E+08 4.99E+07 O.OOE+00 O.OOE+00 3.74E+07 6.05E+07 N/A INHAL. ADULT 1.18E+04 2.7SE+04 1.06E+04 O.OOE+00 O.QQE+00 1.02E+06 1.88E+05 N/A TEEN 1.59E+04 3.7OE+O4 1.43E+04 O.OOE+00 O.OOE+00 1.53E+06 1.78E+05 N/A CHILD 2.07E+04 3.34E+04 1.67E+04 O.OOE+00 0.00E+00 1.27E+06 7.07E+04 N/A INFANT 1.36E+04 2.35E+04 9.48E+03 O.OOE+00 O.OOE+00 1.01E+06 2.48E+04 N/A BONE LIVER .BODY HYROI K DNEY LUNG G.I. SKIN

~Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

~*HAXIHUH VALUES OR PATHWAYS~

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN HILK: H ILK: HEAT: VEGTBLE: INGEST: INHAL.

2.7OE+08 3.17E+08 1.12E+OS 1.24E+OS 8.06E+08 8.71E+08 1.68E+09 1.53E+06 PAGE: 4-9

O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*

ISOTOPE: Co-60 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.

GROUND ADULT 2.13E+10 2.13E+10 2.13E+10 2.)3Ee)0 2,.13E+10 2.13E+10 2.13E+10 2.51Ee10 TEEN 2.13E+10 2.13E+10 2.)3Ee)0 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.51E+10 CHILD 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.51E+10 INFANT 2.13E+10 2.)3E+10 2.13E+10 2.13E+10 2.13E+10 2.)3E+)0 2.)3E+)0 2.5)Ee)0 GOAT ADULT O.DOE+00 1;25E+06 2.76E+06 0.DOE+00 0.60Ee00 0.00E+00 2.35E+07 H/A MILK TEEN O.DOE+00 2.)RE+06 4.78E+D6 O.DOE+00 O.DOE+00 O.DOE+00 2.77E+07 N/A CHILD D.DOE+00 3.30E+06 9.72E+06 D.DOE+00 O.DOE+00 O.DOE+00 ).83E+07 N/4 INFANT O.DOE+00 6.73E+06 1.'59E+07 O.ODE+OD O.DOE+00 O.DOE+00 1.60E+07 N/A COW ADULT O.DOE+00 8.29E+06 ).83E+07 O.DOE+00 O.DOE+DO O.DOE+00 1.56E+08 H/A MILK TEEN D.DOE+00 1.4)E+07 3.1?E+D? O.DOE+00 O.DOE+00 O.OOE+00 ).83E+08 H/A CHILD O.DOE+00 2.18E+07 6.44E+07 O.DOE+00 O.DOE+DO O.DOE+00 1.2)E+08 N/A INFANT O.DOE+00 4.46E+07 1.05E+08 O.DOE+DO O.DOE+CD O.DOE+00 ).06f+08 N/A MEAT ADULT O.OOE+OD 4.19E+07 9.23E+07 O.ODE+OO O.DOE+00 0.00E+00 ?.86E+08 N/A TEEN O.DOE+00 3.25E+07 7.32E+07 O.ODE+OD O.ODE+DD O.DOE+00 4.23E+08 H/A CHILD O.DOE+00 3.S6E+07 1.14E+08 O.DOE+00 O.DOE+DO O.DOE+00 2.14E+08 N/A INFANT O.DOE+DO O.OOEe00 O.DOE+DO O.DOE+00 O.DOE+00 O.ODE+OD O.DOE+00 N/A TBLE ADULT O.OOE+OD 1.5)E+08 3.34E+08 O.DOE+00 O.DOE+00 O.OOE+OD 2.84E+09 H/A TEEN 0.DOE+00 2.35E+DS 5.29E+08 O.DDE+OD O.DOE+00 O.DOE+00 3.06E+09 N/A CHILD O.DOE+CD 3.62E+08 1.07E+09 O.DOE+00 O.DOE+00 O.DOE+00 2.0)E+09 N/A INFANT 0.DOE+00 D.ODE+OD O.DDE+OD O.DOE+CD 0.DOE+00 O.DOE+00 O.DOE+00 N/A TOTAL ADULT O.DOE+00 2.03E+DS 4.47E+08 O.DOE+DO D.DOE+CD O.DOE+00 3.8)E+09 N/A BREST TEEN 0 DOE+00 2.84E+08 6.39E+08 O.DOE+00 O.OOE+OD O.DOE+00 3.69E+09 N/A CHILD D.DOE+00 4.26E+08 ).26E+09 O.DOE+00 O.DOE+DO D.DOE+00 2.36E+09 N/A INFANT O.DOE+DO 5.13E+07 1.21E+08 O.OOE+OD O.ODE+OD O.DOE+00 ).22E+08 N/A INHAL. ADULT O.ODE+OD 1.15E+04 1.48E+04 O.DOE+DO O.DOE+00 5.97E+06 2.85E+05 H/A TEEN O.OOE+OD 1.5)E+04 ).98E+04 D.ODE+OD O.ODE+OO 8.72E+06 2.59E+05 H/A .

CHILD O.ODE+OD 1.3)E+04 2.26E+04 D.DOE+00 O.OOE+OD 7.07E+06 9.62E+04 H/A INFANT O.DOE+00 8.02E+03 ).)BE+04 O.DOE+00 O.OOE+OD 4.51E+06 3.)9E+04 H/A BONE LIV R .BODY HYROID . KIDN LUNG G. I. S N

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

>><<<<MAXIMUM VAL S 0 PA HWAYS>>>>>>

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: INHAL.

2.13E+10 2.5)E+10 2.77E+07 1.83E+08 7.86Ee08 3.06E+09 3.81E+09 8.72E+06 PAGE: 4-10

O.D.C.H.

~ ~ ~ MAXIMUM PATHMAY DOSE FACTORS: RAOIONUCLIDES OTHER THAN NOBLE NSES*

.~QTOPE:~ Hi-63 PATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G- I. SKIN GROUND ADULT O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 'O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 TEEN 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.QOE+00 CHILD O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 INFANT O.OOE+00 O.OOE+00 0-OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 GOAT ADULT 5.19E+08 3.59E+07 1.74E+07 0.00E+00 O.OOE+00 0.00E+00 7.50E+06 N/A MILK TEEN 9.11E+08 6.43E+07 3.09E+07 O.OOE+00 O.OOE+00 0.00E+00 1.02E+07 N/A CHILD 2.28E+09 1.22E+08 7.77E+07 O.OOE+00 O.OOE+00 O.OOE+00 &.24E+06 N/A INFANT 2.24E+10 1.66E+08 9.34E+07 O.OOE+00 0.00E+00 O.OOE+00 8.2&E+06 N/A COM ADULT 3.45E+09 2.39E+08 1.1(E+08 0.00E+00 O.OOE+00 0.00E+00 5.00E+07 N/A MILK TEEN 6.07E+09 4.29E+08 2.06E+OS 0;OOE+00 O.OOE+00 O.OOE+00 6.82E+07 N/A CHILD 1.52E+10 8.15E+08 5.1&E+08 0.00E+00 0.00E+00 0.00E+00 5.49E+07 N/A INFANT 1.79E+10 1.11E+09 6.22E+08 O.OOE+00 O.OOE+00 O.OOE+00 5.52E+07 N/A ADULT 1.06E+10 7.38E+08 3.57E+08 O.OOE+00 0.00E+00 0.00E+00 1.54E+OS N/A TEEN 8.56E+09 6.05F+08 2.90E+08 O.OOE+00 O.OOE+00 O.OOE+00 9.63E+07 . N/A CHILD 1.64E+10 8.79E+08 5.59E+08 O.OOE+00 O.OOE+00 O.OOE+00 5.92E+07 N/A INFANT O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 N/A

'TBLE ADULT 9.43E+09 6.54E+08 3.16E+08 O.OOE+00 O.DOE+00 O.OOE+00 1.36E+08 N/A TEEN 1.52E+10 1.07E+09 5.15E+08 O.OOE+OO O.OOE+00 O.OOE+00 1.71E+08 N/A CHILD 3-79E+10 2.03E+09 1.29E+09 0.00E+00 O.OOE+00 O.OOE+00 1.37E+08 N/A INFANT O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 N/A TOTAL ADULT 2.4OE+10 1.67E+09 8.07E+08 O.OOE+00 O.OOE+00 O.OOE+00 3.48E+08 N/A JNGEST. TEEN 3.07E+10 2.17E+09 1.04E+09.0.00E+OO O.OOE+00 O.OOE+00 3.46E+08 N/A CHII.D 7.USE+10 3.84E+09 2.44E+09 O.OOE+00 O.OOE+00 O.OOE+00 2.59E+08 N/A INFANT 4.04E+10 1.2&E+09 7.16E+0& O.OOE+OO 0.00E+00 0.00E+00 6.34E+07 N/A IHHAL. ADULT 4.32E+05 3.14E+04 1.45E+04 O.OOE+00 O.OOE+00 1.7&E+05 1.34E+04 N/A TEEN 5.8OE+05 4.34E+04 1.98E+04 O.OOE+00 O.OOE+00 3.07E+05 1.42E+04 N/A CHILD 8.21E+05 4.63E+04 2.80E+04 0.00E+00 0.00E+00 2.75E+05 6.33E+03 N/A INFANT 3.39E+05 2.04E+04 1.16E+04 O.OOE+00 O.OOE+00 2.09E+05 2.42E+03 N/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.l. SK N Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

~**HAXIHUH VALU S FOR PA HWAYS*~

GROUND: GROUND: GOAT COW TOTAL T.B./ORG.. SKIN MILK: NILK: HEAT: VEGTBLE: INGEST: IHHAL.

0.00E+00 0.00E+00 2.24E+10 1.79E+10 1.64E+10 3.79E+10 7.18E+10 8.21E+05 PAGE:

A r IJIL I

O.D.C.M. HAXIMUM PATHWAY DOSE FACTORS: RAOIONUCl.IDES OTHER THAN NOBLE GASES*

ISOTOPE: 2n-65 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID. KIDNEY LUNG G.I. SKIN GROUND ADULT 7.40E+08 7.40E+08 7.40E+08. 7.40E+08 7.40E+08 7.40E+08 7.40E+08 8-50E+08 TEEN 7.40E+08 7.40E+08 7.40E+08 7;40E+08 7.40E+08 7.40E+08 7.40E+08 &.50E+08 CHILD 7.40E+08 7.40E+08 7.40E+08 7..40E+08 7.40E+08 7.40E+08 7.40E+08 8.50E+08 INFANT 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 8.50E+08 GOAT ADULT 9.87E+07 3.14E+08 1.42E+08 O.OOE+QO 2.10E+0& O.OOE+00 1.98E+08 N/A MILK 'EEN 1.51E+08 5.26E+08 2.45F+Q& O.OOE+00 3.37E+08 O.OOE+00 2.23E+08 N/A CHILD 2.97E+08 7.92E+08 4.93E+08 O.OOE+00 4.99E+QB O.OOE+00 1.39E+08 N/A INFANT 3.33E+09 1.37E+09 6.31E+08 O.OOE+00 6.64E+08 O.OOE+00'1.16E+09 N/A .

ADULT 6.24E+08 1.99E+09 8.97E+08. O.OOE+00 1.33E+09 Q.OOE+00 1.25E+09 N/A TEEN 9.58E+08 3.33E+09 1.55E+09 O.OOE+00 2.13E+09 O.OOE+00 1.4)E+09 N/A CHILD 1.88E+09 5.01E+09 3.12E+09 O.OOE+00 3.16E+09 O.OOE+00 8.80E+08 N/A INFANT 2.53E+09 8.66E+09 3.99E+09 O.OOE+00 4.20E+09 O.OOE+00 7.31E+09 N/A HEAT ADULT '.&2E+08 5.79E+08 2.62E+08 O.OQE+00 3.87E+OB O.OOE+00 3.65E+08 N/A TEEN 1.28E+08 4.44E+08 2.07E+Q8 Q.OOE+00 2.84E+08 O.OOE+00 1.88E+08 N/A CHILD 1.92E+08 5.1)E+08 3.18E+08 O.QOE+00 3.22E+08 Q.OOE+00 8.98E+07 N/A INFANT O.QQE+QQ 0.'OQE+00 Q.OOE+00 O.OQE+QQ 0.00E+00 O.OOE+00 O.OOE+00 N/A

) P ABLE ADULT 2.83E+08 9.0)E+08 4.07E+08 0.00E+00 6.03E+08 O.OOE+00 5.68E+08 N/A TEEN 3.97E+08 1.38E+09 6.43E+08 O.OOE+00 8.83E+08 O.OOE+00 5.84E+08 N/A CHILD 7.73E+08 2.06E+09 1.28E+09 Q.QOE+00 1.30E+09 O.QOE+OQ 3.62E+08 N/A INFANT Q.QQE+00 Q.OQE+00 O.QOE+00 O.QOE+00 Q.QQE+00 O.QOE+00 O.OOE+00 N/A TOTAL ADULT 1.19E+09 3.78E+09 1.71E+09 O.OOE+00 2.53E+09 Q.OOE+00 2.38E+09 N/A INGEST TEEN 1.63E+09 5.68E+09 2.65E+09 Q.QQE+00 3.63E+09 Q.OOE+00 2.40E+09 N/A CHILD 3.14E+09 8.37E+09 5.21E+09 Q.OOE+00 5.28E+09 O.OOE+OQ 1.4?E+09 N/A INFANT 5.85E+09 1.00E+l0 4.63E+09 0.00E+00 4.86E+09 Q.QOE+00 8.47E+09 N/A INHAL. ADULT 3.24E+04 1.03E+05 4.66E+04 O.QOE+00 6.90E+04 8.64E+05 5.34E+04 N/A TEEN 3.86E+04 1.34E+05 6.24E+04 O.QQE+QO 8.64E+04 1.24E+06 4.66E+04 N/A CHILD 4.25E+04 1.13E+05 7.03E+04 O.QOE+00 7.14E+04 9.95E+05 1.63E+04 N/A INFANT 1.93E+04 6.26E+04 3.11E+04 Q.QOE+QQ 3.25E+04 6.47E+05 5.14E+04 N/A BONE Ll ER ODY H RO K DNEY LUNG G.l. S N

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

<<*MAXIMUM VALUES OR PA HWAYS~"

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN ~ MILK: MILK: MEAT: VEGTBLE: INGEST: INHAL.

7.40E+08 8.5QE+08 3.33E+09 8.66E+Q9 5.79E+08 2.06E+09 1.00E+10 1.24E+06 PAGE: 4-12

O.D.C.H. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*

i~OTOPE: Rb-86 PATHWAY AGE GROUP BONE L'IVER T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 &.89E+06 1.02E+07 TEEN 8.89E+06 8.89E+06 &.89E+06 8.89E+06 8.&9E+06 8.89E+06 8.89E+06 1.02E+07 CHILD 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 1.02E+07 INFANT 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06. 8.89E+06 8.89E+06 1..02E+07 GOAT ADULT O.QOE+00 1.42E+08 6.63E+07 O.QQE+OQ O.OQE+OQ O.OQE+00 Z.&QE+Q7 N/A MILK TEEN O.QQE+00 2.59E+08 1.22E+08 Q.QQE+00 O.OOE+00 O.OOE+00 3.84E+07 H/A CHILD O.QOE+QQ 4.81f+08 2.96E+08 O.QOE+00 O.OOE+00 O.OOE+00 3.09E+07 H/A INFANT 0.00E+00 1.22E+Q9 6.03E+08 Q.QOE+00 O.OOE+00 O.OOE+00 3.12E+07 N/A COW ADULT Q.QQE+QQ 6.78E+08 3.16E+08 O.QQE+00 O.OOE+00 0-OOE+00 1.34E+08 H/A MILK TEEN Q.QQE+00 1.24E+09 5.&QE+08 Q.QQE+qo O.OOE+00 O.OOE+00 1.&3f+08 N/A CHILD O.OQE+00 2.29E+09 1.4IE+09 O.OQE+00 O.OOE+00 O.OOE+00 1.47E+08 H/A INFANT Q.QQE+00 5.8IE+09 2.87E+09 O.QOE+00 O.OOE+00 O.OOE+00 1.49E+08 N/A MEAT ADULT 0.00E+00 1.65E+08 7.67E+07 Q.OQE+00 0-OOE+00.0.00E+00 3.25E+07 N/A TEEN Q.QQE+00 1.37E+08 6.45E+07 O.QQE+00 O.OOE+00 O.QQE+00 '2.03E+07 N/A CHILD 0.00E+00 1.95E+08 1.20E+08 O.QOE+00 O.QOE+OQ O.OOE+00 1.25E+07 N/A INFANT Q.QOE+00 0.00E+00 O.OOE+00 O.QOE+00 0.00E+00 O.OQE+00 O.OOE+00 H/A T8LE ADULT Q.QQE+00 1.32E+08 6.17E+07 O.QQE+00 Q.OOE+00 O.OOE+00 2.6IE+07 N/A TEEN Q.QQE+QQ 1.93E+08 9.07E+07 0.00E+00 O.OOE+00 Q.OOE+OO 2.86E+07 N/A CHILD Q.QQE+00 3.40E+08 2.09E+08 O.QQE+00 O.OOE+00 Q.QOE+00 2.19E+07 N/A INFANT Q.OOE+00 Q.OOE+00 Q.QQE+QO O.QQEtQQ Q.OQE+00 Q.QOE+00 Q.QQE+QQ N/A

. TOTAL ADULT Q.QOE+QQ 1.12E+09 5.20E+08 Q.OQE+00 O.OQE+00 O.OOE+00 2.20E+08 N/A INGEST TEEN Q.QOE+00 1.83f+09 8.57E+08 O.OQE+00 0.00E+00 0.00E+00 2.70E+08 N/A CHILD Q.QQE+OQ 3.31E+09 2.03E+09 O.QQE+00 O.OOE+00 O.QOE+00 2.13E+08 N/A INFANT Q.QQE+QQ 7.03E+09 3.48E+09 O.QQE+QQ Q.OOE+00 O.OQE+00 1.80E+08 N/A INHAL. ADULT Q.QQE+OQ 1.35E+05 5.90E+04 Q.QOE+OQ O.OOE+00 O.OOE+00 1.66E+04 N/A TEEN Q.QQE+QQ 1.90E+05 8.4QE+Qa Q.QQE+OQ 0.00E+OQ O.OQE+00 1.77E+04 N/A CHILD Q.QQE+QQ 1.9BE+05 1.14E+05 Q.QQE+QQ Q.OOE+00 Q.OOE+00 7.99E+03 N/A INFANT Q.QQE+OQ 1.90E+05 8.82E+04 Q.QQE+OQ O.OOE+00 O.OOE+00 3.04E+03 N/A BONE LIVER .BODY HYRQIO Kl HEY LUNG G.l. SK N

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

~ MAXIMUM VALUES OR PATHWAYS~~

GROUND'ROUND: GOAT COW TOTAL T.B./ORG., SKIN MILK: NILK: HEAT: VEGTBLE: INGEST: IHHAL.

&.89E+Q6 1.02E+07 1.22E+Qg 5.&IE+09 1.95E+08 3.40E+08 7.03E+09 1.98E+05 PAGE: 4-13

D.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES>>

ISOTOPE: Sr-89 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 2.14E+04 2.14f+04 2.)4E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.49E+94 TEEN 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.'14E+04 2.14E+04 2.49E+04 CHILD 2.14E+04 2.)4E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.49E+04 INFANT 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.49E+04 GOAT ADULT 1.54E+09 O.OOE+00 4.43E+07 O.OOE+00 O.OOE+00 O.OOE+00 2.47E+08 N/A MILK TEEN 2.84E+09 O.OOE+00 8.14E+07 O.OOE+00 O.OOE+00 O.OOE+00 3.39E+08 N/A CHILD 7.04E+09 O.OOE+OO 2.0)E+08 O.OOE+00 O.OOE+00 O.OOE+00 2.72E+08 N/A

. INFANT 6.37E+09 O.OOE+00 3.84E+08 O.OOE+00 O.OOE+00 0.DOE+00 2.75E+08 ~ N/A CDM ADULT 4.76E+08 O.OOE+00 1.37E+07 O.OOE+00 O.OOE+00 O.OOE+00 7.64E+07 N/A MILK TEEN 8.7&E+08 O.OOE+00 2.5)E+07 O.OOE+00 O.OOE+00 'O.OOE+00 1.05E+08 N/A CHILD 2.17E+09 O.OOE+00 6.20E+07 0.00E+00 0.00E+00 O.OOE+00 8.41E+07 N/A INFANT 4.13E+09 O.OOE+00 1.18E+08 O.oof+00 O.OOE+00 0.00E+00 &.49E+07 N/A ADULT 1. 20E+08 O.OOE+00 3.44E+06 O.OOE+00 O.OOE+00 O.OOE+00 1.92E+07 N/A TEEN 1. 01E+08 0.00E+OO 2.90E+06 O.OOE+00 O.OOE+00 O.OOE+00 1.2)E+07 N/A CHILD 1.92E+08 O.OOE+00 5.4&E+06 O.OOE+00 O.OOE+00 O.OOE+00 7.42E+06 N/A INFANT O.OOE+00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 N/A

'BLE ADULT 8.19E+09 O.OOE+00 2.35E+08 O.OOE+00 O.OOE+00 0.'OOE+00 1.3)E+09 N/A TEEN 1.35E+10 O.OOE+00 3.86E+08 O.OOE+00 O.OOE+00 O.OOE+00 1.60E+09 N/A CHILD 3.29E+10 0.00E+00 9.39E+08 0.00E+00 O.OOE+00 O.OOE+00 1.27E+09 N/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A TOTAL ADULT 1.03E+10 O.OOE+OO 2.96E+08 O.OOE+00 O.OOE+00 O.OOE+00 1.66E+09 N/A INGEST. TEEN ).73E+10 O.OOE+00 4.95E+08 O.OOE+00 O.OOE+00 O.OOE+00 2.06E+09 N/A CHILD 4.23E+10 O.OOE+OO 1.21E+09 O.OOE+00 O.OOE+00 O.OOE+00 1.64E+09 N/A INFANT I.O5E+)O O.OOE+OO 5.OZE+O& O.OOE+OO O.OOE+OO O.OOE+OO 3.6OE+O& N/A INHAL. ADULT 3.04E+05 0.00E+00 8.72E+03 O.OOE+00 0.00E+00 1.40E+06 3.50E+05 N/A TEEN 4.34E+05 O.OOE+00 1.25E+04 O.OOE+00 O.OOE+00 2.42E+06 3.71E+05 CHILD 5.99E+05 O.OOE+00 1.72E+04 O.OOE+00 O.OOE+00 2.16E+06 1.67E+05 N/A INFANT 3.9&E+05 O.OOE+00 1.14E+04 O.OOE+00 O.OOE+00 2.03E+06 6.40E+04 N/A 80NE LIVER . ODY HYROID IDNEY LUNG G. SKI

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yrjuCi/sec

>>>>>>MAXIMUM VALU S OR PA HAYS>>>>*

GROUND: GROUND: GOAT CO14 TOTAL T.B./ORG., SKIN,. HILK:, MILK: HEAT,: VEGTBLE: . INGEST: INHAL.

2.14E+04 2.49E+04 7.04E+09 4.13E+09 1.92E+08 3.29E+10 4.23E+10 2.4ZE+06 PAGE: 4-14

O.D.C.H. HAXIHUN PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE., GASES*

ISOTOPE: Sr-90 PATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN O.OOE+OD 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00

'ROUND ADULT D.DOE+00 Q.DOE+00 'O.DOE+00 TEEN O.OQE+OQ O.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DDE+00 O.DOE+00 CHILD O.DOE+00 D.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 INFANT O.DOE+00 D.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 Q.DOE+DO D.DOE+00 GOAT ADULT 6.30E+10 0.DOE+00'1.55E+10 Q.DOE+00 O.DOE+00 O.DOE+00 1.82E+09 H/A BILK TEEN 8.9)E+10 O.DOE+00 2.20E+10 O.DOE+00 O.DOE+00 O.DOE+00 2.50E+09 N/A CHILD 1.5)E+11 Q.DOE+00 3.82E+10 O.DOE+00 O.DOE+00 O.DOE+00 2.03E+09 H/A INFANT ?.&DE+10 O.DQE+00 4.17E+10 O.DOE+00 O.DOE+00 O.DOE+00 2.05E+09 N/A COW ADULT 2.40E+10 O.DOE+00 5.88E+09 O.DOE+00 O.DOE+00 0.DOE+00 6.93E+08 H/A HILK TEEN 3.39E+10 Q.DOE+00 8.37E+09 O.DOE+DO.O.DOE+00 O.ODE+DD 9.51E+DB N/A CHILD 5.72E+10 Q.DOE+00 1.45E+1Q Q.DOE+00 O.DOE+00 0. DOE+00 "7. 7)E+08 JHFAHT 6.23E+10 O.DOE+00 1.59E+10 O.DOE+00 O.DOE+00 O.DOE+DO 7.78E+08 N/A

'EAT ADULT 7.DOE+09 D.QQE+QO 1.72E+09 D.DOE+00 O.DOE+DO O.DOE+00 2.02E+08 N/A TEEN 4.53E+09 0.DOE+00 1.12E+09 Q.DOE+00 O.DOE+00 O.DOE+00 1.27E+08 N/A CHILD 5.85E+09 D.DOE+00 1.4&E+09 0.DOE+00 O.DOE+00 O.DOE+00 7.8&E+07 N/A INFANT Q.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+DO O.DOE+00 N/A BLE ADULT 5.4&E+ll Q.QQE+OQ 1.34f+11 O.DOE+00 O.DOE+00 O.DOE+00 1.5&E+10 N/A TEEN ?.1DE+11 Q.DQE+QQ 1.75E+11 D.DOE+00 O.DOE+00 O.DOE+00 1.99E+10 N/A CHILD 1.19E+12 O.QQE+OQ 3.02E+ll O.DOE+00 O.DOE+00 O.DOE+00 1.61E+10 N/A INFANT Q.DOE+DO O.QQE+OQ Q.DOE+00 0.00f+00 O.DOE+00 0.00f+00 O.DOE+00 N/A TOTAL ADULT 6.4ZE+ll Q.QQE+OQ 1.5&f+ll D.DOE+00 O.DOE+00 O.ODE+DQ 1.85E+10 N/A INGEST. TEEN 8.37E+ll O.OQE+OQ 2.07E+ll O.DOE+00 O.DOE+00 Q.OOE+OQ 2.35E+10 N/A CHILD 1.4)E+12 Q.DOE+00 3.56E+Il O.DOE+00 O.DOE+00 O.DOE+00 1.89E+10 N/A INFANT 1.4QE+ll O.QQE+OQ 5.76f+10 O.OOE+00'.DOE+00 O.OOE+QQ 2.82E+09 N/A INHAL. ADULT 9.92E+07 Q.QQE+00 6.)Of+06 O.DOE+00 O.DOE+00 9.60E+06 7.22E+05 N/A TffN 1.QBE+Q& O.QQE+OQ 6.6&E+06 0.00f+OQ O.DOE+00 ).65E+07 7.65E+05 N/A CHILD 1.01f+DB O.QDE+QQ 6.44E+Q6 0.DOE+00 Q.DOE+DO 1.48E+07 3.43E+05 H/A INFANT 4.09E+07 O.QQE+QO 2.59E+06 O.DOE+00 D.DOE+00 1.12E+07 1.3)E+05 N/A BONE LIVER T.BODY HYROID KIDNEY LUNG G.l. SKIN Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

~NXINUN VALUES FOR PA HWAYS~*

GROUND: GROUND: GOAT CQW TOTAL T.B./ORG. SKIN HILK: MILK: HEAT: VEGTBLE: INGEST: INHAL.

Q.OQE+00 O.QQE+OQ 1.51E+11 6.23f+)Q 7.00f+09 1.19E+12 1. 41E+12 1.08E+08 PAGE: 4-15

O.O.C.M. MAXIMUM PATHMAY DOSE FACTORS: RAOIONUCLIOES OTHER THAN NOBLE GASES*

"r~dTOPE: Y-90 PATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT D.DOE+DO O.DOE+DO O.DOE+DO O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+DO O.DOE+Do TEEN D.DOE+Do D.OOF+OD O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.ODE+00 O.DOE+DO CHILD O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 O.DOE+DO D.DOE+00 O.OOOO O.aOE+OO INFANT D.DOE+00 O.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 0-DOE+00 0 DOE+Do O.DOE+Do GOAT ADULT 3.83E+00 O.DOE+00 1.03E-O) O.DOE+00 O.QOE+00 D.DOE+00 4.06E+04 N/A HILK TEEN 7.03E+00 D.DOE+00 1.89E-O) O.DOE+00 O.DOE+00 0-DOE+00 5.80E+04 H/A CHILD 1.74E+Ol O.OOE+OO 4.66E-O) O.OaE+OO a.OOE+OO O.aOE+OO 4.95E+O4 H/A INFANT 3.07E+02 O.DOE+00 9.86E-O) O.DOE+00 D.DOE+00 0 DOE+00 5.08E+04 H/A CON ADULT 1-79E+01 O.DOE+00 4-79E-01 O.DOE+00 O.DOE+Do O.QOE+00 1.89E+05 N/A HILK TEEN 3.28E+01 D.DOE+00 8.84E-D) O.DOE+00 D.DOE+00 O.DOE+00 2.71E+05 H/A CHILD 8.12E+01 O.DOE+00 2.17E+Do D.DOE+00 D.DOE+00 O.DOE+Do 2.31E+05 N/A INFANT 1.72E+02 O.DOE+00 4.60E+00 O.DOE+00 D.DOE+00 O.DOE+00 2.37E+05 H/A HEAT ADULT 3.55E+Ol O.DOE+00 9.52E-O1 O.DOE+00 D.DOE+00 O.DOE+00 3.76E+05 H/A TEEN 2.99E+Ol O.DOE+00 8.04E-O) O.DOE+00 O.DOE+00 O.DOE+00 2.46E+05 N/A CHILD 5.65E+01 0.DOE+00 1.5)E+00 O.DOE+00 O.DOE+00 D.DOE+00 1.6)E+05 H/A INFANT 0.DOE+00 O.DOE+00 0.DOE+00 D.ODE+00 0.00E+ao O.DOE+00 O.DOE+DO H/A Y~".TBLE ADULT 4.39E+03 O.DOE+00 1.)BE+02 D.DOE+00 D.DOE+Do O.DOE+00 4.65E+07 H/A TEEN 4. 1OE+03 O.DOE+00 1.10E+02 O.DOE+00 D.DOE+Do D.DOE+00 3.38E+07 H/A CHILD 7.61E+03 0.DOE+00 2.04E+02 O.DOE+00 D.DOE+00 D.DOE+00 2.17E+07 H/A INFANT D.ODE+OO O.OOEe00 O.DOE+00 O.DOE+DO O.DOE+00 D.DOE+00 D.DOE+DO N/A TOTAL ADULT 4.44E+03 O.DOE+00 1.19E+02 O.DOE+00 O.DOE+00 O.DOE+00 4.7)E+07 H/A

&GEST TEEN 4.)7E+03 O.OOE+OO 1.12E+O2 O.OOE+OO O.OOE+OO O.aOE+OO 3.44E+O7 H/A

, CHILD 7.77E+03 0.DOE+00 2.08E+02 0.DOE+00 0.DOE+00 O.DOE+00 2.2)E+07 N/A INFANT 4.78E+02 0.DOE+00 5.59E+00 O.DOE+00 O.DOE+00 O.DOE+00 2.88E+05 H/A INHAL. ADULT 2.09E+D3 0.00E+00 5.6)E+Ol O.DOE+00 0-DOE+00 1.70E+05 5.06E+05 N/A TEEH 2.98E+03 0.DOE+00 8.00E+Dl O.DOE+00 D.DOE+00 2.93E+05 5.59E+05 N/A CHILD 4.1)E+03 O.DOE+00 l. l)E+02 O.DOE+00 O.DOE+00 2.62E+05 2.68E+05 H/A INFANT 3.29E+03 O.DOE+00 8.82E+Ol O.DOE+00 O.DOE+00 2.69E+05 1.04E+05 H/A BONE LIV R . OOY G. S H Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec MAXIMUM VALU S OR PA MAYS~

GROUND: GROUND: GOAT COW TOTAL T. B-/ORG.. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: 'HHAL.

O.DOE+DO O.OOE+00 5.8OE+04 2.7lE+05 3.76E+05 4.65E+07 4.71E+07 5.59E+05 V

PAGE: 4-16 DAT

O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES>>

lbv lOPE: Sr-91 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN tmUNO ADULT 0.00E+00 O.OOE+00 O.OOE+Oa O.OOE+00 0;OOE+00 0.00E+00 0.00E+00 0.00E+00 TEEN 0.00E+00 O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 CHILD O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 O.aaE+00 O.aOE+aa INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 .O.OOE+00

~GOAT ADULT 2.73E+04 O.OOE+00 1.10E+03 0.00E+00 O.OOE+00 O.OOE+00 1.30E+05 N/A iMILK TEEN 5.02E+04 O.OOE+00 2.00E+03 O.OOE+ao O.OOE+00 0.00E+00 2.28E+05 N/A CHILD 1.23E+05 0.00E+00 4.65E+03 O.OOE+00 O.OOE+00 0.00E+00 2.72E+05 N/A INFANT 1.22E+05 O.OOE+00 9.29E+03 O.OOE+00 0 OOE+00 O.OOE+00 3.04E+05 N/A'OW ADULT 7.29E+03 0.00E+00 2.94E+02 O.OOE+00 O.OOE+00 O.OOE+00 3.47E+04 N/A MILK TEEN 1.34E+04 O.OOE+00 5.32E+02 O.OOE+OO O.OOE+OO O.OOE+00 6.07E+04 N/A .

CHILD 3.28E+04 O.OOE+00 1.24E+03 0.00E+00 O.OOE+00 O.OOE+00 7.25E+04 N/A INFANT 6.84E+04 a'.aOE+aO 2.48E+O3 O.OOE+aa a.aOE+aO O.OaE+aO 8.1aE+O4 N/A

. ADULT 5.01E-11 O.OOE+00 2.02E-I2 O.OOE+00 O.OQE+00 O.OOE+00 2.38E-IO N/A TEEN 4.21E-ll 0.00E+OO 1.68E-I2 0.00E+00 O.OOE+00 O.OOE+00 1.91E-IO N/A CHILD 7.90E-II 0.00E+00 2.98E-12 0.00E+00 O.OOE+00 0.00E+00 1.74E-10 N/A INFANT 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 N/A

&LE ADULT TEEN 1.01E+05 9.39E+04 O.OOE+00 4.06E+03 O.OOE+00 O.OOE+00 O.OOE+00 4.79E+05 O.OOE+00 3.74E+03 0.00E+00 0-OOE+00 0-OOE+00 4.26E+05 N/A N/A CHILD l.73E+05 O.OOE+00 6.53E+03 O.OOE+00 O.OOE+00 O.OOE+00 3.82E+05 N/A INFANT O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 N/A TOTAL ADULT 1.35E+05 O.OOE+00 5.46E+03 O.OOE+00 O.OOE+00 0.00E+00 6.44E+05 N/A ZHBEST TEEN 1.58E+05 0.00E+00 6.27E+03 O.OOE+00 0.00E+00 0.00E+00 7.14E+05 N/A CHILD 3.29E+05 0.00E+00 1.24E+04 O.OOE+00 0.00E+00 0.00E+00 7.26E+05 N/A INFANT 1.91E+05 O.OOE+00 l. 18E+04 O.OOE+00 O.OOE+00 O.OOE+00 3.85E+05 N/A INHAL. ADULT 6.19E+01 O.OOE+00 2.50E+00 O.OOE+00 O.OOE+00 3.65E+04 1.91E+05 N/A TEEN 8.80E+Ol- O.OOE+00 3.51E+00 O.OOE+00 O.OOE+00 6.07E+04 2.59E+05 N/A CHILD 1.21E+02 O.OOE+00 4.59E+00 O.OOE+00 O.OOE+00 5.33E+04 1.74E+05 N/A INFANT. 9.56E+Ol O.OOE+00 3.46E+00 O.OOE+00 O.OOE+00 5.26E+04 7.34E+04 N/A BONE LIVER T.BOOY THYROID KIDNEY LUNG G.l. SKIN Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

"*MAXIMUMVALUES FOR PATHWAYS>>>>>>

GROUND: GROUND: GOAT COW TOTAL T.B./ORG.'. SKIN M!LK: MILK: MEAT: VEGTBLE: INGEST: INHAL.

'.OOE+00 0.00E+00 3.04E+05 8.10E+04 2.38E-IO 4.79E+05 7.26E+05 2.59E+05 PAGE: 4-17

0 D.C.M. HAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES>>

ISOTOPE: Y-91 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID . KIDNEY LUNG G.I. SKIN GROUND ADULT 1.06E+06 l.06E+06 1.06E+06 1.06E+06 1.06E+06 '1.06E+06 1.06E+06 1.20E+06 TEEN 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.20@46 CHILD 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.20E+06 INFANT 1.06E+D6 1.06E+D6 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.20E+06 GOAT ADULT 5.32E+02 0.DOE+00 1.42E+Ol D.DOE+00 Q.DOE+00 O.DOE+00 2.93E+05 N/A tGLK TEEN 9.79E+02 Q.DOE+00 2.62E+01 0.DOE+00 O.DOE+00 O.DOE+00 4.01E+05 N/A CHILD 2.42E+03 Q.QQE+QQ 6.47E+Ol Q.QQE+QQ O.DOE+DO O.DOE+00 3.22E+05 N/A INFANT 3.78E+04 Q.DOE+00 1.21E+02 Q.DOE+00 Q.DOE+00 0.DOE+00 3.25E+05 N/A CGM ADULT 2.94E+03'Q.DOE+00 7.85E+01 O.DOE+00 Q.QDE+OD O.DOE+DD 1.62E+06 N/A NILK TEEN 5.40E+03 Q.QQE+00 1.45E+02 Q.QQE+QQ D.DOE+00 Q.DOE+00 2.22E+06 N/A CHILD 1.34E+04 Q.DOE+00 3.57E+02 O.DOE+00 O.DOE+00 O.DOE+00 1.78E+06 N/A JNFANT 2.51E+04 0.00E+00 6.68E+02 Q.DOE+00 Q.DOE+00 Q.DOE+00 1.80E+06 N/A NEAT ADULT 4.65E+05 0.00E+00 1.24E+04 Q.DOE+00 O.DOE+00 Q.DOE+00 2.56E+08 N/A TEEN 3.91E+05 Q.DOE+00 1.05E+04 Q.DOE+00 Q.DOE+00 O.DOE+00 1.60E+08 N/A 7.39E+05 Q.DOE+00 1.98E+04 Q.DOE+00 O.QDE+00 O.DOE+00 9.85E+07 CHILD INFANT Q.DOE+QQ Q.QQE+QQ D.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 '/A N/A 3LE ADULT 4.27E+06 Q.DOE+00 1.14E+05 0.DOE+00 Q.DOE+00 0.DOE+00 2.35E+09 N/A TEEN 7.05E+06 Q.DOE+00 1.89E+05 Q.DOE+00 D.DDE+00 O.DOE+DO 2 89E+09 N/A CHILD 1.72E+07 0.00E+00 4.60E+05 Q.QQE+QQ D.DOE+00 Q.OQE+QO 2.29E+Q9 N/A INFANT O.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 N/A TOTAL ADULT 4.74E+06 Q.DOE+00 1.27E+05 Q.DOE+00 Q.DOE+00 O.DOE+DO 2.61E+09 N/A INGEST TEEN 7.45E+06 0.00E+00 2.DOE+05 O.DOE+00 0.DOE+00 0.DOE+00 3.05E+09 N/A CHILD 1.79E+07 O.OQE+00 4.80E+05 O.DOE+00 D.DOE+00 O.DOE+00 2.39E+09 N/A INFANT 6.29E+04 Q.DOE+00 7.88E+02 Q.DOE+00 Q.DOE+DO Q.DOE+00 2.12E+06 N/A INHAL. ADULT 4.62E+05 Q.QQE+QD 1.24E+04 Q.DOE+00 D.DOE+00 1.70E+06 3.85E+05 N/A TEEN 6.61E+05 Q.QQE+QQ 1.77E+04 D.DOE+00 Q.DOE+00 2.94E+06 4.09E+05 N/A CHILD 9.14E+O5 Q.QQE+QQ 2.44E+04 Q.DQE+QQ Q.DOE+DO 2.63E+06 1.84E+05 N/A INFANT 5.88E+05 Q.QQE+00 1.57E+04 0.00E+QQ 0.DOE+00 2.45E+06 7.03E+Q4 N/A BONE LIVER T.BODY HYROID KIDN Y LUNG G.I.

"Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

"*"HAXIHUHVALUES OR PA HWAYS**>>

GRQUNO: GROUND: GOAT COW TOTAL T.B./ORG. SKIN HILK: HILK: HEAT: VEGTBLE: INGEST: INHAL.

1.06E+06 1.20E+06 4.01E+05 2.22E+06 2.56E+08 2.89E+09 3.05E+09 2.94E+06 p

PAGE: 4-18

O ~ D-C-H.

~ ~ ~ MAXIMUM PATHWAY DOSE FACTORS-'ADIOHUCLIDES OTHER THAN NOBLE GASES*

ISOTOPE: Nb-95 PATHWAY AGE GROUP BONE LIVER' T.BODY THYROID KIDNEY LUNG G.I. SKIN ADULT 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.59E+08 TEEN 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35f+08 1.35E+08 1.35E+08 1.59EAB CHILD 1.35E+08 1.35E+08 1.35E+08 1.35E+08'1.35E+08 1.35E+08 1.35E+08 1.59E+08 INFANT 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.59E+08 GOAT ADULT 4.78E+03 2.66E+03 1.43E+03 O.OOE+00 2.63E+03 O.OOE+QO 1.61E+07 N/A HHK TEEN 8.15E+03 4.52E+03 2.49E+03 O.OOE+00 4.38E+03 O.OOE+00 1.93E+07 N/A CHILD 1.84E+04 7.17E+03 5.12E+03 0.00E+00 6.73E+03 0.00E+00 1;33E+07 N/A INFANT 2.86E+05 1.42E+04 8.1BE+03 0.00E+00 1.01E+04 O.OOE+00 1.19E+07 N/A ADULT 2.44E+04 1.36E+04 7.31E+03 O.OOE+00 1.34E+04 O.OOE+00 8.25E+07 N/A TEEN 4.17E+04 2.31E+04 1.27E+04 0.00E+00 2.24E+04 O.OOE+00 9.89E+07 N/A CHILD 9.-41E+04 3.67E+04 2.62E+04 O.OOE+00 3.44E+04 O.OOE+00 6.78E+07 N/A INFANT 1.7GE+05 7.24E+04 4.18E+04 0.00E+00 5.19E+04 O.OOE+00 6;11E+07 N/A ADULT 8.48E+05 4.72E+05 2.54E+05 0.00E+00 4.66E+05 O.OOE+00 2.86E+09 N/A TEEN 6.62E+05 3.67E+05 2.02E+05 0.00E+00 3.56E+05 0.00E+00 1.57E+09 N/A CHILD 1.14E+06 4.45E+05 3.1BE+05 0.00E+00 4.18E+05 0.00E+00 8.23E+08 N/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 N/A "3LE ADULT 1.10E+05 6.11E+04 3.28E+04 0.00E+00 6.04E+04 0.00E+00 3.71E+08 N/A TEEN 1.64E+05 9.10E+04 5.01E+04 0.00E+00 8.82E+04 0;OOE+00 3.89E+08 N/A CHILD 3.63E+05 1.41E+05 1.01E+05 0.00E+00 1.33E+05 0.00E+00 2.6IE+08 N/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 N/A TOTAL ADULT 9.87E+05 5.49E+05 2.95E+05 0.00E+00 5.43E+05 O.OOE+00 3.33E+09 N/A iNGEST. 'T'IEN 8.76E+05 4-86E+05 2.68E+05 0.00E+00 4.71E+05 0.00E+00 2.08E+09 . N/A CHILD 1.62E+06 6.30E+05 4.50E+05 0.00E+00 5.92E+05 0.00E+00 1.17E+09 N/A INFANT 4.62E+05 8.65E+04 5.00E+04 0.00E+00 6.20E+04 0.00E+00 7.30E+07 N/A INHAL. ADULT 1.41E+04 7.82E+03 4.21E+03 0.00E+00 7.74E+03 5.05E+05 1.04E+05 N/A TEEN 1.86E+04 1.03E+04 5.66E+03 0.00E+00 1.00E+04 7.51E+05 9.68E+04 N/A CHILD 2.35E+04 9.18E+03 6.55E+03 0.00E+00 8.62E+03 6.14E+05 3.70E+04 N/A INFANT 1.57E+04 6.43E+03 3.78E+03 0.00E+00 4.72E+03 4.79E+05 1.27E+04 N/A BONE LIVER T.BODY HYROIO K OHEY LUNG G.I. SKIN I

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3

~

Deposition pathways: units are mrem-m2/yr/uCi/sec

~"HAXIHUN VALUES FOR PATHWAYS~~~

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN HILK- NILK-'EAT: VEGTBLE: INGEST: INHAL.

1.35E+08 1.59E+08 1.93E+07 9.89E+07 2.86E+09 3.89E+08 3.33E+09 7.5IE+05 PAGE: 4-19 A tV

O.D.C-M. MAXIMUM'PATHWAYDOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES>>

ISOTOPE: 2r-95 PATHWAY AGE GROUP BONE , LIVER T.BODY THYROID KIDNEY LUNG . G.I.

GROUND ADULT 2.42E+08 2.42E+08 2.42E+08 2.42E+OS 2.42E+08 2.42E+OS 2.42E+08 2 8IE+08 TEEN 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.81E+08 CHILD " 2.42E+QS 2.42E+QS 2.42E+08 2.42E+08 2.42E+08 2.'42E+OS 2.42E+08 2.81E+08 INFANT 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.81E+08 GOAT ~

ADULT 5.92E+Ol 1.90E+Ol 1.28E+Ol O.OOE+OO 2.98E+Ol O.OOE+OO 6.OlE+04 H/A MILK TEEN 1.03E+02 3.26E+01 2.25E+01 O.OOE+00 4.80E+Ol O.DOE+00 7.53E+04 N/A CHILD 2.40E+02 5.28E+01 4.70E+Ol O.OOE+00 7.56E+01 O.DOE+00 5.51E+04 N/A INFANT 3.56E+03 1.04E+02 7.38E+01 O.OOE+00 1.12E+02 'O.DOE+00 5.18E+04 N/A COW ADULT 3.31F+02 1.06E+02 7.18E+01 O.OOE+00 1.67E+02 0.00E+00 3.36E+05 N/A MILK TEEN 5.79E+02 1.83E+02 1.'26E+02 O.OOE+00 2.68E+02 O.OOE+00 4.21E+05 N/A CHILD 1.34E+03 2.95E+02 2.63E+02 O.OOE+00 4.23E+02 O.DOE+00 3.08E+05 N/A INFANT 2.39E+03 5.82E+02 4.12E+02 O.QOE+00 6.27E+02 O.DOE+00 2.90E+05 N/A MEAT ADULT 7.&3E+05 2.51E+05 1.70E+05 O.QOE+00 3.94E+05 O.DOE+00 7.96E+08 H/A TEEN 6.27E+05 1.98E+05 1.36E+05 O.QQE+00 2.91E+05 O.DOE+00 4.57E+08 N/A CHILD 1.11E+06 2.45E+05 2.1&E+05 O.QQE+00 3.50E+05 O.OOE+00 2.55E+08 N/A INFANT 0.00E+00 O.OOE+00 Q.QQE+00 O.QQE+00 O.QOE+00 O.DOE+00 O.OOE+00 N/A

~BLE ADULT 9.90E+05 3.17E+05 2.15E+05 Q.OOE+00 4.98E+Q5 Q.OOE+00 1.01E+09 N/A TEEN .

1.56E+06 4.91E+05 3.3SE+05 0.00E+00 7.22E+05 O.OOE+QQ 1.13E+Q9 N/A CHILD 3.57E+06 7.85E+05 6.99E+05 Q.OOE+00 1.12E+06 O.OOE+Oo 8.19E+08 N/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Q.QOE+00 O.DOE+00 O.OOE+00 N/A TDTAL ADULT 1.77E+06 5.69E+05 3.85E+05 0.00E+00 8.92E+05 O.DOE+00 ).BOE+09 N/A INGEST. TEEN 2.IBE+06 6.89E+05 4.74E+05 O.OOE+00 1.01E+06 0.DOE+00 1.59E+09 N/A CHILD 4.69E+06 1.03E+06 9.17E+05 O.OOE+00 1.47E+06 O.OQE+00 1.07E+09 N/A INFANT 5.94E+03 6.86E+02 4.86E+02 O.OOE+00 7.39E+02 O.DOE+00 3.41E+05 N/A INHAL. ADULT 1.07E+05 3.44E+04 2.33E+04 O.OOE+00 5.42E+04 1.77E+06 1.50E+05 H/A TEEN 1.46E+05 4.58E+04 3.15E+04 O.OOE+00 6.74E+04 2.69E+06 1.49E+05 H/A CHILD 1.90E+05 4.1SE+O4 3.7OE+O4 O.OOE+OO 5.96E+04 2.23E+06 6. 1)E+O4 N/A INFANT 1.15E+05 2.79E+04 2.03E+04 O.OOE+00 3.1)E+04 1.75E+06 2. 17E+04 N/A BONE LIVER . BODY HYRO KIDN Y LUNG G.I.

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec I

>>HAXIMUH VALUES FOR PATHWAYS*>>*

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. 'SKIN MILK: MILK: HEAT: VEGTBLE: INGEST: INHAL.

'2.42E+08 2.81E+08 7.53E+04 4-2)E+05 ?.96E+OB 1.13E+09 1.80E+09 2.69E+06 4-20

O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE, GASES*

ISOTOPE: Mo-99 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00

'ROUND ADULT D.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 TEEN O.DOE+00 D.DOE+00 D.DOE+00 O.DOE+00 D.DOE+00 O.DOE+00 0.DOE+00 D.DOE+00 CHILD O.DOE+00 D.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 INFANT O.ODE+OO O.ODE+00 O.OOE+OO O.DOE+DO D.OOE+OO O.DOE+00 O.DOE+DO O.DOE+00 GOAT ADULT 0.DOE+00 1.34E+06'.55E+05 O.DOE+00 3.03E+06 O.DOE+00 3- IOE+06 H/A "

HILK TEEN O.DOE+00 2.42E+06.4.61E+05 O.DOE+00 5.53E+06 0.DOE+00 4.33E+06 N/A CHILD O.DOE+00 4.39E+06 1.09E+06 O.DOE+00 9.38E+06 O.DOE+00 3.63E+06 N/A INFANT O.DOE+00 1.12E+07 2.19E+06 O.DOE+00 1.68E+07 O.oaf+DO 3.70E+D6 H/A CDW ADULT O.DOE+00 6.24E+06 1.19E+06 O.DOE+00 1.41E+07 O.DOE+00 1.45E+07 H/A MILK TEEN 0.DOE+00 1.13E+07 2.15E+06 O.DOE+00 .2.58E+07 O.DOE+00 2.02E+07 H/A CHILD O.DOE+Do 2.05E+07 5.07f+06 O.DOE+00 4.38E+07 O.DOE+00 1.70E+07 N/A INFANT O.DOE+00 5.24E+07 1.02E+07 O.DOE+DO 7.83E+07 O.DOE+00 1.73E+07 H/A HEAT ADULT O.DOE+00 3.30E+04 6.27E+03 O.DOE+Do 7.46E+04 O.DOE+00 7.64E+04 N/A TEEN O.DOE+00 2.73E+04 5.20E+03 O.DOE+00 6.'24E+04 O.DOE+00 4.88E+04 N/A CHILD 0.DOE+00 3.79E+04 9.38E+03 O.DOE+00 8.10E+04 D.DOE+DO 3.14E+04 N/A INFANT O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 D.DOE+00 N/A BLE ADULT O.DOE+00 2.03E+06 3.86E+05 O.DOE+00 4.60E+06 O.DOE+00 4.71E+06 N/A TEEN O.OOE+OO 1.86E+06 3.55E+Os O.OOE+OO 4.27E+06 O.OOE+OO 3.34E+06 H/A CHILD O.DOE+00 2.54E+06 6.30E+05 O.OOF+Da 5.43E+06 O.DOE+00 2.10E+06 N/A INFANT a.aoE+oa a.'aoE+oo o.ooE+oo o.ooE+oo o.ooE+oo O.ooE+oo O.DOE+00 N/A TOTAL ADULT a.DOE+00 9.64E+06 1.83E+06 0.00E+00 2.18E+07 O.DOE+00 2.24E+07 N/A XHBEST TEEN D.DOE+Do 1.56E+07 2.97E+06 O.DOE+00 3.56E+07 O.DOE+00 2.79E+07 N/A CHILD O.OOE+00 2.75E+07 6.80E+06 O.DOE+00 5.87E+07 O.DOE+00 2.27E+07 N/A INFANT O.DOE+00 6.37E+Q7 1.24E+07 O.DOE+00 9.51E+07 0.DOE+00 2. 1OE+07 N/A MHAL. ADULT O.DOE+DO 1.21E+02 2.30E+Ol O.DOE+00 2.91E+02 9.12E+04 2.48E+05 N/A TEEN O.OOE+Oa 1.69E+02 3.22E+Ol O.OOE+aa 4.11E+02 1.54E+05 2.69E+05 H/A CHILD O.DOE+00 1.72E+02 4.26E+Ol O.DOE+Do 3.92E+02 1.35E+05 1.27E+05 H/A INFANT O.OOE+Oa 1.65E+02 3.23E+Ol Q.aaf+aa 2.65E+02 1.35E+05 4.87E+04 N/A BONE LIVER .BODY HYROID KIDNEY LUNG G.l. SKIN

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

"*~MAXIMUMVALU S FOR PA HWAYS*"*

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: IHHAL.

O.OOE+aa O.OOE+Oa 1.68E+a7 7.83E+07 8.10E+04 5.43E+06 9.51E+07 2.69E+05 PAGE: . 4-21 Ar V

$1

O.D.C.M. NXIMUM PATHWAY DOSE FACTORS-'ADIONUCLIDES OTHER THAN NOBLE GASES

~OTOPE: Tc-99m PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND .ADULT O.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 0.DOE+00 TEEN O.DOE+00 O.OOE+QO O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+DO O.DOE+00 CHILD O.DOE+00 D.DOE+00 O.OOE+QD Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 INFANT O.DOE+00 Q.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 O.DOE+DO 0.DOE+00 GOAT ADULT 1.79E-Ql 5.Q?E-01 &.46E+00 0.DOE+00 7,70E+00 2.48E-01 3.DOE+02 N/A HILK TEEN 3.11E-Q1 &.68E-Ql 1.12E+Ol 0.DOE+00 1.29E+01 4.82E-01 5.70E+02 N/A CHILD 7.13E-O1 1.40E+00 2.32E+Ql .D.DOE+00 2.03E+Ol ?.10E<<Ol 7.96E+02 N/A INFANT 1.24E+Dl 3.06E+00 3.94F+01 O.DOE+00 3.29E+Ql 1.60E+00 8.89E+02 N/A COW ADULT 8.37E-01 2.36E+00 3.01E+01 Q.DOE+00 3.59E+01 1.16E+00 1.40E+03 H/A MILK TEEN 1.45E+00 4.0SE+00 5.25E+Ol O.DOE+00 6.03E+Ol 2.25E+00 2.66E+03 N/A CHILD 3.33E+DD 6.53E+00 1.08E+02 O.DOE+00 9.49E+01 3.31E+DD 3.71E+03 N/A INFANT 6.92E+00 1.43E+01 1.84E+02 O.DOE+00 1.54E+02 7.47E+DD 4.15E+D3 N/A HEAT ADULT l.47E-ZI 4.14E-21 5.28E-20 O.DOE+DO 6.29E-ZO 2.03E-21 2.45E-18 N/A TEEN l.16E-21 3.25E-21 4.21E-20 O.DOE+DO 4.84E-20 1.8OE-21 2.13E-18 H/A CHILD 2.04E-21 4.01E-Zl 6.64E-20 O.DOE+DO 5.8ZE-ZO 2.03E-21 2.28E-18 N/A INFANT D.DOE+00 O.DOE+DO O.DOE+DO O.ODE+DD D.DOE+DO O.DOE+DO O.DOE+00 N/A

, V<GTBLE ADULT 1.02E+00 2.89E+00 3.68E+Dl Q.DOE+00 4.39E+01 ).42E+00 1.71E+03 N/A TEEN 9.03E-Ol 2.52E+DD 3.26E+Dl D.DOE+DO 3.75E+Ol 1.4DE+00 1.65E+03 N/A CHILD 1.55E+00 3.05E+00 5.05E+Ol O.DOE+00 4.43E+01 1.55E+00 1.73E+03 N/A INFANT O.DOE+00 D.DOE+00 D.DOE+DO O.ODE+DD D.DOE+00 O.OOE+OD O.ODE+OD N/A .

TOTAL ADULT 2.04E+DD 5.76E+00 7.34E+Dl D.DOE+DO 8.75E+Ol 2.82E+00 3.41E+03 N/A INGEST TEEN 2.67E+DD 7.43E+00 9.63E+01 O.DOE+00 1.11E+02 4.13E+00 4.88E+03 N/A

~

CHILD 3.6DE+00 1.10E+Dl 1.82E+02 D.DOE+DO 1.59E+02 5.57E+00 6.25E+03 N/A INFANT 1.93E+Dl 1.73E+01 2.23E+02 O.DOE+00 1.87E+02 9.07E+00 5.04E+03 H/A INHAL. ADULT l.03E-D3 2.91E-03 3.70E-02 O.DOE+00 4.42E-02 7.64E+02 4.16E+03 H/A TEEN 1.38E-03 3.86E-03 4.99E-02 0.00E+OD 5.76E-02 1.15E+03 6.13E+03 H/A CHILD 1.78E-03 3.48E-03 5.77E-02 O.ODE+OD 5.07E-02 9.5IE+02 4;81E+03 H/A INFANT 1.4DE-03 2.88E-03 3.72E-OZ 0.00E+OD 3.11E-02 8.11E+02 2.03E+03 H/A BONE LIV R .BODY THYROID 'KIDNEY LUNG G.I. SK Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are= mrem-m2/yr/uCi/sec

""*MAXIMUMVALUES OR PA HWAYS~~

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: HEAT: VEGTBLE: INGEST: INHAL.

D.DOE+00 D.DOE+00 8.89E+02 4.15E+03 2.45E-18 1.73E+03 6.25E+03 6. 13E+03 PAGE: 4-22 zrrV

O.O.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIOES OTHER THAN NOBLE GASES*

'L ~POPE: Ru-106 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG . G.I. SKIN GROUND ADULT 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4;18E+08 4.18E+08 5.01E+OS TEEN 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4.18E+OS 4.18E+08 5.01E+0&

CHILD 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4.1SE+08 4.18E+OS 4.18E+08 5.01BOS INFANT 4.18E+OS 4.18E+08 4.18E+08 4.18E+08 4.18E+OS 4.18E+08 4.18E+08 5.01E+08 GOAT ADULT 1.50E+03 0.00E+00 1.90E+02 0.00E+00 2.90E+03 0.00E+00 9.71E+04 N/A MILK TEEN 2.76E+03 0.00E+00 3:48E+02 O.OOE+00 5.32E+03 0.00E+00 1.32E+05 N/A CHILD 6.79E+03 O.OOE+00 8.47E+02 O.OOE+00 9.17E+03 O.OOE+00 1.06E+05

. INFANT 1.17E+05 O.OOE+00 1.75E+03 O.OOE+00 1.65E+04 O.OOE+00 1.06E+05 N/A N/A COW ADULT 9.65E+03 O.OOE+00 1.22E+03 O.OOE+00 1.86E+04 O.OOE+00 6.24E+05 N/A MILK TEEN 1.77E+04 O.OOE+00 2.24E+03 O.OOE+00 3.42E+04 O.OOE+00 8.51E+05 N/A CHILD 4.37E+04 O.OOE+00 5.45E+03 O.OOE+00 5.90E+04 O.OOE+00 6.80E+05 N/A INFANT 9.00E+04 O.OOE+00 1.12E+04, O.OOE+00 1.06E+05 O.OOE+00 6.83E+05 N/A NEAT ADULT 1.48E+09 O.OOE+00 1.S7E+08 0.00E+00 2.85E+09 0.00E+00 9.56E+10 N/A TEEN 1.24E+09 0.00E+00 1.57E+08 0.00E+00 2.40E+09 0.00E+00 5.97E+10 AN/A CHILD 2.34E+09 0.00E+00 2.92E+08 0.00E+00 3.16E+09 0.00E+00 3.64E+10 N/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A

~ BLE ADULT TEEN CHILD 1.73E+08 O.OOE+00 2.19E+07 O.OOE+00 3.34E+08 O.OOE+00 1.12E+10 2.91E+08 0.00E+00 3.67E+07 0.00E+00 5.61E+08 O'.OOE+00 1.40E+10 7.11E+08 0.00E+00 8.88E+07 O.OOE+00 9.61E+08 O.OOE+00 1.11E+10 N/A N/A

'N/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A TOTAL ADULT 1.65E+09 O.OOE+00 2.09E+08 O.OOE+00 3.19E+09 O.OOE+00 1.07E+ll N/A INGEST. TEEN 1.53E+09 O.OOE+00 1.93E+08 O.OOE+00 2.96E+09 O.OOE+00 7.36E+10 N/A CHILD 3.05E+09 O.OOE+00 3.81E+08 O.OOE+00 4.12E+09 O.OOE+00 4.75E+10 N/A INFANT 2.07E+05 O.OOE+00 1.30E+04 O.OOE+00 1.23E+05 O.OOE+00 7.90E+05 N/A INHAL. ADULT 6.91E+04 O.OOE+00 8.72E+03 O.OOE+00 1.34E+05 9.36E+06 9.12E+05 N/A TEEN 9.84E+04 O.OOE+00 1.24E+04 O.OOE+00 1.90E+05 1.61E+07 9.60E+05 H/A CHILD 1.36E+05 O.OOE+00 1.69E+04 O.OOE+00 1.84E+05 1.43E+07 4.29E+05 H/A INFANT 8.68E+04 0.00E+00 1.09E+04 0.00E+00 1.07E+05 1. 16E+07 1.64E+05 N/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.l. SKIN Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

*NXIMUM VALUES FOR PATHWAYS*~~

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. .SKIN MILK: Ml LK: MEAT: VEGTBLE: INGEST: IHHAL.

.4.18E+08 5.01E+08 l.32E+05 8.51E+05 9.56E+10 1.40E+10 1.07E+11 1.61E+07 PAGE: 4-23

O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES>>

ISOTOPE: Ag-1 lorn PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 3.4QE+Q9 3.40E+Q9 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.97E+Q9 TEEN 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.97E+09 CHILD , 3.40E+09 3.4OE+09 3.40E+09 3.40E+09 3.40E+09 3.40E+Q9 3.40E+09 3.97E+09 INFANT 3.40E+09 3.4OE+09 3.40E+Q9 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.97E+09 GOAT ADULT 4.19E+06 3.&BE+06 2.30E+06 0.00E+00 7.63E+06 O.OQE+00 1.5SE+Q9 H/A HILK TEEN 6.93E+06 6.56E+06 3.99E+Q6 Q.OOE+00 1.25E+07 O.OOE+00 1.84E+09 N/A CHILD 1.50E+07 1.02E+07 8.12E+06 O.OQE+00 1.89E+07 O.OOE+00 1.21E+09 H/A INFANT 2.32E+08 2.03E+07 1.34E+07 O.OQE+00 2.90E+07 O.QOE+00 1.05E+09 N/A COW ADULT 2.65E+07 2.46E+07 1.46E+07 O.OOE+00 4.83E+07 O.OOE+00 1.00E+10 H/A MILK TEEN 4.39E+07 4.15E+07 2.53E+07 O.OQE+QQ 7.92E+07 O.OOE+00 1.1?E+10 H/A CHILD 9.52E+07 6.43E+07 5.14E+07 O.OQE+00 1.20EtQS O.OQE+00 7.65E+09 N/A INFANT 1.76E+08 1.2&E+OS 8.50E+07 O.OOE+00 1.84E+08 O.OOE+00 6.66E+09 N/A ADULT 3.42E+06 3.17E+06 1.&BE+06 O.OOE+00 6.23E+06 Q.OOE+00 1.29E+09 H/A TEEN 2.59E+06 2.45E+06 1.49E+06 O.OOE+00 4.68E+06 O.OOE+00 6.89E+08 N/A CHILD 4.30E+06 2.90E+06 2.32E+06 O.OOE+00 5.41E+06 O.OOE+00 3.45E+08 N/A INFANT O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A BLE ADULT 9.41E+06 8.70E+06 5.17E+06 O.OOE+00 1.71E+07 O.OOE+00 3.55E+09 N/A TEEN 1.42E+07 1.34E+07 8.1&E+06 O.OOE+00 2.56E+07 0.00E+00 3.?&E+Q9 N/A CHILD 3.06E+07 2.06E+07 1.65E+07 O.OOE+00 3.85E+07 O.OOE+00 2.46E+09 N/A INFANT o.ooE+oo o.ooE+oo o.ooE+oo o.ooE+oo o.ooE+oo o.ooE+oo o.ooE+oo N/A TOTAL AD1JLT 4.36E+07 4.03E+07 2.39E+07 O.OOE+00 7.92f+07 O.OOE+00 1.64E+10 N/A INGEST. TEEN 6.76E+07 6.4OE+07 3.89E+07 O.OOE+00 1.22E+08 O.OOE+00 1.&OE+10 N/A CHILD 1.45E+08 9.80E+07 7.83E+07 O.OOE+OO 1.83E+08 O.OOE+00 1.17E+10 N/A INFANT 4.07E+08 1.49E+08 9.84E+07 O.OOE+00 2.13E+08 Q.OOE+00 7.71E+09 N/A INHAL. ADULT 1.0&E+04 1.00E+04 5.94E+03 O.OOE+00 1.97E+04 4.63E+06 3.02E+05 N/A TEEN 1.3&E+04 1.31E+04 7.99E+03 O.OOE+00 2.5QE+04 6.75E+06 2.73E+05 N/A CHILD 1.69E+04 1.14E+04 9.14E+03 O.OOE+00 2.12E+04 5.4&E+06 1.00E+05 N/A INFANT 9.9&E+03 7.22E+03 5.00E+03 O.OOE+00 1.09E+04 3.67E+06 3.30E+04 N/A BONE LIVER .BOQY HY 0 K ON Y LUNG G.I. SKIN

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

>>*"MAXIMUMVALUES FOR PA HWAYS>>*>>

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: INGEST: INHAL.

3.40E+09 3.9?E+09 1.84E+09 l. l?E+10 3.78E+09 1.80E+10 6.75E+06 VEGTBLE'.29E+09 PAGE: 4-24

I O.D-C-M. MAXIMUM PATHWAY 00SE FACTORS: RADIONUCLIDES

.~OTOPE: I-131 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID OTHER THAN NOSLE GASES*

KIDNEY LUNG SKIN GROUND ADULT 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 2.07E+07'.07E+07 TEEH 1.70E+07 -1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 CHILD 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 2.07E+07 INFANT 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 2.07E+07 GOAT ADULT 1.6OE+08 2.29f+08 1.31E+08 7.50E+10.3.92E+08 0.00E+00 6.04E+07 H/A MILK TEEN 2.90E+08 4.06E+08 2. 18E+08 1.19E+11 6.99E+08 O.OOE+00 8.04E+07 H/A CHILD 7.04E+08 7.08E+08 4.02E+08 2.34E+11 l. 16E+09 O.OOE+00 6.30E+07 N/A INFANT 1.22E+09 1.73E+09 7.61E+08 5.69E+11 Z.OZE+09 O.OOE+00 6.18E+07 H/A COW ADULT 7.46E+07 1.07E+08 6.12E+07 3.50E+10 I;83E+08 O.OOE+00 2.82E+07 N/A MILK TEEN 1.35E+08 1.90E+08 1.02E+08 5.53E+10 3.26E+08 O.OOE+00 3.75E+07 N/A CHILD 3.29E+08 3.30E+08 1.88E+08 1.09E+II 5.42E+08 O.OOE+00 2.94E+07 N/A INFANT 6.86E+08 8.08E+08 3.55E+08 2.65E+l1 9.44E+08 Q.OOE+00 2.88E+07 N/A MEAT ADULT 3.54E+06 5.07E+06 2.90E+06 1.66E+09 8.68E+06 O.OOE+00 1.34E+06 H/A TEEN 2.94E+06 4.12E+06 2.21E+06 1.20E+09 7.09E+06 O.OOE+00 8.15E+05 N/A CHILD 5.46E+06 5.49E+06 3. 12E+06 1.81E+09 9.01E+06 O.OOE+00 4.89E+05 N/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 H/A

'GTBLE ADULT 2.86E+07 4.10E+07 2.35E+07 1.34E+10 7.02E+07 O.OOE+00 1.08E+07 H/A TEEN 2.88E+07 4.03E+07 2.16E+07 1.18E+10 6.93E+07.0.00E+00 7.96E+06 N/A CHILD 5.54E+07 5.57E+07 3.17E+07 1.84E+10 9.15E+07 O.OOE+00 4.96E+06 H/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 H/A TOTAL ADULT 2.67E+08 3.82E+08 2.19E+08 1.25E+11 6.54E+08 O.OOE+00 1.01E+08 N/A INGEST. TEEN 4.57E+08 6.40E+08 3.44E+08 1.87E+ll 1. 10E+09 O.OOE+00 1.27E+08

'/A CHILD 1.09E+09 1.10E+09 6.25E+08 3.64E+11 1.81E+09 O.OOE+00 9,79E+07 N/A INFANT 1.91E+09 2.54E+09 1.12E+09 8.34E+ll 2.97E+09 O.OOE+00 9.06E+07 N/A INHAL. ADULT 2.52E+04 3.58E+04 2.05E+04 l. 19E+07 6.13E+04 O.OOE+00 6.28E+03 N/A TEEN 3.54E+04 4.91E+04 2.64E+04 1.46E+07 8.40E+04 O.OOE+00 6.49E+03 N/A CHILD 4.81E+04 4.81E+04 2.73E+04 1.62E+07 7.88f+04 O.OOE+00 2.84E+03 N/A INFANT 3.79E+04 4.44F+04" 1.96E+04 1.4QE+07 5.18E+04 O.OOE+00 1.06E+03 N/A BONE LIVER T. BODY HYROID KIDNEY LUNG G.l. SKIN

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

tlAXlNUN VALUES FOR PATHWAYS*

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: INHAL.

2-07E+07 5.69E+11 2.65E+1 1 1.81E+09 1.84E+10 8.34E+11 9'AGE:

VEGTBLE'NGEST'.70E+07

1. 62E+07 4-25 HPc'v

O.D.C.N. NAXINUN PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*

I>OTOPE: I-132 PATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G. I. SKIN GROUND ADULT O.OOE+00 O.OOE+00 O.OOE+00 O.QOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 TEEN O.OOE+00 Q.OOE+00 O.OOE+00 0-QOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 CHILD Q.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 INFANT Q.QOE+00 Q.OQE+00 O.OQE+00 O.QOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 GOAT ADULT 8.87E-02 2.37E-OI 8.30E-02 8.30E+00 3.78E-OI O.OOE+00 4.46E-02 N/A HILK TEEN 1.57E-Ql a.l2E-QI l.'48E-Ol 1.39E+Ol 6.4&E-OI O.OOE+00 1.79E-QI N/A CHILD 3.72E-Ql 6.84E-OI 3.14E-Ol 3.17E+01 1.05E+00 Q.OOE+00 8.05E-OI N/A

. INFANT 6.44E-Ql l.57E+00 5.58E-Ol 7.35E+Ql 1.75E+00 O.OOE+00 1.27E+00 N/A COM ADULT 4.14E-Q2 1.11E-QI 3.87E-02 3.87E+00 1.76E-OI O.OOE+00 2.08E-Q2 N/A HILK TEEN 7.34E-02 1.92E-QI 6.89E-02 6.47E+00 3.03E-OI O.OQE+00 8.37E-02 N/A CHILD 1. 74E-Ol 3.19E-QI 1.47E-QI 1.48E+Ql 4.88E-OI O.OOE+00 3.75E-OI N/A INFANT 3.60E-QI 7.31E-QI 2.60E-QI 3.43E+Ol 8.16E-QI O.QOE+00 5.93E-OI N/A HEAT ADULT 2.30E-59 6.14E-59 2.15E-59 2.15E-57 9.79E-59 O.OOE+00 I. ISE-59 N/A TEEN 1.87E-59 4.&&E-59 1.75E-59 1.64E-57 7.69E-59 O.OOE+00 2.13E-59 N/A CHILD 3.37E-59 6.20E-59 2.85E-59 2.&SE-57 9.49E-59 O.OOE+00 7.30E-59 N/A INFANT O.OOE+00 O.OOE+00 O.QOE+00 O.OOE+00 O.QQE+00 O.OOE+00 O.OOE+00 N/A VIABLE ADULT 1.90E+Ol 5.08E+Ql 1.7&E+01 1.7&E+03 8.10E+Ol O.OOE+00 9.55E+00 N/A .

TEEN 1.71E+Ql 4.4&E+Ol 1.61E+Ql 1.51E+03 7.06E+01 O.QOE+00 1.95E+Ol N/A CHILD 3.04E+01 5.59E+Ol 2.57E+01 2.59E+03 8.56E+01 Q.QOE+00 6.5&E+Ol N/A INFANT 0:OOE+QO O.OOE+00 Q.QOE+00 O.OOE+OQ O.OOE+00 O.OOE+00 O.QOE+00 N/A TOTAL ADULT 1 . 91E+Q1 5.12E+Ql 1.79E+Ol 1.79E+03 8.15E+Ql O.OOE+00 9.61E+00 N/A

'INGEST. TEEN 1.74E+Ql 4.54E+Ol 1.63E+Ql 1.53E+03 7.16E+01 Q.QOE+00 1.9&E+Ol N/A CHILD 3.10E+Ol 5. 69f+QI 2. 62E+O1 2.64E+03 8.71E+01 O.QQE+00 6.70E+Ol N/A INFANT 1.0QE+QQ 2.30E+00 8.19E-OI 1.QSE+02 2.57E+00 O.QOE+00 1.86E+00 N/A INHAL. ADULT l. 16E+03 3.26E+03 1. 16E+03 1. 14E+05 5.18E+03 O.OOE+00 4.06E+02 N/A TEEN 1.59E+03 4.3&E+03 1.58E+03 1.51E+05 6.92E+03 O.OOE+00 1.27E+03 N/A CHILD 2.12E+03 4.07E+Q3 1.8&E+03 1.94E+05 6.25E+03 Q.QQE+00 3.20E+03 N/A INFANT 1.69E+Q3 3.54E+03 1.26E+03 1.69E+Q5 3.95E+03 O.QQE+00 1.90E+03 N/A BONE LIVER T.BODY HYROID KIDN Y LUNG G. I. SKIN "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

"" MAXIMUM VALUES FOR PA HWAYS>>>>>>

GROUND: GROUND: GOAT COM TOTAL T.B./ORG. SKIN MILK: MILK: NEAT: VEGTBLE: .INGEST: INHAL.

O.OOE+00 O.OOE+00 7.35E+01 3.43E+Ql 2.8&E-57 2.59E+03 2.64E+03 1.94E+05 4-26

t O.D.C.M. MAXIMUM PATHWAY iiOTOPE: Te-132 PATHWAY AGE GROUP BONE DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*

LIVER" T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 0;OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+OO 0.00E+OO TEEN O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 CHILD '0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOF+00 0.00E+00 GOAT ADULT 1.30E+05 8.39E+04 7.88E+04 9.27E+04 8.08E+05 O.OOE+00 3.9?E+06 N/A MILK TEEN 2.32E+05 1.47E+05 1.38E+05 1.55E+05 1.41E+06 O.OOE+00 4.65E+06 N/A CHILD 5.53E+05 2.45E+05 2.96E+05 3.5?E+05 2.27E+06 O.OOE+00 2.47E+06 N/A INFANT 9.50E+06 5.64E+05 5.2?E+05 8.33E+05 3.53E+06 O.OOE+00 2.09E+06 N/A COW AOULT 6.05E+05 3.91E+05 3.67E+05 4.32E+05 3.77E+06 O.OOE+00 1.85E+07 N/A MILK TEEN 1.08f+06 6.85E+05 6.45E+05 7.22E+05 6.5?E+06 O.OQE+00 2.1?E+07 N/A CHILD 2.5SE+06 1.14E+06 1.38E+06 1.66E+06 1.06E+07 O.OOE+00 1.15E+07 N/A INFANT 5.32E+06 2.63E+06 2.46E+06 3.89E+06 1.65E+07 O.OOE+00 9.74E+06 N/A ADULT 4.68E+05 3.03E+05 2.84E+05 3.34E+05 2.92E+06 Q.OOE+00 1.43E+07 N/A TEEN 3.83E+05 2.43E+05 2.28E+05 2.56E+05 2;33E+06 O.OOE+00 7.6SE+06 N/A CHILD 6.99E+05 3.09E+05 3.74E+05 4.51E+05 2.87F+06 O.OOE+00 3.11E+06 N/A INFANT O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+OO 0.00E+00 N/A ABLE ADULT 1.42E+06 9.18E+05 8.62E+05 1.01E+06 8.84E+06 O.OOE+00 4.34E+07 N/A TEEN 1.29E+06 8.17E+05 7;69E+05 8.61E+05 7.83E+06 0.00E+00 2.59E+07 N/A CHILD 2.31E+06 1.02E+06 1.24E+06 1.49E+06 9.49E+06 Q.OOE+00 1.03E+07 N/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A TOTAL AOULT 2.62E+06 1.70E+06 1.59E+06 1.87E+06 1.63E+07 O.OOE+00 8.02E+07 N/A INGEST TEEN 2.99E+06 1.89E+06 1.78E+06 1.99E+06 1.81E+07 O.OQE+00 5.99E+07 N/A CHILD 6. 15E+06 2.72E+06 3.29E+06 3.96E+06 2.53E+07 O.OOE+00 2.74E+07 N/A IHFANT 1-48E+07 3.2OE+06 2.98E+06 4.72E+06 2.00E+07 0.00E+00 1.1SE+07 N/A INHAL. AOULT 2.60E+02 2.15E+02 1.62E+02 1.90E+02 1.46E+03 2.88E+05 5.10E+05 N/A TEEN 3.60E+02 2.90E+02 2.19E+02 2.46E+02 1.95E+03 4.49E+05 4.63E+05 N/A CHILD 4.81E+02 2.72E+02 2.63E+02 3.17E+02 1.77E+03 3.77E+05 1.3BE+05 N/A INFANT 3-72E+02 2.37E+02 1.76E+02 2.79E+02 1.03E+03 3.4OE+05 4.41E+04 N/A BONE LIVER T.BODY HYROID KIDNEY LUNG G.I. SKIN

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

- ~MAXIMUMVALUES OR PA HWAYS"~

GROUND'ROUND: GOAT COW TOTAL T.B./ORG. SKIN M I LK: MILK: MEAT: VEGTBLE: INGEST: IHHAL.

O.OOE+00 O.OOE+00 9.50E+06 2.17E+07 1.43E+07 4.34E+07 8.02E+07 5.10E+05 PAGE: 4-27

O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES>>

~ISOTOPE: I-133 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID lUDNEY LUNG G.,I. SKIN GROUND ADULT 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 TEEN O.OOE+00 O.OOE+00,0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 CHILD O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 GOAT ADULT 2.09E+06 3.64f+06 1.11E+06 5.34E+08 6.34E+06 0;OOE+00 3.2?E+06 N/A MILK TEEN 3.82E+06 6.48E+06 1.98E+06 9.04E+08 1.14E+07 O.OOE+00-4.90E+06 N/A CHILD 9.28E+06 1.15E+07 4.34E+06 2.13E+09 1.91E+0? O.OOE+00 4.62E+06 N/A INFANT 1.63E+07 2.85E+07 8.35E+06 5.19E+09 3.35E+07 0.00E+00 4.83E+06 N/A CDW ADULT 9.75E+05 1.70f+06 5. 17E+05 2.49E+08 2.96E+06 O.OOE+00 1.52E+06 N/A MILK TEEN 1.78E+06 3.02E+06 9.21E+05 4.22E+08 5.30E+06 O.OOE+00 2.29E+06 N/A CHILD 4.33E+06 5.35E+06 2.02E+06 9.94E+08 8.92E+06 O.OOE+00 2. 16E+06 N/A INFANT 9. 14E+06 1.33E+07 3.90E+06 2.42E+09 1.56E+07 O.OOE+00 2.25E+06 N/A ADULT 1.20E-Ol 2.09E-01 6.38E-02 3.08E+01 3.65E-Ol O.OOE+00 1.88E-Ol N/A TEEN 1.01E-Ol 1.71E-Ol 5.21E-OZ 2.38E+01 3.00E-01 O.OOE+00 1.29E-01 N/A CHILD 1.87E-Ol'.31E-Ol 8.75E-02 4.30E+01 3.86E-Ol O.OOE+00 9.32E-O2 N/A INFANT O.OOE+00,0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A

"""TBLE ADULT 6.88E+05 1.20E+06 3.65E+05 1.76E+08 2.09E+06 O.OOE+00 1.08E+06 N/A TEEN 6.39E+05 1.08E+06 3.31E+05 1.51E+08 1.90E+06 O.OOE+OO 8.20E+05 N/A CHILD 1. 17E+06 1.44E+06 5.45E+05,2.68E+08 2.40E+06 O.OOE+00 5.81E+05 N/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A TOTAL'DULT 3.75E+06 6.53E+06 1.99E+06 9.59E+08 1.14E+07 O.OOE+00 5.87E+06 N/A INGEST TEEN 6.24E+06 1.06E+07 3.23E+06 1.48E+09 1.86E+07 O.OOE+00 8.01E+06 N/A CHILD 1.48E+Q7 1.83E+07 6.91E+06,3.39E+09 3.04E+07 O.OOE+00 7.36E+06 N/A INFANT 2.55E+07 4.18E+07 1.22E+07 7 .61E+09 4.92E+07 O.OOE+00 7.08E+06 N/A INHAL. ADULT 8.64E+03 1.48E+04 4.5ZE+03 2. 15E+06 2.58E+04 O.OOE+00 8.88E+03 N/A TEEN 1.22E+04 Z.QSE+04 6.22E+03 2.92E+06 3.59E+04 O.OOE+00 1.03E+04 N/A CHILD 1.66E+04 2.03E+04 7-;70E+03 3.85E+06 3.38E+04 O.OOE+00 5.48E+03 N/A INFANT 1.32E+04 1.9ZE+04 5.6OE+03 3.56E+06, 2.24E+04 O.OOE+00 2. 16E+03 N/A BONE LIVER .BODY HYRO ID 'KIDNEY LUNG G.I. SKIN

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-mZ/yr/uCi/sec

- >>MAXIMUMVALUES FOR PA HWAYS>>>>>>

GROUND GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTB LE: INGEST: INHAL.

O.OOE+00 O.OOE+00 5,19E+09 2.42E+09 4.30E+01 2.68E+08 7.61E+09 3.85E+06 PAGE: 4-28

O.D.C.N. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*

.-. fOPE: 1-134 rATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN

'ROUND ADULT a.aaE+OO O.aOE+Oa O.OOE+Oa a.OOE+00 O.aaE+aa Q.OQE+aa O.aaE+00 0.00E+00 TEEN O.QQE+GO O.QOE+00 O.QOE+00 0.00E+00 0.00E+00 O.OOE+00 Q.OOE+00 0.00E+00 CHILD 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.0'OE+00 Q.QOE+00 0.00E+00 O.QOE+00 INFANT O.OOE+00 O.OOE+00 O.OOE+OD 0.00E+00 O.OQE+OO O.OOE+OO O.QOE+00 O.OOE+00 GOAT ADULT 1.09E-12 2.96E-12 1.06E-12 5.13E-ll 4.71E-12 O.OOE+00 2.58E-15 N/A MILK TEEN 1.94E-12 5.13E-12 1.84E-I2 8.55E-11 8.09E-12 0.00E+00 6.76E-14 N/A CHILD 4.58E-12 8.51E-12 3.92E-12 1.96E-10 1.30E-11 O.OQE+00 5.64E-12 N/A INFANT 7.92E-12 1.95E-ll 6.92E-12. 4.54E-10 2.18E-11 Q.OOE+00 2.01E-ll N/A COM ADULT 5.08E-13 1.38f-'12 4.94E-13 2.39E-ll 2.20E-12 O.OOE+00 1.20E-15 N/A HILK TEEN 9.03E-13 2.39E-12 8.60E-13 3.99E-ll 3.77E-12 O.OOE+00 3.15E-14 N/A CHILD 2.14E-12 3.97E-12 1.83E-12 9.13E-11 6.07E-12 Q.QOE+00 2.63E-12 N/A INFANT 4.43E-12 9.08E-12 3.23E-12 2.12E-10 1.02E-11 0.00E+00 9.39E-12 H/A ADULT 0.00E+00 Q.OOE+00 O.OOE+OO O.OOE+Oa a.OOE+aO a.aOE+OO a.OOE+OO N/A TEEN O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.QOE+00 O.OQE+00 N/A 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00

'/A CHILD INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+OO O.OOE+00 N/A GTBLE ADULT 3.19E-05 8.65E-05 3.10E-05 1.50E-03 1.38E-04 0.00E+00 7.54E-OB N/A TEEN 2.88E-OS 7.63E-OS 2.74E-OS 1.27E-03 1.20E-04 Q.OOE+00 1.01E-06 N/A CHILD 5.12E-OS 9.50E-05 4.37E-OS 2.19E-03 1.45E-04 O.QOE+00 6.30E-OS N/A INFANT 0.00E+00 0.00E+00 0.00E+QO 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A TOTAL ADULT 3.19E-OS 8.65E-05 3.10E-05 1.50E-03 1.38E-04 0.00E+00 7.54E-08 N/A INGEST. TEEN 2.88E-05 7.63E-OS 2.74E-OS 1. 27E-03 1. 20E-04 O.OOE+00 1. 01E-06 N/A CHILD 5. 12E-05 9.50E-05 4.37E-05 2.19E-03 1.45E-04 0.00E+00 "6 30E-05 N/A INFANT 1 24E-11 2.85E-11 1.02E-11 6.66E-10 3.19f-ll O.OOE+00 2.95E-ll N/A INHAL. ADULT 6.44E+02 1.73E+03 6.15E+02 2.98E+04 2.75E+03 O.QQE+00 1.01E+00 N/A TEEN 8.88E+02 2.32E+03 8.40E+02 3.95E+04 3.66E+03 0.00E+00 2.04E+01 N/A CHILD 1.17E+03 2.16E+03 9.95E+02 5.07E+04 3.30E+03 O.OOE+00 9.55E+02 N/A INFANT 9.21E+02 1.88E+03 6.65E+02 4.4SE+04 2.09E+03 O.QOE+00 1.29E+03 N/A BONE LIVER T.BOOY HYROIO KIDNEY LUNG G. I. SKIN "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

~""NXINUM VALUES FOR PATHWAYS*>>"

GROUND: GROUND: GOAT COM TOTAL T.B./QRG. SKIN HILK: MILK: MEAT: VEGTBLE: INGEST: INHAL.

0.00E+00 0..0OE+00 4.54E-10 2.12E-10 0.00E+00 2.19E-03 2. 19E-03 5.07E+04 PAGE: 4-Z9 OAT

O.D.C.M. MAXIMUM PATHMAY DOSE FACTORS: l AOIONVCLIOES OTHER THAN NOBLE GASES*

ir

~

DTOPE: Cs-134

" PATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E&9 6.79E+09 6-79E+09 7.92E+09 TEEN 6.79E+09 6.79E+09 6.?9E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 7.92E+09 CHILD 6.79E+09 6.79E+09 6.79E+09 6.79&09 6.79E+09 6.?9E+09 6.79E+09 7.92E+09 INFANT 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 7.92E+09 ADULT 1.06E+10 2.53E+Io 2.D?E+10 Q.ODE+00 8.19E+09 2.?ZE+09 4.43E+08 N/A TEEN 1.85E+lo 4.35E+10 2.02E+10 0-DOE+00 1.3&E+10 5.2?E+Q9 5.41E+QB N/A CHILD 4.26E+10 6.99E+10 1.47E+lo 0.DOE+00 2.1?E+lo 7-77E+09 3.77E+08 N/A INFANT 2.29E+10 1.28E+ll 1.29E+10 D.DOE+00 3.30E+lo 1.35E+10 3.48E+08 NfA COM ADULT 2.79E+09 6.63E+09 5.42E+09 Q.DOE+00 2.15E+09.7.12E+08 1.16E+08 N/A MILK TEEN 4.84E+09 1. 14E+)0 5.28E+09 Q.DOE+00'.62E+09 1.38E+09 1.42E+08 N/A CHILD 1.12E+10 1.83E+10 3.86E+09 Q.DOE&0 5.68E+09 2.04E+09 9.87E+07 AN/A INFANT 1.80E+10 3.35E+10 3.39E+09 D.DDE+DD &-63E+D9 3-54E+09 9.11E+07 N/A ADULT 3.59E+08 8.54E+08 6.98E+08 Q.DOE+00 2.76E+08 9.1?E+07 1.49E+07 N/A TEEN 2.85E+08 6.71E+08 3.)ZE+08 Q.DOE+00 2.13E+48 &.ISE+07 8.35E+06 N/A CHILD 5.03E+OS 8.26E+08 1.74E+08 D.ODE+00 2.56E+08 9.1&E+07 4.45E+06 N/A INFANT O.QOE+Oa a.OOE+OO O.OOE+OO O.OOE+OO O.DOE+DO O.OOE+OO O.OOE+OO N/A VEGTBLE ADULT 4.21E+09 1.00E+)0 8.19E+09 D.QDE+Qo 3.24E+09 1.0&E+09 1.75E+08 N/A TEEN 6.70E+09 1.5BE+10 7.3)E+09 0.DOE+00 5.01E+09 1.91E+09 1.96E+08 N/A CHILD 1.53E+10 2.52E+10 5.31E+09 O.DOE+00 7.&DE+09'2.80B09 1.36E+08 N/A INFANT O.QOE+OO O.OOE+OO O.OOE+OO O.ODE+OO O.OOE+OO D.OOE+QO O.OOE+Oo N/A TOTAL ADULT 1.80E+10 4.28E+)0 3.50E+10 Q.DOE+00 1.39E+10 4.60E+09 7.49E+08 N/A INGEST. TEEN 3.03E+10 7. l3E+10 3.31E+10 O.DOE+00 2.27E+10 8.65E+D9 8.87E+08 N/A CHILD 6.96E+10 1.14E+ll 2.41E+10 Q.OOE+QO 3.54E+)Q 1.27E+10 6 16E+08 N/A

'NFANT 4.09E+)0 1.62E+11 1.63E+10 O.DOE+00 4.16E+)0 1.70E+)0 4.39E+08 N/A INHAL. ADULT 3.73E+0~ 8.48E+05 7.28E+05 D.DOE+00 2.87E+05 9.76E+04 ).04E+04 N/A TEEN 5.02E+05 1.13E+06 5.49E+QS Q.DOE+00 3.75E+05 1.46E+05 9.76E+03 N/A CHILD 6.5)E+05 ).01E+06 2.25E+05 O.DOE+00 3.30E+05 1.21E+05 3.85E+03 N/A INFANT 3.96E+05 7.03E+05 7.45E+04 Q.DOE+00 1.90E+05 7.97E+04 ).33E+03 N/A BONE LIVER .BODY HY ROID ON LUNG G. l.

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

- "MAX)MUMVALUES FOR PA HMAYS~

GROUND: GROUND: GOAT COM TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: INHAL.

6.79E+09 7.9ZE+09 ).ZBE+ll 3.35E+lo 8.54E+08 2.52E+10 1.62E+II 1.13E+06 PAGE: 4-30

O D.C-M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIOES OTHER THAN NOBLE GASES*

1'OPE: I-135

'rATHWAY AGE GROUP BONE LIVER T.BODY THYROID 'IONE Y LUNG SKIN GROUND ADULT D.DOE+DO 0.DOE+00 D.DOE+00 Q.DOE+00 O.DOE+00 O.QQE+QO 0.00E+OO O.DOE+DO TEEN D.DDE+00 O.DOE+00 D.DOE+DO D.DOE+00 D.DOE+DO Q.DOE+00 D.DOE+00 D.DOE+DO CHILD 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 D.DOE+00 0.DOE+00 0.DOE+00 Q.DOE+DO INFANT Q.DOE+00 0.00E+00 D.QQE+OO D.DOE+00 D.DOE+DO D.DOE+00 D.DOE+DO D.DOE+00 GOAT ADULT 6.93E+03 1.82E+04 6.70f+03 1.20E+06 2.91E+04 0.DOE+00 2.05E+04 H/A NLK TEEN 1.23E+04 3.17E+04 1.18E+D4 2.04E+06 5.DIE+04 D.DOE+00 3.51E+04 H/A CHILD 2.92E+04 5.25E+04 2.@BE+04 4.65E+06 8.05E+04 D.DOE+00 4.DOE+04 H/A INFANT 5.05E+04 1.21E+05 4.40E+04 1.08E+07 1.34E+05 D.DOE+00 4.37E+04 H/A COW ADULT 3.24E+03 8.47f+03 3.13E+03 5.59E+05 1.36E+04 Q.DOE+00 9.57E+03 H/A MILK TEEN 5.75E+03 1.48E+04 5.48E+03 9.52E+05 2.34E+04 0.DOE+00 1.64E+04 H/A CHILD 1.36E+04 2.45E+04 1.16E+04 2.17E+06 3.75E+04 0.DOE+00 1.87f+Q4 H/A INFANT 2.83E+04 5.63E+04 2.05E+04 5.05E+06 6.27E+04 0.DOE+00 2.04E+04 H/A ADULT 0.DOE+00 0.DOE+00 0.00f+00 Q.DOE+00 0.00f+00 0.DOE+00 0.DOE+00 H/A TEEN 0.DOE+00 0.00f+00 Q.DOE+00 D.DOE+00 Q.DOE+00 0.DOE+00 0.00f+00 H/A CHILD Q.DOE+00 0.00f+00 0.00f+00 Q.DQE+QQ Q.DOE+00 Q.QQE+QQ" Q.DQE+00 H/A t GTBLE TOTAL INFANT ADULT TEEN CHILD INFANT ADULT 0-QDE+QO 0.00f+00 0.DOE+00 Q.DOE+00 1.29E+04 3.37E+04

l. 16E+04 2.99E+04 2.06E+04 3.7ZE+04 O.DOE+00 0.00E+00 2-30E+04 0.00f+00 0.DOE+00 D.DOE+00 1.24E+04 2.22E+06 5.40E+04 1.11E+04 1.92E+06 4.73E+04 1.76E+Q4 3.29E+06 5.70E+04 0.00E+00 Q.DOE+00 D.DOE+00 6.03E+04 2.23E+04 3.98E+06 9.67E+04 D.DOE+DO 3.8OE+04 D.DOE+DO 3.32E+04 Q.DOE+00 2.83E+04 Q.DOE+00 D.DOE+00 0.DOE+00 6.81E+04 N/A H/A H/A H/A H/A H/A INGEST. TEEN 2.97E+04 7.64E+04 2.83E+04 4.92E+06 1.21E+05 O.DOE+00 8.47E+04 H/A CHILD 6.34E+04 1.14E+Q5 5.40f+04 1.01E+07 1.75E+05 Q.DOE+00 -8'70fw04 INFANT 7.88E+04 1.77E+05 6.45E+04 1.59E+07 1.97E+05 0.DOE+00 6.'40E+0'4 H/A INHAL. ADULT 2.68E+03 6.98E+03 2.57E+03 4.48E+05 1.1IE+04 0.DOE+00 5.25E+03 H/A TEEN 3.70E+03 9.44E+03 3.49E+03 6.21E+05 1.49E+04 D.DOE+00 6.95E+03 H/A CHILD 4.92E+03 8.73E+03 4.14E+03 7.92E+05 1.34E+04 Q.DOE+00 4.44E+03 H/A INFANT 3-86E+03 7.60E+03 2.77E+03 6.96E+05 8.47E+03 0.DOE+00 1.83E+03 N/A BONE LIVER .BQOY HYROIO KIDNEY LU G SKIN

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

"* MAXIMUM VALUES OR PA HWAYS~

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: IHHAL.

Q.DOE+00 0.00E+QO 1.08E+07 5.05E+06 Q.DOE+00 3.29E+06 1.59E+07 7.92E+05 PAGE: 4-31

O.D.C.N. NAXINUN PATHWAY DOSE FACTORS: RAOIONUCLIOES OTHER THAN NOBLE GASES*

".,JTOPE: Cs-136 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG .'G.I. SKIN GROUND ADULT 1.49E+08 1.49E+08 1.'49E+08 1.49E+08 1.49E+08 1.49E4$ 1-49F+08 1.69E+08 TEEN 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.69E+QS CHILD 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.69E+DB INFANT 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1 49E+08 I;49E+08 1.49E+08 1.69E+08 GOAT ADULT 3.57E+08 1.41E+09 1.01E+D9 D.DOE+00 7-84E+08 1.07E+08 1.6OE+08 H/A MILK TEEN 6.07E+08 2.39E+09 1.61E+09 D.DOE+00 1.30E+09 2.05E+08 1.9ZE+08 N/A CHILD 1.37E+09 3.77E+09 2.44E+Q9 O.DOE+DO 2.Q1E+09 2.99E+QB 1.3ZE+08 H/A INFANT 8.93E+08 7.88E+09 2.94E+09 0.DOE+00 3.14E+09 6.42E+08 1.20E+08 H/A ADULT 6. 69E+07 2.64E+08 1.90E+08 O.DOE+00 1.47E+08 2.02E+07 3.DOE+07 H/A NILK TEEN 1.14E+08 4.48E+08 3.01E+08 Q.DOE+DO 2.44E+08 3.85E+07 3.61E+07 N/A CHILD 2.57E+08 7.0?E+08 4.58E+08 Q.DOE+00 3.77E+08 5.62E+07 2.4BE+07 . N/A INFANT 5.02E+08 1.48E+09 5.52E+08 0.00E+OO 5.&9F+08 1.20E+QS 2.24E+0? H/A ADULT 4.DOE+06 1.58E+07 1.14E+07 D.DOE+00 8.7SE+06 1.20E+06 1.79E+06 H/A TEEN 3. 12E+06 1.23E+07 8.24E+06 D.DOE+00 6.68E+06 1.05E+06 9.87E+05 H/A CHILD 5.38E+06 1.48E+D7 9.57E+06 O.DOE+00 7.87E+06 1.17E+06 5.20E+05 H/A IHFANT 0.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 D.DOE+DO O.DOE+00 H/A VEGTBLE ADULT 2.03E+07 8.0)E+07 5.76E+07 D.DOE+DO 4.46E+07 6.11E+Q6 9. IOE+06 H/A TEEN 2.43E+07 9.58E+07 6.43E+07 0.DOE+00 5.21E+07 S.ZZE+06 7.7IE+06 N/A CHILD 4.96E+07 1.36E+08 B.BZE+07 O.DOE+DO 7.26E+07 1.08E+07 4.79E+06 N/A INFANT 0.00E+00 0.DOE+00 O.DOE+00 D.DOE+00 O.DOE+00 0.DOE+00 0.00E+00 H/A TOTAL ADULT 4.4&E+OB l.??E+09 1.27E+09 Q.DOE+DO 9.84E+08 1.35E+08 Z.DIE+08 H/A INGEST. TEEN ?.49E+08 2.95E+09 1.9BE+09 O.DOE+00 1.60E+Q9 2.53E+0& Z.3?E+08 H/A

. CHIL9 1.68E+09 4.63E+09 2.99E+09 0.DOE+00 2.46E+09 3.67E+08 1-:63E+08 '8/A INFANT 1.40E+09 9.35E+09 3.49E+09 O.DOE+00 3.73E+09 7.62E+08 1.42E+08 N/A INHAL. ADULT 3.90E+04 1.46E+05 1.10E+05 D.DOE+00 8.56E+04 1.20E+04 1.17E+04 N/A TEEN 5.15E+04 1.94E+05 1.3?E+05 D.DOE+00 1.10E+05 1.7SE+04 1.09E+04 H/A CHILD 6.51E+04 1.71E+05 1.16E+Q5 O.OOE+Oa 9.55E+04 1.45E+04 4.1BE+03 H/A INFANT 4.83E+04 1.35E+05 5.29E+04 O.DOE+00 5.64E+04 1.1SE+04 1.43f+03 H/A BONE LIVER '.BODY HYRO IO KION LUNG G.l. SKIN Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

~~*MAXIMUMVALUES FOR PA HWAYS~~*

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK NEAT:. VEGTBLE: INGEST: INHAL.

1.49E+08 1.69f+08 ?.BBE+09 l. 4BE+09 1.5BE+0? 1.36E+QS 9.35E+09 1.94E+05 PAGE: 4-32 V.

DAT

t O.D.C.M. MAXIMUM PATHWAY 3PE: Cs-137 PAfHWAY AGE GROUP BONE DOSE FACTORS:

LIVER T.BODY RAOIONUCLIOES OTHER THAN NOBLE GASES*

THYROID KIDNEY LUNG G:I. SKIN GROUND ADULT 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10.1.02E+10 1.02E+10 1. 19E+10 TEEN 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.19E+10 CHILD 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1,02E+10 1. 19E+10 INFANT 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1. 19E+10 GOAT ADULT 1.42E+10 1.94E+10 1.27E+10 O.OOE+00 6.59E+09 2.19E+09 3.76E+08 N/A NLK TEEN 2.58E+10 3.43E+10'1.19E+10 0.00E+00 1.17E+10 4.53E+09 4.&BE+08 '/A CHILD 6.20E+10 5.94E+10 8.77E+09 O.OOE+00 1.94E+10 6.96E+09 3.72E+08 N/A INFANT 3.30E+10 1.16E+ll 8.22E+09 0-OOE+00 3.11E+10 1.26E+10 3.62E+08 N/A COW. ADULT 3.78E+09 5.17E+09 3.39E+09 O.OOE+00 1.76E+09 5.84E+08 1.00E+08 N/A MILK TEEN 6.86E+09 9.12E+09 3.1&E+09 O.OOE+00 3.10E+09 1.21E+09 1.30E+08 N/A CHILD 1.65E+10 1.58E+10 2.33E+09 O.OOE+00 5.15E+09 1.85E+09 9.90E+07 " N/A INFANT 2.64E+10 3.09E+10 2.19E+09 O.OOE+00'8.2&E+09 3.35E+09 9.65E+07 N/A ADULT 4.91E+08 6.71E+08 4,40E+08 0.00E+00 2.2&E+08 7.58E+07 1.30E+07 N/A TEEN 4.08E+08 5.42E+08 1.89E+08 0.00E+00 1.85E+08 7.17E+07 7.72E+06 N/A CHILD 7.51E+08 7.19E+08 1.06E+08 O.OOE+00 2.'34E+08 &.42E+07 4'.50E+06, N/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 N/A aTBLE AOULT 5.76E+09 7.88E+09 5.16E+09 O.OOE+00 2.68E+09 8.89E+08 1.53E+08 N/A TEEN 9.5&E+09 1.27E+10 4.44E+09 O.OOE+00 4-34E+09 1.69E+09 1.81E+08 N/A CHILD 2.29E+10 2.19E+10 3.24E+09 0.00E+00 7.15E+09 2.57E+09 1.37E+08 N/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 N/A ADULT 2.42E+lO 3.3ZE+10 2.17E+10 O.OOE+00 1.13E+10 3.74E+09 6.42E+08 N/A TEEN 4.26E+10 5.67E+10 1.97E+10 O.OOE+00 1.93E+10 7.49E+09 8.06E+08 N/A CHILD 1 02E+ll 9.79E+10 1.44E+10 O.OOE+00 3.19E+10 1.15E+10 6':13E408 N/A INFANT 5.94E+10 1.47E+ll 1.04E+10 O.OOE+00 3.94E+10 l.60E+10 4.59E+08 N/A 1NHAL. ADULT 4.7&E+05 6.21E+05 4.2&E+05 0.00E+00 2.22E+05 7.52E+04 8.40E+03 N/A TEEN 6.70E+05 &.4&E+05 3.11E+05 O.OOE+00 3.04E+05 1.21E+05 8.4&E+03 N/A CHILD 9.07E+05 &.25E+05 1.28E+05 0.00E+00 2.&ZE+05 1.04E+05 3.62E+03 H/A INFANT 5.49E+05 6.12E+05 4.55E+04 O.OOE+00 1.72E+05 7.13E+04 1.33E+03 H/A BONE LIVER T.BODY HYROID KIDNEY LUNG G.I. SKIN

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

""*HAXINUHVALU S FOR PATHWAYS*~*

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT VEGTBLE: INGEST: INHAL.

1 . 02E+10 1 . 19E+10 I. IGE+ll 3.09E+IQ 7.51E+08 2.29E+lO 1.47E+ll 9.07E+05 PAGE: 4-33 jest 4' QAt

Q.D.C.N. HAXIHUH PATHMAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*

QTOPE: Ba-140 c'ATHWAY AGE GROUP BONE LIVER T. BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 2.03E+07 2.03E+07 2.03E+07.2.03E+07 2.03E+QT Z.Q3E+07 2.03E+07 2.32E+OZ

.TEEN 2.03E+07 2.03E+07 2.03E+07 2-03E+07 2.03E+07 2.03E+OZ 2.03E+07 2.32E+07 CHILD, 2. 03E+07 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.32E+07 INFANT 2.03E+07 2.03E+OT 2.03E+OT 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.32E&7 GOAT ADULT 1.46E+06 1.&3E+03 9.54E+04 O.OOE+OO 6.22E+02 1.05E+03 3.00E+06 N/A MILK TEEN 2.63E+06 3.22E+03 1.69E+05 O.OOOO 1.09E+03 2'17E&3 4.05E+Q6 N/A CHILD 6.35E+06 5.$ 6E+03 3.TOE+05 O.OOE+OO 1.81E+03 3.31E+03 3.22E+06 N/A INFANT l. 09E+08 1.31E+04 6.73E+05 Q.OOE+00 3.10E+03 8.02f+03 3.21E+06 NJA COM ADULT 6.83E+06 8.S&E+03 4.47E+05 0.00E+00 2.92E+03 4.91E+03 1.41E+07 N/A BILK TEEN 1.23E+07 1.51E+04 7.94E+QS Q.OOE+00 5.IZE+03 1.02E+04 1.90E+07 H/A CHILD 2.97E+07 2.61E+04 1.74E+06 Q.QOE+00 8.48E&3 1.55E+04 1.51E+07 N/A INFANT 6.12E+07 6.12E+04 3.15E+06 0.00E+00 1.45E+04 3.76E+04 1.5OE+07 N/A ADULT 9.52F+06 1.20E+04 6.24E+05 0.00E+00 4.07E+03 6.85E+Q3 1.96E+07 H/A TEEN 7.&7E+Q6 9.65E+03 5.0TE+OS O.OOE+00 3.27E+03 6.49E+03 1.21E+07 H/A CHILD 1.45E+07 1.27E+04 4.4&E+05 O.QOE+Oo 4.14E+03 7.59E+03 T.36E+06 N/A INFANT O.OOE+OO O.OOE+OO O.OOE+OO O.OOF+OO O.OOE+OO O'.OOE+OO 0.00E+00 N/A VEGTBLE ADULT 5.9&E+07 7.5)E+Q4 3.92E+06 O.OOE+00 2.55E+04 4.30E+04 1.23E+08 H/A TEEN T.SOE+07 9.19E+04 4.83E+06 0.00E+00 3.12E+04 6.18E+04 1.16E+08 H/A CHILD 1.62E+08 1.42E+05 9.4&E+06 O.QOE+00 4.63E+04 8.48E+04 8.23E+07 H/A INFANT O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+OO N/A

'OTAL ADULT 7.76E+07 9.75E+04 5.08E+06 O.OOE+00 3.31E+04 5.5&E+04 1.60E+08 N/A INGEST. TEEN 9.7&E+07 1.20E+05 6.31E+06 0.00E+00 4.QTE+04 8.06E+04 1.51E+08 H/A CHILD 2.13E+08 1.87E+05 1.24E+07 O.OOE+00 6.08E+04 l.llE+05 J,%BE+08 INFANT 1.70E+08 7.43E+04 3.83E+06 0.00E+00 1.76E+04 4.56E+Q4 1.&2E+07 ll/A INHAL. ADULT 3.90E+04 4.90E+01 2.57E+03 0.00E+00 1.67E+Ql 1.27F+06 2.1&E+05 N/A TEEN 5-47E+04 6.94E+Ql 3.52E+03 0.00E+00 2.2&E+OI 2.03E+06 2.29E+05 N/A CHILD 7.4OE+04 6.48E+01 4.33E+02 0 OOE+00 2.11E+Ol 1.74E+06 1.QZE+QS H/A INFANT 5.60E+04 5.60E+Ol 2.90E+03 0.00E+00 1.34E+Ol 1.60E+06 3.84E+04 N/A BONE LIVER T.BODY HY ROID K ION LUNG G. I. S I "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

"""HAXIHUH VALUES FOR PATHMAYS~

GROUND: GROUND: GOAT COM TOTAL T.B./ORG. SKIN HILK: HILK: HEAT: VEGTBLE: INGEST: INHAL.

2.03E+07 2.32E+07 1.09E+08 6.12E+07 1.96E+07 1.62E+08 2.13E+08 2.03E+06 PAGE: 4-34

Q.D.C.M. MAXIMUM PATHMAY DOSE FACTORS: RADIQNUCLIDES OTHER THAN NQBLE GASES*

'I

.TOPE: La-140 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID 'IDNEY LUNG G. I. SKIN GROUND ADULT O.QQE+00 Q.OQE+00 0.00E+00 Q.QQE+00 .Q.QQE+00 Q.OOE+00 0.00E+Qo 0.00F+00 TEEN Q.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 Q.OQE+00 0.00E+00 O.OOE+00 CHILD 0.00E+00 Q.QOE+00 0.00E+00 0.00E+00 Q.QQE+00 0.00E+00 O.OQE+00 Q.OQE+00 INFANT O.OQE+00 O.OQE+00 Q.QOE+00 Q.OQE+00 Q.OOE+00 Q.QQE+00 O.OOE+OO O.QQE+aa GOAT ADULT 2.44E-O1 1.23E-Ol 3.25E-O2 Q.QQE+OO O.OOE+OO O.OOE+OO 9.02E+03 H/A MILK TEEN 4.38E-Ol 2.15E-01 5..72E-02 Q.QOE+Qo Q.OOE+00 0-OOE+00 1.24E+04 H/A CHILD 1.05E+00 3.66E-01 1.23E-01 0.00E+QO O.OOE+00 Q.OOE+Oo 1.02E+04 N/A INFANT 1.82E+01 8.63E-Ol 2.22E-01 O.QOE+00 O.QOE+00 0.00E+00 1.01E+04 N/A COM ADULT 1.14E+OQ 5.73E-Ol 1.51E-01 Q.OQE+00 Q.QOE+00 Q.QQE+00 4.21E+04 N/A MILK TEEN 2.04E+00 1.00E+00 2.67E-Ol Q.QOE+00 O.QOE+00 Q.QOE+00 5.76E+04 N/A CHILD . 4.89E+00 1.7IE+00 5.76E-ol 0.00E+00 Q.QQE+00 Q.OOE+00 4.76E+04 " H/A INFANT 1.02E+01 4.03E+00 1.04E+00 Q.OOE+aa O.OOE+00 O.QQE+00 4.73E+04 A/A 1

MEAT ADULT 1.22E-02 6.16E-03 1.63E-03 0.00E+00 Q.QOE+00 0.00E+00 4.53E+02 H/A TEEN 1.01E-02 4.94E-03 1.32E-03 Q.OQE+QD O.QQE+DO O.QOE+Oo 2.84E+02 H/A CHILD 1.84E-02 6.44E-03 2.17E-03 Q.QOE+00 O.OOE+Oo 0.00E+00 1.79E+02 'N/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OQE+00 0.00E+00 O.OOE+00 H/A

.GTBLE ADULT 6.53E+02 3.29E+Q2 8.69E+01 O.aOE+aa a.aOE+OO O.aOE+aO 2.4IE+07 H/A TEEN 5.96E+02 2.93E+02 7.79E+Ol 0.00E+00 Q.OOE+00 0.00E+00 1.68E+07 N/A CHILD 1.07E+03 3.74E+02 1.26E+02 O.QOE+00 Q.QOE+00 0.00E+QO 1.04E+07 N/A INFANT O.OOE+00 O.OOE+00 0.00E+00 O.OQE+00 O.OQE+00 O.QQE+00 O.OOE+00 H/A TOTAL ADULT 6.54E+02 3.30E+02 8.71E+01 0.00E+00 Q.OOE+00 Q.oof+00 2.42E+07 H/A INGEST. TEEN 5.99E+02 2.94E+02 7.83E+01 Q.OQE+00 O.OOE+00 O.OQE+00 1.69E+07 N/A CHILD 1.08E+03 3.76E+02 1.27E+02 O.OOE+00 O.OOE+00 O.QOE+00 1;OS&07 H/A INFANT 2.85E+01 4.89E+00 1.26E+00 0.00E+00 0.00E+00 0.00E+00 5:74E+04 N/A INHAL. ADULT 3.44E+02 1.74E+02 4.58E+01 Q.QQE+00 a.ooE+oo 1.36E+05 4.58E+05 H/A TEEN 4.79E+02 2.36E+02 6.26E+Ol O.OOE+00 Q.QOE+00 2.14E+05 4.87E+05 H/A CHILD 6.44E+02 2.25E+02 7.55E+01 O.OOE+00 O.OOE+00 1.83E+05 2.26E+05 N/A INFANT S.QSE+O2 2.OOE+e2 5.15E+Ol Q.OOE+OO 0.00E+00 1.68E+05 8.48E+04 N/A BONE LIVER .BODY THYROID KIDNEY LUNG G.l. SKIN Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

"~MAXIMUMVALUES FOR PATHWAYS"~

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTB LE: INGEST: INHAL.

O.OOE+00 O.OOE+00 1.24E+04 5.76E+04 4.53E+02 2.41E+07 2.42E+07 4.87BOS PAGE: 4-35 r

OAT

O.D.C.M. HAXIMUM PATHWAY 00SE FACTORS: RAOIOHUCLIOES OTHER THAN NOBLE GASES*

?.'OPE: Ce-141 o~fHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G..I. 'KIN GROUND ADULT 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1-35E+07 1.52E+07 TEEN 1.35E+07 1.USE+07 1.35E+D7 1.35E+D7 1.35E+D7 1.35E+07 1.35E+07 1.52E+07 CHILD 1.35E+07 1.35E+07 1'.35E+07 1.35E+D7 1.35E+07 1.3SE+07 1.35E+07 1.S2E+D7 INFANT 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.52E+07 ADULT 2.78E+02 1.88E+02 2.13E+01 O.DOE+00 8.73E+Dl O.DOE+00 7.'9E+05 N/A TEEN 5.10E+02 3.40E+02 3.91E+01 0;00E+00 1.60E+02 0.DOE+00 9.74E+05 N/A CHILD 1.26E+03 6.26E+02 9.30E+01 0.00E+00 2.75E+02 0.DOE+00 7.81E+05 N/A INFANT 2.07E+04 1.52E+03 1.79E+02 0.00E+00 4.68E+02 O.DOE+00 7.84E+05 N/A COM ADULT l. 41E+03 9.51E+02 1.08E+02 0.00E+00 4.42E+02 0.DOE+00 3.64E+06 N/A HILK TEEN 2.58E+03 1.72E+03 1.98E+02 0.00E+00 8.11E+02 O.DOE+00 4.93E+06 N/A CHILD 6.35E+03 3.17E+03 4.70E+02 0.00E+00 1.39E+03 O.DOE+00 3.95E+06 NIA INFANT 1.26E+04 7.68E+03 9.04E+02 O.OOE+00.2.37E+03 0.DOE+00 3.97E+06 N/A ADULT 5.11E+03 3.46E+03 3.92E+02 0.00E+00 1.61E+03 O.DOE+00 1-32E+07 N/A TEEN 4.29E+03 2.87E+03 3.29E+02 0.00E+00 1.35E+03 O.DOE+00 8.20E+06 N/A CHILD 8.08E+03 4.03E+03 5.99E+02 0.00E+00 1.77E+03 0.DOE+00 5.03E+06 N/A INFANT O.OOE+00 D.OOE+00 0.00E+00 0.00E+00 O.DOE+00 O.DOE+00 O.DOE+00 N/A VEGTBLE ADULT 1.49E+05 1.01E+05 1.14E+04 0.00E+00 4.69E+04 O.DOE+00 3.86E+08 N/A TEEN 2.38E+QS 1.59E+05 1.83Et04 O.DOE+00 7.49E+04 0.DOE+00 4.55E+08 N/A CHILD 5.73E+05 2.86E+05 4.25E+04 0.00E+00 1.25E+05 O.DOE+00 3.57E+08 N/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.DOE+00 0.00E+00 O.DOE+00 N/A TOTAL ADULT 1.56E+Q5 1.06E+05 1.20E+04 O.OOE+00 4.90E+04 0.00E+00 4.03E+08 N/A INGEST. TEEN 2.46E+05 1.64E+05 1.88E+04 0.,DOE+00 7.72E+04 0.00E+00 4.69E+08 N/A CHILD 5.89E+05 2.94E+05 4.36E+04 0.00E+00 1.29E+05 0.00E+00 3:67E408 N/A INFANT 3.33E+04 9.20E+03 1.08E+03 0.00E+00 2.84E+03 O.DOE+00 4.75E+06 N/A IHHAL. ADULT 1.99f+04 1.35E+04 1.53E+03 O.OOE+00 6.26E+03 3.62E+05 l.20E+05 N/A TEEN 2.84E+04 1.90E+04 2.17E+03 0.00E+00 8.88E+03 6.14E+05 1.26E+05 N/A CHILD 3.92E+04 1.95E+04 2.90E+03 0.00E+00 8.55E+03 5.44E+05 5.66E+04 N/A

., INFANT 2.77E+04 1.67E+04 1.99E+03 0.00E+00 5.25E+03 5.17E+05 2.16E+04 N/A BONE LIVER T.BODY HY ID KIDNEY LUNG G.I. SKIN

~Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

"""MAXIMUMVALUES FOR PA HAYS~~~

GROUND: GROUND: GOAT COM TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: IHHAL.

1.35E+07 1.52E+07 9.74E+05 4.93E+06 1.32E+07 4.55E+08 4.69E+OB 6.14E+05 PAGE: 4-36 A

0AT

O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIOHUCLIDES OTHER THAN NOBLE GASES*

APE: Pr-143 w~fHMAY AGE GROUP BONE LIVER T.BODY THYROID .KIDNEY LUNG G ..I. SKIN' GROUND ADULT 0.00E+00 0.00E+00 O.oof+00 G.OOE+00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO TEEN O.OOE+00 O.OOE+00 O.OOE+00 0-OOE+00 O.OOE+00 O.oof+00 0.DOE+00 O.OOE+00 CHILD O.OOE+00 O.OOE+OO O.OOE+OO O.OOE+00 O.OQE+00 O.OOE+00 O.oof+00 Q.OQE+00 INFANT 0.00E+00 O.OOE+00 O.DOE+00 O.OOE+00 O.OOE+00 0.DOE+00 O.OOE+00 0.00E+00 GOAT ADULT . 8.57E+00 3.44E+00 4.25E-01 O.OOE+00 1.98E+00 O.OOE+00 3.75E+04 N/A MILK TEEN 1.57f+Ol 6.28E+00 7.83E<<01 0.00E+00 3.65E+00 O.DOE+00 5.18E+04 N/A CHILD 3.89E+01 1.17E+Ol 1.93E+00 0.00E+00 6.33F+00 O.OOE+00 4.20E+04 N/A INFANT 6.71E+02 3.01E+01 3.99E+00 O.OOE+00 1 12E+01 0 OOE+00 4s25E+04 N/A CON ADULT 4.02E+Ol 1.6IE+01 1.99E+00 0.00E+00 9.31E+00 O.OOE+00 1.76E+05 N/A HILK TEEN 7.39E+Ol 2.95E+Ol 3.68E+00 O.OOE+00 1.7IE+01'O.OOE+00 2.43E+05 N/A CHILD 1.83E+02 5.49E+01 9.07E+00 O.oof+00 2.97E+01.0.00E+00 1.97E+05 ~

, N/A INFANT 3.78E+02 1.41E+02 1.87E+Ol O.OOE+00 5.26E+Ol O.OOE+00 2.00E+05 H/A NEAT ADULT 6.96E+03 2.79E+03 3.45E+02 O.OOE+00 1.6lf+03 O. OOE+00, 3. 05E+07 H/A TEEN 5.86E+03 2.34E+03 2.92E+02 O.OOE+00 1.36E+03 O.OOF+00 1.93E+07 N/A CHILD 1.11E+04 3.33E+03 5.50E+02 O.OOE+00 1.80E+03 O.OOE+00 1.20E+07 N/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A GTBLE ADULT 3.04E+04 1.22E+04 1.51E+03 0.00E+00 7.04E+03 0.00E+00 1.33E+08 N/A TEEN 4.00E+04 1.60E+04 1.99E+03 O.OOE+00 9.27E+03 O.OOE+00 1.31E+08 N/A CHILD 8.98E+04 2.69E+04 4.45E+03 O.OOE+00 1.46E+04 0.00E+00 9.68E+07 N/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A TOTAL ADULT 3.74E+04 1.50F+04 1.86E+03 O.OOE+00 8.67E+03 0.00E+00 1.64E+08 N/A INGEST. TEEN 4.59E+04 1.83E+04 2.28E+03 O.OOE+00 1.07E+04 O. OOE+00 '1. 51E+08 N/A CHIU) 1 01E+05 3.03E+04 5.01E+03 0.00E+00 1.64E+04 O.OOE+00 1';09E+08 N/A INFANT 1.05f+03 1.72E+02 2.27E+01 0.00E+00 6.38f+Ol O.OOE+00 2:42E+05 N/A XNHAL. ADULT 9.36E+03 3.75E+03 4.64E+02 O.OOE+00 2.16E+03 2.81E+05 2.00E+05 N/A TEEN 1.34E+04 5.31E+03 6.62E+02 O.OOE+00 3-09E+03 4.83E+05 2.14E+05 N/A CHILD 1.85E+04 5.55E+03 9.14E+02 O.OOE+00 3.00E+03 4.33E+05 9.73E+04 N/A INFANT 1.40E+04 5.24f+O3 6.99E+02 O.OOE+00 1.97E+03 4.33E+05 3.72E+04 H/A LIVER .BODY YOD KIDNEY LUNG G. SKIN

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

"**MAXIMUMVALUES FOR PATHWAYS~*"

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: HEAT: VEGTBLE: INGEST: IHHAL.

0.00f+00 G.OOE+00 5.18E+04 2.43E+05 3.05E+07 1.33E+08 1.64E+08 4.83E+05 PAGE: 4-37

~ OAT

O.D.C.H. HAXIHUM PATHWAY DOSE FACTORS: RADIQNUCLIDES OTHER THAN NOBLE GASES*

'3TOPE: Ce-144 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G- I- SKIN GROUND ADULT 6.88E+07 6.88E+07 6.8BE+07 6.88E+07 6.88E+07 6.88E+07 6.88E+07 7.96E+07 TEEN 6.88E+07 6.8BE+07 6.88E+07.6.88E+07 6.88E+07 6.88E+0? 6.88E+07 7.96E+07 CHILD 6.88E+07 6.88E+07 6.88E+07 6.8BE+07 6.88E+07 6.88E+07 6.88E+0? 7.96E+07 INFANT 6.88E+07 6.88E+07 6.88E+07 6.88E+0? 6.88E+07 6.8&E+07 6.88f+07 7.96E+07 GOAT ADULT 2.60E+04 1.09E+04 1.39E+03 0.00E+00 6.44E+03 0.00E+00 8.?BE+06 N/A HILK TEEN 4.78E+04 1.98E+04 2.57E+03 O.QQE+00 1.18E+04 O.OOE+00 1.20E+0? N/A CHILD 1.18E+05 3.69E+04 6.2BE+Q3 O.QQE+00 2.04E+04 0.00E+00 9.63E+06 N/A INFANT 1.41E+06 6.91E+04 9.46E+03 0.00E+00 2.79E+04 0.00E+00 9.68E+06 N/A COW ADULT 1.65E+05 6.91E+04 B.BBE+03 0.0QE+00 4.10E+04 O.OOE+00 5.59E+07 N/A MILK TEEN 3.04E+05 1.26E+Q5 1.63E+Q4 O.QQE+00 7.52E+04 0.00E+00 7.65E+07 N/A CHILD ?.5QE+05 2.35E+05 4.00E+04 O.OQE&0 1.30E+05 O.OOE+00 6.13E+07 N/A INFANT 1.07E+06 4.40E+QS 6.02E+04 O.QQE+00 1.78E+05 0 OQE+00 6.17F+07 N/A ADULT, 7.55E+05 3.16E+05 4.05E+04 0.00E+00 1.8?E+Q5 O.QQE+00 2.SSE+08 N/A TEEN 6.36E+QS 2.63E+05 3.42E+04 0.00E+00 1.57E+05 O.OQE+00 1.60E+08 N/A CHILD 1.20E+06 3.76E+05 6.40E+04 Q.QQE+00 2.08E+05 O.OQE+00 9.80E+07 N/A INFANT Q.OOE+OQ Q.QQE+QQ Q.QQE+00 O.QQE+00 O.OOE+00 O.QQE+00 O.OQE+OO H/A VEGTBLE ADULT 2.94E+07 1.23E+07 1.58E+06 O.QQE+00 7.3OE+06 O.OQE+00 9.95E+09 N/A TEEN 4.95E+07 2.05E+07 2.66E+06 O.QOE+00 1.22E+07 Q.OOE+OQ 1.24E+10 N/A CHILD 1.21E+08 3.BQE+07 6.46E+06 0.0QE+00 2.10E+07 Q.OQE+00 9.90E+09 N/A INFANT 0.00E+00 0.00E+OQ O.QQE+00 Q.QQE+OQ O.OQE+00 O.OQE+00 O.QQE+00 N/A TOTAL ADULT 3.04E+02 1.2?E+07 1.63E+06 0.00E+00 7.53E+06 0-DOE+00 1.03E+10 N/A INGEST. TEEN S.OSE+02 2.09E+07 2.71E+06 Q.QQE+00 1.25E+07 0.00E+00 1.2?E+10 N/A CHILD =

1.23E+08 3.86E+07 6.57E+06 O.QQE+00 2.14E+07 O.QQE+00 I DIE+10 H/A

'INFANT 2.48E+06 S.Q9E+05 6.97E+04 O.QOE+00 2.06E+05 O.QQE+00 7.14E+07 INHAI . ADULT 3.43E+06 1.43E+06 l.84E+05 Q.QQE+00 8.4BE+05 7.7BE+06 8.16E+05 H/A TEEN 4.89E+06 2.02E+06 2.62E+05 Q.QQE+00 1.21E+06 1.34E+07 8.64E+05 N/A CHILD 6.77E+06 2.12E+Q6 3.6IE+05 Q.QOE+OO 1.17E+06 1.20E+07 3;89E+05 H/A INFANT 3.19E+06 1.21E+06 1.26E+05 Q.OOE+00 5.38E+05 9.84E+06 1.4BE+05 N/A BONE LIVER .BODY HYROID KIDNEY LUNG G. I. SKIN

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposi ti on pathways: uni ts are mrem-m2/yr/uCi/sec

"*NXINUN VALUES FOR PATHWAYS~~

GROUND: GROUND: GOAT . COW TOTAL T.B./ORG. SKIN MILK: MILK: HEAT: YEGTBLE: INGEST: INHAL.

6.88E+Q? 7.96E+Q2 1.2QE+Q7 2.65E+Q2 2.55E+08 1.24E+10 1.27E+10 1.34E+07 PAGE: 4-3&

rv DAT

O.D C.M- MAXIMUM PATHMAY DOSE FACTORS: RADIOHUCLIDES OTHER THAN NOBLE GASES*

fOPE: Pr-144 PATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G- I- SKIN GROUND ADULT Q.OOE+00 O.DOE+00 Q.DOE+00 0.DOE+00 O.OQE+00.0.00E+QQ Q.OOE+00 Q.QOE+00 TEEN 0.00E+OO O.OQE+00 0.DOE+00 O.QQE+00 0.00E+OO O.OOE+00 0.00E+00 O.QQE+00 CHILD O.OOE+00 O.DOE+00 0.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.00E+00 INFANT O.DOE+00 0.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 GOAT ADULT Q.OOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.00E+00 O.DOE+00 0 ~ OQE+00 N/A tGLK TEEN 0.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 0.DOE+00 O.DOE+00 N/A CHILD 0.00E+00 0.DOE+00 Q.DOE+00 0.DOE+00 0.00E+00 Q.DOE+00 0.DOE+00 N/A INFANT 0.DOE+00 D.DOE+00 0.00E+00 Q.DOE+00 O.DOE+00 O.DOE+00 0.00E+00 N/A COM ADULT O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 N/A MILK TEEN 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 O.DOE+00 N/A CHILD Q.DOE+00 O.DOE+DO D.DOE+00 O.ODE+DQ O.DOE+00 O.DOE+00 Q.DOE+00 N/A INFANT 0.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 O.OOE+QD O.ODE+OD O.DOE+00 N/A MULT D.DQE+00 D.DOE+00 0.DOE+00 O.OQE+QO O.DOE+00 O.DOE+00 O.DOE+00 N/A TEEN O.QOE+OQ D.OQE+OQ O.QQE+OO O.OQE+OO O.OQE+OO O.OOE+Oo O.DOE+00 N/A CHILD D.DOE+00 0.DOE+00 O.DOE+00 O.OQE+OQ 0;ODF+OO O.OOE+OO O.OOE+OO N/A INFANT D.DOE+00 0.00E+00 D.DOE+00 O.oof+00 O.DOE+00 0.00E+OQ D.OQE+QQ N/A ABLE ADULT Q.DOE+00 0.DOE+00 Q.DOE+00 0.00E+00 Q.DOE+00 Q.DOE+00 O.DOE+DO N/A TEEN O.DOE+00 Q.DOE+00 O.DOE+00 0.00f+00 0.DOE+00 O.DOE+00 0.DOE+00 N/A CHILD O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 N/A INFANT O.DOE+00 O.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 N/A TOTAL ADULT 0.DOE+00 0.00E+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Q.DOE+00 N/A INGEST. TEEN D.DOE+00 O.DOE+00 D.DOE+00 O.DOE+00 D.DOE+00 0.DOE+00 0.DOE+00 N/A CHILD 0 DOE+00 D.ODE+00 0.DOE+00 0.DOE+00 D.DOE+00 D.DOE+00 0'ROE+00 N/A INFANT O.DOE+00 D.DOE+00 O.DOE+DO O.DOE+00 O.DOE+00 Q.DOE+00 O.DOE+DO N/A INHAL. ADULT 3.01E-02 1.25E-OZ 1.53E-03 O.ODE+QD 7.05E-03 1.02E+03 2.15E-OB N/A TEEH 4.30E-QZ 1.76E-02 2.18E-03 0.DOE+00 1.01E-02 1.75E+03 2.35E-04 N/A CHILD 5.96E-OZ 1.85E-02 3.00E-D3 O.DOE+00 9.77E-03 1.57E+03 1.97E+02 N/A INFANT 4.79E-02 I.&SE-02 2.41E-D3 O.COE+00 6.72E-03 1.61E+03 4.2&E+03 N/A BONE LIVER T.BOOY THYROID KIDNEY LUNG G.I. SKIN Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

"""NAXINUN VALUES fOR PATHMAYS*""

GROUND: GROUND: GOAT COM TOTAL T.B./ORG. SKIN MILK: MILK: NEAT: VEGTBLE: INGEST: INHAL.

D.DOE+00, O.DOE+DO O.DOE+00 O.DOE+DO D.DOE+DO D.DOE+00 D.DOE+00 4.2&E+03 PAGE: 4-39 OAT

O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*

"OPE: Nd-147

'..cHMAY AGE GROUP BONE LIVER T . BODY THYROID KIDNEY LUNG G.. I. SKIN GROUND ADULT 8.31E+06 8.31E+06 8.31E+D6 8.31E+06 8.3IE+06 8.31E+06 8.31E+06 9.97E+06 T)EN 8.31E+06 8.31E+06 8.31E+06 8.31E+06 8.3IE+06 8.31E+06 8.31E+06 9.97E+06 CHILD 8.3IF+06 &.31E+06 &.31E+06 &-31E+06 &.31E+06.&.31E+06 8.31E+06 9.97E+06 INFANT 8.31E+06 8.31E+06 8.31E+06 8.3IE+06 8.3IE&6 8.31E+06 8.31E+06 9.97E+06 GDAT ADULT 5 09E+00 5 89E+00 3 52E 01 0 sOOE+00 3 44E+00 0 DOE+00 2 83E+04 N/A HILK TEEN 9.&DE+00 1.07E+01 6.38E-01.O.DOE+00 6.26E+00 D.DOE+00 3.84E+04 N/A CHILD 2.40E+01 1.95E+01 1.51E+00 O.DDE+00 1.D7E+01 O.ODE+DD 3.09E+04 N/A INFANT 3.97E+02 4.90E+01 3.DOE+00 0.DOE+00 1.89E+Dl Q.DOE+00 3.10E+04 N/A COM ADULT 2.3&E+01 2.75E+01 1.65E+00 0.DOE+00 1.61E+01 0-OOE+OD 1-32E+05 N/A HILK TEEN 4.5&E+Ol 4.98E+01 2.9&E+00 O.DOE+00 2.93E+01 O.DOE+00 1.80E+05 N/A CHILD 1.12E+02 9.11E+Ol 7.05E+00 O.DOE+00 5.DOE+01 0.DOE+00 1.44E+05 N/A

. INFANT 2.23E+02 2.29E+02 1.40E+Ol O.DOE+00 8.82E+01 D.OOF+00 1.45E+05 N/A AOULT 2.34E+Q3 2.70E+03 1.62E+02 O.DOE+00 1.5&E+03 O.DOE+00 1.30E+07 N/A TEEN 2.06E+03 2.24E+03 1.34E+02 0.DOE+00 1.31E+03 O.DOE+00 8.0&E+06 N/A CHILD 3.86E+03 3.13E+03 2.42E+02 0.DOE+00 1.72E+03 0.DOE+00 4.96E+06 N/A INFANT 0.00E+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 N/A VEGTBLE ADULT 1.39E+04 1.6lE+04 9.61E+02 0.DOE+00 9.39E+03 O.DDE+00 7.71E+D7 N/A TEEN 1.72E+04 1.87E+04 1.IZE+Q3 O.DOE+00 1.10E+04 O.DOE+00 6.74E+07 N/A CHILD 3.65E+04 2.95E+04 2.29E+03 0.DOE+00 1.62E+Q4 0..DOE+00 4.6&E+Q7 N/A INFANT 0.DOE+00 0.00E+00 D.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 N/A TOTAL ADULT 1.63E+04 1.88E+04 1.12E+03 O.DOE+00 1.10E+04 O.DOE+00 9.03E+07 N/A INGEST. TEEN 1.93E+04 2. 10E+04 1.26E+03 O.DOE+00 1.23E+04 O.DOE+00 7.57E+07 N/A CHILD 4.05E+04 3.28E+04 2.54E+03 0.00E+00 1.80E+04 O.DOE+00 5;19E+07 N/A INFANT 6.20E+02 2.7&E+02 1.70E+01 Q.DOE+00 1.07E+02 O.DOE+00 1.76E+05 N/A ZNHAL. ADULT 5.27E+03 6.10E+03 3.65E+02 O.DOE+00 3.56E+03 2.2IE+05 1.73E+05 N/A TEEN 7.86E+03 8.56E+03 5.13E+02 O.OOE+00 5.02E+03 3.72E+05 1.82E+05 N/A CHILD 1.08E+04 8.73E+03 6.81E+02 0.DOE+00 4.81E+03 3.2&E+05 8.21E+04 N/A INFANT 7.94E+03 &.l3E+03 5.DOE+02 0.DOE+00 3.15E+D3 3.22E+05 3.12E+04 N/A BONE LIVER . ODY HY ID KI NY LUNG G.I. SKIN

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

","MAXIMUM VALUES FOR PA HAYS***

GROUND: GROUND: GOAT CQW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: INHAL.

8.31E+06 9.97E+06 3.84E+04 1.80E+05 1.30E+07 7.71E+07 9.03E+07 3.72E+05 PAGE: 4-40

O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*

9TOPE: Np-239 I'ATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G- I. SKIN GROUND ADULT 0.00E+00 O.OOE+00 Q.OOE+00 Q.OOE+00 0.00F+Qo 0.00E+00 o.aoE+oO o.aaE+ao TEEN 0.00E+00 O.OOE+00 O.QOE+00 0.'OOE+00 Q.OQE+00 Q.OOE+00 a.aoE+oo O.OOE+00 CHILD o.ooE+ao o.aoE+ao o.ooE+Qo o.aoE+Qo o.ooE+oo o.ooE+oo Q.OOE+00 0.00E+00 INFANT O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Q.OOE+00 O.OOE+00 O.QOE+00 GOAT ADULT 1.98E-Ol 1.95E-02 1.08E-02 0.00E+00 6.08E-02 O.OOE+00 4.00E+03 H/A MILK TEEN 3.79E-01 3.57E-02 1.98E-02 0.00E+00 1.12E-Ol O.OOE+00 5.74E+03 N/A CHILD 9.32E-01 6.69E-02 4.70E-02 O.OOE+00 1.93E-Ol O.OOE+00 4.95E+03 N/A INFANT 1.64E+Ol 9.96E-02 9.96E-02 0.00E+00 3.5IE-01 0.00E+00 5.09E+03 N/A COW ADULT 9.26E-Ol 9.10E-02 5.02E-02 0.00E+00 2.84E-Ol Q.OOE+00 1.87E+04 N/A MILK TEEN 1.77E+00 1.67E-01 9.25E-02 0.00E+00 5.23E-Ol O.QOE+00 2.6&E+04 H/A CHILD 4.35E+00 3.12E-Q1 2.19E-Q1 0.00E+00 9.02E-01 O.OOE+00 2.31E+04 N/A INFANT 9.19E+00 G.ZZE-01 4.64E-ol O.OOE+00 1.64E+00 O.OOE+OO 2.38E+04 N/A ADULT 8.54E-OZ 8.40E-03 4.63E-03 O.OQE+00 2.62E-O2 0.00E+00 1.72E+03 H/A TEEN 7.47E-OZ 7.04E-03 3.91E-03 O.OOE+00 2.21E-02 O.OOE+00 1.13E+03 N/A CHILD 1.41E-,Ol 1.01E-OZ 7.09E-03 O.OOE+00 2.92E-02 O.OOE+00 7.47E+02 N/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 H/A

"-GTBLE ADULT 4.71E+02 4.63E+Ol 2.55E+Ol O.OOE+00 1.45E+02 O.OOE+00 9.50E+06 N/A TEEN 4.57E+02 4.31E+Ol 2.40E+01 0.00E+00 1.35E+02 O.OOE+00 6.94E+06 N/A CHILD 8.44E+02 6.0GE+Ol 4.26E+01 O.OOE+00 1.75E+Q2 O.OOE+00 4.49E+06 N/A INFANT O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+aO O.aOE+Oa O.OOE+OO Q.OOE+00 N/A TOTAL ADULT 4.72E+OZ 4.64E+01 2.56E+Ol 0.00E+00 1.45E+02 0.00E+00 9.53E+06 N/A INGEST. TEEN 4.6OE+02 4.33E+01 2.41E+Ol O.OOE+00 1.36E+02 O.OOE+00 6.97E+06 H/A CHILD 8.50E+02 6.10E+Ol 4.29E+Ol O.OOE+00 1.76E+02 O.OOE+00 4;52E+06 N/A

'INFANT 2.56E+Ol 9.22E-Ol 5.64E-01 O.OOE+00 1.99E+00 O.OOE+00 2.89E+04 N/A INHAL. ADULT 2.3OE+02 2.26E+01 1.24E+Ol 0.00E+00 7.00E+Ol 3.76E+04 1.19E+05 N/A TEEN 3.38E+02 3.19E+Ol 1.77E+01 O.OOE+00 1.00E+02 6.49E+04 1.32E+05 N/A CHILD 4.66E+02 3.34E+Ol 2.35E+Ol O.OOE+00 9.73E+Ol 5.81E+04 6.40E+04 N/A INFANT 3.71E+02 3.32E+01 1.88E+01 O.OOE+00 6.62E+01 5.95E+04 2.49E+04 N/A BONE LIVER T.BODY THYROID KIDNEY LUNG G. I . SKIN

Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec

"*MAXIMUMVAlUES FOR PATHWAYS"**

GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: HEAT: VEGTBLE: INGEST: INHAL.

O.OOE+00 O.OOE+00 5.74E+03 2.68E+04 1.72E+03 9.50E+06 9.53E+06 1.32E+05 4-41

5.0 V U SE DUE TO W. BO U S C C ON 3.11.1.2 - THE DOSE OR DOSE COMMITMENT TO A MEMBER OF THE PUBLIC FRO.

RADIOACTIVE MATERIALS IN LIQUID EFFLUENTS RELEASED FROM EACH REACTOR UNIT TO UNRES )

AREAS (SEE FIGURE 5.1.3-1) SHALL BE LIMITED:

a. DURING ANY CALENDAR QUARTER TO LESS THAN OR EQUAL TO 1.5 MREM TO THE TOTAL BODY AND T LESS THAN OR EQUAL TO 5 MREM TO ANY ORGAN, AND

b. DURING ANY CALENDAR YEAR TO LESS THAN OR EQUAL TO 3 MREM TO THE TOTAL BODY AND TO LES THAN OR EQUAL TO 10 NREM TO ANY ORGAN.

The calculations of dose rec'eived by the hypothetical maximally exposed individual are based on ingestion of fish, drinking water and exposure on the shoreline. Drinking water is taken from the 'nearest public drinking water intake location (Danville Mater I

Authority). Shoreline and fish ingestion are associated with the SSES river outfall (edgi of initial mixing zone).

Methodology for calculating dose to the maximum hypothetical offsite individual has been developed (l)(2) for separate (fish, drinking water and shoreline exposure) and c ite liquid effluent pathways. This methodology incorporates usage, dilution, and trans parameters specific to the SSES site.

(1) PP8L Calculation EC-ENVR-0501 (2) PPEL Calculation EC-ENVR-0502 OnT Rev. 1 21

Table 5-la: Dose Factors for Fish Pathway: Maximum Hypothetical Adult (Page I of 2)

Dose Factor Units: mrem-ft /Ci-sec

.1.ocation: Outfall/FIXED DILUTION

~

Ussoe iUsp) )kg/yr:F)SH) ~ 21 Deut)an illMp:F)SH) ~

Trsnsit time itf) bra ~

T. Body 1 H-S 0.00o+00 147e44 147e44 147e44 147e44 147~ 147e44 2 C-14 1.ado+ 01 3.&Os+00 SA)dot od 3.&os+00 3.80etoo SA)dot 00 S.&oetoo 3 No.24 7.78e42 7.7ae42 7.78e42 7.78s42 '.78e42 7.78e42 7.78e42 4 M2 B.dos+02 4A)7etol 3.09e+0 1 OANe+00 OANe+00 0.00s+00 &A)as+01 6'r.sl O.doe+00 O.doe+00 7.53e44 1.&de44 1.&ae41 e Mn.S4 0.00s+ OO 2.&So+00 S.ode41 O.doe+00 7A)$o41 O.doe+00 8.12o+00 7 Mse 0.dec+00 B.oee45 1A3e45 O.dos+00 1.02e44 O.Ms+00 2.57e43 8 Fe.55 3.99e41 2.70e41 0.43e42 0.des+00 OANe too 1.Sie41 1.5&e41 9 FS8 d.20o41 1Aeo+00 6,59s41 OANo+00 OANe too 4Al7e41 4.&do+00 lo c 59 O.doe+00 Sdee42 1.2~1 O.doe+00 O.dos+00 O.dos+00 1.dao+00 11 Ce40 0.dec+00 1.55o41 3.43o41 O.doe+00 .OANotoo OANo+00 2.92e+M 12 Ni.03 1.89o+ 0 1 14lot00 0.33o41 O.doe+00 OANo+00 OANs+00 2.73o41 13 Ni-05 7.91e45 1.OSo4S 4.09o40 OANs+00 OANe+00 0.00e+00 2.01e44 14 Cu.04 O.ooo+00 1.SSo43 O.doe+00 SAQKQ OANe+00 142e41 1S 2n-05 1Aooto'l 4.40s+0 1 2.02e+01 OANe+00 2.98e+01 OANo+00 2.&le+01 10 2n49 2.3So-10 4Aao.l 0 3.13e.l 1 0.00e+00 2Al2e 10 OAXhtoo 0.76e-l 1 17 Br<3 0.des+00 0.des+00 1.74e45 OANe+00 OANst00 OANe+00 2.51o46 18 Br%4 0.dec+00 O.dos+00 2.14e-l 0 O.doe+00 O.Met 00 O.doe+00 1.&ae 21 19 Br.as 0.00e+00 0.00e+00 O.dos+00 0.00o+00 OANe+00, O.dos+00 O.doe+00 20 Rb-ad O.Ms+ 00 5.&Os+01 2.76o+01 O.doe+00 OANe+00 O.dos+00 l.leo+01 21 Rb.aa O.Me+ 00 0.dec+00 O.Me+00 O.Mst00 OANetoo OAXbt00 O.dos+00 22 Rb.89 O.Me+00 0.00e+ 00 0.00s+ OO O.doe+00 0.des+00 O.doe+00 O.dos+ 00 23 Sr 89 1.32s+01 0.00o+ 00 3.80e41 O.doe+00 O.dos+00 0.des+00 2.12o+00 24 Sr.ae 3.30o+02 t O.Mo 00 &.1 1 o+ 01 O.doe+00 O.doe+00 0.00o+00 9.sic+00 25 Sr-91 3.99o42 O.OOe+ OO '1.0'l e43 O.Met 00 O.dos+ 00 0.dec+00 1.$ 0o41 2d Sr-92 1.S7s-04 0.00o+ 00 0.77o40 O.doe+00 OAXbtoo 0.des+00 27 Y.90 2.07e44 O.Ms+00 7.16e40 O.dos+00 OANo+00 '.doe+00 2.&So+00 28 Y aim 2.84o-'1 S 0.00o+00 1.10s-le O.ooo+00 O.dos+00 O.dos+00 844e 15 29 Y-91 S.oeo43 0.00o+00 1A~ O.dos+00 O.dos+00 OANo+00 2.7ae+00 30 '82 240e47 0.00e+00 0.71o49 O.doe+00 .O.dos+00 O.doe+00 4.02o43 31 Y-83 1.7So45 0.00o+00 4.83e47 0.00s+00 0.des+00 O.ooe+00 S.sso41 32 2r.95 1.44o44 4.02o45 3.13e45 0.00o+ 00 7.26o46 0.des+ 00 1.4eo41 33 Zr.97 2.89ioe 5.83o47 2.07o47 O.Met 00,8.80e47 0.dec+00 '.81e41 34 Nb 95 2.00~01 1 A8e41 7.94e42 0.00o+00 'l Aee41 0.00o+00 8.97e+02 35 Mo 99 0.00o + 00 4.82o42 B. 1 eo43 0.00o+00 1.09o41 O.dos+ 00 1.12o41 5-la(1)

Rev. 1

,Table 5-la: Dose Factors for Fish Pathway: Maximum Hypothetical Adult (Page 2 of 2)

Dose Factor Units: mrem-ft /Ci-sec Locati on: Outfal l /FIXED DILUTION lsot ~

Liver 54 icl 01 LLl To 99m 3.03e 07 8.55e-07 1.09e 05 0.00eKO 1 30e.05 C.19c 07 5 06e OC Te 101 0.00tt00 0.00eKXI 0.00eKS 0.00eKS 0.00eKXI 0.00eKO Ru 103 2.64e 03 0.00eKO 1.54e-03 O.OOeKN 1.01e 02 0.00eKO 3.08e 01 Ru-105 4.52e 06 0.00eKO . 1.?8e-06 0 00etDO ',84e 05 0 00e+00 2 T6e 03 40 Ru 106 3.99e 02 0.00eKS 5.05e 03 0.00eKO 0.00eHO 2.55eKO 41 Ag. 5 50m 5.33e-OC 4.93e 04 0.00eKS 0 00eHS 2.0le 01 42 Te 525m 5.54e+00 5.5?e 05 2.06e 05 C 63e-05 6.2beKO 0 00eKS bot4cKlO

,"Tc 52?e 3.95cKN 1.40eKS 4.T6e-01 9.99e 01 5.59c405 0 00eKO 5.55~5 Te 127 1.00c 02 3.60e-03 2.17e 03 ?ARe 03'.08e 02 0 00eKS ran Ot CS Te 529Ic 6.54eHS 2.4C F00 5.04e+00 2.25ee00 2.?3et05 0 ORNER 3 R9e45 Te 129 i 1.79e.02 6.71e 03 4 35e-03 t 3?e 02 7.51e 02 0.00eHO 1.35e.02 C7 Te 53ta "5.64e 01 2.76e 01 2 30e 01 4.3?e-01 2.80eKS 0.00e+00 2.74+45 48 Te-535 1.08e 20 4.51e 21 3.Ctc-25 8.87e 21 4.73e 20 0 00eKS 1.53e-21 Te-132 1.5?F00 T.59e 01 7.12e-01 8.38e-01 7.31eKO 0.00e400 3.59eKI5 50 5 130 4.05e.03 5.20e 02 4.72e 03 1 Ote+00 1.8?e 02 0.00eKO 1 03e 02 51 l 131 8.29e-02 1.19e Ol 6.79e-02 3 88et05 2.03 01 0.00eKN 3.13e 02 52 5-132 2.36e.06 6.32e.06 2.21c-06 2.25e OC 1.0le-05 0.00eKO 1 19e 06 53 l-533 1.35e 02 . 2.34e-02 7.53e-03 3.4Ca+00 C.OBe-02 0 00eKO 2.10e 02 54 5-134 6.26e.12 1.70e 11 6.08c 12 2.94e-10 2.TOe-tt 0.00e40 1.C8e 14 55 5-135 7.02e-04 1.84e.03 6.78e 04 1.21e 01 2.95e 03 0.00e+OO 2.08e 03 56 Cs-534 1.81e+02 4.30e+02 3.51 F02 0.00eKS 5.39eKQ 4.62e+05 7.52ekS 57 Ca-536 1.79~5 7.0?e+05 5.09eKlt 0.00eHR '

93e405 5.39e+00 8.03cKS Cc-537 2.32 a+OR 3-5?F02 2.0?eH52 0.00e+00 '1.08eKQ 3.57~5 6.53eKS Cs-538 1.620 15 3.20e 15 1.59e 15 0.00e+00 2;3Se-15 2.32e~tb 1.3?e-20 Bc 539 2.13e.09 1.5R0 12 6.23e-11 0.00eKS 1 42e-52 8.60e 13 3.77e 09 61 B@ 540 1.11e 05 1.40e.OC 7.30e 03 0.00e+00 C.76e 05 8.02e 05 2.30e 01 62 Bc 1C1 0.00e+OO 0.00e+00 0.00e+00 0.00eHS 0.00e+00 0.00e+00 0.00eKS 80.1C2 O.OOc+00 0.00e+00 0.00eKS 0.00e+00 0.00+HO 0.00cKIO 0.00eKN La-140 5.90e.OS 2.9?e.OS ?.a 06 0.00eKO 0.00eKS 0.00e+00 2. 58eKS 65 Lc 142 8.78e.ll 3.99e 15 9.95e-t2 0.00e+M 0AOe+00 2.92e-07 Oe-141 1.33e-OS 8.99e-06 1.02e-06 0.00e+00 4.18c 06 0.00e+OO 3.44e-02 67 Ce~543 5.42e~0& 1 050 03 1.1&e OF 0.00e+00 4.61e OF 0. 00e+00 3.92e 02 Ce 1CC 7.0?e 04 2.9&e.OC 3.80e.OS 0.00e+00 1.75e-04 0.00e+00 2.39e 01 69 Pr-143 3.5?c-OC 1.2?e-OC 1.57c 05 0.00eKS 7.34e-OS 0.00et00 1.39eKN Pr-144 0.00e+OO 0.00e+00 0,00e+00 0.00e+00 O.OOPS 0AOe+00 O.OO~

71 II($ ~ 147 2.54e-OC 2.4?e.OC 1.C8e OS 0.00e+00 1.45e-OC 0.00e+00 1.59eKO M-587 8.&8e-02 7.25e.02 2.54e.OZ O.OOe+00 0.00eKS 0.00e+00 2.38et05 IIP-239 1.2?e.OS 1.25e-06 6.90e.07 O.OOOO 3.90e-O& 0.00e+00 2.5?e-01 5-Ia(Z)

DAT~

t Table 5-)b Dose Factors for Fish Pathway: Haximum Hypothetical Teen (Page 1 of 2)

Dose Facto r'Units: mrem-ft'/Ci-sec Location: Outfa11/FIXED DILUTION Ussso tUsp) {ks/yrF)SH) a le Diction lllMp:FISH) ~ 15.8 TNw't t)mo g) ~'

T. Body O.doe+00 'lA)do44 1ANe04 1.05e4C 1.00s44 C.'14 2.07o+Ol 4.13otoo 4.13s+00 4.13otoo 4.13o+00 4.13otoo 4.13s+00 Ne.24 8.02e42 BA)2e42 8.02e42 BA)2e42 8.02e42 BA)2e42 8.02e42 P-32 8.71e+02 SAoe+Ol 3~tol OA)Oetoo OAX)otoo OAOe+00 742etol

& Cr 51 O.doe too OA)Ost00 7.7Se44 441e44 1.70o44 1.'1 lo43 0 Mn-54 0.00e+00 2.01 e+00 6.17e41 O.doe+00 7.77e41 OAOe+00 $ 45etoo 7 Mse O.ooe+00 BA4eOS 1.50e4S O.doe+00 1.07e44 . O.ooe+00 6.66e43 Fe-65 4.18o41 2.80s41 eA)le42 O.ooetoo O.ooe+00 lA)ss41 1.28s41 Fo-58 e.39o41 1A9e+00 6.70o41 OAOetoo OA)Oetoo 4.71o41 3.53otoo 10 Co68 0.doe+00 5.33o42 '1.23e4') O.doe+00 'O.doe+00 0,00e+00 7>4ool 11 'o40 O.doe+00 1.5So41 3.50e41 O.doe+ 00 O.doe+00 0,00e+00 2.02e+00 12 1.See+01 148otoO 0.04e41 '.doe+00 O.doe+00 O.doe+00 2.20o41 13 Ni-05 8.55o45 1.09s45 4.$ 8o40 O.doe+00 OA)oetoo O.doe+00 6.$ 3oo4 11 ~4 0.00otoo 1.03o43 7.05s44 0.00o+00 4.12e43 OA)dot oo 14do41 1.27e+01 4.41e+Ol 2.des+01 O.ooo too 2.83s+Ol O.doe+00 1A)7e+0'l le zn-0$ 2.55o 10 4.87e-lo 3Als-11 O.ooe+ 00 3.18s 10 O.doe+00 BJ)7o-10 17 )b 83 0.00e+00 0.00s+00 1.8$ e45 O.doe+00 OAXbtoo O.doe+00 O.doe+00 18 Br-84 O.ooe+00 0.00e+00 220s 10 ~ OAXhtoo OAootoo O.dost 00 O.ooe+00 Br-85 0.00s+00 O.ooe+00 O.dos+00 0.00o+00 O.ooe+00 O.doe+00 OAOotoo 20 Rb-sd 0.00s+OO 0.35e+01 2.8$ s+Ol O.dos+00 OA)dot oo O.OO +OO 8.39e+OO 21 Rb.ss O.OOe+OO O.doe+00 0.00e+ 00 '.00e+00 OAX)e+00 O.doe+00 O.doe+00 22 Rb-89 O.OOe+ OO O.OOs+ OO OAIOstoO OA)Oo too 0.00e+ 00 0.00o+00 O.dos+00 23 &.89 1.44s+ 01 O.dos+ OO 4.12o41 O.doe+ 00 0.00o+00 O.doe+00 1.72e+00 24 & SO 2.70s+02 0.00etoo dAIlo+01 0.00e+00 O.dos+00 O.OOo+OO 7.7~tOO 25 & 91 4.32o42 0.00s+00 1.72o43 0.00o+00 O.dos+00 O.ooetod l.sdo41 2d & 92 l.dse44 O.OOo+00 741~ O.OOo+00 O.doe+ 00 O.doe+00 4.31o43 27 28 Y 90 Y-9 1m 2.89o44 3.07o.15 O.doe+00 O.OOo+00 7.7$ ~

1,17e-ld 0.00o+00 0.00e+00 O.ooe+ 00 O.doe+00 0.00e+00 O.dos+00 2.39e+00 1A6e-13 Y.s 1 SA9e43 O.dos+ 00 1.47oOO 0.00e+ 00 0.00s+ 00 0.00e+00 2.26e+00 30 Y-92 2.51 o47 ~

O.OOs + OO 0.00e+OO O.dos+ OO 0.00e+ 00 0.88e43 31 Y.93 1.$ 1 e45 O.OOs t 00 5.23s47 O.OOe+ OO 0.00o+ OO O.OOe+00 6.82o4'l 32 Zr.95 1AQMl 4.7os45 O.OOe+ OO 0.90e45 O.OOs+00 1.08s41 33 Zr.97 3.11 s40 0.1ss47 2AI3s47 0.00e+00 922o47 0.00s+00 1.00e41 34 Nb-85 2.07s41 1.48s41 8.17s42 0.00e+ Oo 1.44o41 O.doe+00 04tot02 35 Mo.$ 9 O.OOs+00 5.13e42 $ .7$ o43 O.doe+ OO 1.17o41 0.00s+00 9.19e42 5-)b())

Rev. 1 DAT

Table 5-1c: Dose Factors for Fish Pathway: Naximum Hypothetical Child (Page 1 of 2)

Dose Factor Units: mrem-ft'/Ci-sec

-,'ocation: Outfall/FIXED DILUTION O<<oge lU<<p) lkg)yr'F)SH) ~ 0.9 OSution {)lMp:FSH) ~

Trsre)t tine ltf) bro ~

T. 8od)r )br<<col 0.00<<+00 8.72<<4S 8.72<<4S 8.72<<45 8.72sO5 8.72sO5 8.72<<46 C14 2.00<<+Ol 541<<too 541<<too Sdl o+00 Sdlo+00 54) <<too 541<<t00 3l No-24 8.72<<42 8.72<<42 8.72<<42 8.72s02 8.72<<42 8.72<<42 8.72<<42 1.12<<t03 S>0<<t01 4>3<<t01 OA)0<<t00 OA)0<<t 00 OA)0<<t 00 3.10<<+01 0.00<<+00 0.00<<+00 848<<44'.04<<toO 4.59+04 849s44 4~2 O.OOe+00 SA3<<41 OA)0<<too $ ,72+01 OA)O<<too 1.71<<+00 0.00<<+00 7.09<<45 1.74<<45 0.00<<+00 9~S OA)0<<too 1.11<<42 SA9<<41 2.91<<41 -

9.02<<42 0.00<<+00 OA)0<<too 1.05<<41 549<<42 7.76<<41 1AS<<too 0DS<<41 OA)0<<too OA)0<<too 3A)4sol 1>1<<+00 10 Co.SB 0.00<<+00 4.26<<42 1~<<41 OA)0<<too OA)O<<too 0.00<<+00 2A8<<41 0.00<<+00 1.20<<41 3.72<<41 OA)0<<too OA)0<<too OA)0<<too dAIS<<41 Ni.03 2.67<<+01. 147<<too 8.74<<41 OA)0<<too OAX)<<+00 0.00<<+00 840<<42 13 Ni45 1A)9<<44 1.03e45 0.01<<40 0.00<<+00 OA)O<<too OA)0<<too 120<<43 14 0.00<<+00 1 AS<<43 9.03s04 3.01<<43 'A)0<<+00 OA)0<<too 7.01<<42 Zn-05 1.30<<+01 3.47<<+01 2.10<<+01 .0.00<<+00 2.19<<+01 O.OO +OO 0.1O +OO 10 3.28<<-10 4.74<<.10 448<<-11 0.00<<+00 2A)8<<-10 OAX)<<too 2AI9<<48 Br.83 0.00<<+OO 0.00<<+00 2A3<<45 0.00<<+00. 0.00<<+00 OA)0<<t 00 O.doe+00 18 0.00<<+00 0.00<<+00 2.08<<-10 0.00<<+00 OAX)<<+00 OAO<<too 0.00<<+00 0.00<<+00 0.00<<+00 0.00<<too 0.00<<+00 0.00<<+00 0.00<<+00 0.00<<+00 Rb-80 0.00<<+ OO 0.16<<+01 3.79<<+0 1 0.00<<+00 OA)0<<too 0.00<<+00 3A)0<<too 21 0.00<<+00 0.00<<+00 0.00<<too OAXI<<too OA)0<<too OA)0<<too 0.00<<+00 22 Rb 89 0.00<<+00 0.00<<+00 0.00<<+00 OA)0<<too 0.00<<+00 0.00<<+00 O.ooe+00 23 Sr.89 1.80<<+ 01 0.00<<+ 00 522<<41 0.00<<+00 0.00<<+00 0.00<<+00 7>l <<41 24 2.43<<+ 02 0.00<<+00 0,17<<tol 0.00<<+00 0.00<<+00 0.00<<+00 3.28<<+00 Sr.91 5.55<<42 t 0.00<< 00 2.09<<43 0.00<<+00 0.00<<+00 0.00<<+ 00 1.22<<41 Sr S2 2.10<<44 0.00<<+OO 8.00<<40 0.00<<tOO 0.00<<+00 0.00<<+00 4.09<<43 27 Y-90 3.74<<44 0.00<<+OO 1.00<<45 0.00<<+00 0.00<<+00 t OAX& 00 1.07<<+00 28 Y-Qlm 3.92<<.15 0.00<<too 1A3<<.10 0.00<<+00 0.00<<+00 0.00<<+00 7.08<<-12 Y 91 7.10<<43 0.00<<+ 00 1.90<<44 O.ooo+00 0.00<<too 0.00<<+00 9AS<<41 30 Y92 3.21<<47 0.00<<t 00 9.20<<49 0.00<<+00 OA)0<<too 0.00<<+00 '.29<<43 Y.93 2AS<<46 t 0.00<< 00 0,72<<47 0.00<<+00 0.00<<+00 0.00<<t OO 3.06+01 32 2r 95 1.91<<44 3.97<<45 3.54<<45 0.00<<+00 5.09<<45 O.doe+00 4.14<<42 33 2 97 3.95<<40 S.71<<47 3>7<<47 0.00<<+00 8.19<<47 O.OO<<+OO 8.0~2 Nb.95 3.10<<41 1.23<<41 8.78<<42 0.00<<+ 00 1.16<<41 0.00<<too 227<<t02 Mo99 0.00<<toO 4.88<<42 1.21<<42 0.00<<+00 1.04<<41 0.00<<+00 4.04<<42 5-1c(1)

OAT Rev. 1

Table 5-lb: Dose Factors for Fish Pathway: Maximum Hypothetical Teen (Page 2 of 2)

Dose Factor Units: mrem-ft /Ci-sec Location: Outfall/FIXED DILUTION lsat . Liver Th old L Ol Ll.l Tc-99 3.10e-07 8.64e-o? 1.12e 05 1.29e-05 C.Soe.o? 5-65e-04 36 37 Tc 101 O.ooe+00-," O.ooe+00 0.00eKO O.ooe+00 0.00eKN '.00eKN 0.~ 0.00eKO 2.31e-ol 38 Ru-103 2.??e-03 0.00eKS 1.18e 03 O.oooo 9.77e 03 O.ooeKN 39 Ru-105 4.8?e 06 0.00eKS 1.59e-06 O.ooe+00 6 14e 05 0.00HOO 3.9$ e 03 CO Ru 106 4.33e 02 O.ooe+00 0.00eKS 5 35e-02 0.08ea00 2.NEO llom 5.20e 04 4.92e 04, 3.00e-04 O.ooa+00 9.39e 04 0.00euR 1.38e-ol 41 42 R

Te-125m 1.67e+00 6.03e-ol 2.2Ce 01 4.68e Ol O.aoeeo 1.72et01

. 0.~

O.ooeKS 1.06+%1 C3 Te-127m 4.25e+00 1.51e+00 5.06e 01 1.01 a+00.

44 Te-127 1. 10e.02 3.89e 03 2.36e 03 7.56e-03 4.44e-02 O.ooe+00 SA?e-01 45 Te-129m 7.06e+00 2.62e+00 1.12e+00 2.28eKN 2.~1 0.00eKS 2.65ee01 46 Te 129 1.94e 02 7.24e 03 4.72e-03 1.39e-02 5.15e.02 0.00eKO 1.0be 01 47 Te.131m 6.06e.ol 2.91e-ol 2A3e-01 4.3?e-ol 3.03eKS O.ODDS 2.33e+01 CS Te 131 1.16e-20 C.SOe-21 3.64e-21 S.9?e-21 5JSe 20 0 00eKO 9.56e-22 49 Te 132 1.24')0 7.84e 01 7.38e-ol 5.2?e 01 7.63eKS 0.00+40 2 ASCOT 50 1-130 4.210.03 1.2? e-02 4.86e-03 9.93e 01 1 55e 02 O.ooe+00 9.36e 03 51 1-131 8.88e-02 1.24e 01 6.68e.02 3.63et01 2.1Ce 01 0.00+40 2A6e 02 52 1.132 2.48e-06 6.48e 06 2.33e-oo 2.18e-04 1.02e 05 O.ooeKO 2.52e 06 53 l -133 1 ASe-02 2A6e.02 7.51e-03 4.32e-o? 0.00e+00' Sbe 02 54 55 1.134 l.135 6.56e-12 7.36e-04 1 74e 11 1.89e 03 6.25e-12 7.02e-04 2.90e-lo 1.22e 01 2?4e 'll 2.99e 03 0.~

0.00eKS 2.29e-13 2.10e 03 56 Cs-134 1.85e+02 C.36e+02 2.02e+02 0.00eKO 1.38e+02 5.29')1 SA2eKN 57 Cs-136 1.80@+01 7.08e+01 '4 76e+01 0.00eKS 3,66et01 6.08e+00 5.70eKS 58 Cs-137 2.48e+02 3.30e+02 1.15e+02 O.OOOO 1.12e+02 4,36et01 4 69eKIO 59 Cs 138 1.74e-l5 3.34e.l5 .1.6?e- 15 0.06eKS 2A6e-15 2.S7e-lb 1.51e-l8 60 Ba-139 2.32e.09 '.64e 12 6.7?e-'ll O.ooeKN 1 54e.'l2 1.13e-12 2.0?e-08 61 Ba 1CO 1. 19e.ol 1.46e 04 ?.66e 03 O.ooe+00 9.79e 05 1.83e 01 62 Ba-141 0.00e+00 O.ooe+00 O.ooe+00 O.ooeKS O.ooe+00 O.ooe+00 O.ooe+00 63 Be-142 O.ooe+00 O.ooe+00 0.00e+00 0.00e+00 0 ooe+00 O.ooe+00 O.ooe+00 64 La-140 6.26e.o5 3.08e 05 8.18e.ob O.OOPS O.ooe+00 0.00eKO 1.7?a+00 65 La-142 9.36e.ll C.16e ll 1.04e- 1 1 O.ooe+00 O.ooe+00 0.00e+OO 1.2?e-06 66 Ce-141 1.4Ce 05 9.6le 06 1.10e-ob O.ooeKN 4.53e.06 O.ooe+00 2.75e-02 67 Ce-1C3 1.54e 06 1.12e.03 1.25e-o? O.ooe+00 5.02e 07 O.ooe+00 3.3?e-02 65 Ce-1CC 7.68e.04 3.18e-04 C.13e.05 0.00e+00 1.9oe.04 O.ooe+00 1.93e-03 69 Pr-143 3.44ei04 1.37e-OC 1.71e-05 0.00eKN 7.98e.05 O.ooe+00 1.13eKN

?0 Pr 144 O.OOMOO O.ooe+00 0.00e+00 O.ooe+OO O.ooe+00 O.ooe+00 O.ooe+00 71 kd-14? 2.C3e 04 2.64e-OC 1.58e-05 0.00e+00 1.55e.04 O.ooe+00 9.54e-ol

?2 u-18? 9.3?e-02 7.64e 02 2.68e.02 O.OOe+OO 0 ooe+OO O.ooe+00 2.0?a+01

?3 kp-239 1.43e.05 1.35e-06 ?.510.0? 0.00e+00 C.24e.06 0.00+40 2.18e 01 5-]b(2) wC ~

OrT

Table 5-1c: Dose Factors fol'ish Pathway: Maximum Hypothetical Child (Page 2 of 2)

Dose Factor Units: mrem-ft3/Ci-sec Locati on: Outfal l /FIXED D ILUTIO>

lsat T Id al-LLt Tc-99m 3.72e-07 7.29e 07 05 0.00eKS 1.06e-05 3.70e-OT C.15e-OC 37 Tc 101 0.00eKN 0.00eKO 0.00tKN O.Ne400'.21e 0.00eKS 0.00eHS 0.00eKO 0.00eKN Ru 103 3.C3c-03 1.32e-36 0.00eKO 8.62e-03 0.00eKN 39 Ru-105 6.21e-06 0.00cKS 2,25e 06 0.00eKO SA6e-05 0.00eKN 4-06e 03 40 Ru-106 5.57e 02 0 00eKS 6,96e 03 0+Net 7 53e 02 0.00eKS d.67e-01 4 -110e 3.98e 04 3.19e-04 0.00eKO TA?e-OC 0.00eKO 4.74e-02 Te-125e 2.15e+00 5.83e 01 2.87c 01 6.03e 01 0.00eKO 0 00eKO 2.07eKS Tc-127m 5.48et00 1 ASKS 6.Sle 01 1.31 AN 1 56+%1 0.00e+00 4A4eKS Te 127 1.Cle.02 3.50c-03 3.02e 03 9.76e-03 4.01e-02 0.00eKO 5.Slc-01 45 Te-129m 9.10e+OO 2.54e+00 1.Cled 2.93eKS 2.67et01 0.00eKO 1.1tet01 Te 129 2.500 02 6.99c-03 5.94e.03 1.79e.02 0.00e+00 1.56eKO Tc-131m 7.72c-01 2.67e-01 2.84e.01 SA9e 01 2.She OO 0.00eKO 1 08+41 Te-131 1 A9e-20 4.55e 21 4.4Ce-21 t.tCe-20 4.52e-20 0.00eKO 7.85e-20 Tc-132 1.55eKO 6.84e Ol d.2bc 01 9.96s 01 6.35 eke 0.00eKS 6.85eKS 50 1 130 5.15c-03 1.04e 02 5.3be 03 1.1S+40 1.S5e-02 0.00e+00 51 1-131 1.13e-01 1.13e-01 6A3e 02 3.7CetOt 1.6be-01 0.00e+00 1.01e-02 I 132 3.06c 06 2.59c 06 2.6le-04 d.die 06 0.00eKS 6.62e.06 I 133 1.84e-02 2.28e 02 0.00eHR 9.18e 03 l-t34 8.12e-l2 1.51e 1'I 6.94c-l2 3A7e 10 2.31e 11 0.00eKS 1.00c-ll 55 I 135 Q.ttc-04 1.64e-'03 T.76c.04 1ASe-Ot 2.51e-03 O.OOPS 1.25e-03 56 Cs-134 2.23c+02 3.66')2 7.73~t 0.00eo00 'l.t4et02 4.07~1 1.97eKN 57 Cs-136 2. 12et01 5.84~1 3.78e+Ot .0.00eKN . 3.1 tetOt 4A4eKN 2.05eKS 58 Cs-137 3. 12+42 2.99c+02 4.41~1 9.74ecOt 3.50+%1 1.87e400 59 Cs-138 2.20c 15 3.0be-15 1.94c-l5 2.15e-15 232e-td 1 Cte 15 Bs-139 2.99c-09 1.59e 12 d.d5c 11 0.00eKS 1.39e-12 9.37e-13 1.72~7 Bs-1CO 1.50c 01 1.31c-04 d.75e-03 0.00eKO C.26e-05 7 83c-05 62 Bs-1C'I 0.00c+00 0.00c+00 0.00tKO 0.00e+00 0.00e+00 0 00eKS Bs 142 0.00eKS 0.00eKR 0.00eKN 0.00eKN 0.00eKS 0.00eKS 0.00eKS L@ 140 7.83c.05 2.74e-05 9.23c-06 0.00eHS 0.00eKO 0.00eKO 7.63e 01 Ls-142 1.15c-10 3.77c-ll 'I. 1 dc- 1 1 O.OOc+OO 0.00etOO 0.00c+00 7.C6c 06 Ce 141 1.65e.05 9.24c 06 1.37c-06 O.OOe+00 4.05c-06 0.00c+OO 1.15c 02 67 Ce.t43 1.97c.06 1.07c 03 1.55c 07 0.00tKS 4.49e-07 0.00c+00 1 57e 02 Cc-144 9.90c.04 3.10c 04 5.29c 05 0.00c+OO 1.72e.OC 0.00eKO 8.09e-02 69 Pr -143 4.CSc.04 1.34c OC 2.2lc.05 0.00e+00 7.23e 05 0.00eKO C.dde 01 Pr-144 0.00c+00 0.00eKS 0.00eKO 0.00e+00 O.OOeKN 0.00c+00 O.OOc+00 Nd-t47 3.12e.04 2.53e-04 I.Qbc 05 0.00e+OO 1.39c 04 0.00c+00 4.00c-Ol M.167 1.19e 01 7.03c 02 3.lbc 02 O.~OO 0.00e+OO O.OOPS 9.55c+00 MP-239 1.84c.05 1.32c-06 9.3 1ci07 0.00t+OO 3.83c.06 O.OOMOO 9.50c.02 5-1c(2)

C~

DA'.2 pe

Table 5-Za: .Dose Factors for potable Uatcr pathway: )lamias Kypothetical Rdwtt (PACE 1 oF 2)

Dose Factor Units: cree-ft /Ci-sec Location: Danvi L le Receiwr/VAR$ N$LE DlLUTTDK Ussoe CUs ) (ky/ TKATER) ~

lsot Bone Liwr T. Body Th id 0$ LLl li 3 D.Doe+00 8ASe-02 8.43e 02 8.43e-02 &A3e-02 &A3c 02 &A3c.02 C-$ 4 2.2&e+Oa,', ( 4.56e.01 4.56e 01 4 56e 01 4.56e.01 4 56e 01 4.56e.01 Ka 24 1.37e+00 1.37e+00 1.37eKO 1 37e400 1.37c+00 1.37eKO P 32 1.55e+02 9 6CetN 5,99eKS 0AOe40 O.~- O.aac+00 1.74e+01

.5 Cr-51 O.Doe+00 0 Doe+00 2.14e 03 1.28c.03 4.71e-04 2.53e.03 S37e-0$

O.Doe+00 3.67eKS 7.00e 01 O.Doe+00 1.09c+00 O.aae+00 1.12e+01 Kn 56 O.DOMOO 9.23e 02 1.64e 02 0.00eKS 1.17ci0$ 0.00e4R '.95eKN Fe 55 2.2$ MOO 1.53et00 3.56e 01 0 00eHS 0.00eKS 8.Sle 01 ',75e 01 Fe 59 3.49e+00 8.19eKS 3.$ 4eKS 0.00erO) O.Doe+00 2.29eKS 2.73+4$

10 Coe55 O.aae+00 5.98e-al 1.34e+00 '.00eKN.

O.aaerO) 0.00eKS 1.21@41 Co-60 O.Doe+00 1.72eroo 3.79e+00 0.Doe+00 0.00eKS 0.00eKS 3.23')1 12 Ki-63 1.04e+02 7.24 eked 3.50e+00 O.aaeroo D.aoeraa O.Doe+00 1.51 MOO 13 Ki 65 4.24e 0$ 5.51e 02 2.51e 02 0.00eKO 0 00e400 D.Doc+00 1 40eKN O.aae+00 6.69c 02 3.14e-az 0 Doe+00 1.69c.al O.aae+00 5.7D AS 15 2n-65 3.89e+00 '.24~$ 5.59e+00 0 Doe+00 8.27e+00 O.aae+00 7a79cKO 16 Zn-69 5.27e-03 1.5&e-02 1.$ 0e-03 0AOeKN 1.03e-az O.aae+N 2.3&a 03 17 Br-83 D.Doe+DO D.Doe+00 3.23e-02 O.No+00 O.Doc+00 O.N+HS 4.65e.02

$ 8 O.Doe+00 D.oae+DO 4.1&e 02 O.aaeKS 0.00eKS 0.00e+00 3.28e 07 19 Br-85 O.aae+00 O.oae+00 1.72e-03 O.ODORS 0.00eKO O.Doe+00 0.00eKS 20 O.aae+00 1.69e+01 7.59e+OO O.Doc+00 0.00eKO O.Doe+00 3.34+40 2$ Rb.&8 O.aoe+N 4.86e 02 2.5&c 02 O.Net00 O.Net O.Doe+00 6.71e 13 Rb-89 O.Dao+00 3.22e DZ 2.26e 02 O.Doe+00 O.Doe+00 O.O~N 1.87e 15 Sr-89 2.47e+02 O.Net 7.10e+DO O.Doc+Do 0.00eKS 0.00eKO 3.97e+01 24 Sr-90 6.09e+03 O.Doe+DO $ .49~3 0.00~ 0.00eHS 0.00&00 1 76e+02 25 Sr-9$ 4.55e+OO a.aac aO $ .54e-a$ 0.00e+00 O.Doe+DO 0.00+40 2.17e+01 26 Sr-92 1.73@+DO 0.00' 7.47e 02 O.Nmo O.oae+00 O.aae+Oa 3.42~$

27 Y-90 7.72e 03 O.oac+OO 2.07c-04 O.Doc+00 0.00etN 0 00e+00 &.19+<1 2& Y 9$ m 7.3oe.05 O.oaeKS 2.53e 06 O.aae+OO O.Nehru O.aac+Oo 2.14c.04 29 Y 91 1.13e.ol O.aae+DO 3.03e.03 O.aae+N O.Doe+00 0.00et00 6.23+%1 30 Y-9Z 6.79e-04 O.oae+OO 1.9&e-a5 O.aac+00 0.00eKO O.aae+00 1. $ 9~$

Y-93 2.15e.03 O.Net 5.94e OS O.oac+00 O.Neraa O.Doe+00 6.83~$

32 Zr-95 2.44e-oz 7.83e-03 5.30e 03 O.aae+00 1.23c.02 O.Doe+DO 2.48e401 33 Xr-97 $ .35e.a3 2.72e-04 $ .24c.a4 O.aae+DO 4.11e 04 O.Doc+DO 34 4.99c.o3 2.7&e 03 '$.49e.03 D.Dacha 2.75c.03 O.aac+OO 1.69~$

35 Ko-99 0 Doc+00 3A6c+00 6.5&e al O.aae+00 7.54e+Oo O.aae+Do 5.02e+00 5-2a(l)

Table 5.2a- oose Factors for potable llater Pathways llaxtaa Rypotbetfcal adult CPage 2 of 2)

Oose Factor Units: arce-Ft /Ci-acc Locat ionf Oanvl 1 le Receiver/VARIABLE DILIITINI lsot Bone Liver Th Id GliLLI 36 Tc-99m 1.9$ o 04 5.60e 04 7+14e 03 0.00eKO 8.51e 03 2.75e 04 3.32e 01 37 Tc-101 2.04e 04 2.94e-04 2.88e 03 O.aaeKO 5.29e 03 1 Sae-04 8.83a 16 3$ Ru.103 1.C9e Ol 0.00eKS 6AOe 02 O.aae400 ~ 5.67e-af ll 00eKS 1 73e$ 01 39 Ru-t05 1.24e 0.00eKO 4.8de-03 1 60e-Ot O.Gaea 7 5&e$ 00 02'.21 Ca Ru 106 et00 0.00+40 2.79e 01 0 OaeKO 4.2&eKN 0.00eKO 1A3e$ 02 Cl 4 tt0s 1.28e.al 1 19e 01 O.aaeKS 2 3Ce O'I 0.00et00 C.85~1 C2 Te 125a 2 tSeKS 7 dae 01 2 dde 01 5A7e-01 0.00tKO 8.5%HOO 43 Te 127a 5ACeKS 1.94eKS 6 62e 01 2.21eKII 0.00eKS .t.82~1 44 'Te-127 8.83e.OZ 3.17e.aZ 1 91 ~ 02 6.54e-02 3.60e-al O.aaeKN CS Te-129a 9.23e+00 3.44 a+00 1A6eKO 3.17eKO 3.55eoOt 0.00eKO 4.65eaat C6 Te 129 2.520 02 9A8o 03 6 tCe 03 \ 94a 02 1.06e 01 0.00eKO '1 90e 02 C7 To-131m 1.39eKN 6.79e.al 5.66e 01 1~0$ eKN 6.8ScKS a.ooze 6.75~1 Cd Te.131 1.5$ 0 02 6.61e-03 4.99e-03 1.30e 02 6 93e-02 O.Gaea 2.2Ce-ls C9 Te 132 2 02e+00 t.31 AS 1.23eKS t ASSN 1.26e401 0.00tKS 6 19e$ 0t 50 I 130 6.07e~at 1.79e+00 7.07e 01 1.52eKQ 2.79e+00 1.54eKN 51 I 'I31 3 34e+00 4.78~00 2.74eKO 1.57eK6 8. 1 9eKS 0.00eKN 1 26o+00 52 I 132 f.&3e 01 43&e.at 1 S3e Of 1.5Xe<t 6.95e 01 O.aae+00 d.t9e 02 53 1-133 1.14e+OO 1 95eKS 6.05e.al 2.91 eked 3A6eKS 0.00e+00 1 78eKO 54 I-13C 8.51e-02 2 3te 0'I 8.27e-02 4.01 AS 3.6$ e 01 O.aae+00 2.02e 04 SS I-135 3.5&e Ot 9.31e-al 3A4e 01 6.Ne441 1 CQeKO 0.00eKO 1.05 ad%

5& Cs-134 4 99maf 1.19e+02 9.72~1 0.00eKO 3.85etOI 1.2$ c at 2.05eKS 57 Cs 'I36 5.23e+00 2.06e+Of 1.49') I 0.00eKS 1.15')t 1.57e+00 2.3C AS 5$ C$ 137 6.40e+01 8.75~1 5.73e+Of 0,00'Ã 2.97+41 9*8$tKO 1 69eKN

~ 59 Cs 13$ 4.430 02 d.75e 02 C.34e-02 0.00eKO 6.43c-02 6.35c-03 3.73e 07 60 Ba 139 7.79$ -02 5.55e 05 2.2$ e.a3 0.00eKS 5.19e-05 3.15$ -05 1 3$e 01

&l Ba-1CO 1.63e+Of 2.05e 02 '1.07eKS 0.00e400 6.96c 03 1.17e.02 3.36e401

&2 Ba. 'l41 3.78e-aZ 2.86a 05 1.2$ e 03 0.00eKS 2~6&a 05 1 62e-05 1 78e tf 63 Ba ICZ 1.7le 02 1.7&e OS t.ada-a3 O.aaa+00 1A9a-05 9*96e.06 2.Cte-20 La-1CO 2.ale.03 1.01e 03 2.67e 04 0.00eKN a.aac+aa 0.00eKO 7A3e41 65 La 1C2 1.03e-aC 4.67e-OS 1.1&e 05 O.aae+00 0.00eKS 0 Oaetaa 3Ate 01 66 Ce-141 7.52e.03 S.ade-03 5.77e-04 0.00eKS 2.36e.03 O.aae+00 1.94e$ 01 67 Ce-143 1.320-03 9.80e-01 1.0$ $ OC 0.00e490 4.31 a-OC 0.00e+00 3.66+41 Ce-144 3.92e O'I 1.64e 01 2.10e-02 O.Gaea 9.72e.02 O.aae+00 1.32eKQ

&9 Pr-143 7.39$ -03 2.96e.03 3.66e 04 O.aaa+00 1.71e 03 O.aae+00 3.2CeoOf 70 Pr 144 Z.CZe-OS 1.00e-OS 1.27e 06 0.00eKS 5.66e 0& O.aae+00 3.Cde 12 7I Kd-147 5.05$ .03 5.84$ .03 3.49e 04 0.00eKS 3A1e 03 0.00eKR 2.80etOI 7Z u-1$ 7 8.27e-OZ &.91e.02 2.42e.a2 O.aae+00 0.00e+00 0.00e+Oa 2.2~1

?3 Kp-239 9.5&a 04 9.COe-OS 5.18e.OS O.Gaea% 2 93e.04 0.00e+Oa 1.93~1 5-2a(2)

I DAT

Table 5-2b: Oose Factors for Potable lfater patlwayc Haxiaa Nypothetical Teen (page 1 of 2)

Oose Factor Units: rem.ft~/Ci.sec Location: Danvi lie Rect'Iver/VhglABLE D)LUTTOM sa e (Us ) (kg/ rtMhTER) a 510 lsot T. 8 Th id L'i 0$ $ .Ll H3 0.00m+00 5.95e 02 5.95e 02 5.95e-02 5.95e-02 5 95e 02 5.95e-02 C $4 2.28e+00, 4.56e-01 4.56e-01 4.56e-01 4.56e 0'1 C.56e 01 C.56e-0$

Na-2C $ .29MOO '.29eKS 1.PPeKS $ .29eRS '.29eKS 1.29eKO P 32 1.55e+02 9.59e+00 6.00eKN 0.00eKN 0.00eHS 0.00e+00 1.30e40$

5 Cr-51 O.OOMOO O.ooe+00 2.02e 03 1.12e 03 4A3e OC 2.88e 03 3.39e-01 0.00t+00 3.31 a+00 6.56e 01 0.00eKO 9.87e 0$ 6.79eKN 7 Hn-56 0.00cv00 8.86e 02 1.58e 02 0.00eKN 1.12e-01 0.00eKO 5.83eKS 8 F~55 2.12e+00 $ .50eKS 3.51e-o1 0.00eKS 0.00eKO 9.54e 01 8.5$ e 0$

9 Fe-59 3.29e+00 7.69eKS 2.97e&0 0.00et00 O.ooeKS 2A2eKO 1.82~$

10 Co-58 0.00e+00 5A5e-01 1 26eKÃl O.~ 0.00+40 0.00eKS 7.52eKN Co-60 0.00w00 1.58e+00 3.55~0 O.ooeKN 0.00eKO 0.00eKÃ 2.05m$

Ni-63 9.93w0$ 7.01e+00 3.37eKN 0.00eKS 0.00eKS 0.00eKO 1.$ 2eKO 13 Ni-65 4.20e.0$ 5.37e-02 2.CSe 02 0.00eKS 0.00eKS 0.00eKS 2.9$ eKN Cu-64 O.OOMOO 6.45e 02 3.0Ce-02 O.ooe+00 $ .63e-0$ O.ooe+00 5.00e+00 15 Zn-65 3.23e+00 1.12e+01 5.23eKS 0.00eKS 7 $ 8eKO 0.00eKO 4.75eKN 16 Zn 69 8.250.03 1.57e-02 1.Toe~03 0.00eKS 1.03e-02 O.ooe+00 2.89e 02 17 O.OOc+OD O.ooe+OO 3.22e 02 0.00eKO 0.00eKS 0.00eKN 0.00eKS Br-84 O.OOMOO O.ooe+00 4.05e-02'.71e 0.00eKS O.oo AN D.ooeKN 0.00eKS 19 Br-85 O.ooe+00 O.ooeue 03 0 00eKO 0.00eKO 0.00eKS 0.00eKO 20 21 Rb-86 Rb-88 0.00e+00 O.ooe+00 1.67e+01 C.78e 02 7.85e+00 2.55e-02 0.00eKS 0.00eKS 0.0~

O.ooe+00 0.~

0.00eKS 2A7eKN 4.10e 09 22 Rb-89 O.OOMOO 3.09e.02 2.18e 02 O.ooe+00 0.00eKN 0.00eKO 4.73e-11 Sr-89 2.C7e+02 O.ooe+00 7.07eKS 0.00eKS 0.00eKS O.ooe+00 2.9Ceo0$

24 Sr -90 4.66w03 O.ooe+00 1. $ 5eK6 O.ooe+00 O.ooe+00 O.ooe+00 1.3'l e<02 Sr 91 C.53 F00 O.ooe+00 1.80e-01 0.00eKS O.ooe+00 0.00eKO 2.05~$

26 Sr-92 $ .7$ e+00 O.ooe+OO 7.29e-02 0.00eKO O.ooe+00 O.ooe+00 4.36e40$

27 Y 90 7.69e.03 O.ooe+00 2.07e OC 0.00eKS O.OOPS O.ooeKO 6 34~$

28 Y-9$ e 7.2Ce.05 O.ooe+00 2.77e~o6 O.ooe+00 0.00eKO 0.00eKO 3A2e-03 29 Y.91 1.13e.0$ O.ooe+00 3.02e 03 O.ooet00 O.ooe+00 0.00eKO 4.62~$

30 Y 92 6.79e.OC O.ooe+00 '.96e-05 O.ooe+00 O.ooe+00 O.ooeKN 1.86+4$

31 Y.93 2 ~ 15e.03 0.00e+00 5.89e-O5 O.ooeKN 0.00eKN O.ooe+00 6.56+4$

32 Zr 95 2.31e.02 7.29e.03 5.02e-03 0.00~0 1.07e.02 O.ooeKN 1 65m%1 33 ,Zr-97 $ .33L ~ 03 2.63e.OC 1.21e.OC O.ooe+00 3.99e-04 O.ooe+00 7. $ 2~$

34 Mb.95 4.61e.03 2.560.03 1.C1e 03 O.ooe+00 2.CBe 03 O.ooeKO 1.09~$

35 Ho-99 O.ooe 00 3.38e+00 6.45e 0$ 0.00tKO 7.74e+00 . O.ooe+00 6.06eKN 5-2b(1)

table 5-2b: bose Factors for Potable uater Path>cay: ltasi~ Kypothctkcst Taco CPaac'2 of 2)

Dose factorst atcfc ft~lCI scc Locattont Oawlglc Receiver per CRT table 5~2 VI &l~OIMlN lsot Thyroid Ol lit Tc %ha l.bbe.OC $ .19c-04 6.73c-03 0.00tKO 2 55c 04 3Atc 01 37 Te 101 2.02c 2.87e 2.52c 03 0.00cKS 1.75e QC C.9le 11 t~t OC OC 38 Ru-'!03 1.C3c 01 0.00e+00 6.1tc 02 5.04e-at 0 00eKO 1 39 Ru 105 1.22e 02 Q.ISeo00 0.00eKO t.~t 0.00eNO 9.57eKN Ca Ru 106 2.20eKO 0.00eNO 2.7le 01 0.00eKS 4.24cKO 0.00eNO 1.05ec02 41 Ay tt0e 1.15c 01 1.09~1 6.62e 02 2.~1 0+aaeKO 42 Te 125a 2. ISIS 7.74~1 2.5Te 01 6.~1 O.OOOO 0,00oKO 6.3CeKO 43 Tc 127e 5.42eKO 1.92eKO 6.45~1 1 29eKN 2 20ecat 0,00eKS 1 DSeKN 44 Te 127 S.bbc 02 3.1Cc 02 1.9le 02 3 S~t Oi00eKS '6 54eKS 45 Te 129a 9.14eKS 3.39 eked t 4%eKO 2 95ef00 3.83ecat 0 00e+00 3s43ec01 45 Te 129 2.5lc 02 9.37c-03 6.11e 03 1.05~1 0.00eNO 1.37~1 47 'Te 13ta 1.37eKO 6.56e 01 5.4Sc 01 9.57~1 6.84eKO - O.aaef00 5.27etOt CS Te-'l3t I.STc.02 6.45c-03 4.d9e-03 6.d4e 02 O.OQeKS 49 Tc 132 1.9beKS 1.2C AN 1.17+40 1&teKS 1.21efat 0.00et00 3.93~1 50 I-13a S.Tbc Ol 1.67eNO 6.~1 2.57eKN 1 28eKO S'l I 131 3.2beKO 4.59eNS 2.47eKO 1 34eKS 7.91eKN 0.00e+00 9.09e 01 52 I-132 I.STc.al 4.'lac 01 1.47e 01 1 38&01 6A~t t.75~1 53 1-133 l. 13~0 1.9teKN 5.83e 01 2'67eKk 0.00eKS 1.45eKO 5C I 134 5.19c 02 2.17c-al 7.80e-02 3.62eKN 3A2c-01 0.00eKS 2.86e.03 55 I 135 3A2c.al d.dlc.al 3.27e 01 5 67e401 1>>39efaa 0.00eKO 9.76e Ol 56 Cs-134 C.TO~I I.t 1~2 5. t3~1 0 aacc00 3.5teeOt 1D4etOt 1 37eKS 57 Cs-136 t.~l 1.27~i 0.00eKO 1 JSeo41 1.63eNO 1.53eKO Sb Cs 13T 6.25 eel 5.36+41 2.9teKl1 0.00eKO 2.54etOI 1.1 tetOI t. 19eKO 59 Cs-13S C.35c.02 8.3bc 02 C.18c-02 0.00eKS i 6.1lc.02 7.1Sc-03 60 Ba 139 T.bac 02 S.C9c 05 2.2lc 03 0.00eKN S.tie-OS 6.~1 61 ba 1CO 1.59~1 1.95c OZ 1.QXa+CO 0.00cKS 6.62c 03 1.31e-02 2.46eKlt 62 Sa ICl 3.7be-02 2.blc OS l.2be-03 0.00eKO 2 61c 05 d.02e-ab 80 IC2 1.65c-02 1.65c 05 1.03e 03 0 00eKN 1.42c-05 5.15e~tC ~

64 Ls-1CO 1.95e 03 9.59c-04 2.55'4 0.00e+00 0.00m+00 0.00tKS 5.51~1 65 La. 142 I.OOc 04 4.4be.OS l.llc 05 0.00eKO 0 00et00 0.00eKO 1.36eKS 66 Cc lCl T.Cbc 03 4.95c.03 5.72c 04 0.00eKN 2.34e-03 0.00eNO 1.42eKII 67 Cc-1C3 1.32c 03 9.59c OI I O'Fc 04 0.00eKN 4.3ac 04 0.00eKO 2.5bc+Ot 68 Cc-144 3.90e Ol 1.62c Ol 2. lac 02 0.00eKN 9.65c 02 0.00eKS 9.82c 01 69 Pr-143 7.35c-a3 2.93c-03 0.00eKN 1.7lc.03 0.00eKS 2.42+%1 70 Pr 144 2.Clc 05 9.dlc.ab 1.22c Ob 0.00eKO 5.67c-06 O AORS 2 bbc 08 t 71 Kd 147 5.2bc-03 ,S.nc-03 3.43ci04 0.00eKS 3.36c 03 0.00eKS 2.06et01 72 u-tbl 5.19c-o2 b.bbe 02 234c 02 0.00eKS 0.00eNS 0.00eKS t.dte401 9.57c-OC 9.3lc 05 5 ~ tlceOS 0.00e+00 2.92c-OC O.OOPS 1.50~1 5-2b(2)

Table 5.2a. Oooo Footers (or Potable Waar Pathway: Mtttantan Hypothotiaal ChSrI (PRO% 1 OF 2I We~t ~(tv ~

Danvilo Rooahror/VhRABLE OLUTION Usage (UapI (kQIyrNATN n 51Q T. Body H3 Q.des+00 1.14o01 1.14e01 1.'I 4e0'1. 1.14o0'I 1.14e01'.14e01 2 C-14 8.79o+00 Mtht00 l~t00 1~+00. l~t00 l~tN l~tN 3 No 14 3.25e+00 LRQt00 345ot00 MQt00 02&t00 32Qt00 4 P42 4.83o+02 2.17o+01 '1.7&a+01 OAIOet00 OAIOst00 OAOot00 1M+01 5 Cr 61 0.00o+00 OAOet00 4AIQe03 7.57e04 2.8Se01 8 Mn-64 0.00o+00 dAXht00 1AXIe tN OAIQet N 1 AI&at N OAOet N 7 Mn Sd 0.00e+N 1AI7e01 MSe42 OAIOst00 K27o01 OAIQot00, 2.71e+Ol 8 Fe.66 BASo+00 3A2o+00 1.0de+00 OAOe+00 . OAXIst00 1AMetN d~l 9 FSQ 94&st00 1.50s+01 7Ads+00 OAOo+00 OAXIet00 4~tN l,See+01 10 Co.58 0.00o+00 1.01o+00 3.09o+00 O.Not N 0.des+00 OAOet00 5.8&a+ 00 .

11 Co 60 0.00o+00 2.97o+00 8.76o+00 OAIOot00 O.Not N 0.00o+00 1.84+01 12 Ni.83 t 3.02s 02 1.82s+ 01 1.03o+01 0.00e+00 OAOetN O.Noted 1.0$ e+00 13 NH$ 5 1.25a+00 1.17e01 8.84o02 OAIOet00 OAOe+00 OAIQetN 1.44e+01 Ii Cu-84 0.00o+ 00 1>7s01 8~2 0.00 a+00 342e01 OAIQotN d.4$ e+00 15 Zn46 7.8&a+00 2AISot01 127et01 0.00e+00 . 1Mt01 OAXIetN ld Zn0$ 2.4&e02 3.$ 5e02 3.2&e03 O.OOe+00 2.16e02 0.00o+00 2.24e+00 17 Sr-83 0.00o+QQ '.00o+00 0.des+00 OAXIet00 Q.QQe+00 0.00e+00 18 0.00o+00 0.des+00 1.11e01 0.00e+00 OAOe+00 OAOo+00 0.00e+00 19 Sr<5 0.00s+ 00 0.00e+00 S.'I 2o03 0.00o+00 0.des+00 O.Net N 0.des+00 0.00o+00 3.7&a+01 Mlet01 0.00e+00 OAIQetN O.Not00 2AZe+00 20 21 22 Rb Bd Rb.&8 Rb-89 0.00o+00 0.00o+00 1.07e01 d.Sde02 7A1o02 5AI3o02 OAXIst00 0.00o+00 OAOst00 OAIQet00 OAOotQQ 0.00e+00 S~

5.71o04 7A1o+02 0.00e+00 1.1 le+01 0.00ot00 0.00o+00 0.des+00 2.87e+01 24 8.54o+ 03 0:QQo+00 ZA2o+03 OAIOe+00 0.00o+00 OAOet00 14&a+02 25 Sr.91 125o+QI 0.dec+00 S.Q&e01 0.00e+00 0.00e+00 OAXIet00 2.87e+01 28 Sr 92 5.07e+ 00 0.00o+ 00 2.03e01 0.00o+00 O.Net00 0.00et00 9.6&a+01 27 Y.90 2.31~2 0.00 a+00 8.17e04 0.00e+00 OAXIet00 0.00e+QQ e.Se +01 29 Y.91m 2.14e04 0.00o+ 00 7.&Qe0& 0.00o +00 Q.dec+00 Q.QQo+00 4.20e01 29 Y.91 3.3&o01 Q.QQo+QQ S.03e03 0.00o+00 OAXht00 QAOs+00 4.50e+Ol 3Q Y-92 2.02~3 Q.QQo+00 $ .7&eE)$ 0.00o+00 0.00o+00 0.00o+00 5.&3o+01 31 Y.93 8.400.03 Q.QQo+00 1.78e04 0.00e+00 0.00e+00 0.00o+00 9.54+01 32 8.51 ~ 02 1.43o02 1.27e02 0.00e+00 2.05e02 OAOet00 1AQe+01 33 Zr.97 3.92~3 5.87~ 3>ie04 0.00e+00 8.13e04 0.00ot00 S.S&a+01 34 Nb-95 1.2&e02 4.91o03 3.51o03 0.00e+00 4.82o03 0.00o+QQ Q.Q9o+00 35 O.QQo+00 7.4&at 00 '.&So+ 00 0.00e+ 00 1.59e+ 01 0.00st 00 d.l ie+00 5-2c(1) l V

op; : cubi/Ia-..

Table 5 2d! Oose Factors for Potable Mater Fathwyt suxieaa Synthetical Ififant page 1 of 2)

Oose Factors: arearft /Ci.sec Location: OanvIIIe Receiver per CAROL Table 5.2-23/VARIABLK OILIITIOR Usa o (Ua ) (k / FVATER) lsot Bone Th id L'I L GI LLI II 3 0.00et00 1.12e 01 1.12e 01 1.'12e-01 1.12e 01 1.12e-ol 1.12e-ol C 1C 8.60etOO 1.84etoo 84eKO 1 84eKS 1 JL4etN 1 SLeKO Ma-24 3.67e+N 3.67eKN 3.67eeao 3.&7ee00 3A7eKN 3.67~ 3.67eKN P-32 6.17+42 3.63eHOI 2.39ee01 ' O.ooeKN 0.00aKO 0.00e+00 MSRKN Cr-51 0.00e+OO 0.00e+00 5 12e 03 3DCe-03 7 3IhHOC 6.50e-03 1A9e 01 lin-54 0.00etIO 7m22IHOO 1.64eKN 0.00eKS 1 60eKS 0.00eKS 2.65eKO 7 IIn-56 0 Ooe+OO 2 97e-01 5.12~ 0.00eKS '2 5~1 0.00et00 2.70eeal 8 Fe-55 5.05+40 3.26aKO 8.71~1 0.00eKN O.aaeKO 1 59eKN 4 '14e Fe-59 1.12e+01 1.95+%1 7.70euN O.aoeKS 5 77e4IOO 9.33eKN01'.00e4R Co-58 O.ooe+OO 1.31 ada 3.26+HO 0.00eKS O.aoeKS 0.00e+00 3.26eKO 11 Co 60 0.00e+OO 3.92eKO 9.2betM 0.00et00 0.00eKO 0 00eKO 9.33eKO 12 MI 63 2.30e+02 I A2~1 7.9%HO) O.IRhHOO O.OO+eO O.~ 7.OS Ol

'I3 NI 65 1.7le+OO 1 93e 01 8 78e 02 0.00et00 O.ooeKS 0.00eKN 1A7~1 1C Cu-64 2.21e 01 1.02e 0'I 0.00eKS 3.74e 01 0.00eKS 4.54eKS 15 2n-65 Zn-69 O.OOe+OO 6.6Se+00 3.39e-02 2.29~1 6.10e.o2 1.06e+01 0.00eKO 1 11eeol '0 00eKS 0.00e4$

I,~I 4.97eKO 16 4.54e 03 0.00eKN 2.53e 02 17 Br 83 0.00e4$ 0 00eKS 1.32e 01 0.00eKN 0.00eKS 0.00eKS O.ooe+00 18 Sr-84 0.00e+00 O.ooe+00 1.39e 01 0.00eKS '.00eKO O.ooe+00 0.00eKS 19 Sr-SS O.ooe+OO 0.00cKO 7.0Ce-03 0.00eKO O.oaetao 0.00eKO 0.00oKS 20 Rb-86 0.age+00 6.17e+01 3.05~1 0.00et00 0.00etoo 0.00eKO 1.5SeKO 21 22 Rb.88 Rb 89 0.00e+OO 0.00e+00 1 Sle-Ol 1.04e-ol 9.91e 02

'7.15e 02 0.~ 0.~ 0.~

0.00eKS 0.00eKS 0.00eKO 1.7&e-O1 3.54e 02 Sr-S9 9.11e+02 0.00eKS 2.61e+OI 0;00eKS 0.00eKO O.ooe+OO 1.87eIOI Sr-90 6.72ek6 O.ooe4S 1 7Ie+03 0.00eKS 0.00eKS 0.00eKS 8.39etOI 25 Sr-91 1 82e+01 0.00e+00 &.57e 01 O.IOcHIS 0.00eKO 0.00e+00 2.15+<1 26 Br-92 6.97e+OO O.ooe+OO 2.59e 01 O.ooe+00 0.00eKS 0.00eKO 7.51et01 27 Y-90 3.15e-02 0.00eKS 8.4&e 04 O.aoet00 0.00eKO O.ooe+00 4.36etOI 28 Y-9)m 2.94e 04 O.ooe+00 I.ooe.05 0.00eKO 0.00eKS 0.00eKS 9.80e 01 29 Y-91 C. loe-01 0.00eKN 1.09e-a2 O.ooe+00 0.00eKR O.ooe+00 2.94e401 30 31 Y-93 2.78e-03 8.82e-03 O.ooe+OO O.ooe+OO 7.80e.05 2AOe 04 0.~

0.00eKO O.aortae O.ooet00 0.~

O.OIhHOO 5.3~1 6.97+%1 32 Zr-95 7.CSe-02 1.82e.02 1.29e 02 0.00e+0) 1.96e 02 O.ooeKIO 9.08eKO 33 2r-97 5.37e-03 9.22e 04 4.21e OC 0.00eKS 9.29e-oC O.ooe+00 5.58+%1 kb 95 1.52e-02 &.28e.o3 3.&3e 03 0.00et00 C.50e-03 O.ooe+OO 5 30etoo 35 Ilo-99 O.OOe+00 1.23e+OI 2.41e+00 O.ooe+00 1 84HOI 0.00eKN C.07e+00 5-2d(1)

Table 5-2ct Dose factors for potable Mater Pathway: Naxbaa Rypotbetioal Dhild (Page 2 of 2)

Dose factors: mrem-f t~/CI-scc Location: Danvi1 le Receiver/VlRINLE DILVTION lsot Liver Th Itl 'KI OI LLI 36 Tc-99m 5.18e 04 1.02e 03 1.6$ e-02 1 48e 02 5.16e-04 5.7$ e 01 3? Tc 101 &.OOe-04 &.2$c 04 ?.9?c-03 0.00e+00 1.07e 02 2 OOe 03 38 Ru.103 4.10e.OI 0.00eKN 1 Sdc O'I 0.00e+00 1.03eNN 0.00ea00 ~ 1 06et01 39 Ru 105 3.62c.02 0.00eKN 1.31aM 0-00eKN 3.18e 01 0.00iKN 2.%eK)1 CO Ru 106 6.56eKS 0 00eKS 8.19c 01 0.00eKS d.86eKO 0.00eKO 1.02e+D2 Cl R 110m 3.02e 01 2.0Ce-01 1.&3c Ol 0.00e+00 3.80e 01 0.00c+00 2A3e41 C2 Te 125m 6.40eKN 1.73et00 d.53c-01 1 80eKO 0.00eKN 0.00e+00 . 6.1?AN 43 Tc-12?m 1.62e+01 4.36e+M 1 92eKN 3.6$ eKS C.&2e401 0 00eKN 1.3le41 CC Te 127 2.6Ce-01 7.12e D2 5.67e.02 1.83e 01 7 52c 01 0.00eKS $ .03ef01 45 Tc-129m 2.75c+01 7 63@%0 4.24eKS 8.81 a+00 8.02~1 0.00eKS 3.33~1 46 Te-129 7.52e 02 2.10e 02 1.78e-02 5 3&c 02 2 2Dc 01 0.00eHS 4.68eKS 47 Te.131m 4.04e+OO 1AOe+00 1A9eKN 1.35ct01 0.00eKN 5.67~1 4$ Tc 131 4.66e 02 1.C2e 02 1.39e 02 3.56e 02 1A1e 01 0.00eHN 2ASc 01 C9 Te 132 5.67e+OO 2.51e+00 3.03eKS 3.65eKO 2.33c+01 0.00e+DO 2.52~1 50 1.130 1.64e+00 3.31e+00 1.71 AS 3.65~2 4.95 a+00 0.00eKO 1.55eKO 51 I 131 9.65c+OO 9.71e+00 5.51eNS 3.21et03 1.59t+01 0.00'Ã 8.64e 01 52 I 132 C.C9e 01 8.25e 01 3.79e-01 3.83e+01 1.26e+00 0.00eKS 9.?le 01 53 I 133 3.32e+DO C.lie+DO 1.55eKO 7.63e+02 6.84e+00 0.00eKN 1.65eKN 54 1-134 2.350.01 4.3&e.01 2.01e.01 1.00e+01 6.68c 01 0.00e+N 2.89e-01 I-135 9 82e 01 1.7?~00 8.36e 01 1.5?a+02 2a?1 a+00 0.00eKS 1.35eK4 55 56 5?

Cg 134 Cg-13&

1.31et02 1.32e+OI 2.15e+02 3.62e+01 4.54e+Ol 2 34~I 0.~

0.00e+00 6.68e+01 1.93e+01 2.40etOI 2.88+40 1 16eKO 1.2?eKl0 58 C$ 13? 1.83e+02 1.76e+02 2.59e+O'I 0.00e+00 5.72c+01 2.06+41 1.10et00

'59 Cg-13$ 1.2$ e 01 1.78e.01 1.13e-01 0.00eKS 1.25e-01 1.35e 02 8.19e-02 60 Ba.139 2.32e 01 1.24e.OC 6.73e.03 0.00e+00 1.08e 04 7.29e.05 1.34+%1 61 Be~140 4.6&e+01 4.0$ e 02 2.72eKS 0.00e+00 1.33e-02 2A3e 02 2 36+41 62 Ba.141 1.12e-01 6.2$ e.05 3.65e 03 0.00eKS 5A4e-05 3.69c-04 6AOe 02 63 Ba 1C2 4'.90e.02 3.53e.05 2.74e.03 0.00e+00 2.86e 05 2.0$ e-05 6.COe.04 La ICO 5.&7e.03 'I 9$ e.03 6.6$ e OC O.DOe+00 0.00e+00 0.00eKS 5.52~1 65 La.1C2 2.94e.04 9.3?e.05 2 93e.05 0.000400 0.00e+00 0.00m%0 1.86+41 Co*141 2.23e.02 1. 'I l c.02 1.65e 03 0.00e+00 4.8?e-03 O.Doe+DO 1.39~1 67 De IC3 3.92e 03 2.13NOO 3.0$ c.OC O.OOe+OO 8.92e 04 0.00c+OO 3.11eKN Ce. ICC 1. I?F00 3.6&e.OI 6.23e.02 0.00e+00 2.03c-01 0.00e+OO 9.54ivOI 69 Pr 1C3 2.20c.02 6.62e 03 1.09e.03 0.00e+00 3.58e-03 0.00c+OO 2.3St401 70 Pr 1CC ?.2Ce-05 2.24e.05 3.64e.D& 0.00e+OO 1.18c-05 0.00c+OO 4.82c-02 71 M6 147 1.57c 02 1.2?e 02 9.$ 2e OC 0.00e+00 6.96c 03 0.00et00 2.01+41 72 M-18? 2.41e 01 1.42e.01 &.CO~.OZ O.OOMOO D.OOe+00 0.00e+OO 2.00~1 73 Kp 239 2.95e.03 2.1'le.OC 1.49e~OC D.DOe+00 6.11e-04 0.00et00 1.5?F01 5-2c(2)

DAT yc.

I

MREMNZWRKEWRRMRtmlae K%RmmaKEHRRK%KRME~mm~amr~aPZ.'HARD~

%%V..'Kama%

~gg~l~~~l~<~IL Qg>~II +~it I~a ~A.~>~ .~<~~

K%R555~%%5HRRK.'~%K.'~NHE~REH~R?E~R3K~

~ ~

K'%RK~RPH55%

RBNRE~KK~RK~

KK~ RK~~~K~~HRKK~

RK~RK~RK~KK~RX~M,

~i~~~Q~~~~~~~i~

REÃNTRZ%%KBHRRKKKRNKVKXEK~MKK~~iRNK!~53K~

RKKRKEMW65HRRKP~RK~K3K~KK~KK~RXb~ gg~

~MR~R3KZHRRKE?RKKH~RlKK%NX"~R3C~MZ~

~ggi~gg++g~~~~a~~~~~~~ ~

kX%RK~KKCHRKKKE%ÃERHRRE~RKMTRXK.'~KKMM RK%RHKI~NKHKTSRKRKRRlKKERKK~MK~R?E~RKM

~

RSEEMRK~KRI~MM~RKE~~~~~R?K~

RXRllK~RXE~83K~KlK~RKHErÃ~~R'?E~

RM~~RKHKRRRHHRRK~QXZ~~~KK~53K~

RRRKEr~RRHKRRK~RMHRRKKHRkK~RK~REHEAR',

RZRREE~RKK~RRXR~RK+~RK.~RKZ~K2M~RK~

RMNK~KRHKiR~KKRR5255%RKRETR~~~R?M~R3E~

KMNK~NKH~RKMMRXHKCRRX~~~~RK~RSME!%,

N%RK~RK~RWKEHRRK~RRK~RKK~MMHRRK~iR'MRK~KEHKRME~RKE5%RPK~REZEKRKK~&R~HR'MK5E~RKEHRRK~REiKCRRK~RKXH%%~2%83K~

KMRK~RKEERNXZ~K~HRRlK~REHKtRMKMERKIK~

RTEE~KKKWRKHKRKK5HRR~~RKHH%NK~~MRK~H%,

RTR~NRXECRR362L5ESRK~RFK~RKHKRKEXEZRREz~

RZRRSL~NKKCR~~~KRRE ~~~R3K~R~~

RERRRXM~KERRKHEHRRRHKRRK~KK~RKK~NXM5%',

NR~R~HRRRHKQRKRKRRK'.~KK~RK~KHZ~

NR~RKRHRRI6BHRRKRKR~~NPM~RK.'~EKE~

NRXMRMKRREMÃRK2KRRM~RKz2K%KK~

mammmaemmammammmam~ammaam~am~

NK~R~~NKH%KR~~RK~RKaKKRKK~RKZ~

RHRKMKK56%REEEZSRIERKRRK~RKHK'%~~WMHK

%5%RK~NKWRRKRKKRRKHKRNK~RKHK%RK'.~%K~~~

KHRER~RKKHHRRKKtRRKZKKRRK~~~RK'.~%KEEK KWREEH~RKHKTSRKHKQ~KER~~KK~RK"~MME RaRR&~RKEHSRKKR~KRWM~RK?KRAK~

Table 5-3 Radioactive Decay Constants Hoff4fo Period Decoy Hoff4fe Period Doooy IS,M.H.D.YI Constont 18.MPl.D.YI Conotont IHro.ll IHre.ll H.3 12.28 d.44eO1 $8 f4-103 7~4 C14 6730. 39 . Av-'l06 1A4 1.&deO1 N+24 ~ i.d2e42 40 lh 101 7$ 4e46 1448 2.02eO3 41 Ay 1 lcm 1.14eO4 27.704 1.04o43 42 Te 125m 4.08eO4 312.7 9.24eO& 43 Te 127m 10Q. 2.1&eO4 2.5785 2.10eOl 44 Te.127 7.4leO2 2.7 46 Te.120m $ 3.1 D d.eeoO4 r 68 44.13 41 Te 120 10 Co-58 70.8 4.08eO4 47 Te-131m 2.3le42 5.271 1.50eOS 48 Te.131 25. 'I.dec+ 00 12 Ni.13 100.1 7 JRe47 48 Te 1$ 2 78.2 13 2.52 2.7SeOl &0 l.130 12ze &.dleO2 12.701 5.41eO2 51 l 1$ 1 3.69eO3 244.4 1.18eO4 52 1-132 3.01eO1 5&.d 7.47eO1 53 l.l$3 3~2

, 2.39 2.90eO'I . 54 l.1$ 4 62.1 7.89eOI 18 31.8 1> le+00 &5 l.l$6 e.dl 1AI&eOl 172. 1A6o+O'I 51 Ce 1$ 4 $ .84eO5 18.ee 1.5&eO3 67 Ce.131 13.1d 2.10eO3 21 Itb-88 17.8 2.33o+00 58 Co-137 $ 0.17 2.12eO1 1&A4 2.19o+00 59 Ce-138 32.2 1.29o+00 23 Sr 89 50.5& 5.7 I eO4 dO Bo-'139 83.1 4.09eO1 24 28.1 2.77eOe 11 Be.'140 12.780 2.21eO3 2& Sr 91 9.5 7.30eO2 12 Be-141 18.27 2.27o+00 21 Sr 92 2.71 2.51eO'I 13 Bo.142 10.7 3.88o+00 27 Y 90 1.08eO2 14 Lo-140 40.22 1.72eO2 28 Y.9 1m 49.71 8.3SeOI 4S Le-142 SSA 4.3SeO1 29 Y-Ql 58.51 4.91eO4 11 Co-141 32.& 8.8QeO4 30 Y.92 3.54 1.94oOI 47 Ce 143 2.10eO2 31 Y.93 10.1 e.eeeO2 18 Co-144 281> '1.02eO4 32 14.02 4.51eO4 19 Pr 143 13.61 2.13o43 11.9 4.10oO2 70 Pr 144 17.28 2AOot 00 Nb 95 35.01 8.24eOt 71 Nd-147 10.98 Z.d3oO3 35 Mo 99 41.02 1.0&e02 72 W-187 23.83 H 2JlleO2 31 Tc.99m 1.02 I.l&oOI 73 N p-239 2>55 1.23oO2 Tc 101 14.2 2.92o+ 00

Table 5-4 (Page 1 of 2)

Dilution Factors and Transit Times for SSES Effluents to Oanville, Pa RIVER DEPTH RIVER DEPTH RIVER LEADING HEAS. AT ENV. LAB HEAS. AT HCR DISCHARGE EDGE DILUTION (FEET INCHES CFS HOURS FACTOR 1.5 144 500 68.7 136.4 1.6 145 530 67.8 140.1 1.8 148 600 66.3 147.3 150 670 64.8 155.5 2.2 152 730 63.3 164.5 2.4 155 780 61.8 D3.9 2.5* 156* 825* 61.1* 179.1*

2.6 157 870 60.3 184.5 2.8 160 930 5&.8 195.7 162 1000 57.2 208.3 3.2 164 1200 52.7 250.6 3.4 167 1400 48.2 291.5 3.5* 168* 1500>> 45.9" 280.9*

3.6 169 1600 43.5 271.0 3.8 172 1800 39.0 250.6 174 2000 35.5 250.6 4.2 176 2280 35.2 254.5 4.4 1?9 256Q 34.? 259.1 4.5* 180* 2?30* 34.5* 261.4*

4.6 181 2900 34.2 263.9 4.8 184 3300 33.7 270.3 186 3700 33.0 277.8 5.2 188 4140 32.3 284.1 5.4 191 4580 31.7 292. 4 5.5>> 192* 4820* 31.4>> 297.2*

5.6 193 5060 31.0 302.1 5.8 196 5580 30.2 312.5 198 6100 29.5 323.6 6.2 200 6?8Q 28.5 339.0 6.4 2Q3 ?460 2?.5 354.6 6.5>> 204* ?890" 26.9* 366.3*

6.6 205 8320 26.2 3?8.8

Interpolated value

Table 5-4 (Page 2 of 2)

Dilution Factors and Transit Times for SSES Effluents to Danville, Pa RIVER DEPTH RIVER DEPTH . RIVER LEADING MEAS. AT ENV. LAB MEAS. AT MCR DISCHARGE EDGE DILUTION (FEET) INCHES (CFS HOURS FACTOR 6.8 208 9360 24.7 413.2 210 10400 23.0 456.6 7.5 216 12500 20.0 588.2 14900 16.5 869.6 222'34 8.5 17500 15.3 980.4 20700 14.7 1071.8 9.5 '240 24000 14.2 1173.7 10 246 27000 13.5 1285.3 10.5 252 30100 13.0 1373.6 258 34570 12.2 1567.4 11.5 264 38730 11.3 1795.3 12 270 42530 10.7 2057.6 12.5 276 "",'82 46490 10.0'0.0 2398.1 13 50630 2597.4 13.5 288 54940 10.0 2832.9 14 294 59430 9.8 3067.5 14.5 300 64090 9.8 3311.3.

15 306 68930 9.8 3558.7 15.5* 312* 74030* 9.8* 3802.3*

16 31& 79130 9.8 4081.6 16.5* 324* 84580* A &* 4347.8*

17 330 90030 9.7 4651.2 17.5* 336* 95830* 9 7* 4926.1*

l& 342 101630 9.7 5235.6 1&.5* 348* 1077&0* "9 7* 5540.2*

354 113930 9.7 5&82.4 19.5* 360* 120430* 9.6+ 6192.0*

20 366 126930 9.5 6535.9 20.5* 372* 133780* 9.5* 6&72.9*-

21 378 140630 9.5 7246.4 21.5* 384* 147830* 9 4* 7604.6*

22 390 155030 9.3 8000.0

Interpolated value 5-4(2)

Table 5-5: Dose factors for Shore Exposure Pathway; All Age Groups (Page I of ?)

Dose Factor Units: mrem-ft /Ci-sec Location: Edge of Initial Mixing Zone/FIXED OILUTION Oiiution <1/:SNORE) c 15.9 Trcnsit tice Cts) hrs c Scdieent . tice (tb) hrs o 131400 Vssye 12 67 1C

( )(hri ) ~

lsot T. B Skin T. B Skin Skin 0.00+88 0.00eKO 0 00eKS 0.00e+00 O.aae+00 II 3 C-14 Ka 2C 0.00eHR 2.48e-04 O.aae+00 2.8le OC O.NeKN 148e 03 0.~ 0.~ a.~

1 60e 03 O.aae+00 2.89e-OC 3 35e OC P-32 O.aac+00 O.aae+00 0.00e+00 0.00eKO 0.00eKO 0.00et00 Cr~sl 1.01e OC 1.19e-OC 5.6Ce OC 6.67e OC 1 18c-04 1.39e-04 Hn-54 3.0lc-02 3.53e-02 1.6be.01 1 97e 01 3.51e-OZ 4.12e.02 Mn-56 1.Sac-aS 1.77c-aS 8.37~05 '9 90e 05 1;75e.as 2.07e 05 Fe 55 0.00et00 0.00eKN 0.00eKO 0.00eKN 0.00eKO 0.00eKO Fe-59 5.92c 03 6.9&e-03 3.31e 02 3.89e 02 6.9'lc 03 6.12e 03 10 Co~58 8.23e-a3 9.64e-03 C.59e 02 5DSe-02 9.60e 03 1.12e-02 Co-60 4.68c.01 5.50c-al 2.&le+00 3.07e+00 5ASe 01 6A2e-01 12 Mi 63 0.00+40 O.aae+00 0.00eKO O.aae+00 O.aae+00 0.00eKS Mi ~&5 4.90c 06 5,69e 06 2.74e 05 3.15e 05 5 72e-0& 6.64e-a&

14 Cu-64 1.25c-as 1A1e-05 6.97e-as 7 9ae 05 1 Cbe 05 1.65e-as 15 Zn 65 1.62c-02 1.8le-02 9.06e-02 1.04e 0'l 1.89e 02 2.1be-02 Zn-69 O.aaeKO O.aae+00 0.00eKN 0.00eKS O.aac+00 O.aac+00 Bri83 T.92e 05 1 ~ 15c-07 4A2e 07 6AZe-07 9.2Cc-ad 1.34e-07 18 Br-84 l.20c.ab 1.39c-06 6 67e-06 7 79e 06 1 39e 0& 1.63e.a&

Br-65 0.00eKO O.aac+00 0.00eKO 0.00eKN O.aac+00 O.aae+00 20 Rb-86 1.95e.04 2.23e.04 1.09c-03 1.2Ce-03 2.27e-04 2.60e.04 21 Rb.dd 6.99c Od 7.99e 05 3.90e-al 4A6e 07 d.16c 08 9.32e 08 22 Rb 69 1.52e-a7 2.18e 07 1.02e 06 1.22e-06 2.12e-07 2.SSe-al Sr 89 C.7ae-07 5 Ase-07 2.62e-06 3.04e 06 SAbe 07 63&c-07 24 Sr.91 C.34c-05 S.alc-as 2A2e-OC 2.83e-a4 5.06c.as 5.92c.as Sr-92 1.31e 05 1.CSe.aS 7.29c 05 8.11e-aS 1.52e.as 1.69e 05 Y.90 9.65c-ad 1.1Cc-al 5.39c 07 6.37e 07 1.13c.07 1.33e 07 Y.91e 9.47e 07 1.10e.06 5.29c 06 6.12e-06 1.10e-06 1.26e 06 28 Y 91 2.33e.aS 2.62e-aS 1 30e 04 '1.C6e 04 2.72e-05 3.06c.as 29 Y.92 3.22c.06 3.63c.ab l.dac 05 2.14c-as .T&c.06 4A6c-06 30 Y-93 3.72c 06 5.09c.06 2.0de 05 2.84e-as .3Ce-06 5.94e-06 31 Zr-95 5.31c-a3 &. lbe-03 2.9le-aZ 3A4c-02 ~ 20e.03 7.19e.03 32 Zr 97 6. l7e-05 7.15c.05 3.45e-04 4.01e 04 .20c.as 8.36c 05 33 Nb 95 2.97c.03 3.C9c 03 l.bbe 02 1.95c 02 .4&c 03 4.07c 03 Ho.99 d.59c.as 9.94c 05 4.79c-OC 5.S5c 04 ~ aac.aC 1.1&e-OC DAT

Table 5-5: Dose Factors for Shore Exposure Pathway, A11 Age Groups (Page 2 of 2)

Dose Factor Units: mrem-ft /Ci-sec Location: Edge of Initial Hixing Zone/FIXED DILUTION TEEN lsoto Skin T. B Skin T. Body Skin 35 Tc-99at 3.5&a.0& 4.08e 0& 1.99e 05 2.28e 05 4.16e 06 4.7&e 06 36 Tc-101 2.3$ e-08 2.65e 08 1 33e Q? 1Ade 07 2?de 0$ 3 09e 0$

37 Ru-103 2.3Se S 2.7Ce 03 1.31e-02 1.53e-02 2.74e.S 3.20e 03 38 Ru-105 1.18e 05 1.34e-05 6.60e-OS 7Ade-05 1.38e-05 1.56e-05 39 Ru 106 9.1'Fe.S 1.10e 02 5.12e 02 6.14e 02 1.07e 02 1.2$ e.02 CO A 110m 7A?e 02 8.71e-02 4.17e 01 4.8&e Ol 8 71e 02 1 02e 01 4'l Te-125m 3.37e-05 4.62e 05 2.Sde-OC 3.93e 05 SB9e-05 C2 Te 12?e 1.99e 06 2.35e-06 1.11e-05 1.31e-05 2.32e-06 2.74e-06 C3 Te-127 6.0le-08 6.6le-05 3.35e-07 3.69e-07 7.01e-08 7.?le-08 44 Te-12'5 4.29e.OC 2,40eeS 2.80e-03 5.01e-04 S.85e-04 Te-129 3.1Cc-07 3.?2e-0? 1.76e-06 2.08e-06 3.6?e-OF 4.3Ce-0'F C6 Te-131'e 1.70e-OC 2.0'le 04 9 5le 04 1.12e S 1.99a-OC 2.3Ce-04 C7 Te 131 1.21e.07 1A3e OC 6.74e 07 ~ 7.97e-OC 1Ala-07 1.6?e-04 48 Te-132 9.12e.05 1.0?e-04 5.09e-OC 5.99e-04 1.06e-04 1.25e OC C9 1-130 1.13e OC 1.3?e 04 6.32e-04 ~ 7.67e 04 1 32e 04 1.60e-04 50 1-131 3.?2e.04 4.52e-04 2.08e-S 2.53e 03 4.35e 04 5.28e.04 51 1.132 2.00e.05 2.35e.05 1.12e-04 1.31e-04 2.33e-05 4.75e-05 52 1-133 5.15e-05 6.2&e.05 2 dde OC 3.50e.04 6.01e-05 7.31e-05 53 1-134 CA2e 06 5.25e 06 2.C7e-05 2.93e-05 5.15e-06 6.12e 06 54 1 135 4.94e 05 5 7&a+05 2.7&e-04 3.22e-OC 5.76e 05 6.73e<5 55 Cs 134 1.49e 01 1.74e 01 5.32e-01 9.70e 01 1.74e-01 2;03e-01 5& Cs-136 3.27e-S 3.? le-S 1.83e-02 2.07e-02 3.52e-S 4.32e.03 Sl Cs-13? 2.24e-Ol 2.6le Ol 1.25eKS '1 A6e400 2.61e 01 3.05e 01 58 Cs-138 2.15e.06 2A&e 0& 1.20e-05 1.3?e-05 2.5le-0& 2.5?e.06 59 Bs-139 1.40e-O& 1.S?e-06 7.die 06 8.78e.06 1.63e-0& 1.84e-06 60 Ba-1CO C.45e OC 5.08e OC 2.Cde-03 2.84e-03 5 19e 04 5.93e 04 61 Bs-141 9.36e-0$ 1.07e-07 5.23e 0? 5.96e-0? 1.09e.0? 1.2Ce.ol 62 Bs-142 2.02e.0$ 2.30e.0$ '1.13e-07 1.28e OF 2.36e.0$ 2.68e 0$

63 La-140 4.10e.04 4.65e.04 2.29e 03 2.60e.03 4.79e 04 S.C2e-04 64 La-142 1.0?e 05 1.2$ e-05 5.9?e 05 7.1?e-05 1.25e-05 1.50e 05 65 Ce-141 2.9?e 04 3.3Ce.OC 1.66e.S 1.5?e.03 3.46e.OC 3.90eiOC 66 Ce-143 4.92e 05 5.59e 05 2.75e-04 3.12e-04 5.74c-05 6.52e 05 6? Ce-144 1.51e S 1.75e.03 8A3e-S 9.75e-03 1.76c" 03 2.04e 03 68 Pr-143 0.00e+00 0.00e+00 0. 00e+00 0.00e+00 0.00eKS 0.~0 69 Pr-144 3.62e 09 4.1&e.09 2.02e-05 232e.08 C.22e.09 4.85e 09

?0 Nd.14? 1.82e-OC 2.15e.04 1 02e 03 1.22e.03 2.12e 04 2.55e 04

?1 u-18? 4.9&e-05 5.?&e 05 2.??e-OC 3.22e.04 5.?9e.05 6.?3e.05

?2 Mp-239 3.6?e-05 4.25e.05 2.05e-04 23?e-04 4.28e 05 4.9&a 05 5-5(2)

'AT 1

Table 5-6a: Composite Dose Factors: Maximum Hypothetical Adult (Page 1 of 2)

Dose Factor Units: mrem/Ci Released

~

-'<cation: Danville (Water Ing.)/Outfall (Fish and Shoreline)/FIXED DILUTION Ussao iUsp) ikglyrRSH) ~ 2'l Ussae iUsp) kka)yrWAT80 ~

Ussae iUsp) BrriyrAHORQ ~ oQLrt)on lliMpsHORQ ~ 16%

Oikrt)on lliMp:F)SH) ~ OQMt)on ttiMpWATSR) n Trsnslt tkno itf) hrs ~ 26 Trsnsit time ltor) hrs ~

Trsnsit time itp) hrs ~ Transit tkne Bb) hro ~ 131IOO T. Body 0.00e+00 3.5$ e45 3.5$ e45 3.59e45 3.58<<05 O.ooe+00 1.70e+00 3.I1<<01 3Ale41 S.ile41 3.Ile41 3.11e41 3Ale41 O.ooe+00 N<<2I 7.0$ o43 7.09o43 "7.12<<43 7AIQe43 7.09e43 7A)as43 7.08<<43 2.58e46 P<2 7.lao+ 01 IAds+00 2.77e+00 OANo too O.ooe+00 o,doe+00 8.07e+00 O.dos+00 0.00o+00 0.00e+00 7.72o45 I.07<<05 1.50e45 9.0ie46 1.71<<02 lAI7o45 OANe+ 00 23$ o41 IA)2e42 OANe+00 7.10e42 OANo+00 7>1<<01 '.17o43 O.doe+00 7.26<<40 2.03e40 O.doe+00 $ 41<<00 O.dos+00 2>1 o4I 1.59o4d.

3.04o42 2.52o42. 5.87e43 OANe+00 OANetoo 1.IO<<02 1AI<<02 OANe+00 6.05<<02 1~o41 5.1S<<42 OANe+00 OANe+00 3.72e42 IA3e41 10 Co 58 O.doe+00 I.$7<<03 1.19e42 OANe+00 OANe+ 00 O.ooe+00 1.0 l e41 B.die4i O.oos+00 1Aie42 7>7e42 O.ooe+00 OANotoo O.ooe+00 2.71e41 IA)3o42 12 Ni43 1.72o+00 1.18e41 5.78<<42 OANe+00 O.ooe+00 O.doe+00 2.lae42 OAX4+00 13 Ni46 7~<<od QOSo47 B.0de47 O.doe+00 OANe+00 O.ooe+00 ~7e45 S.lle47 C~OI O.doe+00 1A3o4I OA)I<<05 0.00e+00 3.01<<OI OANe+00 1A2e42 1.27e40 16 2rds 1Ddo+00 IANo+00 1A)le+00 OANe+00 2.08e+00 OANe+00 2.52e+00 1.07e4 15 2.11o.l 'I I.03o-l 1 2.80e-12 O.doe+00 2.02s 11 O.odo+00 O.odo-12 O.ooo+

17 )k 83 0.00s+ 00 0.00o+00 1.57<<40 O.doe+00 OANo+ 00 O.doe+00 2.2do40 1.03o48 18 Br Bi O.ooo+00 0.00o+00 1AI7o47 O.doe+00 O.doe+00 O.dos+00 1.51o-22 ~

1DSe47 Br 85 O.OOo+OO O.OOo+00 O.ooe+OO O.OOo+00 O.doe+00 O.dos+00 O.ooo+00 OANs+00 20 Rb 85 0.00s+ 00 5.29o+00 2.I7e+ Oo 0.dos+00 OANe+00 O.ooe+00 1A)Is+00 2.00<<OS 21 Rb 88 0.00o+ 00 0.00o+00 0.27e49 O.ooo+00 O.doe+00 O.doe+00 O.ooe+00 7.17<<48 22 Rb-89 0.00o+00 0.00e+00 1.03e48 O.doe+00 O.doe+00 O.ooe+00 O.ooe+00 1.$ 0e48 23 Sr.89 1.26o+00 0.00o+00 3.00e42 O.dos+00 O.ooetoo O.ooe+00 ~

2.01e41 I.BQo48 3.13o+ 01 O.ooo+ 00 7.dao+00 O.doe+00 O.ooe+00 O.doe+00 B.OSe41 OANe+00 26 Sr.al 3.77o43 O.ooo+00 t.sdo44 O.oos+00 O.dos+00 O.ooe+00 1ANo42 I.SSe40 Sr-82 1.17o46 OANot00 1.8'l o45 O.dos+00 O.doe+00 0,00s+00 2.81<<OI 1~o40 27 Y 90 2.56o45 0.00s+00 O.ai<<07 0.00o+00 O.doe+00 O.ooo+00 2.71o41 1.02o48 28 Y Qlm 2.0is-l 0 O.dos+00 8 A9o48 0.00o+00 0.00e+00 O.OOe+OO 7.7I<<1 0 9.83o48 29 Y-91 I.BSo4i 0.00o+00 1.5 1 e46 O.OOs+ 00 O.ooe+ 00 0.00s+00 2.07e41 2>so40 Y92 2.18s48 OANo+00 2.90<<07 O.ooo+00 OANe+00 O.dos+00 3.82e4I 3A3e47 31 Y.83 l.d7<<05 0.00e+ 00 3.80o47 O.doe+00 O.doe+00 ~ O.doe+00 I.54e47 32 l.a7<<os 4.31o44 i.8 <<OI 1 O.dos+00 Q.aoe40 O.dos+00 2.00<<42 33 'r-97 3.80o47 7.87o48 S.S7o45 0.00s+00 1.1$ o47 0.00o+00 2AI <<02 0AIe45 3i Nb.86 2.38<<42 1 43o42 7>ao43 0.00o+00 1>1 o42 0.00o+00 B.oie+Ol 3.13e4i 5-6a(l)

Dr'TE Rev. 1

Table 5-6a: Composite Dose Factors: Naximum Hypothetical Adult (Page 2 of 2)

Dose Factor Uni <<: mrem/Ci Released Location: Danville (Water Ing.)/Outfall (Fish 8 Shoreline)/FIXED DILUTION lsot Bone Liver T. 8 Th ld Cl LLt Bktn 35 Ho 99 O.OOMOO S.O&e-03 9.7oe 04 0.00c+OO 1.15r02 O.ooe+00 1.17e 02 8.92c 06

'Tc 99m 3.00e.08 8.47e-08 1AOe-06 O.OOe+00 1.29e-06 4.15e-od 5.01e-05 3.66e-07 Tc 101 O.OONOO '.ooe+OC 2.14e 09 0.00eKO 0 00eHS 0.00e+00 0.00eKO 2 37e 09 Ru 1N 2.77e-04 0.00e+00 3.30e-OC 0.00eKO 1.06rN 0.00e+00 3.24e-02 2A6rOC 39 Ru 105 4 67e.07 O.OOe+00 1.24e-06 Oi00e+00 6.03e 06 O.ooe+00 2.85e OC 1 20r06 Ru 106 4.19e-O3 O.OOc OO 1.35e-N 0.00eKN d 09r03 0.00eHS 2.7te 01 9.57e-04 41 R .tt0e 8.36c-OS 7.73e 05 6.74e 03 0.00cKN 1.52e-OC 0.00et00 3.16e.02 T.die-03 C2 Te-125a 1.39e 01 5.02e 02 1.86e 02 4.17c 02 5.63e 01 0.00eKS 5.53e Ol 4.14r06 Te-127m 3.52e 01 1.26e Ol 4.29e-02 9.00c-02 1A3eKN 0.00+40 1.18c+00 2.1'le-07 44 Te-127 9.02e.oC 3.24c OC 1.95e-OC 6.68c-oC 3.67e-03 O.ooe+00 7.tRe'-02 5.93r09 45 Te-129m 5.89c ol 2.20e.01 933 e-02 2.02e-ol 2A6eKS O.ooe+00 2.97e+00 4.50ros 46 Te-129 1.61e.03 6.05e.OC 4.27c-oC 1.23e-N 6.T6e 03 O.ooet00 1.21e-03 4.20e-os Te-131m 5.08e-02 2.49e 02 2.0Te.o2 3.94r02 2.52e 01 0.00ecoo 2ATe+00 t~dOr05 Te-131 9.69e 22 4.05e.22 1.08e.od 7.97c-22 C.24e 21 0.00et00 1.37e-22 1 25e OS 49 Te-132 1.06e.ol 6.84e-02 6.C2e-02 T.sse-02 6.58e 01 O.ooet00 3.23eKS 9.62e 06 50 1-130 C.OCe.04 1.19e 03 4.80e 04 t.ole 01 1.86e 03 0.00e4$ 1.02e 03 1.23c 05 1-131 8.28e-o3 1.18e-02 6.82e.03 3.68eKS 2.03e 02 O.ooecoo 3.t3e N C 06e 05 52 1-132 2.31e.o7 6.18e.07 2.0le-o& 2.16c 05 9.85e 07 O.ooe+00 1.16e 07 2.11e 06 53 l-133 1.34e.03 2.330.03 T.16e OC 3ASe 01 2.10e-N 5.62e-06 54 55 l -134 l-135 5.95e.13 6.96e OS 1.62e.12 1.82c 04 3.96e 07 7.17e-os Z.BOc 11 1 2oe-02 4 07e 03 2.57e 12 2.92e 04

~

0.~

0 doe+00 0.00eKS 1.41e-l5 2.06e 04 4 Toe 5.17e.06 OT 56 Cs 134 1.62e+Ol 3.8&c+Ot 3. tset01 0.00c+00 1.25etOt C. 14et00 6.75e-ot 1.56r02 57 Cs-136 1.61 F00 6.35e+00 4.57e+Oo 0 OOe+00 3.53eKN 4.54e 01 T Rle Ol 3 32e 04 58 Cs-137 Z.OBcIot 2.84&01 1.86e+01 O.OOe+00 9.65eKS 3.21 F00 5.50c 01 2.34e-02 59 Cs-138 1.4&e-t& 2.87e-l6 1.93e-07 O.OOe+00 2.11e-16 2.09e 17 1.23e-21 2.2le 07 60 Bc.t39 2.46e 10 1.75c.13 1.2Se-07 O.OOc+OO 1.64e \3 9.94e-tC 4.36e-to 1Atc 07 61 Bc-140 1.43e.02 l.dOe-oS 9.77c-04 0 00e+00 6.1'le-06 1Neos 2.94e OZ 4.5&rOS 62 Bc-141 O.OOMOO 0.00e+00 8.39e-09 0.00e+00 O.ooet00 O.ooe+00 O.ooe+00 9.57r09 Bc-1C2 O.OOe+00 O.OOe+00 t.dte-09 0.00eKO O.Ooe+00 0.00e+00 0.00etoo 2.06e 09 Lc-tCD S.&Se-O& Z.BSc-O& 3.7se-os 0.00c+Oo O.ooe+00 O.ooeKN 2.09e 01 4.17e-os 65 Ln-tCZ 8.2&e. 1 2 3.7&e.12 9.60c.o7 O.OOPS O.OOe+OO O.ooeKS 2.74e.od t.tsr06 Ce-141 3.25e.o& 2.19c 0& 2.68e-OS 0.00 F00 1.02c-o6 0.~00 5.39c 03 3.00ros 67 Ce.1C3 Cc.144 3.42e.07 1.73e-oC 2.53e 04 7.22e OS C.44c.06 1.45e-oC O.OOeKN 0.00eKO 1.11e 07 C.28e 05 0.~

0.00e+00 9A6e.N S.BCe-02 5.0le 06 1.57c-04 69 Pr-1C3 3.04e-oS 1 ~ 22e.os l. Sic-06 0.00e+00 7.03e 06 O.OOe+00 1.33e-ol 0 00eKS 70 Pr-1CC O.OOe+00 O.OOe+OO 3.24e 10 O.OOe+00 O.OOe+OO O.ooe+00 0.00eKS 3 73e 10 Rd-147 2.05e-OS 2.37e-05 1.77c.OS O.OOe+00 1.39e-oS 0.00e+00 1.14e 01 1 96e 05 M-t87 7.79r03 6.52e-os 2.28e.03 0.00e+OO O.OOe+OO O.OOe+OO 2.13e+OO 5.17e 06 wp-239 1.34e-O& 1.31e.07 3.36e.O& O.ooeKR 4.1O .07 O.OOOO 2.69c-02 3.81e.o6 5-6a(2)

PAT

Table 5-6b: Composite Dose Factors: Maximum Hypothetical Teen (Page 1 of 2)

Dose Factor Units: mrem/Ci Released

.-~ocation: Danville (Mater Ing.)/Outfall (Fish and Shoreline)/FIXED DILUTION Ueeao tUep) tka/yr:FISH) n 1$ Ueeao lUep) QrdfyrWATER) a 510 Uoeao lUop) thrIIrrSHOREI > Oikrbon llNpSHORQ ~

Ot)rrden llNp:RSH) n Oarrt)on tlNgWATEf0 n Tronett t)mo its hro n Trenelt time lNr) trro n 25.8 Trenott time ttp) bro n Trenit tine ltb) trre ~ 1S1400 T. Body O.ooo+00 2.$ 1e45 2.ele45 2.81+05 2A)1e45. 2A) 1o05 2.elo45 O.doe+00 C14 2

3 Ne24 P<2 1.86o+00 7>oe43 7.82e+01 3.7)F01 740oOS 4.84e+00 3.71e41 7A3e4S 3.03o+00 3.71e41 7~3 O.doe+00 7~

S.7le41 OA)de+00 3.71+0) 7~3 O.ooe+00 3.71e41 7~e43 d.S7e+00 O.doe+00 1.44e44 O.doe+00 S CrS1 O.doe+00 0.00o+00 1A1~ 3.~5 1.54e45 1.18e42 S.aso46 e Msi O.doe+00 245~1 . $ .1 do02 OAee+00 7A)oo02 4A)1o41 1.77o42 Mn.se O.ooo+00 7.59o4d B.sde4d O.doe+00 9.$ 1o4$ OA)de+00 S.OOe44 S.SSe4e 8 Fe55 3.8 1 e42 2.70e42 e.SOo43 O.doe+00 OAOe+00 1.71e02 1.17e42 O.doe+00 10 9 Fsa Co 58 6.82o02 O.doe+00 1.3$ o41 S.SSe42 O.doe+ 00 O.doe+00 'o02 3>1 e41 3Aae43 4.$ 3e43 1.5So42 O.doe+ 00 OAX)e+00 O.doe+00 $ .79e42 4.81e43 11 O.doe+00 1.44e42 2.$ 7o41 O.doe+00 OAOe+00 O.ooe+00 1.87o41 2.76e41 12 N)43 1.78o+ 00 1.28e41 $ .06o02 O.doe+00 OAOe+00 OAXh+00 2A)1 e42 O.ooo+00 13 N)46 7.77e4$ 8.93e47 2.91~ O.ooe+00 OA)de+00 O.doe+00 6 ~o45, 2.86e4$

14 Crr44 O.doe+00 1.50e44 7.$ 9e45 OA)de+ 00 MO+ER OA)de+00 1.17o42 7.08e4$

1.14e+00 3.ado+00 1.see+ 00 OA)do+00 2$ ie+00 O.ooe+00 1.$ 8e+00 845e43 1 d Zn49 2.29o-l 1 4.37o-ll 3.0$ e-12 OAOo+00 2.8So-l 1 O.doe+00 S.OSo-l 1 O.doe+00 17 Br 83 O.ooo+00 O.doe+00 1.74o4$ O.ooo+ 00 0.00o+00 O.doe+00 O.doe+00 5.7eo48 18 Br.84 O.ooo+ 00 0.00e+ 00 5.99o47 O.ooe+ 00 O.ooe+00 O.ooe+00 O.ooe+00 d.aso47 19 Br 85 O.doe+00 O.doe+00 O.ooe+00 OA)do+00 OAOo+00 O.doe+00 O.doe+00 O.ooo+00 20 Rb-Sd O.doe+00 5.70o+00 2.dao+ 00 O.doe+00 OA)de+00 O.ooo+00 8A3o41 21 Rb 88 O.ooo+00 O.doe+00 3.50o08 0.00e+ 00 O.doe+00 O.doe+00 O.doe+00 4.00o48 22 tsr.sa O.ooe+00 O,doe+00 9.1 1o08 O.doe+00 O.doe+00 O.ooo+00 O.ooe+00 1.09e47 6 sa 1.3$ o+00 O.doe+00 3.89o42 O.oooo 00 O.ooo+ 00 O.doe+ 00 1.$ 2o41 2.73o47 24 Snao 2.doe+01 O.doe+00 $ A3e+00 O.doe+ 00 O.doe+00 O.ooe+00 7.3oo41 O.doe+00 26 $ 81 4.07o43 O.doe+00 1.8io44 O.ooo+ 00 O.doe+00 O.ooe+00 1.85o42 2.5ie45 2$ Sr-82 1.Sso45 O.ooe+ 00 7.12e4$ OAXIo+00 O.doe+00 O.doe+00 4.03o44 7.27e4$

27 Y-90 2.78o45 O.ooo+ 00 7.91o47 O.oooo oo O.doe+00 O.ooe+00 2.27o41 6.7'I e48 28 Y-aim 2.8io-l 6 O.doe+00 4,7io47 O,oooo 00 O.ooe+00 O.doe+00 134o-14 6A9e47 29 Y91 5.24o44 O.doe+00 2.57o45 O.oooo 00 O.doe+00 O.doe+00 2.16o41 1.31o45 30 Y-a2 2.37e48 O.doe+00 1.$ 'I o0$ O.oooo 00 OAX4+00 O.doe+00 $ .5Oo44 1.92~

31 Y93 1.81e4$ O.doe+00 1.9 I o4$ O.ooo+ 00 O.doe+00 O.doe+00 5.63o42 2,56o4$

32 2n$ 6 1.97o45 $ .23ood 2.$ $ o4S O.doe+ 00 9.leod O.doe+ 00 1 A4o42 3.09e43 33 1r.87 4.07o47 B.odo48 S.oao46 O.oooo 00 1A2e47 O.doe+00 2.18o41 3.eoe45 34 ttb-96 2AOo41. 1.33o42 8.8 1 e43 O.ooo + 00 1.29o02 O.ooe+00 S.$ 9o+01 'l.76oos 5-6b(1)

V Rev. 1 PAT

Ih l

Table 5-6b: Composite Dose Factors: Maximum Hypothetical Teen .(Page 2 of 2)

Dose Factor Units: mrem/Ci Released Location: Danville". (Water Ing.)/Outfall (Fish 8 Shoreline)/FIXED DILUTION Isot T. Bocty TII IcI CI LLI Sktn 0.00e+00 5.33e-N lo0&e-N 0.00eKS 1.22e-02 0.00e+00 9.54e N 4.98e 05 36 Tc-99a 3.05e-08 8.50e-08 2.d9e-06 0.00e+00 3.2?c-06 4.?2e.08 5.58e.05 2.04e-06

., 37 Tc-101 0.00e+00 0".00eKS 1.19e-08 0.00et00 0.00eKS 0.00e+00 '0.00e+00 t.33e-od 38 Ru-1N 2.88e-04 0.00eKS 1.30e.N 0.00eKO 101eN 0.00ct00 2AOe~02 1.3?e~N 39 Ru 105 4.98e-07 0.00eHS b.tte 06 0.00et00 6.28e 06 0.00eHS 4.02e-OC 6.?te 06 CO Ru-106 4.50e-03 0.00etOO 5.16e.N 0.00e+00 8.6?c-N 0.00eKS 2.16e 01 5.51eiN Cl Ay 110a, 7.87e-05 7ASe-05 '.7Ce-02 0.00e+00 1A2e-OC 0.00e+00 2.09e 02 C.36e 02 42 Te-125a 1.51e 01 SA3e 02 2.02e 02 4.21e 02 0 00eKN '0,00eHS 4ASe 01 2.31e 05 43 Te-12?a 3.83e 01 t.3&e 01 4.55e-02 9.11e 02 1.55eKO 0.00eKS 9.5Ce-01 1;lde 06 44 Te-127 9.8?e 04 3.50e-OC 2.12e-OC 6.81e-OC 4.00e-03 0.00e+00 7.62e-02 3.31 ~ 05 C5 Te. 1 R9a 6.36e-01 2.36e 01 1.0le 01 2.05e-01 0.00eHN 2 39eHS 2.51e 04 C6 Te-129 1.75e-03 6.52e-04 6.23e.04 1.25e-03 7.3Ce-N 0.00eHS 9.56e 03 234e 04 47 Te 131a 5 A6e.02 2.62e 02 2.19e.02 3.94e 02 2.?3e-OI 0.00cHS 2.10eHN 1.01 ~ OC 48 Te.131 1.05e-21 4.3le-22 6.05e-M 8.05c-22 4.5?e-21 0.00cHS 8.58e-23 ?.15e-05 C9 Te.132 l.lie.01 7.06e-02 6.65e 02 ?A4e-02 6.8?e 01 0.00cKO 2.24e+00 5 3?e-05 SO I 130 4.15e-04 1.20e-N 5.3?e-04 9.80e 02 1.85e-N 0.00eKS 9.24e 04 6.Me 05 51 I 131 B.doe-03 1.23e.02 6.80e-N 3.59cKS 2.12e-02 O.OOHOO 2.44e-03 2.26e-04 52 l.132 2.40e.07 6.29e 07 1.02e-05 2.t2e-05 9.91e-07 0.00+HO 2.74e.07 1.18e 05 53 I 133 1.43e-03 2.43e-03 7.68e 04 3.40e 01 C.2?e 03 0.00eKS l.bCe-N 54 I 134 6.22e.13 1.65e 'I2 2.21e 06 2.75e-ll 2.60e 12 0.00et00 R.t?e-tC 2.63e 06 55 I.135 ?.24e-05 1.86e 04 1.20e-02 0.00e+00 2.07e 04 2.89e 05 56 Cs 134 1.66e+01 3.9lwOI 1.82etOI 0.00e+00 t.24~1 4.?Ce400 4.86e.0'I 8.?O 02 57 Cs 136 1.62e+00 6.36e+00 4.2?e+00 0.00e+00 5.CSe-01 5.12e 01 1.86e 03 58 Cs.137 2.23e+Ot 2.96e+01 1.04e+Ot 0.00e+00 1.01+%1 3.9teKS 4.21e O'I 1.3t~t 59 Cs.138 1.56e.l6 2.99e-16 1.05e 06 0.00e+00 2.21e 16 2.57e 17 1.36e 19 1.23e 06 60 Ba-139 2.64e-10 I.BSe-t3 7.00e-07 0.00e+00 1.?Se-13 1.25e-13 235 e-09 7.~7 61 Ba.1CO 1.C9e-02 1.82e-05 I.lde 03 0.00eKN 6.1?e-06 1.22e.05 2.29e 02 2.55t44 62 Ba-141 0.00e+00 0.00e+00 4.69e~08 0.00e+00 0.00e+00 0.00eKR 0 ~ 00e+00 5.34e 08 63 Ba-142 0.00e+00 0.00e+00 1.01e.05 0.00eKN 0.00eHO 0.00eKN 0.00e+00 1.15e-08 64 La.1CO 5.96e.06 2.93e.06 2.06e OC 0.00e+00 0.00et00 0.00cHS 1.68e-01 2.33e-04 65 La-142 8.77e.12 3.59e.12 S.36e 0& 0.00e+00 0.00eKl0 0.00eKO 1.19e-07 6.43e-06 66 Ce.141 3.33e.06 2.22e.06 I.C9e-04 0.00eKS 1.05e-06 0.00e+00 6.36e.03 1.6?e-OC 67 Ce-143 3.52e.07 2.56e.04 2.C7e.05 0.00e+00 1.15e 07 0.00eKS 7.70e 03 2.80e 05 65 Ce-1CC t.?de-04 7.35e-05 ?.66e-04 0.00eKS 4.39e-05 0.00eKO C.C?e-04 69 Pr-1C3 3.28e.05 1.3le 05 1.63e-06 0.00e+00 7.60e 06 0.00~00 1.08e.01 0.00e400.

70 Pr-144 0.00'0 0.00e+00 I.dte~09 0.00eKN 0.00e+00 0.00e+00 0.00e+00 2.05e 09 7I Nd.147 2.32e.05 2.52e 05 9.26e-OS 0.00e+00 1.CBe 05 0.00e+00 9.09e-02 1.09e OC

?2 M.187 8.42e.03 6.56e 03 2.43e-03 0.00e+00 0.00e+00 0.00e+00 1.86e+00 2.89e 05 73 Kp-239 1.C9e'0& 1.COe 07 1.55e 05 0.00eKN C.COe-07 0.00e+00 2.26e-02 2.13e-05 5-6b(2)

Table 5-6c: Composite Dose Factors: Maximum Hypothetical Child (page 1 of 2)

Dose Factor. Units: mrem/Ci Released Location: Danville (Water Ing.)/Outfall (Fish and Shoreline)/FiXED DELUT10N Uooge IUop) IkgfyrFSH) ~ Ueege IUop) IbglyrNATER) a 510 Uoogo IUop) ihrfyrNORB ~ 14 Dgubon I1IMpA80RQ ~ 1bAI O$ uHon It)Mp&SH) ~ 16AI NuOort IllMp:WATSRI.a Trono)t tee ItA hre i Trono)t time Itw) hro e ~ 26$

Trono)t one Itp) hro ~ Treneit time Itb) hro i 1S1400 T. Body Lung OILU Mn Q.ooo+00 SAIOe45 3AIOe4S Saee45 Oaee+00 C.14. 2~+00 4.77e41 4.77e41 4.77o41 4.77o41 4.77o41 4.77o41 OAOe+00 3 No 24 B.loe43 8.10e43 8.12e43 B.loe43 8.10e43 8.10e43 B.loo43 S.ole46 P42 1.01e+02 4.72e+00 3.8$ o+00 O.ooe+00 Oaoe+00 Oaoo+00 2.70o+00 Oaeo+00 5 Cr 61 Q.ooo+00 O.ego+00 8.52e45 4~5 1.1Se45 7.55e46 ial e43 1.26o46 e M bi Q.ooo+00 1.84oo'I 5.23e42 Q.ooe+00 5.17o42 O.ooe+00 1.5~1 3.59o43 Q.ooe+00 5.96e45 3.14o45 Oaoo+00 8.41e45 Oaoo+00 1.01~ 1 abo45 Fe.SS 5.1~2 2.71e42 8.38e43 O.ooe+ 00 O.coo+00 1.53e42 6.0'le43 OAOe+00 7> le42 1.17e41 5AIVe42 Oaoe+00 OAOe+00 348o42 1 41o41 MSrOi O.ooe+00 4.09o43 OAOe+00 Oaoe+00 O.ooe+00 2~2 1ale43 11 Co-50 Q.ooe+00 1.21e42 8A7o42 Oaeo+00 ~ Oaeo+00 Oaoo+00 LVSe42 6.76e42 12 Ni 53 2>9e+00 1.28e41 8.12e42 Oaoe+00 Oaeotoo oao +oo B.clue Qao +oo 13 1A)lo45 0.50e47 1AIV~ Q.ooo+00 Oaeo+00 O.oeo+00 'l.1eo44 SAIOo47 1ASe44 8.70e46 Q.ooe+00 3.47e44 OAOe+00 LVSe43 1A8o45 16 Zn45 1.17e+00 S.'12o+00 1.04o+00 0.00e+00 1AIVe+00 Oaeeooo SABe41 labe43 le Zn49 2.96e-ll SAHo 12 Oaoo+00 2$ 8e 11 O.ooe+00 2.59o40 O.ooe+

17 Br.83 Q.ooe+00 0.00o+00 2.21o45 Q.ooo+00 O.ooe+00 O.ooe+00 O.ooe+00 1

'IS Br 94 Q.ooo+ 00 ~ O.ooe+ 00 1.26e47 0.00e+00 O.ooe+00 Oaoo+00 1AOo47 19 Br-8S Q.ooo+00 0.00o+00 OAXh+00 O.ooo+00 OANe+00 Oaoe+00 Q.ooe+00 OaOe+00 20 ~85 Q.ooo+00 6.S3o+00 SAoo+ 00 Q.ooo+00 0.00o+00 Q.ooe+00 S.bee41 2~6 21 Rb-88 O.ooe+00 O.ego+00 741o49 Q.ego+00 O.oooo 00 O.ooe+00 Q.ego+00 845e40 22 Rb-89 O.ooo+00 0.00e+00 'I.goe48 Q.ooo+00 O.ooo+00 Q.ooo+00 O.ooo+00 K28e4&

2S Sr49 1.89o+ 00 Q.ooe+ 00 645o42 0.00o+00 O.ooo+00 Q.ooe+00 VDOo42 5.71o48 24 Sr.90 2ASo+ 01 0.ego+00 5.2le+00 Q.ego+00 Q.ego+00 O.ooo+00 3~1 Q.ooo+00 26 Sr 91 5.5~3 0.00o+00 2.14o44 Oago+00 O.ooe+00 Q.ooo+00 142o42 S>1o45 25 8 $2 2.13e45 Q.ooe+00 2.22e45 0.00o+00 0.00e+00 O.ooe+00 4A)3eoi 1.52e45 27 Y.$0 3.84e45 Q.ego+00 1.0io45 0.00e+00 O.ooe+00 0.00e+00 1.0$ o41 1.1$ e48 28 Y 81m 3.78o 15 Q.ego+00 0.00e+00 O.ooo+00 O.ooe+00 7Aoo 13 1.16e47 Y-91 7&o44 O.ooo+ 00 2.20e46 Q.oooo 00 O.ooe+00 O.ooo+00 0.72o42 *74o45 30 Y.92 3.2io48 0.ego+00 3.38e47 Q.oooo oo O.ooo+00 Q.ooo+00 0.37o44 iaoe47 31 Y.03 0.ego+00 4.59e47 Q.goo+00 Q.ooo+00 Q.ooo+00 3.73o42 S>2e47 32 Zr 9S 3A2e45 7.51e45 6.5~4 0.geo+00 1.08o46 O.ooe+ 00 VANo43 OA6e44 33 Zr.97 7.34e47 1.05o47 5.62o45 O.ooe+00 1.52e47 O.ego+00 1.5 1 e42 7.51 eoe Si Nb 96 2.83o42 1.10a02 8.I9o43 0.00o+ 00 1.0~2 0.00o+00 2.04o+Q1 3.5~

5-6c(1)

Pev. 1 DAT

Table 5-6c: Composite Dose Factors: Maximum Hypothetical Child (Page 2 of 2)

Dose Factor Units: OIrem/Ci Released Location: Danvi1 le (Mater Ing.)(OLItfall (Fish 8 Shoreline)/FIXED DILUTtOH Isot 0.~jd Th CI LLI Sktn No 99 0.00ehR 1A9e 03 1.27e OR 0.00e400 4.94e-03 1.04e 05 5.97'.07e 36 Te.%ha Ob 7.99e 08 1.70e 06 0.00eKS 1 16e 06 4.06e-08 C.SSe-05 C.27e 07 Tc-tbt 0.00eKS . 0.00ee00 2A9e 09 0.00eKO 0.00eKS 0.00eKS 0.00eKN 2.77e-09 ku 103 C.20e 04 0.00eKO 0.00eKO .0.00ee00 1 09e 02 2.87e 04 Ru-105 737ei07 0.00eKO 0.00eKO 0.00eKO 4.81e OC 'IAOe 06 40 I.dtei03 0 00eKS

~

Bu 106 6.83e 03 0.00eKO 0.00eKN 9.22e 03 1.0&e 01 1.15e-03 41 42 43 A 1tba Te 125a Te-127a 137e 1.95~1 4.9~I 04 I.~t 7.89e 03 2.59e 02 5 89e 02 0.00eKS 5.~2

1. 19~1 0.00eKO 1.41eKO

'.73~

0.00eKS 0 00eKS 0.00eKS I ~t 1.10e OZ 4.02e 01 9.lie C

2.~7 03 Te0127 1.27e-03 2.73e 04 8.82e OC 3.63e.03 0.00tKS C.9be 02 6.91e-09 45 Te-12%a 8.24e 01 2.30e Ol 1;2be 01 Z.6&e 01 2.42e400 0.00e+N 1.00eKN 5.25e 05 46 Te-129 2.27e-03'.9be 6.33e-04 5.79e-04 1.62e 03 6.63e-03 0.00eKN 1 Ale-Ot C.90e 05 47 Te 13ta 02 Z.Cled 2.57e 02 4.97e 02 2.3Ce-01 0 00eKN 9.79e-01 2 10e 05 48 Te-131 t.34e-21 4.09'2 1.2&e 08 1 03e 21 4.06e Rl 0.00eKS 7.05e-21 1A9e 05 t.tZ~

49 50 51 Te 132

'I30 I.131 1.40e~01 5.69e-OC 1.26e-02 6: 19~2 1.26e-OZ 7 Cbee02

&.OCe 04 7.21e 03 9.01e 1.27e 02 Ol 4.15et00 5 75e 01 T.n~03 2.07e 02 0.00eKS 0.00eKN 0.00eKO 6.23e-01 5.3be OC 1.12e 03 t.~

4,73e 05 52 I.132 3.27e<7 6.0le&7 2.37e-06 2.79e 05 9.20e 07 0.00e+00 7.08e 07 2A6e 06 I 133 C.70e 01 0 00eKN 1.02e 03 6.5$ e-06 I 134 8.23e 13 1.53e 12 4.&Ze-07 3.$ 2e 11 2.3Ce-12 0.00eKS 1.01e 12 SA9e 07 55 I 135 1.00e 04 9.03e-05 1.59~2 2.7~ 0.00eKS 1.37e-04 6.03e 0&

56 Ca-134 2.Oleic)1 3.~t 6.96eKS 0.00eKS 1.02eeOI 3 A+KM 1.77e 01 1.~2

57. Ca-136 1.9te+00 S.2S ed%

~t 3.39e+00 0.00eKS 2.79eKO C.17e 01 1.84e 01 3.~

2.~

t.~t 2.57~7."

~

58 'a-137 Z.~t 2 0.00eKN 3.15eKS 59 Ca-138 1 9be-16 2.7Se 16 2.25e&7 0.00et00 1.93e 16 2 Obe 17 1.26e-16 Be 139 C.32e-lO 2.3te-t3 1.~7 0.00eKS 2 Ole 13 1 3&e 13 2A9e Ob 1.~7

&I Be-140 2.57e-OR 0.00eKO 7.3Ce 06 1 34e-05 1.30e 02 SM~

62 Be 141 0.00eKO 0.00eKO 0.00et00 0.00eKN 0.00eKN 0.00eKO t.tZ~

Be 142 0 00eKN 0.00eNO 0.00eKN 0.00eKS 0.00eKN 0.00ehS 2Ale 09 La-140 8.04e 06 R.die-06 4 39e-05 0.00e+00 0.00eKS 0.00eKS 7.83e 02 C.~

65 Le 142 1.17e I I 3.73e 12 1.12e-06 0.00e+00 0.00e+00 0.00@KM 7.3be 07 1.34e 06 Ce 141 7.74e-O& 3.86e-0& 3.16e 05 0.00e+00 1.69e 06 0.00eKN C.82e-03 3.50e 05 67 69 Ce 143 Ce 144 Pr-143 8.14e-07 4.57e 05 1.37e 05 5.2'Ie-06 1.80e 04 2.27e-06 0.00e+00 0.00~

0.00e+00 1.85e 07 7.19~

7 43e 06 0.00eKN 0.~

0.00eKS 6A7e-03 3.3de-02 C.93e 02 t.~

5.85e 06 O.OOOO 70 Pr 144 0.00eKO 0.00eKN 3.78e 10 0.00e+00 0.00eKS 0.00eKS 0.00eKN C.3Se 10 71 KO-t47 3.20e 05 2.60e.05 2.10e.05 0.00~ l.CRe 05 0.00@AN C.lie 02 Z.~

V-187 1.07e 02 6.33~3 2.84e-03 0.00e+00 0.00eKO B.d9e O'I Ko 239 2 ~ 25e-0& 1.&Ze.07 3.95e-06 C,&be 07 0 00eKS 1.20e.02 4ASe.06 5-6c(2}

Table 5-6d: Water Ingestion Dose Factors: Haximum Hypothetical Infant (Page 1 of 2)

Dose Factors: mrem/Ci Released Location: Danville ReceiverlFIXED OILVTION Use tu ) (k / NCYRR) ~ 330 0l lution Ci gMiYRR) ~ 321 troratt t{~ {Mated) hre 25 8 cot id at Ll.l H 3 0.00eNN 3.12e-oS 3 12e 05 1

3.12ros 3.t2e 05 '.'t2cL 05 3.12e 05 2 C1C 2.Coe 03 5. 13r04 5.13r04 13r04 S 13r04 5-13r04 5.13e 04 3 Ro 24 3.11e 04 3.11e-04 3 tie 04 3v'lie 04 3.ttr04 3.ttr04 3.1te 04 32 1.64e 01 9.63c 03 6.34e 03 O.oocNO Q OQeKN 0.00eKN 2.21e 03 r-St 0.00eKS 0.00tt00 1.39e-06 9.08r07 1.98r07 1.77e-ob 4.06e-os 6

7 Nn 54 Hn-56 0.00eKS 0 AORS 2.0le-03 8.OTe-ad 4.~

1 39e 08 0.00eKN 0+Oaecaa 4 46r04 0.00eKO 0.~ T 40r04 7.33r06 e-55 1.41e 03 loc 2,43r04 Q.ooeKO 0.00eKN CASe 04 1.16e-o4 e S9 3.07e 03 0.00eKS 9 OC 5.37e-03 3.61e-04 2.1 te-03 9.OtrOC 0.~

0.~ 0.00e400 0.00eKS 1 59e 03 0.00eKS 2.S6e 03 9.00e 04 10 11 12 Co 55 Co-60 Ni 63 0.00eKN 6.43c 02 1.09c 03 3.98r03 Z.s9 03 2.23e 03 0.~

0.00et00 0 00cKO 0.00eKO 0.00eKO

'.ate-03 1 98ro4 13 RI 65 3.05c.07 CA7c 05 2 03c 05 0 00eKO 0.00eKS 0.00eKO 3AOe 06 1C Cu-64 Q.oaeNO 1.$ 1c-os T.OO 06 O.OOeeOO 2.5&ras 0.00eKO 3.10e 04 15 Zn-ds 1.86e-03 6~35r03 2 94e 03 O.OQeKO 3.09r03 0 00eKN 5~03 16 Zn 69 C.09c 1C T.36c 14 5 Ade-15 0 00eKS 3 06e 14 0 00eKO 6.00c 1'2 17 Rr 83 0 00eKO 0.00tKO 2.07rad 0AoeKN 0.00e400 0.00eKS 0.00eKO .

lb Rr ~84 0.00eKN 0.00eKS 9 19c 20 0 Met00 0.00eKO 0.00e400 0 00et00 19 20 dr 85 Rb 8&

0 00e+00 Q.ooeKS 0.00eKO 1.66c QZ 0.00eKS d 19e 03 OAOet00 0 00eKO 0.00eKO 0.~

0 00eKO 0.00eKO 4.24e 04 2l 22 Rb 85 Rb-80 O.ooeKS O.ooeKS 0.00eKO 0.00eKS 0.00eKO O.aoeeo 0.00eKS O.aocKS 0.~

0.00eKO 0.00eKO 0.00eKO 0 00eKO O.~

23 Sr 89 2.5te&t 0.00eKN 7 20r03 a.ooeeoo 0.00eKO tbr03 2C 25 Sr-90 Sr 01 7.72e oc 0.00eKO 0.00eKN 4.78 at 2.79r05 0.~

0.~

0~00eKO 0.00eKO 0 00eNN 0.00eKO 0.00eKO 5

2~02 9~14r04 Zb 2T Sr 92 Y.90 Z.&srob

&.67c Ob 0.00eKS Q.ooeKN 9ASc 05 1 79c-07 0.~

0.00eKO 0 00eKO 0 00eNO 0.00eKO 0.00eKN 2.86e 05 9.21c 03 25 Y 9 la 3.62c-lT Q.ooeKS 1.23c-lb 0.00eKS 0.00e+00 1.21c-l'3 20 Y 01 1.13e OC 0.00eKO 3.01e 06 0.00eKN 0.00eKO 0.00eKS 8.11e-03 30 Y-92 4.96e 09 0.00eKS 1.40c-la 0.00eKS 0.00eKN 0.00eKO 9ATe-05 31 Yi03 C.20c-OT O.ooeKO 1.14rod 0.00eNO OAOeKN 0.00eKS 3&le~

32 Zr-95 2.0Te-oS 5.03c 06 3.5Tc 06 0.00eKS 5A2c 06 O.tXheKS 2 S'le.ia 33 Zr 9T 5.21c OT 8.94c 05 C.odc-od 0.00eHR 9.01c-ad 0.00cKS 5.70r03 34 Nb-05 C.17e-06 1.72c.ob 0.93c.oT 0.00eKO 1.23e 06 0.00eKS 1 Asc 03 35 No.00 O.oorao 2.63c.0$ S.13c.OC 0.00e+00 3.93e-03 0.00eKO 8.66c 04 5-6d(l}

Table 5-6d: Water Ingestion Dose Factors: Haximttm Hypothetical Infant (Page 2 of 2)

Dose Factors: nrem/Ci Released Locati on: Oanv'1 l l e Rece i ver(FIXED DILUTION taot f. 8 fh td fc-99a 9.98e~09 2.0be 08 2.&5e Ol 2.22c 07 1.08e 08 5.98e 06 fe 101 0.Doe+00 0.00eNS Q.Doe+00 0.00eKS 0:OR+M 0.00eKO

<<g'38 Ru-103 1.47e 04 0.00eKS OAOe+OO . 3.07e-04 0.00e400 1.79c 03 Ru 't05 2.4&e.07 0.0~ . 8.27c-ob 0.00eeoo 1.8le 06 0.00eKO 9.7le.05 40 Ru '106 2.C4e 03 D.OOOO 3.05c-04 0.00ceoo 2.88e 03 0.00eKO 41 R ~1 toa 1.01e.OC 7.35e-05 4.8&e 05 0.00et00 1.05e 04 0.00e+00 3.8te-03 t.tt~

C2 43 1 e-125a fe'127a fe 127 2.33e.03 5.89e 03 1.50e OS T.me~DC 1.95e~03 S.OZc-06 3.15e.04 7.13e 04 3.22e-o&

7.85e 04 1.70e 03 1.22e 05 O.ooceoo 1 A5~

3.65e 05 0.00eKS 0.00eKO 0.00e+00 2~

3.15~

45 fe 129a - 9.92e*03 3.COe 03 1.53e 03 3.8te 03 2.48e 02 O.ooeeoo te-129 2.82e.QS I 9.71e-ob 6.5be 06 2.36e 05 7.01e 05 O.ooeKO 2 25~

CT fe 13la 8.49e 04 3.42e-OC 2.82e OC 6.93e 04 2.35i 03 0.00eKS 5.7~

fe 131 4 'de ZC t.&5eiZC 1.25e-2C 3.98e-ZC 1.14e-23 0.00+AS 1.80c-22 fe 132 1.68e 03 8.3lc 04 50 I 130 1.C3e OC 3.15e 04 t. 2&e-04 3;53e-02 3.46e 04 O.ooetoo I.131 3.32e.03 3.91e 03 72ee03 1.2SeKS 4.57e 03 O.ooetoo 52 I.'t32 7.07e 08 1;44e 07 5.11e 08 6.73e 0& 1.&oe Ol 0.00eKS t.t~7 53 1.133 5.37e-OC 7.81e-OC 2.29e-04 1A2e-ot, 9.19c-OC 0.00eKS

'.91e l 134 1.27e-13 2.47c~05 ZAOe 13 9.25e 1C 6.06e 12 13 0.00eKS t.~

2.69c 1~

13

~

55 1 135 C.91e 05 1.79e 05 CAoe 03 5 ATe.05 0.00eKS 56 Cc-134 3 82e-02 7.12e 02 7. f9~3 0.00eKS 1.83e-02 7.52ei03 57 Ca-136 C.COe 03 1.~2 4.83e 03 0.00eKO 5.16e 03 1.05e-03 1 5.29e.02

~

58 Cs 137 6.20e 02 C.39e 03 0.00e+00 1.&6e 02 6.73e.03 59 Cs.138 1.76e 19 2.86e-19 1.39e l9 0.00eKS 1.43e 19 2.23e-20 C.5Te 'l9 61 Bc 139 Be 140 2 26c 1.64e 02

'10 1.50e 13 1.64e-05 6.55e 12 8.43e 04 0.~

0.00e+00 9.02e-tC 3.88e 06 9.09e-14 1.00e 05

\

O.~ 0.00eNN 0.00eKN 0.00et00 Be 141 Be 142 t ~ -'t40 0.~

1.3le 0.00eKN SAle 07 0.00eKO 0,00eKO O.Doer% 0.00eKS 0.00e+00 D.Doe@00 0.00ekS O.ooceOO

&~

D.oocKO 06 1.39e 07 0.00eKS O.ooeKS 65 t.e- 142 1.C9e 12 S.CTe 13 1 3te-13 0.00e+00 O.ooeKN 0.00et00 Ce 14'1 T.boe-06 4.76e-ob 5.&oe-ol O.ooeKO 1.47e.06 0.Doe+00 67 Ce-143 8.73e-QT 5.79e-04 6.&le-ob 0 00eKO 1.69e-ol 0.Doe+00 Ce-144 3.01e-04 1.23e-04 1.69e 05 0.00eKS C.99e 05 0.00e+Q) 69 Pr 143 7.80e-od 2.92e.ob 4.12e~

Pr-144 Kd 147 0.~

5.24e 06 0.00eNN 3.87e 07 O.Doer 3.30e.ol 0.00cKS 0.00cKN 1.08e 06 O.Doe+00 Q.Doe+00 0.Doe+00 0.00eKN 3.41e 03 71 S.38e 06 0.00eKS 2.08e-06 0.Doe+00 u 187 4.32e-05 3.01e.OS 1.04e-OS 0.00eKS 0.00eKS 0.Doe+00 1.77c-03 Kp 239 8.20e-07 7.34e-ob 4.15e-08 0. 00e+00 1.C6e 07 0.00e+00 2.'l2e.03 5-6d(2)

5.1 Fish Pathway Liquid Effluent Dose Calculation Hethodology The following expression is used to calculate the fish ingestion pathway dose contribution for the total release period from all radionuclides released in liquid effluent to unrestricted areas:

R~ 4pj g ~ Z ~ p ll

<< Cg << V~ << k (Eq- lo) where: R,)pj Total fish ingestion dose during period to organ j to individuals of age group a from all radi'onuclides i in pathway p (mrem);

i<pl Fish ingestion dose conversion factor to organ 3 of individuals of age group a from all radionuclides i in pathway p (mrem-ft /Ci-sec:

Tables 5-la,b, and c);

c, Average concentration of radionuclide i in undiluted liquid effluent during batch release from radwaste uCi, 1e-6 Ci

( m2 uCi Y, Total undiluted batch volume released from radwaste (gallons);

Conversion factor (3.785 e3 ml/gallon);

Minimum blowdown flow (ft /sec).

22 g r

5-2 Potable Mater Pathwav Effluent Dose Calculation Hethodology The follow~no exoresscon is used to ca1culate the fish ingestion pathway dose contribution for the total release period from all rad(onuclides releasea in liquia effluent to unrestricted areas:

K~) ~ eXp(-X~t f ) + Cq! o V, ~ k 4$ D7 (Eq 11}

A P

~nere R- Total potable water ingestion dose during period to organ j to individua1s of age group. a from all raaionuc)ides i in pathway p (mrem);

)p j Potab l e water i ngestion Dose conversion factor to organ j of individuals of age group a from all radionuclides i in path~ay p (mrem-ft /C$ -sec: Tables 5-2a,b,c, and d);

Radioactive decay constant (hr ~: Table 5-3);

River transit time (hr: Table 5-4);

I OF, - Dilution factor (unitless: Table 5-4);

other factors oescrcbed in Section 5.1.

23

5.3 Shoreline Exposure Pathway The following expression is used to .calculate the shoreline exposure pathway dose contribution for the total, release period from all

.radionuclides released in liquid effluent to unrestricted areas:

where R,-, J Total shoreline dose during period to organ j (total body or skin) to individuals of age group a from all radionuclides i in pathway p (mrem);

K> - Shoreline dose conversion factor to organ j of individuals of age group a from all radionuclides i in p (mrem-fthm/Ci-sec: Table 5-5); 'athway other factors described in Section 5.1.

5.4 Projected Dose from l,iquid Effluent The following expression is used to estimate the combined fish, water ingestion and shoreline exposure pathway dose contribution for the F

projected release period and volume from all radionuclides released in liquid effluent to unrestricted areas:

24

R~~p~ E [K~~~ + Cg + V~ k] (Eq 13) where R>

alp) Total projected dose during peri'od to organ j from fish, water ingestion and shoreline exposure to individuals of age group a from all radionuclides i in pathway p (mrem};

K,fpj Composite dose conversion factor'adult, teen, child} or water

. ingestion dose factor (infant) to organ j of individuals to age group a from all radionuclides i in pathway p (mrem/Ci released:

Tables 5-6a,b,c, and d);

other factors described in Section 5.1.

The projected quarterly dose contribution from batch releases for which radionuclide concentrations are determined by periodic composite sample analysis, as .stated in Table 4. 11.1. 1. 1-1 of the SSES Technical Specification may be approximated by assuming an average concentration based on the previous monthly (rolling 31-day} or quarterly composite analysis.

The calculated dose contributions from these radionuclides shall be base on the actual composite analysis- The cumulative dose comnjtment to the total body or any organ for a quarterly or annual analysis shall be based on the calculated dose contributions from each batch release occurring during that time period.

In actual practice, the LAOTAP II computer code developed by the NRG to implement the liquid dose methodology of Regulatory Guide 1.109 will be used to perform the individual liquid pathway dose calculations for the SSES. The methods outlined above are consistent with those of the LAOTAP II code.

A discussion of the LADTAP II code as applied to SSES liquid effluent, is given in Section A.3.1 of Appendix A.

26

6.0 INOIV DUAL DOSE OUE TO AI BOR FF UENT 6.1 NOBLE GASCS S CIFICATION 3. - THE AIR DOSE OUE TO NOBLE GASES RELEASED EFFLUENTS, FROM EACH REACTOR UNIT, TO AREAS AT AND BEYOND IN'ASEOUS THE SITE BOUNDARY (SEE FIGURE 5.1.3-1) SHALL BE LIMITED TO THE FOLLOWING:

a. DURING ANY CALENDAR QUARTER: LESS THAN OR EQUAL TO 5,MRAD FOR GAMMA RADIATION AND LESS THAN. OR EQUAL TO 10 FARAD fOR BETA RADIATION, AND ATION.

b. DURING ANY CALENDAR YEAR: LESS THAN OR EQUAL TO 10 MRAD FOR GAMMA RADIATION AND LESS THAN OR EQUAL TO 20 HRAD FOR BETA RAD I The air dose in unrestricted areas beyond the site boundary due to noble gases released in airborne effluents from the site shall be determined by the following equation for gamma radiation during any specific time period:

0 3.17 x 10 g M. (X/Q)v Qi (Eq. 14) and by the following equation for beta radiation during any specified time period:

Ob 3.17 x 10 g N,. (X/Q)v Q,.v (Eq. 15)

Where:

the air dose factor due to gamma emissions for each identified noble g~s radionuclide (i)

(mrad/yr per uCi/m ) from Table 2.

the air dose factor due to beta emissions for each identified noble ga~ radionuclide (i)

(mrad/yr per uCi/m ) from Table 2.

(X/Q)v the highest calculated annual average relative concentration for any area at or, beyond the site boundary in an u~restricted area from vent release point (v) (sec/m ) such as from Table 3.

the total gamma air dose from gaseous effluents for specified time period (mrad).

27 V

PAT

D r the total beta air dose for gaseous effluents for a specified time period (mrad).

the integrated release of each, identified noble 9as radionuclide (i} in gaseous effluents from all vents (v) for a specified time. period (uCi}.

3.17 x 10 the inverse of seconds in a year (yr/sec).

A discussion of the method used to calculate the individual dbse from gaseous effluents is given in Section A.3.2 af Appendix A.

Also,. sample calculations for determining gamma and beta air doses from noble gas radionuclides released from the SSES are given.

6.2 0 ONUC ID S 0 THAN 0 G S SP C F CAT ON 3. .3 - THE DOSE TO A MEMBER OF THE PUBLIC FROM IODINE-131, TRITIUM, AND ALL RADIONUCLIDES IN PARTICULATE FORM MITH HALF-LIVES GREATER THAN 8 DAYS IN GASEOUS EFFLUENTS RELEAS'ED, FROM EACH REACTOR UNIT, TO AREAS AT AND BEYOND THE SITE BOUNDARY (SEE FIGURE 5.1.3-1) SHALL BE LIMITED TO THE FOLLOWING:

a. DURING ANY CALENDAR QUARTER: LESS THAN OR EQUAL TO 7.5 MREMS TO ANY ORGAN, AND

b. DURING ANY CALENDAR YEAR: LESS THAN OR EQUAL TO 15 MREMS TO ANY ORGAN.

The critical organ dose to an individual from I-131, tritium, and radioactive materials in particulate form with half-lives greater than 8 days released in airborne effluents from the site to unrestricted areas can be determined by the following equation during any specified time period:

'D 3.17 x 10 Z,. (R.) (W) (Qiv) (Eq. 16) 1 28

where:

P a, the total dose to a critical orgari from radio-nuclides other than noble gases for a specified time period {mrem).

R) the dose parameter .for each identified radionucli4e (i) for the inhalation pathway (mrem/yr per uCi/m')

and for food and ground plane pathways (m mrem/yr per uCi/sec) from Table 4.

w the highest annual average'ispersion parameter for estimating the dose to the critical individual; relative concentration (Xg) (sec/m ) for the pathway and relative deposition rate (D/g)

'nhalation (m ) for the food and ground pathways such as from Table 3.

g) e the integrated release of each identified radio-nuclide other than noble gases (i) in gaseous effluents from all vents (v) for a specified time period (uCi).

3.17 x 10 the inverse of seconds in a year (yr/sec).

1n actual practice, the GASPAR computer code developed by the NRC to implement the airborne dose methodology of Regulatory Guide 1.109 will be used to perform the individual airborne pathway dose calculations for the SSES. The methods outlined above are consistent with those of the GASPAR code; site specific dose factors have been computed and are available for implementing the method described above, if required.

A discussion of the GASPAR code is given in Section A.3.2 of Appendix A.

29

7.0 OS N - THE ANNUAL (CALENDAR YEAR) DOSE OR DOSE COMMITMENT TO ANY MEMBER OF THE PUBLIC, DUE TO RELEASES OF RADIOACTIVITY AND RADIATION, FROM URANIUM FUEL CYCLE SOURCES SHALL BE LIMITED TO LESS THAN.

OR EQUAL TO 25 MREMS TO THE TOTAL BODY'R ANY ORGAN EXCEPT THE THYROID, MHICH SHALL BE LIMITED TO LESS THAN OR EQUAL TO 75 MREMS.

The cumulative dose to any member of the public due to radioactive releases from the SSES site is determined by suaeing the calculated doses to critical organs from the previously discussed effluent sources. The annual dose to critical organs of a maximally exposed individual for the liquid effluents is determined by using Equations 10, 11, and 12 of Section 5. The annual dose to critical organs of a real individual for the noble gases released in the gaseous effluents is determined by using Equation 14 modified by replacing Mi with Ki from Table 2 for the whole-body dose and by Equation 15 modified by replacing Ni by [Li+((1.11 Mi)(S,))] from Table 2 for the skin dose of Section 6.0:

D 3.17 x 10 Ki (X/0)(0'I)(SF) (Eq. 17)

\

0 3.17 x 10 [L. + ((1.11M )(S,))](X/g) (g', ) (Eq. 18)

The annual dose to critical organs of a real individual for the radionuclides other than noble gases released in the gaseous effluents is determined by using Equation 16 of Section 6.0. For all dose calculations from airborne effluents, the deposition rate used in the analysis should be at the receptor location of the individual being evaluated, not the highest calculated annual average relative concentration or relative deposition rate for any area at or beyond the site boundary as given in Table 3. The direct radiation from the site should be determined from the environmental monitoring program's direct radiation (TLD) monitors. Since all other uranium fuel cycle sources are greater than 20 miles away, only the SSES site need be considered as a uranium fuel cycle source for meeting the EPA regulations.

In actual practice, the LADTAP and GASPAR computer code developed by the NRC to implement the liquid and gaseous dose methodology of Regulatory Guide 1.109 will be used to perform the total dose calculations for the A 30 OAT Rev. 2 j

NRC to implement the liquid and gaseous dose methodology of Regulatory Guide 1.109 will be used to perform the total dose calculations for the SSES. The methods outlined above are consistent with those of. the LADTAP and GASPAR codes.

A discussion of the methods used to calculate the total dose to critical organs of a maximally exposed individual is given in Section A.4 of Appendix A.

31

8.0 Y F 8.1 SP CIF C ON 3 . 3 - THE LIQUID RADWASTE TREATMENT SYSTEM, AS

'F DESCRIBED IN THE ODCM, SHALL BE OPERABLE;- THE APPROPRIATE PORTIONS THE SYSTEM SHALL BE USED TO REDUCE THE RADIOACTIVE MATERIALS IN LIQUID MASTE PRIOR TO THEIR DISCHARGE WHEN THE PROJECTED DOSES DUE TO THE LIQUID EFFLUENT, FROM EACH REACTOR UNIT; TO UNRESTRICTED AREA (SEE FIGURE 5.1.3-1) MOULD EXCEED 0.06 MREM TO THE TOTAL BODY OR 0.2 MREM TO NY ORGN IN A 31-DAY PERIOD.

The SSES Liquid Rad Waste Management system consists of three processing sub-systems, liquid, chemical and laundry. Redundant and backup equipment, alternate process routes, interconnections and spare volumes are designed into the system to provide for operational and unanticipated surge waste volumes due to refueling, abnormal leakage rates, decontamination activities and equipment downtime, maintenance and repair. The Liquid Rad Maste Management System processes equipment drain and floor drain liquids collected in a common plant drainage system. The system also processes filter backwash, resin transfer liquids and resin cleaning liquids. The system has piping connections to allow the installation of vendor-supplied equipment to provide specific treatment of off-normal wastes or to enhance the,.normal treatment capabilities as necessary. Appropriate vendor-supplied equipment may also be used in place of installed equipment to allow for repair or replacement of components.

Low conductivity liquid wastes are processed in the Liquid Radwaste Treatment Sub-system. Liquid is collected in three pairs of LRW Collection tanks. Each pair of tanks has an approximate capacity of 28,000 gallons. Surge capacity is maintained with two pairs LRW Surge Tanks also with a 28,000 gallon/pair capacity.

Liquids from these tanks are normally processed through two vertical centrifugal discharge precoat filters with 300 ft filter area at a 200 gpm normal flow rate. Liquid from the filters is then sent to a mixed bed demineralizer with a volume of 140 ft and normal flow rate of 200 gpm. The demineralizer effluent is collected in three pairs of LRM Sample Tanks. Each 32 DAT Rev. 2

pair of tanks has an approximate capacity of 28,100 gallons. The is isolated in these tanks for analysis prior'to recycle to 'ater Unit 1 or discharge to the Susquehanna river. Off-specification liquids can be recycled back to the Liquid Rad Maste Hanagement System for additional processing.

High conductivity wastes are collected in the Chemical Drain Tank and in specific sumps located in the Turbine and Radwaste Buildings. Liquid from these sources is collected in a Chemical

Maste Tank of approximately 12,000 gallons capacity. This liquid can then be sent to any one of two pairs of Chemical Maste Neutralizing Tanks. Each pair. has a capacit'y of 31,000 gallons.

The liquid is then sent to a vendor-supplied Chemical Waste Processing Sub-system for radionuclide removal. The effluent from the Chemical Waste Processing Sub-system is routed to the Evaporator Distillate Sample Tank where it can be isolated for analysis prior to discharge. The capability exists to return the liquid to the Liquid Rad Maste Hanagement System for additional processing if necessary.

The Laundry Waste Sub-system collects water from washdown, laundry and decontamination facilities in one of two Laundry Drain Tanks. Each tank has a capacity of approximately 820 gallons and has an independent mechanical filter system. One tank is normally valved to receive waste while the other is valved for processing. Effluent from these tanks is routed to the Laundry Drain Sample Tank where it can be isolated for analysis prior to discharge. Non-specification liquid can be returned to the Chemical Maste Processing Sub-system.

A flow diagram of the Liquid Radwaste Management System is shown in Figure l.

Appropriate treatment for liquid effluents from SSES fs defined in ODCN Policy Statement 10.6. In cases when a batch of liquid waste must be released with treatment less than that specified in Section 10.6, a dose assessment using LADTAP or the methodology 33 DAT 6 s Rev. 2

of Section 5.4 shall be performed prior to release to ensure that the limits of Specification 3.11.1.3 are not exceeded."

8;2 S US A P C ICAT ON 3 . . - THE GASEOUS RADMASTE TREATMENT SYSTEM SHALL BE IN OPERATION.

~AR I I: IIEEEEIIER TIIE IAIO CIOOEEEER AIR ERECTOR EEIACEATIOET SYSTEM IS IN OPERATION.

C F 0 5 - THE APPROPRIATE PORTIONS OF THE VENTILATION EXHAUST TREATMENT SYSTEM SHALL BE OPERABLE AND SHALL BE USED TO REDUCE RADIOACTIVE MATERIALS IN GASEOUS MASTE PRIOR TO THEIR DISCHARGE MHEN THE PROJECTEO DOSES DUE TO GASEOUS EFFLUENT RELEASES FROM EACH REACTOR UNIT TO AREAS AT AND BEYOND THE SITE BOUNDARY (SEE FIGURE 5.1.3-1) WHEN AVERAGED OVER 31 DAYS MOULD EXCEED 0.3 MREM TO ANY ORGAN IN A 31-DAY PERIOD.

The SSES off gas treatment system operates with four steam jet air ejectors maintaining condenser vacuum. Noncondensible gases are passed through one of three recombiners (one for each reactor unit plus a common recombiner), reducing the amount of gases to be filtered and released. Gases pass through a two to nine minute holdup pipe before entering the off gas treatment system, which consists of one 100 percent capacity system per reactor unit. Each system consists of precoolers, chillers, reheaters, guard beds, and five charcoal absorbers and an outlet HEPA filter. Monitored, filtered air then exits to the turbine building vent. A flow diagram of the off gas and recombiner system is shown in Figure 2.

Filtered exhaust systems serve selected areas of Zone I, II, and III of the SSES reactor building. The Zone I and Zone II equipment compartment and Zone III filtered exhaust systems each consist of two 100X capacity redundant fans and two 55% capacity filter trains. Each filter train has, in the direction of air flow, roughing filters, upstream HEPA filters, a charcoal filter bed, and downstream HEPA filters. Exhaust fan discharge is then routed to the atmosphere via the reactor building vents, where effluents are continuously sampled and monitored.

34 I DAT /E 'ev. 2

The turbine building filtered exhaust system draws air from those areas of the building that are most likely to become contaminated.

Two 100X capacity fans serve each system, which contains two 50X capacity filter housings made up of a particulate prefilter, an upstream HEPA filter, a. charcoal filter; and a downstream HEPA filter. Discharged air is released via the turbine building vent's, which are continuously sampled and monitored.

The radwaste building filtered exhaust system draws potentially contaminated air from selected areas of the radwaste building.

The system contains two 100K capacity fans and.two 50K capacity filter housings, each containing a particulate filter bank and a HEPA filter. Filtered air is, discharged via the turbine building vent.

1 In order to minimize the quantities of radioactivity in airborne effluents from the station, the ventilation exhaust treatment (filtered exhaust) systems are normally kept in service at SSES.

As the need arises, these systems are periodically rendered inoperable for maintenance or testing activities. If the most recent 31-day dose projection indicates that dose may exceed 0.3 mRem to any organ when averaged over the projected 31-day period, treatment systems rendered inoperable will be restored to operable status as quickly as is practicable.

The dose projections are performed at least once per 31 days based on the most recently available effluent data. If it is known prior to performing the dose projection that a treatment system will be out of service, and if data exists which indicates how the lack of treatment will impact effluents, these factors will be considered when performing the dose projection.

35 V

Rev. 2 DAT

8.3 S C - THE SOLID RADWASTE SYSTBI SHALL BE USED IN ACCORDANCE WITH A PROCESS CONTROL PROGlUN, FOR THE PROCESSING AND PACKAGING OF RADIOACTIVE WASTES TO ENSURE HEETING THE REgUIREHENTS OF 10 CFR PART 20, 10 CFR PART 71, AND FEDERAL REGULATIONS COVERING THE DISPOSAL OF THE MASTE.

The SSES solid radwaste system collects all wet wastes produced from the operation of other plant systems.

The'astes are then processed and packaged by a vendo} -supplied system into a waste form that meets all applicable Federal, State and local requirements for transportation, storage and disposal. The processing methodology and acceptance criteria for the final waste forms are'controlled by the Process Control Program.

Filter material from the Reactor Mater Clean-up Systems and the Fuel Pool Clean-up Systems are collected in Backwash Receiving Tanks. There is one RWCU tank per unit, each with a capacity pf approximately 2450 gallons and one similar tank for the FPCU System. Wastes from these tanks are directed to one of two 6300 gallon capacity Phase Separators. Normally, one Phase Separator is valved to collect waste while the other is isolated to provide time for radioactive decay. The solid content of the waste is concentrated in the Phase Separator and transferred and processed through a vendor-supplied system and packaged for storage or final disposal. The supernatant liquid is collected and processed by the Liquid Rad Maste Hanagement System.

The Waste Sludge Phase Separator is a 9500 gallon capacity phase separator tank that accepts input from the Regen Waste Surge Tanks. The concentrated waste is then transferred and processed through a vendor-supplied system and packaged for storage or final disposal. The supernatant liquid is collected and processed by the Liquid Rad Waste Management System.

36 OAV Rev. 2

Spent bead resin from the Condensate System and from the Liquid Radwaste Oemineralizer are collected in the Spent Resin Tank. These are then processed through a vendor-supplied system and packaged for storage or final disposal.

Spent filter material from the Liquid Radwaste Filters are collected in two Waste Mixing Tanks. The contents of these tanks are processed through a vendor-supplied system and packaged for storage or final disposal.

A flow diagram of the SSES solid radwaste treatment system is shown in Figure 3.

Dry Active Waste (DAW) consists of contaminated plastic, paper, clothing, metal or other trash and is collected throughout the RCA of SSES. DAW is processed and packaged for storage or disposal using off-site vendor-supplied super compaction and incineration services. DAW may also be compacted with an on-site drum compactor into 55-gallon drums. An automated DAW monitoring system is used to ensure non-radiological waste collected in the RCA is free from radiological contamination prior to release.

A flow diagram of DAW processing at SSES is shown in Figure 4.

-37 Rev. 2

AKhCTOA 1IKLL SEAL LEAK DRAIN AKACYOA SLDO. OAAIHS FIGURE EVAP. s ZHO STEAN COHDS. RETURN TANK OAYttKLL DRAINS LIQUIO RAOY!ASTE SYSTEM Fl.OYl DIAGRAM YLRSINK SLOO. OAAIHS PHASE SEPARATOAS APOWASYK SLOtt. DRAINS (DECANTAYE) LIOUID AADIIASTE AHR SYSTEII AttCU SYSTEN LIOUID AADWASTE Lloulo LIQUID L laulo COLLECTION S SUAOE IlhDWASTE RAOWASTE RADNASTE TAHKS FILTERS DEIIIHERALIZER SAIIPLK TANKS OT-302 A THAU F OF-302 A,B OF.301 OT-303 A THAU F OT-30l A THAU 0 CONOKNSATE DKVIN.

AFSIH REOHKRATIHO TANK LAtt COLLECT 10k YhkK PstPS TO WASTE NIXIHO TANKS OT-307 A>B OT-32'OHOENSATE TO SPKNT RKSIII TAHK STORAOK TANKS OT 522 A,B OP-301 A,S>C CH'ElllCAL WASTE NEUTRAL IIER TANKS 1T-130 A,B 2T-130 A,B RAPNASTE DISTILLATE E VAPO AATOA SAIIPLE TANK CST BEAII WATER CHES. lthSYK OE-302 A,B OT.321 SAltPLE STATIONS IfKllTAALI II tt0 TO COOLIH4 AUX BOILER BLOWDOWNS TANK PCS RWCU CHENICAL DECOH. IP ~ 130 hsb TOWBl SL(N LAB AHD DECOII. DRAINS 2P ~ 130 A,b DOWN PIPE g . LRW SANPLE TAIS(

PINPS OP 305 A,B,C CHENICAL WASTE CHEN ICAL WASTE PROCKSSIHO SUS-SYSTEN CHBl WASTE TAHK (VENDOR SUPPLIED)

TANK PINPS OT.SIi OP-320 A,b EVAPORATOR CONCENTRATE STORAOE TANK LAUINAY OAAIHS OT-322 RKNATKO SHOP NIAINS PERSONAL OKCONTANe INATIOH (OEYSIOBIYS) TD WASTE CASK CLKNIINS ORAIHS IIIXIN4 TANKS OT-SOT hgB LAUNDRY DRAIN DAAIN OT TANtt 814 A,B

'AUNDRY TANK PUNPS OP 31S A,B LAUNDRY DRAIN LAVHIXlYDRAIN FILTERS SANPLE TANK OF-513 A,B OT-312 CONCENTRATE STORAOK TANt OISCH. FINP OF.328 LhbNORY DRAIN SANPLE YANK PmtPS OP.310 hsS I

j OAT Rev.'.

AMbtENT TEMPERATURE Ctth'RCOAL OI IGAS AICOMOIHER SYSIEM I OF F GAS SYSTEM UNIT I SlfhM Ã1 Atn f JECfOA UHII I Iunelnf etDG MAIR L AUtt SIEAM E X IIAUS1 IF 303 OU LET IIEPA Fll.ff. IAA OAL AD Abf fl bf S UNIT I FROM <HII I EL illhl IAACIHG I 1 310 I 1 30S I T.30e 11301 I I 300 Ithlh Sf Eh+

I I IIAS b YPASS Ql OILUflOHSf f AM I

I llI a

II it DELAY tltf IF3 IA 5 lb. Ih IF. 3 TA '1 IO I'1 30Th I

COII I

$ 1EAA I 014 I lfl If1 I 7 ttnll '<<SIArE hlb EIEC 104 eh t

IS ITS nfcnMA VFSSEL I

IC 13 ~

MQltVE Slf AM IHI.ET IIEPA fttfEA PAE rs<<LI1n ~~ GUhnti CON OEII SEA

)net SIAGa I I I It 131 8-i JET r.nHO M~~

REcoMe COHO COMMON OF F GAS AECOMblHEA SVST EM SIEhM JET AIR EJECf04 COHDEHSEA Ilhlh UNI I 2 D'ELAY tltf STEA COII ~ AMblENTTEMtERATURE.CIIAACOAt OEA. OFFOASSYSTEM SEA UNIT 2 ehll f OFFOAS AECOMblNER SY5TEM 2 OFFOAS bYPASS Mhth S AUX TUAblHE bLDG EXHAUST STEAV UNIT 2 FROM UHIT2 FlGURE 2 OFFGAS AND RFCOHBIHER SYSTN FLOM DIAGRAN PAT Rev. 2

FIGURE 3 SOLID Y/ASTE MANAGEMENT SYSTEM FLOII DIAGRAM CONDENSATE RADWASTE COHOEHSATE FUEL P001.

DEHIH RESIH DEIIIHERALI2ER DENIH RESIN RWCU BACKWASH RWCU BACKWASH F/D SACllhSH RECEIVIHO TANK STORAOE VESSEL STOAAOE VESSEL STORAOE VESSEL RECEIVIHO TANK RECEIVINO TAHK 1T ~ 159 OF-301 2T-155 1T.225 2T-225 OT-203 REaEH WASTE REOEH WASTE SUROE TANKS SURGE TANKS SPENT RESIH 1T-105 A,S27-105 A,B TANK OT-324 1P-105 A,B REOENERATIOH WASTK J

2P-108 A B TRANSFER PUMPS SPENT RESIN I TRANSF ER PUHP OP-320 I TO VENDOR LIOUID RADWASTE WASTE SLUDOK FILTERS PHASE SEPARATOR OF-502 A)B WASTE SLUDOK OT 331 DISCHAROK 1IXINO PUHP RWCU PHASE RWCU PHASE OP-332 SEPARATOR 5KPARATOll OT-318 A OT $ 18 b TO RWSS PUHP WASTE NIXIHO TANKS OT.30T A,S EVAPORATOR CONCENTRATE STORAGE TANK OT-322 RWCU SLUDGE DISCHARGE ~

EVAPORATOR IIININO PUNP CON CKNTRATE OP-33I TO VENDOR STORAGE TAHK FROH DISCHARGE PUIS'P-328 EVAPORATOR

FIGURE 4 SSES DRY ACTIVE WASTE (DAN) PROCESSING Non-r adiological Paper, Plastic, Rags, Trash from RCA Clothing from RCA Second-Sort DAW Dry Active Waste (DAW)

Monitoring System PP&L Drum Compactor Vendor Yes Services Radioactive?

Supercompaction Incineration 55-gal. Drums or Boxes No Free Released 41 DAT Rev. 2

9.0 0 OG A N ROMM ONT GP G 9.1 IIEFFIM Tt N Meekly: Once in each calendar week ht intervals of approximately 7 days, plus or minus 2 days.

Semi-Monthly: Twice each calendar month at intervals. of approximately 15 days, plus or minus 4 days.

Monthly: Once each calendar month at intervals of approximately 30 days, plus or minus 6 days.

quarterly: Once in each three month period .of a calendar year at intervals of approximately 13 weeks, plus or minus 3 weeks.

9.2 0 0 G 0 AN SP 3. - THE RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM SHALL BE CONDUCTED AS SPECIFIED IN TABLE 3.12.1-1.

Environmental samples shall be collected and analyzed (as a minimum) according to Table 6 at locations shown in Figures 5 and 6.

Analytical techniques used shall ensure that the detection capabilities in Table 7 are achieved.

A dust loading study (RMC-TR-81-01) was conducted to assure that the proper transmission factor was used in calculating gross beta activity of air particulate samples. This study concluded that the sample collection frequency of once per week was sufficient and that the.use of 1 for the transmission correction factor for gross beta analysis of air.particulate samples is valid.

The charcoal sampler cartridges used in the airborne radioiodine sampling program (Science Applications, Inc., Model CP-100) are designed and tested by the manufacturer to assure a high quality of radioiodine capture. A certificate from the manufacturer is supplied and retained with each batch of cartridges certifying the percent retention of radioiodine versus air flow rate through the cartridge.

42 Rev. 2

The results of the radiological environmental monitoring program are intended to supplement the results of the radiological effluent monitoring by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected on the basis of the effluent measurements and modeling of the environmental exposure pathways. Thus, the specified environmental monitoring program provides measurements of radiation and of radioactive materials in those exposure pathways and for those radionuclides which lead to the. highest potential radiation exposures of individuals resulting from station operation. Program changes may be proposed based on operational experience. Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment, and other legitimate reasons. If specimens are unobtainable due to sampling equipment malfunction, an effort shall be made to complete corrective action prior to the end of the next sampling period. All deviations from the sampling schedule shall be documented in the next Annual Radioactive Effluent and Waste Disposal report. Reporting requirements for the radiological environmental surveillance program are given in Appendix B.

~RR PR M SP C FICAT ON 3. 2. - A LAND-USE CENSUS SHALL BE CONDUCTED AND SHALL IDENTIFY WITHIN A DISTANCE OF 8 KM (5 MILES) THE LOCATION IN EACH OF THE 16 METEOROLOGICAL SECTORS OF THE NEAREST MILK ANIMAL, THE NEAREST RESIDENCE AND THE NEAREST GARDEN* OF GREATER THAN 50 M2 (500 FT2) PRODUCING BROAD LEAF VEGETATION.

Broad leaf vegetation sampling of at least three different kinds of vegetation may be performed at the site boundary in each of two direction sectors with the highest predicted 0/9's in lieu of the garden census. Specifications for broad leaf vegetation sampling in Table 3.12.1-1, item 4C shall be followed, including analysis of control samples.

43 DAT Rev. 2

If a land use census identifies a location(s) with a higher average annual deposition rate (0/Q) than a current indicator location, the following shall apply:

1. If the D/Q is at least 20 percent greater than a previously high D/Q, the new location shall be added to the program within 30 days of documented identification of sampling feasibility. The indicator location having the lowest D/Q may be dropped from the program after October 31 of the year in which the land use census was conducted.

2. If the 0/Q is not 20 percent greater than the previously highest D/Q, direction, distance, and D/Q will be considered in deciding whethe}

to replace one of the existing sample locations. If applicable, replacement shall be within 30 days.

Any evaluations of possible location replacement should include the past history of the location, availability of sample, milk production history, and other applicable environmental conditions.

A land use census will be conducted at least once per calendar year by a door-to-door or aerial survey, by consulting local agricultural authorities, or by any combination of these methods.

9.4 NT R ABO ORY COMPAR SON PROGRAM SPEC F C TION 3. 1 .3 - ANALYSES SHALL BE PERFORMED ON RADIOACTIVE MATERIALS SUPPLIED AS PART OF AN INTERLABORATORY COMPARISON PROGRAM WHICH HAS BEEN APPROVED BY THE COMMISSION.

The laboratories of the licensee and licensee's contractors which perform analyses shall participate in the Environmental Protection Agency's (EPA's) Environmental Radioactivity Laboratory Intercomparisons Studies (Crosscheck) Program or an equivalent program which has been approved by the Commission. This participation shall include some of the determinations (sample medium-radionuclide combination) that are offered by EPA and that are also included in the monitoring program. The results of the analyses of these crosscheck samples shall be iacluded in the annual report.

'A 44 DAT Rev. 2

If the results of analyses performed by the licensee or licensee's contractor in conjunction with the EPA crosscheck program (or equivalent program) are outside the specified control limits, the laboratory shall investigate the cause of. the problem and take steps to correct it. The results of this investigation and corrective action sha11 be included in the Annual Radiological Environmental Operating Report.

Rev. 2

FIGURE 5 ENVIRONMENTAL MONITORING LOCATIONS WITHIN ONE MILE OF THE SSES GOULD ISI AND 2 ~

I G

~~ ~ m m ~

I p ~ ~ ~ ~ ~ ~ ~ csJ I

lSQ IT ]

T t

I N T ~

i/

I I

(y I

TT~

~" Ii gggf I

Tn ~

t mmeJ iF az aa gQS I

/ ae~ l I

I r--"~> I

~

y C

/Q~ fan%

ae wm m m m eP'ITE BQUNNRY S

~SUSQUEIQLNNA 0 RIVER T

~lCC 1NR ~:

DMS~

OAT~ Rev. 2 46

FIGURE 6 ENVIRONMENTAL MONITORING LOCATIONS GREATER THAN ONE MILE FROM THE SSES SUSQ&HIANNA NANTICOKE RIVER I

T GLEN LYON 15F1 SHICKSHINNY,gg 14 MOCANAQUA

~ 4K2 POND HILL

~m1 QT VAPVALLOPEN i2 BERNICE T

~ IRAN Q .un MIFFLIN VILLE NESCOPECK gg To~

K

/r CON YNGHAM HAZLETON 8 qa g} DRQfKNC %ATIR nm DATF 47

Page 1 of 3 TABLE 6 OPERATlOOL RADIOLOG1CAL ENV IRONKENTAL NNlTiIIN6 PROGRAH Exposure Pathways NImker of Santplos Smspllng and Type and and or S le ~alld oc4 t t Igts f Ana irboIne Continual sampler operation >>lth Radioiodine Canister: analyze Radioiodine and 1251 0.4 mi VSV - E.O.F. Building sample collection weekly.*~ weekly for 1-131 12E1 4.7 mi VSV - Scr>>lck Hospital 7G1 14 mi SE - PPSL Hazleton Complex Particulates'ree 1053 0.6 mi SSV - East of Confer's Lane, South of Towers Club 1356 0.4 mi V - Former Laydown Arcs, Vest of Confer's Lane Particulate Samp1e:

Analyze for gross beta radioactivity less than 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months folio>>ing filter change. PerforIa isotopic analysis on composite sample (by location) quarterly.

Radi ion 152 Peristetcr Fence - 0.2 mi N quarterly Gasma Dose: quarterly.

102 Hocanaqua - 4.0 mi N 253 Peristcter Fence - 0.2 mi NNK 283 Durabond Corporation - 1.3 mi NNE 2Fl St. Adalbcrts Cemetery - 5.9 mi NNK 354 Perimeter Fence - 0.3 mi NE 3D1 Pond Hill/Lily Lake Fire Co. - 3.4 mi KE 3Fl Valanla Residence - 9.1 ml NE 3GS Vilkes-Barre-Parrish St. Substation-18 mi Vest of S5ES APF - 0.2 mi NE'S3 ENE 4E1 Rockies HI11 Road Pole tg) 46422/N35197 - 4.8 @ii EKE 461 Crest>>cod industrial Park-14 mi Perimeter Fence - 0.3 mi E ENE'S7 5E2 S1oss Farm - 4.5 mi K 654 Pcrimetcr Fence - 0.2 mi ESE 6A4 Rivcrsidc Restaurant - 0.6 mi ESE Rev. Z

Page 2 of 3 Exposure Pathways Ntsrker of San@les Sampling and ~ Type and and or a~nd acetlons Co lection F 0 6E1 St. James Church - 4.7 mi ESE 659 Perimeter Fence - 0.2 mi ESE 756 Perimeter Fence - 0.2 mi SE 7E1 Harrood Transmission Line Pole l2-4.2 I@i SE 7G1 PPSL Hazleton Complex - 14 ml Perimeter Fence - 0.2 ml SSE SE'52 882 LaMall Residence - 1.4 mi SSE 803 Harry Residence - 4.0 ml SSE 952 Security Fence - 0.2 ml 5 904 Country Folk Store - 3.6 mi 5 1051 Post South of Switching Station - 0.4 mi SSV-1001 Ross Rynan Fare - 3.0 mi.SSM 1153 Security Fence - 0.3 ei SV llE1 Ihomas Residence - 4.7 mi SV 1253 Perimeter fence - 0.4 ml MSM 12E1 Berwick Hospital - 4.7 mi MSV 1ZGl PPLL Bloensbur'9 Service Center - 15 mi Perimeter fence - 0.4 ml V VSV'352 13E4 Kess1er farm - 4.1 mi V 1455 Beach Grove Rd. 6 Confer 's Lane Intersection 0.5 ml VXV 14E1 Canouse fare - 4.1 mi VtN 15F1 Zawatski Fans - 5.4 ml NV 1555 Perimeter Fence - 0.4 mi HV 1651 Perimeter Fence - 0.3 mi RHM 1652 Perimeter Fence - 0.3 mi RIM 16FI Hldlay Residence - 7.8 HlN

~Va erbo r Surface 6SB river water intake line'57 Honthly composl te Gasrsa isotopic.ana1ysis.

cooling tower blowdown discharge line Honthly composl te Composite trestles analysis at 1east quarterly.

Orlnking 12H2 Oanville 'Mater Co. Honthly composite Gross beta and gaama isotopic tApproximate)y 30 mlles downstream) analyses monthly. Composite for tr itias analysis at least quarterly.

Sediment from Shoreline 7B Bell Bend - 1.2 mi SE Semi-annually GasnLs isotopic analysis seal-annually.

DAT Rev. 2

Page 3 of 3 Sampling'nd Exposure Pathways Nmker of Samp)es

~and ocatian ~ Co ection Illlk" 1293 Young Farm - 2.0 ml MSM Semi-month)y when animals are on Gasms Isotopic and 1-131 analysis IOGI Oavls Farm - Il ml. pasture, monthly otherwise of each sea@le.

Ray Roman Farm - 3.5 ml.

SSM'002 SSM 1001 RCC Roman Farm - 3.0 ml. SSM

'ish and Inver tebrates Outfall area Semi-annualiy. One sample'rom Gamna Isotopic on edlb)e portions.

2H Falls, each of two reacreatlonally PA'Approximately 30 ml NNE) Important species from any of the fol)owing families: bullhead catfish, sunfish, pikes, or perches.

Food Products 1101 2ehner Farm - 3.3. ml SM At time of harvest GasnuL isotopic on 4edible portions.

vegetable 12F1 tupinI Farm - 8.3 ml MSM vegetable

'The location of samples and equipment were designed using the guidance in the Branch Technical Position.to NRC Rev. Guide 4.8, Rev. 1, Now. 1919, Reg. Guide 48. 1975 and ORP/SID 12-2 Environ>>ntal Radioactivity Surveillance Guide. Therefore, the airborne san@Ter locations were based upon X/Q and/or 0/Q.

"A dust loading study (RIIC-TR-BI-OI) concluded that the assonptlon of I for the transmission correction factor for gross beta ana)ysls of air partlcu)ate samples Is valid. AIr particulate samples need not be weighed to determine a transmission correction factor.

"Ifa milk sample Is unavailable for more than two sampling periods from one or mare of the locations, a vegetation sample shall be substituted until a suitab)e milk location Is evaluated. Such an occurrence will be docmsented ln the REHP annual report.

Control sample Tocatlon.

b Two-week composite if calcu)ated doses due to consumption of water exceed one mill lrem per year. In these cases, 1-131 analyses wI)1 be performed.

c The samp1e co11ector will determine the species based upon availability, which may vary seasonally and yearly.

TABLE 7 DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYSIS LoWel'imit of Detection (LLD)

Airborne Particulate Water or Gas Fish Milk Food Products Sediment

~Anal sis @Cia Ci m' Ci k wet fgCi~l fpC~ikq, w~nt gy~Ci k d~r gross beta x 10 H-3 2000 Hn-54 15 130 Fe-59 30 260 Co-58 130 Zn-65 30 260 Zr-95 30 1-131 Ib 7 x 10 60 Cs-134 15 5 x 10 130 60 150 Cs-137 18 6x10 150 18 180 Ba-140 60 60 La-140 15 15 Rev. 2

TABLE 7 (Continued) t The LLD is the smallest concentration of radioactive material in a sample that will be detected with 95 percent probability and with 5 percent probability of falsely concluding that a blank observation represents a "real" signal.

For a particular measurement system (which may include radiochemical separation):

Ll.D 4.66 s, 2.22 EVY exp (-A h t) where:

LLD is the "a priori" lower limit of detection as defined above (as pCi per unit mass or volume).

sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate '(as counts per minute)

E is the counting efficiency (as counts per transformation)

V is the sample size (in units of mass or volume) 2.22 is the number of disintegrations per minute per picocurie Y is the fractional radiochemical yield (when applicable) is the radioactive decay constant'for the particular radionuclide, and is the elapsed time between sample collection (or end of the sample collection period) and time of counting.

In calculating the LLD for a radionuclide determined by gama-ray spectrometry, the background should include the contributions of other radio-nuclides normally present in the samples (e.g., potassium-40 milk samples).

Typical values for E, V, Y, and t should be used in the calculations.

It should be recognized that the LLD is defined as an g ~~~r'before the fact) limit representing the capability of system and not as g tf tt f tttt <<t

~

a measurement t t b

LLD for drinking water.

DAT Rev. 2

10.0 S SS NT 10.1 Selection fA a u For determination of compliance with SSES Technical Specification dose limits, effluent totals shall be based only on. activity positively detected at the 95% confidence level.

10.2 ssi nme t o Releases ea r' s

For determination of compliance with SSES radioactive effluent dose limits which are on a "per reactor unit" basis:

a. Effluents from the Unit 1 Reactor Building vent and the Unit 1 Turbine Building vent shall be included as Unit 1 releases.

b. Effluents from the Unit 2 Reactor Building vent and the Unit 2 Turbine Building vent shall be included as Unit 2 releases.

c. Effluents from the Standby Gas Treatment System vent shall be equally divided between Unit 1 and Unit 2 release totals.

d. Waterborne effluents shall be equally divided between Unit 1 and Unit 2 release totals.

10.3 valuatio and Honi or n ri r'a or f P thwa Potential unmonitored effluent pathways will be evaluated on a case-by-case basis. Periodic sampling and/or realistic evaluation will be performed in order to demonstrate the significance of a potential effluent pathway. Results of sampling and/or evaluation may be used to classify a potential unmonitored effluent pathway into one of the following categories:

a. ot an ffl nt Pathw : Realistic evaluation (e.g.,

engineering design, system operation, radionuclide inventory) demonstrates that the pathway has no potential for release of radioactive material (Table 8). Although not required, periodic 53 DAT Rev. 2

sampling may at times be performed to confirm the result of the evaluation.

b. Evaluation and/or periodic sampling demonstrate that the pathway may contain radioactive effluents, however, these effluents may not be reasonably expected to exceed 10 percent of the appropriate unrestricted area ffPC value (fractional HPCs sutmed when appropriate) listed in Table II of Appendix 8 to 10 CFR 20 (Table 9). A release pathway which falls in this category will be sampled periodically.

c. Si 'cant f Pat wa : Evaluation and/or periodic sampling demonstrate that the pathway may contain radioactive efflue'nts, and these effluents may be reasonably expected to exceed 10 percent of the appropriate unrestricted area HPC value (fractional HPCs sumed when appropriate) listed in Table II of Appendix B to 10 CFR 20. A release pathway which falls in this category will be sampled continuously.

Analyses of samples will be performed consistent with techniques used for samples of the same types collected from normal effluent pathways. Any radioactive materials detected in samples collected from either the Insignificant or the Significant Release Pathways will be included in determining compliance with site dose limits.

Additionally, any such occurrences will be reported in the Annual Effluent'nd Waste Disposal Report.

10.4 low from GTS V w n tern

'hen the Standby Gas Treatment is not being used, there remains a small amount of flow from the SGTS vent. This residual flow is exhaust from the battery rooms in the control structure. Because there are no identifiable sources of radioactivity in these rooms, auxiliary particulate and iodine sample and noble gas grab sample at 4-hour intervals are not required from the SGTS vent when the SGTS continuous vent monitor is out of service, ~vied ~t DAT 4 Rev. 2

a. the Standby Gas Treatment System is not being used,

b. there are proper administrative controls in place to ensure that the required sampling will begin within 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months if the treatment system is operated.

10.5 0 CM Set oi ts are U e Effluent monitor alarm/trip setpoints calculated in accordance with the ODCH shall be considered upper limit values. Higher (less conservative) setpoints shall not be used, however lower (more conservative) setpoints may be used as required to maximize the utility of the monitor.

10.6 Defi it'on of " r ate Trea me t"'d stes Technical Specification 3.11.1.3 requires that the appropriate portions of the liquid waste treatment system be operable and be used to reduce radioactivity in liquid wastes prior to their release when projected doses from each reactor unit to unrestricted areas would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31 day period.

o The normal treatment, which is considered appropriate for each subsystem, is as follows:

Filtration is considered appropriate treatment for the Liquid Radwaste Laundry Processing Subsystem, which consists of high conductivity liquid wastes, such as those from equipment washdown and personnel decontamination facilities, or laundry.

The atmospheric demineralizer (a vendor-supplied system which is directed to the Distillate Sample Tank) is considered appropriate for the Liquid Radwaste Chemical Processing Subsystem.

Rev. 2

Demineralization and filtration are considered appropriate treatment for low conductivity/low organic contaminant liquid wastes entering the Liquid Radwaste Processing Subsystem (LRN collection tanks}, except for batches which yield projected doses prior to treatlent of less than or equal to 6.45-04 mrem to the total body and 2.15E-03 mrem to any organ, where filtration alone is appropriate, or o For batches which have no identified gaaea activity above .the Technical'Specification Liquid. Effluent LLD level (Table 4.11.1.1.1-1), release without. treatment is considered appropriate.

BASES The projected dose threshold values used are derived by dividing the site-total maximum projected doses without treatment (0.12 and 0.4 mrem) by 31 days and by 6, the maximum possible number of batches released per day, to yield per-batch dose action levels. The two levels of "appropriate" treatment are in place so as not to require application of demineralization for treating low activity, high conductivity water (e.g;, from Circulating or Service Mater leakage). This would increase the overall efficiency of the solid radwaste program while ensurin9 calculated doses remain at a suitable fraction of 10 CFR 50 design objectives and Technical'Specification 3.11.1.2 limit.~"~ ~

(1) Reference Calculation No. OT-RKB-92-001: Calculation of Liquid Isotope Offsite Dose Consequences for Use of Atmospheric Demineralizer System, PLI-70360; 2/4/92.

'Reference Lette~ R. K. Barclay to R. A. Breslin: Atmospheric Demineralizer Effluent Results, PLI-70612, 3/4/92.

DAT 'ev. 2 56

10.7 onitor i e o s o r ct'n order to correct for airborne effluent monitor sample line loss, the following correction factors shall be applied to monitor data and sample analysis results:

OUTIN FF U Reactor Building Unit 1 3.2 Reactor Building Unit 2 1.5 3.2 Turbine Building Unit 1 1.6 3.6 Standby Gas Treatment 1.5 3.9

'urbine Building Unit 2 1.6 3.6 QN CTO S POST ACCIOENT VENT NON T S TCU S Turbine Building Unit 1 1.7 4.2 Standby Gas Treatment 1.6 Turbine Building Unit 2 1.7 4.3 Each indicated iodine and particulates concentration shall be multiplied by the appropriate correction factor to estimate the actual concentration at the inlet to the sample line.

10.8 Selection of Oata for a on o ose Rate Com liance Airborne effluent monitor setpoints are maintained in accordance with Section 2.2 to alarm before the dose'rate limits of Specification 3.11.2.1 are exceeded. Station alarm response procedures contain instructions for investigation and verification of monitor alarms. Because setpoint calculations must include assumptions about the composition of the monitored effluent, a monitor high alarm does not necessarily indicate that a dose rate limit has been exceeded.

57 Rev. 2

Valid ten-minute averaged data should be the primary information used to determine 'the compliance status of an incident. One-minute aver aged data should also be reviewed if available, but they may or may not provide additional information depending on the magnitude of the release due to the manner in which the monitors update values to be stored and associated statistical considerations. Averages over a longer period should be'used only when data with higher resolution is not aVailable. Grab sample analyses should be performed whenever possible .to confirm or disprove monitor data, and to provide indication of the nuclide-specific composition of the effluent. When grab sample data are available which, based on vent monitor data, are indicative of the period of elevated release, dose rate calculations should be performed using the actual effluent'ix. The determination of compliance status should not be based on monitor data alone when it is possible to collect and analyze a vent sample which will be representative of the period of elevated release.

10.9 ow-Level Radioactivit in the Sewa e eat e t P a t Like all sewage processing facilities, the SSES sewage treatment plant can under certain conditions receive low levels of radioactive materials. The most notable scenario is when individuals who work on-site have been subjected to the medical administration of radiopharmaceuticals for diagnostic or therapeutic purposes. In these cases, normal'biological elimination processes can easily result in levels of radioactivity in sewage treatment plant solutions and suspensions which are within the detection capabilities of the associated sampling and analysis program.

Because disposal of sewage treatment plant sludge by controlled dispersal on specified tracts of land is a common practice, the following guidelines have been established:

a. All sludge collected in the sludge holding tank should be ~:

sampled and analyzed prior to land disposal to quantify any 58 Rev. 2 DAT

radioactivity present above natural background levels.

b. Sludge containing nuclides with short half-lives, for example iodine-131, should be contained on-site to permit decay to less than detectable levels. .

c. When sludge is contaminated with nuclides .which have half-lives sufficiently long to make hold-up for decay impractical, the following options should be coniidered:

1. Dispose of the sludge as low level radioactive waste.

2. Obtain a special permit pursuant to the requirements of 10 CFR 20.302.

d. The sewage treatment plant effluent should be sampled monthly for radioactivity. This can be accomplished by drawing a sample from the chlorine contact chamber.

59 DAT Rev. 2

'I

11. 0 ODCH R V W AND R SION CONTRO The Supervisor-Environmental Services-Nuclear shall ensure that a total review of the ODCH is performed during each even-numbered year..

Comments shall be documented and revisions initiated as appropriate.

,Each ODCH page shall be numbered and provided with an approval and date box. The ODCH Table of Contents shall present the current revision date for each page so that any manual holder can check manual completeness based on a current Table of Contents.

All ODCH revisions shall be reviewe'd by PORC before approval by the Manager-Nucle'ar Technology. PORC review shall be indicated by PORC chairperson or designee signature on ODCH cover.

ODCM copies shall be issued in a controlled fashion by the staff of the Nuclear Department Library. The distribution list shall be maintained by the Nuclear Department Library Staff.

Any comments on ODCM contents or proposed revisions should be directed to the Supervisor-Environmental Services-Nuclear.

60 Rev. 2 OAT

,P TABLE 8 SYSTEMS CLASSIFIED AS NOT AN EFFLUENT PATHWAY (Page 1 of 2)

SYSTBl DESCRIPTION REFERENCE Domestic Water River Mater Hakeu Intake Com ressed Air Screens and Screenwash Fire Protection Water Fire Protection CO Fire Protection. Halon Turbine Buildin Closed Coolin Water Buildin Drains: NON RAD Water Pretreatment Condensate and Refuel Water Transfer Low Pressure Air Condensate Demins Lube Oil Transfer Purification Coolin Tower Acid Chlorination Circulatin Water Condenser Tube Cleanin Feedwater Extraction Steam Feedwater Heaters Residual Heat Removal Reactor Core Isolation Coolin Core S ra Hi h Pressure Coolant Injection Standb Li uid Control Control Rod Drives (I) PPBL Calculation EC-ENVR-1008 61 DAT A Rev. 2

TABLE 8 SYSTEHS CLASSIFIED AS NOT .AN EFFLUENT PATHWAY (Page 2 of 2)

SYSTBI DESCRIPTION REFERENCE Su ression Pool Primar Containment Vacuum Breakers Su ression Pool Cleanu Reactor Water Cleanu Reactor Pressure Vessel Reactor Recirculation System Radwaste Chilled Water Solid Radwaste Cement Silo LRW Collection Tb and Cond. Outer Area Sum s LRW Processin Radwaste Eva orator Gaseous Radwaste Recombiner Closed Coolin Water Nitro en Stora e Hydro en Stora e Sam lin Stations Post Accident Sam lin S stem By ass Steam Hain Steam Isolation Valves/

Nuclear Steam Su ly S stem Shutoff Automatic De ressurization System HSIV Leaka e Control Hoisture Se arators Turbine Steam, Seals Electrohydraulic Control Stator Coolin Hain Generator Storm Drains (I) PP8L Calculation EC-ENVR-1008 DAI'ev. 2 62

0 TABLE 9 SYSTENS CLASSIFIED AS INSIGNIFICANT EFFLUENT PATHWAY SYSTEN DESCRIPTION REFERENCE H Seal Oil Condensate Stora e Tank Hain Turbine/RFPT Lube Oil Instrument Air Service Air Tem orary Laundry Facilit Second Sort (DAW Volume Reduction Facilit Low Level Radwaste Handlin Facility (1) PP8L Calculation EC-ENVR-1008 (2) Safety Evaluation NL-90-029: Temporary Laundry Facility (3) Safety Evaluation NL-89-002: Dry Active Waste Volume Reduction System (4) Safety Evaluation NL-92-007: Operation of LLRWHF at SSES 63 DAT Rev. 2

. APPENDIX A SAMPLE CALCULATIONS OF ODCM PA A. I ~SPOINTS A.l. I waterborne Effluent Monitors A. l. 1.1 Li uid Radwaste Oischar e Line Monitor For an unidentified mixture with an assumed MPC of IE-7 uCi/ml, an actual activity concentration of If-5 uCi/ml, and a blowdown flow setpoint of 5000 gpm, the high radiation setpoint concentration, c, can be determined from c x(A). If x 3, then the actual high radiation setpoint concentration is:

c 3 (A) 3 (IE-5) c 3E-5 uCi/ml The Alert radiation setpoint is 0.8 times the high radiation setpoint, or 1.6 times the actual activity concentration. The setpoint value for the liquid effluent monitors is then determined by Equation 3 in the ODCM. For the above release conditions, the setpoint value, assuming a typical calibration factor of 1.3 x 10 uCi/ml per cpm, would be:

Setpoint cpm- + Background (cpm)

Cal. Factor B k "B 1.3 x 10 Setpoint cpm - 2.3E3 + Background The LRM discharge Row setpoint is then determined as fo11ows:

A-1

F+f Y(A) f MPC F

where Y is made equal to 10.

5000+

~

f f 10 (1E-5) 1E-7 f~ 5 gpm For an identified mixture 'with an actual HPC of 7.22E-7 uCi/ml and the same activity concentration, blowdown flow and X and Y values as above, the LRW discharge monitor setpoint value and LRW discharge flow setpoint become:

High radiation setpoint concentration (c) 3E-5 uCi/ml High radiation setpoint value 2.3E3 cpm + Background LRW discharge flow setpoint (f) 36 gpm A.l. 1.2 Service Water Monitor Background 300 cps Calibration .Factor 1.5E-8 uCi/ml per cps Activity concentration - 2E-5 uCi/ml (2E-5)/Cal. Factor 1333 cps Because 300 cps is less than 1333 cps:

HI RAD Setpoint 0.5 Background + (2E-5)/Cal. Factor

- 0.5 (300 cps) + (2E-5)/(1.5E-8)

- 150 cps + 1333 cps 1483 cps DOWNSCALE Setpoint - 0.5 Background (0.5)(300 cps) 150 cps 14 0 Calibration Factor 1.5E-B uCi/ml per cps (2E-5)/Cal. Factor 1333 cps Because 1400 cps is greater than 1333 cps:

HI RAD Setpoint Background + (0;5)(2E-5)/Cal. Factor 1400 cps + (IE-5)/(1.5E-B) 2067 cps A-2

OOMNSCALE Setpoint = Background - 0.5 (ZE-5)/Cal.

Factor

= 1400 cps - 0.5 (ZE-5)/1.5E-8)

= 1400 cps - 667 cps -"'33 cps A. 1. 1.3 RHR Service Mater Monitor

~61 0 6: 0 ill 6 .

= l60*

, Calibration Factor 3.9E-9 uCi/ml per cpm (2E-5)/Cal. Factor ~ 5128 cpm Because 160 cpm is less than 5128 cpm:

HI RAO Setpoint = 0.5 Background + (2E-5)/Cal. Factor

= Q.5 (16Q cpm) + (ZE-5)/(3.9E-9)

= 80 cpm + 5128 cpm ~ 5208 cpm LOW RAO Setpoint = 0.5 Background

= 0.5 (160 cpm) = 80 cpm ALERT Setpoint = 0.8 HI RAD Setpoint ~ 4166 cpm 0000 Calibration Factor = 3.9E-9 uCi/ml

-per cpm (ZE-5)/Cal. Factor ~'128 cpm Because 6000 cpm is greater than 5128 cpm:

HI RAD Setpoint Background + (0.5)(2E-5)/Cal. Factor 6000 cpm + ( lE-5)/(3.9E-9)

- 6000 cpm + 2564 cpm 8564 cpm LOM RAG Setpoint Background - 0.5 (2E-5)/Cal. Factor

~ 6000 cpm - 0.5 (ZE-5)/(3.9E-'9) 6000 cpm - 2564 cpm = 3436 cpm ALERT Setpoint - 0.8 HI RAD Setpoint 6851 cpm Gaseous Effluent Honitors A.1.2.1 Noble Gas Honitor To determine the release rate limit for noble gases, an isotopic mixture representative of plant effluents is selected. For example, the following mixture from A-3 DEC g j 1989

0 Argon-41 25 Ci/yr per reactor Krypton-83m 4 Krypton-85m 1,700 Krypton-85 270 Krypton-87 . 32 Krypton-88 660 Xenon-131m 71 Xenon-133m . 14 Xenon-133 12,500 Xenon-135m 220 Xenon-135 590

~Xe on- 38 Total

~0 16,376 Ci/yr per reactor The above annual release quantities are entered into GASPAR with the following annual average dispersion estimates (

Reference:

1982 SSES Meteorology Report):

Relative Concentration 4.1E-5 sec/m 3 Decayed Relative Concentration 4.1E-5 sec/m Decayed Depleted Relative Concentration 3.8E-5 sec/m 3 Deposition Rate 4.2E-B m This set of annual average meteorological parameters is the most conservative over the period 1973-1982.

The total body dose via the plume pathway which results is 18.3 mrem. Equation 5 of the ODCM is then used to calculate the limiting release rate from each of the five plant release points:

Limiting Release Rate 32 752 Ci 500 mrem r 8.95E4 Ci/yr per vent (36.6 mrem) (5 vents)

A-4 DAT

This limiting release rate is then converted to limiting.(setpoint) concentrations using Equation 6 of the ODCN and high limit vent flow rates.

Sample High Limit Vent Flow Rates:

Unit 1 Reactor Building Vent 4.77E9 cc/min Unit 2 Reactor Bu)lding Vent 4.77E9 cc/min Standby Gas Treatment System Vent 5.05E8 cc/min Unit 1 Turbine Building Vent 8.64E9 cc/min Unit 2 Turbine Building Vent 6.52E9 cc/min Limiting Vent Concentration 8.95 4 Ci r vent 1E6 uCi Ci 3.57E-5 uCi/cc (5.26E5 min/yr) (4.77E9 cc/min) for Reactor Buildings 182 Substituting the other vent flow rates into Equation 6 as above, the following noble gas high radiation set-point concentrations are calculated for the remaining vents:

Standby Gas Treatment System 3.37E-4 uCi/cc Unit 1 Turbine Building 1.97E-5 uCi/cc Unit 2 Turbine Building 2.61E-5 uCi/cc A.1.2.2 1odine -131 Monitor When the FES expected annual release quantity for I-131 (2.40E-l curies) is entered into GASPAR with the dispersion estimates of A. 1.2.1, the maximum calculated organ dose via the inhalation pathway is 4.88 mrem to the child thyroid. Using Equation 5 of the ODCN, the limiting 1-131 release rate is calcu-lated as follows:

A-5

Limiting Release Rate

. 24 Ci 1500 mrem r 1.48El Ci/yr/ven (4.88 mrem) (5 vents)

Using Equation 6 of the ODCM, the limiting (setpoint) 1-131 concentrations can be calculated for each of the five plant vents.

Limiting Vent Concentration 14.8 Ci r vent 1 6 uC Ci 5.90E-9 uCi/cc for.

(5.26E5 min/yr) (4.77E9 cc/min) Reactor Buildings 152 Substituting the other vent flow rates into Equation 6 of the ODCH above, the high ra'diation setpoints for the remaining plant vents are calculated to be the following:

Standby Gas Treatment System 5.57E-8 uCi/cc Unit 1 Turbine Building 3.26E-9 uCi/cc Unit 2 Turbine Building 4.32E-9 uCi/cc A. 1.2.3 Particulate Monitor Following are the SSES Final Environmental Statement (FES) expected annual release quantities for particu-late radionuclides:

A-6

Cr-51 1.2E-4 Ci/yr per reactor Hn-54 3.6E-4 Fe-59 1. 6E-4 Co-58 5.8E-5 Co-60 1.1E-3 Zn-65 5.5E-5 Sr-89 1.8E-S Sr-90 3.1E-6 Zr-95 8.7E-6 Sb-124 5.1E-6 Cs-134 1.3E-4 Cs-136 1.3E-3 Cs-137 2.1E-4 Ba-140 4.2E-5 Ce-141 ~2.9 -5 Total 3.6E-3 Ci/yr per reactor When the above annual release quantities are entered into GASPAR with the annual average dispersion esti-mates of A. 1.2.1, the maximum calculated organ dose via the inhalation pathway is 1.33E-2 mrem to the teen lung. Using Equation 5 of the OOCH, the limiting release rate of particulates can be calculated:

Limiting Release Rate 7.2E-3 Ci 500 mrem r (2.66'-Z mrem) (5 vents)

Using Equation 6 of the OOCM, the limiting (setpoint) particulate concentrations can be calculated for each of the five plant vents.

Limiting Vent Concentration 8.12El Ci r vent 1 6 uCi Ci 3.24E-8 uCi/cc for (5.26ES min/yr) (4.77E9 cc/min) Reactor Buildings 152 A-7

When the vent flow rates for the.remaini'ng five plant vents are substituted into Equation '6 as above, the following high radiation setpoint concentrations result.

Standby Gas Treatment System 3.06E-.7 uCi/cc Unit 1 Turbine Building 1.79E-8 uCi/cc Unit 2 Turbine Building . '.37E-8 uCi/cc A.2 AIRBORNE EFFLUENT DOSE RATE CALCULATIONS A.2.1 Noble Gases To evaluate the annual whole-body or skin dose from noble gas release rates, the highest calculated annual average relative concentration for any sector is selected from Table 3. For the SSES site, the critical downwind sector is the West sector with an annual dispersion factor of 2.6 x 10 sec/m . The expected release rate of the principal noble gas radionuclide, xenon-133, is 396 uCi/sec. To calculate the annual whole-body dose due to the release of any noble gas in the gaseous effluent, Equation 7 in the ODCN should be used. The whole-body dose factor (K.)

1 from Table 2 for xenon-133 is 2.94 x 10 mrem/yr per uCi/m 3 . Substituting these values in Equation 7, the whole-body dose contribution from xenon-133 releases from the SSES would be 3.0 mrem/yr:

Dwb (K.)(X/9) (g') (Equation 7) 2 Deb (2.94 x 10 ~mrem r) (2.6 x 10 sec) 3 uCi/m X (396 uCi/sec) 3.0 mrem/year To calculate the annual skin dose due to release of any noble gas in the gaseous effluent, Equation 8 in A-8

the OOCH should be used- The skin dose factor (Li) from Table 2 for xenon-133 is 3.06 x 10 2 mrem/yr per uCi/m . The air dose factor (Mi) from Table 2 for xenon-133 is 3.53 x 1Q mrad/yp per uCi/m .

Substituting these values and the previous values for release rate and annual dispersion factor in Equation 8, the skin dose contribution from xenon-133 from the SSES would be 7.1 mrem/yr:

D (Li + 1.1 M ) (X/Q)(Q'.) (Equation 8) 0 (3.06 l02 ~mr em r'

uCi/m

+ 1.1 (3.53 x 102 tt'ra ~r))

3 (2.6 x 10 )

uCi/m. m x (396 uCi/sec} 7.1 mrem/year

A.2.2 Rad onuc de Other Tha Nob e Gas To evaluate the annual critical organ dose from radionuclides other than noble gases, th'e highest annual average dispersion parameter for estimating the dose to the critical receptor is selected from Table 3. The highest annual dispersion factor is

-5 3 sec/m in the Mest sector. The expected

~

2.6 x 10 release rate of iodine-131 is 3e8 x 10 uCi/sec. The expected release rate of cesium-137 is 6.66 x 10 uCi/sec.

To calculate the annual critical organ dose due to the release of radionuclides other than noble gases in the gaseous effluent, Equation 9 in the ODCM should be used. The inhalation pathway parameter (R ) from Table 4 for iodine-131 is 1.62 x 10 mrem/yr per 3

uCi/m . Substituting these values in Equation 9, the maximum thyroid dose contribution from iodine-131 would be 1.6 mrem/yr from the inhalation pathway.

o, - (R;) (Mv) (0';v) (Equation 9) 0 (1.62 x 10 m~rem r) (2.6 x 10 sec)

~ 3 uCi/m m X (3.8 x 10 uCi/sec) 1.6 mrem/year INHALATION PATHl)tAY, I-131 A-10 DAT

0 0

0

A.3 ~tt L 0 A.3.1 Waterborne ff uents The liquid effluent dose calculations are performed using the Liquid Annual Dose To All. Persons (LADTAP. II) computer program.

This program may be used to calculate the quarterly (or. any other time period) doses to the maximum individual. The computer code LADTAP II, which was developed by the NRC to perform dose calculations in accordance with Regulatory Guide 1.109, is used.

The User's Manual for the LADTAP II program contains details of.

the calculational procedures. The total number of curies released for each radionuclide during the time period being evaluated must be supplied from the SSES radiation monitoring program.

A.3.2 Airborne Effluents The airborne effluent dose calculations are performed using the GASPAR computer program. This program may be used to calculate the maximum individual and population doses due to radionuclides released in gaseous effluents from the SSES. The code implements the semi-infinite cloud model and the dose calculational models of Regulatory Guide 1.109 and is used to calculate all maximum individual and population doses and maximum individual organ doses from the SSES. A more detailed description of the GASPAR code can be found in the GASPAR dose code manuals dated October 17, 1975, and February 20, )976. The total number of curies released for each radionuclide during the time period being evaluated must be supplied from the SSES radiation monitoring program. The meteorological parameters must be provided from the SSES meteorology program.

rl 0

To evaluate the air dose from noble gas release rates, the highest calculated annual average relative concentration for any sector is selected from Table 3. This critical downwind sector is .5the West sector with an annual dispersion factor of .2.6 x 10 sec/m . The expected release rate of the principal noble gas radionuclide, xenon-133, is 396 uCi/sec. The total release in a calendar quarter would be 7.9 x 10 6 seconds times 9

396 uCi/sec or 3.13 x 10 uCi. To calculate the quarterly gamma air dose due to the Xenon-133 release in the gaseous effluent, Equation 12 in /he GDCH should be used. The gamma air dose factor (H.) from Table 2for xenon-133 is 3.53 x 10 2 mrad/yr per uCi/m . Substituting these values in Equation 12, the quarterly gamma air dose contribution from xenon-133 releases from the SSES would be 0.9 mrad:

0 = 3.17 x 10 gr H,. (X/g)9i- (Equation 14) sec 0 - (3.17 x 10 ~r)(3.53 x 10 prad~r)(2.6 x 10 sec) 3 sec uCi/m m X (3.13 x 10 uCi/qtr)

= .9 mrad/quarter To calculate the quarterly beta air dose due to the xenon-133 release in the gaseous effluent, Equation 13 in the ODCH should be used. The beta air dose factor (N,.) from Table 2 for xenon-3 133 is 1.05 x 10 mrad/yr per uCi/m . Substituting these values 3'n Equation 13, the quarterly beta air dose contribution from xenon-133 releases from the SSFS would be 2.7 mrad:

Db 3.17 x 10 Zr N. (X/g) (l'Equation 15)

Db - (3.17 x 10 Zr )(1.05 x 10'ec

~mrad r)(2.6 s )0 sec) 3 uCi/m m X (3.13 x 10 uCi/qtr) 2.7 mrad/quarter

Since the beta air dose is greater than the gamma air dose by a factor of 3 for xenon-'33 and the dose limits are only a factor of 2 greater for beta than gamma radiation, the beta air dose would be controlling for xenon-133 releases.

A.E ~TA AL 4 The total cumulative annual dose to any member of. the public from .

operations at the SSES should be determined 'by summing the critical organ doses to real individuals from all three sources of radiation. Only the maximum dose or dose commitment to a real individual needs to be evaluated.

A.4.1 Li uid Effluents The cumulative dose to any member of the public due to liquid effluents from the SSES should be determined from the LADTAP II program used for evaluating the individual doses as stated in Section A.3. 1 of this Appendix.

A.4.2 Gaseous Effluents The cumulative dose to any member of the public due to gaseous effluents from the SSES should be determined from the GASPAR program used for evaluating the individual doses as stated in Section A.3.2 of this Appendix.

A.4.3 Direct Radiation The direct radiation to any member of the public due to operations at the SSES should be determined from the environmental monitoring program results.

A-13

APPENDIX B REPORTING RE UIREMEHTS B. 1 ANNUAL ENVIRONMENTAL OPERATING REPORT, PART B, RADIOLOGICAL A repor t on the radiological environmental surveillance program for the previous calendar year shall be submitted to the Director of the HRC Regional Office (with a copy to the Director, Office of Nuclear Reactor Regulation) as a separate document by Hay of each year. The period of the first report shall begin with the date of initial criticality. The .

repor ts shall include a suaeary (format of Table 8-1.), interpretations, and an analysis of tr ends from the results of the radiological environmental surveillance activities for the. report period, including a comparison with operational controls, preoperational, studies (as" appropriate), and previous environmental surveillance reports and an-assessment of the-observed impacts of. the station operation on the-environment.

lm the event that some results are not available, the report shall be submitted noting and explaining the reasons for the missing results; The missing data shall be submitted as soon as possible in a supplementary report.

B.2 .NONROUTINE RAOIOI OGICAL ENVIRONMENTAL OPERAT NG REPORTS When the level of radioact'ivity in an. environmental sampling medium averaged over 'any quarterly sampling period exceeds the reporting level given in Table B-2, a written report shall be submitted to the Director of the NRC Regional Office (with a copy to the Director, Office of Nuclear Reactor Regulation) within 30 days. If it can be demonstrated that the level is not a result of station effluents (i.e., by comparison with control station or preoperational data) a report need not be submitted, but an explanation shall be given in the Annual Radiological Environmental Operating Report.

When more than one I

of the radionuclides in Table B-2 are detected in the medium, the reporting level will have been exceeded if:

concentration I + concentration 2 + ... 1 reporting level (1) reporting level (2)

If radionuclides other than those in Table B-2 are detected and are due from station effluents, a reporting level is exceeded if the potential annual dose to an individual is equal to or greater than the design objective doses of 10 CFR Part 50, Appendix I. This report shall include an evaluation of any release conditions, environmental factor, or other aspects necessary to explain the anomalous result.

7" ai a'v ..~ .$2 B-2 L(/,

TABLE B-I SAMPLE ENVIRONMENTAL RADIOLOGICAL HOHITORIHG PROGRAH ANNUAL

SUMMARY

Reporting Period: 1/1/79 - 12/31/79 All Indicator Location with Highest Hedium or Type and l.ower Limit Locations Annual Hean Control Locations Number of Pathway Sampled Total Humber of Name, Honroutine (Uni t of of Analyses Detection Hean Distance 8 Hean Reported Heasurement Performed Direction Ran e Mean Ran e Heasurements Air Particulates

( 10 pCi/m ) Gross Beta 336 26.6(234/234) 102 29.9(52/52) 28.2(102/102)

(7.7-71) 3.7 mi H (11-71) (9.8-64)

CO I

4J Gaaea 28 Be-7 81(20/20) 3D1 82(4/4) 85(8/8)

(37-130) 3.2 mi HE (54-130) (51-140)

Cs-137 0.6 1.6(4/20) 1D2 5.7(2/4) 2.7(1/8) 0 (1.1-1.8) 3.7 mi HE (2.3-9.0) (2.7) 0 Air Iodine 1-131 160 1.5 - (0/109) H/A H/A -(0/51)

(10 pCi/m )

o e; e examp e a a are provided for illustrative purposes only.

~ 1 J98g

t TABLE B-2 REPORTlNG LEVELS FOR NOHRouTIHE OPERATING REPORTS Broad Leaf Mater Airborne Particulate Fish Nil k Vegetation

~Anal sls QCi~l of Gases Ci k , wet Q)~Ci (~l Ci/k wet 2 x 104(')

Mn-54 1 x 10 Ci/m'.9 3 x 10 Fe-59 4 x 10 1x10 3 4 Co-58 1x10 3 x 10 Co-60 3 x 10 1x10 4 4

2n-65 3 x 10 2 x 10 Zr-Hb-95 4 102( )

1-131 2 3 1x10 Cs-134 30 10 1x10 60 1x10 3

Gs-137 50 20 2 x 10 70 2 x 10 Ba-La-140 2 x 102(b) 3 x 102(b) a a value.

For drinking water samples. This is 40 CFR Part 141 Total for parent and daughter.

APPENDIX C SITE SPECIFIC INFORMATION USED BY'ASPAR CODE

1) The distance from the facility to the NE corner of the U.S. (Maine} in miles 590 miles.

2) Fraction of year leafy vegetables are grown 0'.33

3) Fraction of year cows are oh 'pasture Oe60 (April-Nov.)

4) Fraction of crop from garden 0.76 5} Fraction of daily intake of cows derived from pasture while on pasture.

0. 42 6} Absolute humidity over growing season ~9.0 /m-Relative humidity is 67.6% if T is supplied.

7) Average temperature over growing season 60.2'F 8} Fraction of year goats are on pasture 0.60 g) Fraction of daily intake of goat from past.ure while on pasture 0.75

10) Fraction of year beef cattle are on pasture 0.60 11} Fraction of daily intake of beef cattle derived from pasture while on.

pasture O.55

APPENDIX D SITE SPECIFIC INFORNATION USED B LAD AP I CODE

1) Total discharge per unit: 11 cubic feet per second, or specific to release period.

2) 'Total Annual Blowdown Volume: 6.94ES cubic feet

3) Dose to Maximum Hypothetical Individual Shorewidth Factor: 0.2 Sediment exposure time: 131,400 hr.

USAGE FACTORS PATHWAY INFANT CHILD TEEN ADULT Fish k r 6.9 16 21 Potable Water 330 510 510 730 liter yr Shoreline 14 67 12 hr yr DILUTION FACTORS (DF)

PATHWAY LOCATION DF Fish Outfall 15.9 Potable Water Danville 321*

Shoreline Outfall 15.9

For estimating purposes. Actual dilution factors at Danville, Pa., for various river levels located in Table 5-4.

TRANSIT TINES (Tp)

PATHWAY LOCATION T hr Fish Outfall 25**

Potable Water Danville 25.8*

Shoreline Outfall

For estimating purposes. Actual river transit times at Danville, Pa., for various river levels located in Table 5-4.

- Includes one hour transit from outfall plus 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months to consumption.

D-1 A

DAT i> O'ev. 1

k 0:

ML17164A589

Text

1.0 INTRODUCTION

Reference:

SUMMARY

Navigation menu

Search